Acronyms of Clinical Trial Names: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(New page: {{SI}} {{CMG}} {{EJ}} {| cellspacing="1" cellpadding="1" border="1" | '''''Acronym''''' | '''''Trial Name''''' |- | 3CPO | Effect Of Continuous Positive Airway Pressure And Noninvasive P...)
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
(34 intermediate revisions by 7 users not shown)
Line 2: Line 2:
{{CMG}}
{{CMG}}


{{EJ}}


{| cellspacing="1" cellpadding="1" border="1"
 
''For other acronyms involved in clinical trials, click [[Clinical trial acronyms|here]]''
<br>
 
''For detailed instructions on how to contribute to WikiDoc's Clinical Trials Wiki, click [[Help:How to add a trial to the clinical trials wiki|here]]
<br>
 
 
{| id="acronyms" cellspacing="1" cellpadding="1" border="1"
| '''''Acronym'''''
| '''''Acronym'''''
| '''''Trial Name'''''
| '''''Trial Name'''''
|-
|-
| 3CPO
| [[3CPO]]
| Effect Of Continuous Positive Airway Pressure And Noninvasive Positive Pressure Ventilation In Acute Cardiogenic Pulmonary Oedema
| [[Effect Of Continuous Positive Airway Pressure And Noninvasive Positive Pressure Ventilation In Acute Cardiogenic Pulmonary Oedema]]
|-
| [[3T/2R]]
| [[Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel]]
|-
| [[4D]]
| [[Deutsche Diabetes Dialysis Study]]
|-
| [[4E]]
| [[Efficacy And Safety Of Eplerenone, Enalapril, And Eplerenone/Enalapril Combination Therapy In Patients With Left Ventricular Hypertrophy]]
|-
| [[4S]]
| [[Scandinavian Simvastatin Survival Study]]
|-
| [[6C trial]]
| [[Cooperative Colorectal Cancer Combination Chemotherapy Clinical]]
|-
| [[A to Z, Phase A]]
| [[Aggrastat To Zocor]]
|-
| [[A to Z, Phase Z]]
| [[Evaluation Of Early Versus Delayed Initiation Of Simvastatin In Patients Who Receive Guideline Based Treatment For Acute Coronary Syndrome]]
|-
| [[A4 Study]]
| [[Catheter Ablation Versus Antiarrhythmic Drugs For Atrial Fibrillation]]
|-
| [[AAASPS]]
| [[African American Antiplatelet Stroke Prevention Study]]
|-
| [[AACHEN]]
| [[Angiotensin II Receptor Blocker Candesartan Cilexetil On Intimal Hyperplasia After Coronary Stent Implantation]]
|-
| [[AASK]]
| [[African American Study Of Kidney Disease And Hypertension]]
|-
| [[ABACAS]]
| [[Adjunctive Balloon Angioplasty Following Coronary Atherectomy Study]]
|-
| [[ABC study]]
| [[Association Of Black Cardiologists Study Of Hypertension]]
|-
| [[ABCD]]
| [[Alternans Before Cardioverter Defibrillator]]
|-
| [[AbESTT]]
| [[Abciximab Emergent Stroke Treatment Trial]]
|-
| [[ABOARD]]
| [[Immediate Versus Next Day Catheterization In Non-St Elevation Acute Coronary Syndrome]]
|-
| [[ABSORB: 6-month and 2-year results]]
| [[A Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions]]
|-
| [[ACADEMIC]]
| [[Azithromycin In Coronary Artery Disease: Elimination Of Myocardial Infection With Chlamydia]]
|-
| [[ACAS]]
| [[Asymptomatic Carotid Atherosclerosis Study]]
|-
| [[ACC AMI GAP]]
| [[American College Of Cardiology Acute Myocardial Infarction Guidelines Applied To Practice Study]]
|-
|-
| 3T/2R
| [[ACCENT]]
| Tailoring Treatment With Tirofiban In Patients Showing Resistance To Aspirin And/Or Resistance To Clopidogrel
| [[A Crohn's Disease Clinical Trial Evaluating Infliximab In A New Long-Term Treatment Regimen]]
|-
|-
| 4D
| [[ACCEPT]]
| Deutsche Diabetes Dialysis Study
| [[The Accupril Canadian Clinical Evaluation And Patient Teaching Study]]
|-
|-
| 4E
| [[ACCESS]]
| Efficacy And Safety Of Eplerenone, Enalapril, And Eplerenone/Enalapril Combination Therapy In Patients With Left Ventricular Hypertrophy
| [[Acute Candesartan Cilexetil Evaluation In Stroke Survivors]]
|-
|-
| 4S
| [[ACCLAIM]]
| Scandinavian Simvastatin Survival Study;
| [[Advanced Chronic Heart Failure Clinical Assessment Of Immune Modulation Therapy]]
|-
|-
| 6C trial
| [[ACCOMPLISH]]
| Cooperative Colorectal Cancer Combination Chemotherapy Clinical;
| [[Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension]]
|-
|-
| A to Z, Phase A
| [[ACCORD]]
| Aggrastat To Zocor
| [[Action To Control Cardiovascular Risk In Diabetes]]
|-
|-
| A to Z, Phase Z
| [[ACCT]]
| Evaluation Of Early Versus Delayed Initiation Of Simvastatin In Patients Who Receive Guideline Based Treatment For Acute Coronary Syndrome
| [[Sex And Age Related Antihypertensive Effects Of Amlodipine]]
|-
|-
| A4 Study
| [[ACCURACY]]
| Catheter Ablation Versus Antiarrhythmic Drugs For Atrial Fibrillation
| [[Assessment By Coronary Computed Tomographic Angiography Of Individuals Undergoing Invasive Coronary Angiography]]
|-
|-
| AAASPS
| [[ACE]]
| African American Antiplatelet Stroke Prevention Study
| [[Abciximab-Carbostent Evaluation]]
|-
|-
| AACHEN
| [[ACE]]
| Angiotensin Ii Receptor Blocker Candesartan Cilexetil On Intimal Hyperplasia After Coronary Stent Implantation
| [[Anticoagulation For Cardioversion Using Enoxaparin]]
|-
|-
| AASK
| [[ACE (Carotid Endarterectomy)]]
| African American Study Of Kidney Disease And Hypertension
| [[Asa And Carotid Endarterectomy Trial]]
|-
|-
| ABACAS
| [[ACES]]
| Adjunctive Balloon Angioplasty Following Coronary Atherectomy Study
| [[Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease]]
|-
|-
| ABC study
| [[ACES]]
| Association Of Black Cardiologists Study Of Hypertension;
| [[Clinical Experience Study]]
|-
|-
| ABCD
| [[ACIP]]
| Alternans Before Cardioverter Defibrillator
| [[Asymptomatic Cardiac Ischemia Pilot Study]]
|-
|-
| AbESTT
| [[ACME]]
| Abciximab Emergent Stroke Treatment Trial
| [[Angioplasty Compared To Medicine]]
|-
|-
| ABOARD
| [[ACME-2]]
| Immediate Versus Next Day Catheterization In Non-St Elevation Acute Coronary Syndrome
| [[Angioplasty Compared To Medicine - Two-Vessel Disease]]
|-
|-
| ABSORB: 6-month and 2-year results
| [[A-COMET-I]]
| A Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions
| [[Azimilide—Cardioversion Maintenance Trial–I]]
|-
|-
| ACADEMIC
| [[A-COMET-II]]
| Azithromycin In Coronary Artery Disease: Elimination Of Myocardial Infection With Chlamydia
| [[Azimilide—Cardioversion Maintenance Trial–II]]
|-
|-
| ACAS
| [[ACORN]]
| Asymptomatic Carotid Atherosclerosis Study
| [[Assessment Of A Cardiac Support Device (Csd) In Patients With Heart Failure]]
|-
|-
| ACC AMI GAP
| [[ACRE]]
| American College Of Cardiology Acute Myocardial Infarction Guidelines Applied To Practice Study
| [[Appropriateness Of Coronary Revascularization]]
|-
|-
| ACCENT
| [[ACST]]
| A Crohn'S Disease Clinical Trial Evaluating Infliximab In A New Long-Term Treatment Regimen
| [[Asymptomatic Carotid Surgery Trial]]
|-
|-
| ACCEPT
| [[ACT]]
| The Accupril Canadian Clinical Evaluation And Patient Teaching Study
| [[Effects Of Physical Activity Counseling In Primary Care: The Activity Counseling Trial]]
|-
|-
| ACCESS
| [[ACT]]
| Acute Candesartan Cilexetil Evaluation In Stroke Survivors
| [[Angioplasty Compliance Trial]]
|-
|-
| ACCLAIM
| [[ACTION]]
| Advanced Chronic Heart Failure Clinical Assessment Of Immune Modulation Therapy
| [[Coronary Disease Trial Investigating Outcome With Nifedipine Gits]]
|-
|-
| ACCOMPLISH
| [[ACTION]]
| Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
| [[Actinomycin Eluting Stent Improves Outcomes By Reducing Neointimal Hyperplasia]]
|-
|-
| ACCORD
| [[ACTIV in CHF]]
| Action To Control Cardiovascular Risk In Diabetes
| [[Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure]]
|-
|-
| ACCT
| [[ACTIVATE]]
| Sex And Age Related Antihypertensive Effects Of Amlodipine
| [[Acat Inhibition On The Progression Of Coronary Atherosclerosis]]
|-
|-
| ACCURACY
| [[ACTIVE A]]
| Assessment By Coronary Computed Tomographic Angiography Of Individuals Undergoing Invasive Coronary Angiography
| [[The Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events]]
|-
|-
| ACE
| [[ACTIVE W]]
| Abciximab-Carbostent Evaluation
| [[Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events]]
|-
|-
| ACE
| [[ACUITY]]
| Anticoagulation For Cardioversion Using Enoxaparin
| [[Acute Catheterization And Urgent Intervention Triage Strategy Trial]]
|-
|-
| ACE (Carotid Endarterectomy)
| [[ACUITY PCI: 30-day and 1-Year Results]]
| Asa And Carotid Endarterectomy Trial
| [[Acute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results]]
|-
|-
| ACES
| [[ACUITY Timing Trial]]
| Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease
| [[Acute Catheterization And Urgent Intervention Triage Strategy Timing Trial]]
|-
|-
| ACES
| [[ACUTE]]
| Clinical Experience Study
| [[Assessment Of Cardioversion Using Transesophageal Echocardiography]]
|-
|-
| ACIP
| [[ACUTE]]
| Asymptomatic Cardiac Ischemia Pilot Study
| [[Analysis Of Coronary Ultrasound Thrombolysis Endpoints In Acute Myocardial Infarction]]
|-
|-
| ACME
| [[ACUTE II]]
| Angioplasty Compared To Medicine
| [[Assessment Of Cardioversion Using Transesophageal Echocardiography]]
|-
|-
| ACME-2
| [[ADAM]]
| Angioplasty Compared To Medicine - Two-Vessel Disease
| [[Aneurysm Detection And Management Veterans Affairs Cooperative Study]]
|-
|-
| A-COMET-I
| [[ADAM]]
| Azimilide—Cardioversion Maintenance Trial–I
| [[Amsterdam Duration Of Antiretroviral Medication Study]]
|-
|-
| A-COMET-II
| [[ADAPT]]
| Azimilide—Cardioversion Maintenance Trial–Ii
| [[Alzheimer's Disease Anti-Inflammatory Prevention Trial]]
|-
|-
| ACORN
| [[ADCS]]
| Assessment Of A Cardiac Support Device (Csd) In Patients With Heart Failure
| [[Alzheimer's Disease Cooperative Study]]
|-
|-
| ACRE
| [[ADEMEX]]
| Appropriateness Of Coronary Revascularization
| [[Adequacy Of Peritoneal Dialysis In Mexico]]
|-
|-
| ACST
| [[ADEPT]]
| Asymptomatic Carotid Surgery Trial
| [[Advanced Elements Of Pacing Trial]]
|-
|-
| ACT
| [[ADIOS]]
| Effects Of Physical Activity Counseling In Primary Care: The Activity Counseling Trial
| [[Antiarrhythmic Drug Improve Outcome Study]]
|-
|-
| ACT
| [[ADMIRAL]]
| Angioplasty Compliance Trial
| [[Platelet Glycoprotein IIb/IIia Inhibition With Coronary Stenting For Acute Myocardial Infarction]]
|-
|-
| ACTION
| [[ADMIRAL]]
| Coronary Disease Trial Investigating Outcome With Nifedipine Gits
| [[Abciximab Before Direct Angioplasty And Stenting In Myocardial Infarction Regarding Acute And Long-Term Followup]]
|-
|-
| ACTION
| [[ADMIT]]
| Actinomycin Eluting Stent Improves Outcomes By Reducing Neointimal Hyperplasia
| [[Arterial Disease Multiple Intervention Trial]]
|-
|-
| ACTIV in CHF
| [[ADONIS]]
| Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure
| [[Aspirin Dose Optimized In Noncardioembolic Ischemic Stroke]]
|-
|-
| ACTIVATE
| [[ADOPT]]
| Acat Inhibition On The Progression Of Coronary Atherosclerosis
| [[Atrial Dynamic Overdrive Pacing Trial]]
|-
|-
| ACTIVE A
| [[ADOPT]]
| The Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
| [[A Diabetes Outcome Progression Trial]]
|-
|-
| ACTIVE W
| [[ADOPT-A]]
| Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
| [[Atrial Dynamic Overdrive Pacing Trial-A]]
|-
|-
| ACUITY
| [[ADVANCE]]
| Acute Catheterization And Urgent Intervention Triage Strategy Trial
| [[A Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions]]
|-
|-
| ACUITY PCI: 30-day and 1-Year Results
| [[ADVANCE]]
| Acute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results
| [[Additive Value Of Tirofiban Administered With The High-Dose Bolus In The Prevention Of Ischemic Complications During High-Risk Coronary Angioplasty]]
|-
|-
| ACUITY Timing Trial
| [[ADVANCE]]
| Acute Catheterization And Urgent Intervention Triage Strategy Timing Trial
| [[Action In Diabetes And Vascular Disease: Preterax And Diamicron Modified Release Controlled Evaluation]]
|-
|-
| ACUTE
| [[ADVANCE]]
| Assessment Of Cardioversion Using Transesophageal Echocardiography
| [[A Dosing Evaluation Of A Vasopressin Antagonist In Chf Patients Undergoing Exercise]]
|-
|-
| ACUTE
| [[ADVENT]]
| Analysis Of Coronary Ultrasound Thrombolysis Endpoints In Acute Myocardial Infarction;
| [[Assessment Of Diabetes Control And Evaluation Of The Efficacy Of Niaspan Trial]]
|-
|-
| ACUTE II
| [[AEGIS]]
| Assessment Of Cardioversion Using Transesophageal Echocardiography
| [[Alternative Graft Investigational Study]]
|-
|-
| ADAM
| [[A-F]]
| Aneurysm Detection And Management Veterans Affairs Cooperative Study
| [[Vascular Protection In High-Risk Non–St-Elevation Acute Coronary Syndromes: The Angioplasty Balloon-Associated Coronary Debris And The Ez Filterwire]]
|-
|-
| ADAM
| [[AFASAK]]
| Amsterdam Duration Of Antiretroviral Medication Study
| [[Atrial Fibrillation, Aspirin, Antikoagulation]]
|-
|-
| ADAPT
| [[AFASAK-2]]
| Alzheimer'S Disease Anti-Inflammatory Prevention Trial;
| [[Second Copenhagen Atrial Fibrillation, Aspirin, And Anticoagulation Study]]
|-
|-
| ADCS
| [[AFCAPS]]
| Alzheimer'S Disease Cooperative Study
| [[Air Force Coronary Atherosclerosis Prevention Study]]
|-
|-
| ADEMEX
| [[AFCAPS/TEXCAPS]]
| Adequacy Of Peritoneal Dialysis In Mexico
| [[Air Force Texas Coronary Atherosclerosis Prevention Study]]
|-
|-
| ADEPT
| [[AF-CHF]]
| Advanced Elements Of Pacing Trial
| [[Atrial Fibrillation And Congestive Heart Failure]]
|-
|-
| ADIOS
| [[AFFIRM]]
| Antiarrhythmic Drug Improve Outcome Study
| [[Atrial Fibrillation Follow-Up Investigation Of Rhythm Management]]
|-
|-
| ADMIRAL
| [[AFIB]]
| Platelet Glycoprotein Iib/Iiia Inhibition With Coronary Stenting For Acute Myocardial Infarction
| [[Atrial Fibrillation Investigation With Bidisomide]]
|-
|-
| ADMIRAL
| [[AFREGS]]
| Abciximab Before Direct Angioplasty And Stenting In Myocardial Infarction Regarding Acute And Long-Term Followup
| [[Armed Forces Regression Study]]
|-
|-
| ADMIT
| [[AGENT]]
| Arterial Disease Multiple Intervention Trial
| [[Angiogenic Gene Therapy]]
|-
|-
| ADONIS
| [[AGENT-2]]
| Aspirin Dose Optimized In Noncardioembolic Ischemic Stroke
| [[Angiogenic Gene Therapy Trial 2]]
|-
|-
| ADOPT
| [[AGENT-3]]
| Atrial Dynamic Overdrive Pacing Trial
| [[A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options]]
|-
|-
| ADOPT
| [[AGIS]]
| A Diabetes Outcome Progression Trial;
| [[Advanced Glaucoma Intervention Study]]
|-
|-
| ADOPT-A
| [[A-HeFT]]
| Atrial Dynamic Overdrive Pacing Trial-A
| [[African-American Heart Failure Trial]]
|-
|-
| ADVANCE
| [[AiMI]]
| A Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions
| [[A Prospective, Randomized, Controlled Trial Of Thrombectomy With The Angiojet In Acute Myocardial Infarction]]
|-
|-
| ADVANCE
| [[AIMS]]
| Additive Value Of Tirofiban Administered With The High-Dose Bolus In The Prevention Of Ischemic Complications During High-Risk Coronary Angioplasty
| [[Apsac Intervention Mortality Study]]
|-
|-
| ADVANCE
| [[AIR]]
| Action In Diabetes And Vascular Disease: Preterax And Diamicron Modified Release Controlled Evaluation
| [[Aerosolized Iloprost Randomized Placebo-Controlled Study]]
|-
|-
| ADVANCE
| [[Air PAMI]]
| A Dosing Evaluation Of A Vasopressin Antagonist In Chf Patients Undergoing Exercise
| [[The Air Primary Angioplasty In Myocardial Infarction Study]]
|-
|-
| ADVENT
| [[AIRCRAFT]]
| Assessment Of Diabetes Control And Evaluation Of The Efficacy Of Niaspan Trial
| [[The Australian Intervention Randomized Control Of Rate In Atrial Fibrillation Trial]]
|-
|-
| AEGIS
| [[AIRE]]
| Alternative Graft Investigational Study;
| [[Acute Infarction Ramipril Efficacy Study]]
|-
|-
| A-F
| [[AIST-ASH]]
| Vascular Protection In High-Risk Non–St-Elevation Acute Coronary Syndromes: The Angioplasty Balloon-Associated Coronary Debris And The Ez Filterwire
| [[Acute Ischemic Stroke Trial: Oral Aspirin Vs Intravenous Heparin On Stroke Progression]]
|-
|-
| AFASAK
| [[ALBION]]
| Atrial Fibrillation, Aspirin, Antikoagulation
| [[Assessment Of The Best Loading Dose Of Clopidogrel To Blunt Platelet Activation, Inflammation, And On-Going Necrosis]]
|-
|-
| AFASAK-2
| [[ALERT]]
| Second Copenhagen Atrial Fibrillation, Aspirin, And Anticoagulation Study
| [[Assessment Of Lescol In Renal Transplantation]]
|-
|-
| AFCAPS
| [[ALERT]]
| Air Force Coronary Atherosclerosis Prevention Study
| [[Adjunctive Lamictal In Epilepsy And Response To Treatment]]
|-
|-
| AFCAPS/TEXCAPS
| [[ALIVE]]
| Air Force Texas Coronary Atherosclerosis Prevention Study
| [[Azimilide Post-Infarct Survival Evaluation]]
|-
|-
| AF-CHF
| [[ALIVE]]
| Atrial Fibrillation And Congestive Heart Failure
| [[Adenosine Lidocaine Infarct Zone Viability Enhancement]]
|-
|-
| AFFIRM
| [[ALIVE (amio vs. lidocaine]]
| Atrial Fibrillation Follow-Up Investigation Of Rhythm Management
| [[Amiodarone As Compared With Lidocaine For Shock-Resistant Ventricular Fibrillation]]
|-
|-
| AFIB
| [[ALKK]]
| Atrial Fibrillation Investigation With Bidisomide
| [[Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte]]
|-
|-
| AFREGS
| [[ALLAY]]
| Armed Forces Regression Study
| [[Aliskiren In Left Ventricular Hypertrophy]]
|-
|-
| AGENT
| [[ALLHAT]]
| Angiogenic Gene Therapy
| [[Antihypertensive And Lipid-Lowering Treatment To Prevent Heart Attack Trial]]
|-
|-
| AGENT-2
| [[ALLIANCE]]
| Angiogenic Gene Therapy Trial
| [[Aggressive Lipid-Lowering Initiation Abates New Cardiac Events]]
|-
|-
| AGENT-3
| [[ALOFT]]
| A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options
| [[Aliskiren Observations Of Heart Failure Treatment]]
|-
|-
| AGIS
| [[ALPHA]]
| Advanced Glaucoma Intervention Study
| [[T-Wave Alternans In Patients With Heart Failure]]
|-
|-
| A-HeFT
| [[ALPHABET]]
| African-American Heart Failure Trial
| [[Effects Of Beraprost Sodium, An Oral Prostacyclin Analogue, In Patients With Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial]]
|-
|-
| AiMI
| [[ALTS]]
| A Prospective, Randomized, Controlled Trial Of Thrombectomy With The Angiojet In Acute Myocardial Infarction
| [[Ascus/Lsil Triage Study ]]
|-
|-
| AIMS
| [[AMADEUS]]
| Apsac Intervention Mortality Study
| [[Comparison Of Idraparinux With Vitamin K Antagonists For Prevention Of Thromboembolism In Patients With Atrial Fibrillation]]
|-
|-
| AIR
| [[AMAZE]]
| Aerosolized Iloprost Randomized Placebo-Controlled Study; Sponsor: Schering Ag
| [[A Multicenter Trial Using-Zestril Versus To Evaluate The Effects On Lowering Blood Pressure ]]
|-
|-
| Air PAMI
| [[AMEthyst]]
| The Air Primary Angioplasty In Myocardial Infarction Study.
| [[Assessment Of The Medtronic Ave Interceptor Saphenous Vein Graft Filter System]]
|-
|-
| AIRCRAFT
| [[AMIGO]]
| The Australian Intervention Randomized Control Of Rate In Atrial Fibrillation Trial (Aircraft).
| [[Atherectomy And Multilink Stenting Improves Gain In Outcome Trial]]
|-
|-
| AIRE
| [[AMIGO]]
| Acute Infarction Ramipril Efficacy Study
| [[Ac2993: Diabetes Management For Improving Glucose Outcome]]
|-
|-
| AIST-ASH
| [[AMIHOT]]
| Acute Ischemic Stroke Trial: Oral Aspirin Vs Intravenous Heparin On Stroke Progression
| [[Acute Myocardial Infarction With Hyperoxemic Therapy]]
|-
|-
| ALBION
| [[AMIHOT II]]
| Assessment Of The Best Loading Dose Of Clopidogrel To Blunt Platelet Activation, Inflammation, And On-Going Necrosis
| [[Acute Myocardial Infarction With Hyperoxemic Therapy II]]
|-
|-
| ALERT
| [[AMIOVIRT]]
| Assessment Of Lescol In Renal Transplantation
| [[Amiodarone Versus Implantable Defibrillator In Patients With Nonischemic Cardiomyopathy And Asymptomatic Nonsustained Ventricular Tachycardia Study]]
|-
|-
| ALERT
| [[AMISTAD I]]
| Adjunctive Lamictal®] In Epilepsy And Response To Treatment
| [[Acute Myocardial Infarction Study Of Adenosine Trial]]
|-
|-
| ALIVE
| [[AMISTAD II]]
| Azimilide Post-Infarct Survival Evaluation
| [[Acute Myocardial Infarction Study Of Adenosine II]]
|-
|-
| ALIVE
| [[AMRO]]
| Adenosine Lidocaine Infarct Zone Viability Enhancement
| [[Amsterdam-Rotterdam Trial]]
|-
|-
| ALIVE (amio vs. lidocaine)
| [[ANBP2]]
| Amiodarone As Compared With Lidocaine For Shock-Resistant Ventricular Fibrillation
| [[Australian National Blood Pressure Study Group]]
|-
|-
| ALKK
| [[ANDROMEDA]]
| Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte
| [[Increased Mortality After Dronedarone Therapy For Severe Heart Failure]]
|-
|-
| ALLAY
| [[ANTHEM–TIMI-32]]
| Aliskiren In Left Ventricular Hypertrophy
| [[Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32]]
|-
|-
| ALLHAT
| [[ANTIBIO]]
| Antihypertensive And Lipid-Lowering Treatment To Prevent Heart Attack Trial
| [[Antibiotic Therapy After An Acute Myocardial Infarction]]
|-
|-
| ALLHAT Lipid Lowering Trial
| [[ANZ-Carvedilol]]
| Antihypertensive And Lipid-Lowering Treatment To Prevent Heart Attack Trial
| [[Australia-New Zealand Heart Failure Research Collaborative Group Carvedilol Trial]]
|-
|-
| ALLIANCE
| [[APAF]]
| Aggressive Lipid-Lowering Initiation Abates New Cardiac Events
| [[Ablation For Paroxysmal Atrial Fibrillation (Apaf) Trial]]
|-
|-
| ALOFT
| [[APASS]]
| Aliskiren Observations Of Heart Failure Treatment
| [[Antiphospholipid Antibody Stroke Study]]
|-
|-
| ALPHA
| [[APC]]
| T-Wave Alternans In Patients With Heart Failure
| [[Adenoma Prevention With Celecoxib]]
|-
|-
| ALPHABET
| [[APEX AMI]]
| Effects Of Beraprost Sodium, An Oral Prostacyclin Analogue, In Patients With Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
| [[Assessment Of Pexelizumab In Acute Myocardial Infarction]]
|-
|-
| ALTS
| [[APLAUSE]]
| Ascus/Lsil Triage Study
| [[Anti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion]]
|-
|-
| AMADEUS
| [[APOCARD]]
| Comparison Of Idraparinux With Vitamin K Antagonists For Prevention Of Thromboembolism In Patients With Atrial Fibrillation
| [[Imaging In Cardiac Transplant Patients]]
|-
|-
| AMAZE
| [[APPRAISE-1]]
| A Multicenter Trial Using-Zestril®* Versus To Evaluate The Effects On Lowering Blood Pressure (*Atacand As Add-On Therapy With Zestril]
| [[Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial]]
|-
|-
| AMEthyst
| [[APPROACH]]
| Assessment Of The Medtronic Ave Interceptor Saphenous Vein Graft Filter System
| [[Assessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History]]
|-
|-
| AMIGO
| [[APRES]]
| Atherectomy And Multilink Stenting Improves Gain In Outcome Trial
| [[Angiotensin-Converting Enzyme Inhibition Post Revascularization Study]]
|-
|-
| AMIGO
| [[APRICOT]]
| Ac2993: Diabetes Management For Improving Glucose Outcome
| [[Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis]]
|-
|-
| AMIHOT
| [[APRICOT-2]]
| Acute Myocardial Infarction With Hyperoxemic Therapy
| [[Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2]]
|-
|-
| AMIHOT II
| [[ARBITER 2]]
| Acute Myocardial Infarction With Hyperoxemic Therapy Ii
| [[Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2]]
|-
|-
| AMIOVIRT
| [[ARCH]]
| Amiodarone Versus Implantable Defibrillator In Patients With Nonischemic Cardiomyopathy And Asymptomatic Nonsustained Ventricular Tachycardia Study
| [[Amiodarone Reduction In Coronary Heart Trial]]
|-
|-
| AMISTAD
| [[ARCHeR]]
| Acute Myocardial Infarction Study Of Adenosine;
| [[For Revascularization Of Carotids In High-Risk Patients]]
|-
|-
| AMISTAD I
| [[AREDS]]
| Acute Myocardial Infarction Study Of Adenosine Trial
| [[Age-Related Eye Disease Study]]
|-
|-
| AMISTAD II
| [[ARG-911]]
| Acute Myocardial Infarction Study Of Adenosine Ii
| [[Argatroban-911]]
|-
|-
| AMRO
| [[ARG-915]]
| Amsterdam-Rotterdam Trial
| [[Argatroban-915]]
|-
|-
| ANBP2
| [[ARGAMI-2]]
| Australian National Blood Pressure Study Group
| [[Argatroban For Acute Myocardial Infarction]]
|-
|-
| ANDROMEDA
| [[ARIC]]
| Increased Mortality After Dronedarone Therapy For Severe Heart Failure
| [[Atherosclerosis Risk In Communities]]
|-
|-
| ANTHEM–TIMI-32
| [[ARIES 1 and 2]]
| Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32
| [[Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2]]
|-
|-
| ANTIBIO
| [[ARISE]]
| Antibiotic Therapy After An Acute Myocardial Infarction
| [[Aggressive Reduction Of Inflammation Stops Events]]
|-
|-
| ANZ-Carvedilol
| [[ARMS]]
| Australia-New Zealand Heart Failure Research Collaborative Group Carvedilol Trial
| [[Apsac Reocclusion Multicenter Study]]
|-
|-
| APAF
| [[ARMYDA]]
| Ablation For Paroxysmal Atrial Fibrillation (Apaf) Trial
| [[Atorvastatin For Reduction Of Myocardial Damage During Angioplasty]]
|-
|-
| APASS
| [[ARMYDA-2]]
| Antiphospholipid Antibody Stroke Study
| [[Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2]]
|-
|-
| APC
| [[ARMYDA-3]]
| Adenoma Prevention With Celecoxib;
| [[Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3]]
|-
|-
| APEX AMI
| [[ARMYDA-4]]
| Assessment Of Pexelizumab In Acute Myocardial Infarction
| [[Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4]]
|-
|-
| APLAUSE
| [[ARMYDA-5]]
| Anti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
| [[Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5]]
|-
|-
| APOCARD
| [[ARMYDA-ACS]]
| Imaging In Cardiac Transplant Patients
| [[Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes]]
|-
|-
| APPRAISE-1
| [[ARMYDA-RECAPTURE]]
| Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial
| [[Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture]]
|-
|-
| APPROACH
| [[ARMYDA-RELOAD]]
| Assessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
| [[Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload]]
|-
|-
| APRES
| [[ARPEGGIO]]
| Angiotensin-Converting Enzyme Inhibition Post Revascularization Study
| [[Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes]]
|-
|-
| APRICOT
| [[ARREST]]
| Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
| [[Amiodarone For Resuscitation After Out-Of-Hospital Cardiac Arrest Due To Ventricular Fibrillation]]
|-
|-
| APRICOT-2
| [[ARREST]]
| Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
| [[Angiorad Radiation For Restenosis]]
|-
|-
| ARBITER 2
| [[ARTIST]]
| Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2
| [[Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial]]
|-
|-
| ARCH
| [[ARTISTIC]]
| Amiodarone Reduction In Coronary Heart Trial
| [[Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary]]
|-
|-
| ARCHeR
| [[ARTS]]
| For Revascularization Of Carotids In High-Risk Patients
| [[Arterial Revascularization Therapies Study]]
|-
|-
| AREDS
| [[ARTS I - Five year follow-up]]
| Age-Related Eye Disease Study
| [[Five Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study]]
|-
|-
| ARG-911
| [[ARTS-II]]
| Argatroban-911
| [[Arterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions]]
|-
|-
| ARG-915
| [[ASAP]]
| Argatroban-915
| [[Effect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia]]
|-
|-
| ARGAMI-2
| [[ASAP]]
| Argatroban For Acute Myocardial Infarction
| [[Azimilide Supraventricular Arrhythmia Program ]]
|-
|-
| ARIC
| [[ASCENT]]
| Atherosclerosis Risk In Communities
| [[Acs Stent Clinical Equivalence In De Novo Lesions Trial]]
|-
|-
| ARIES 1 and 2
| [[ASCOT]]
| Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
| [[Anglo-Scandinavian Cardiac Outcome Trial]]
|-
|-
| ARISE
| [[ASCOT - Blood Pressure Arm]]
| Aggressive Reduction Of Inflammation Stops Events
| [[ Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm]]
|-
|-
| ARMS
| [[ASCOT - Lipid Arm]]
| Apsac Reocclusion Multicenter Study
| [[ Anglo-Scandinavian Cardiac Outcomes Trial]]
|-
|-
| ARMYDA
| [[ASFAST]]
| Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
| [[Atherosclerosis And Folic Acid Supplementation Trial]]
|-
|-
| ARMYDA-2
| [[ASIS]]
| Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty Study
| [[Angina And Silent Ischemia Study]]
|-
|-
| ARMYDA-3
| [[ASPAC]]
| Atorvastatin For Reduction Of Myocardial Dysrhythmias After Cardiac Surgery
| [[Asian-Pacific Collaboration On Chd Risk Factor Intervention]]
|-
|-
| ARMYDA-4
| [[ASPECT]]
| Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
| [[Anticoagulants In Secondary Prevention Of Events In Coronary Thrombosis]]
|-
|-
| ARMYDA-5
| [[ASPECT]]
| Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
| [[Asian Paclitaxel-Eluting Stent Clinical Trial]]
|-
|-
| ARMYDA-ACS
| [[ASPECT-2]]
| Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
| [[Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.]]
|-
|-
| ARMYDA-RECAPTURE
| [[ASPEN]]
| Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
| [[Atorvastatin Study For The Prevention Of Endpoints For Patients With Niddm]]
|-
|-
| ARMYDA-RELOAD
| [[ASPIRE]]
| Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
| [[Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation]]
|-
|-
| ARPEGGIO
| [[ASSENT 3]]
| Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
| [[The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi]]
|-
|-
| ARREST
| [[ASSENT 3 PLUS]]
| Amiodarone For Resuscitation After Out-Of-Hospital Cardiac Arrest Due To Ventricular Fibrillation
| [[Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3]]
|-
|-
| ARREST
| [[ASSENT-1]]
| Angiorad™ Radiation For Restenosis;
| [[Assessment Of The Safety and Efficacy Of A New Thrombolytic: Tnk-Tpa]]
|-
|-
| ARTIST
| [[ASSENT-2]]
| Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
| [[Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2]]
|-
|-
| ARTISTIC
| [[ASSENT-4 PCI]]
| Angiorad™ Radiation Therapy For In-Stent Restenosis Intracoronary;
| [[Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction]]
|-
|-
| ARTS
| [[ASSERT]]
| Arterial Revascularization Therapies Study
| [[Aortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial]]
|-
|-
| ARTS I - Five year follow-up
| [[ASSET]]
| Five Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
| [[Anglo-Scandinavian Study Of Early Thrombolysis]]
|-
|-
| ARTS-II
| [[ASSIST]]
| Arterial Revascularization Therapies Study Part Ii: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
| [[Assessment Of Implementation Strategies]]
|-
|-
| ASAP
| [[ASSIST]]
| Effect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia
| [[A Stop Smoking In Schools Trial]]
|-
|-
| ASAP
| [[ASSURE]]
| Azimilide Supraventricular Arrhythmia Program;
| [[Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations]]
|-
|-
| ASCENT
| [[ASTAMI]]
| Acs Stent Clinical Equivalence In De Novo Lesions Trial
| [[Astami]]
|-
|-
| ASCOT
| [[ASTEROID]]
| Anglo-Scandinavian Cardiac Outcome Trial
| [[A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden]]
|-
|-
| ASCOT - Blood Pressure Arm
| [[ASTIS]]
| Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
| [[Autologous Stem Cell Transplantation International Scleroderma Trial]]
|-
|-
| ASCOT - Lipid Arm
| [[ASTRAL]]
| Anglo-Scandinavian Cardiac Outcomes Trial
| [[Angioplasty And Stenting For Renal Artery Lesions]]
|-
|-
| ASFAST
| [[ASTRID]]
| Atherosclerosis And Folic Acid Supplementation Trial
| [[Atrial Sensing Trial To Prevent Inappropriate Detections]]
|-
|-
| ASIS
| [[ASTRONAUT]]
| Angina And Silent Ischemia Study
| [[Acid Suppression Trial: Ranitidine Zantac Versus Omeprazole]]
|-
|-
| ASPAC
| [[AT LAST]]
| Asian-Pacific Collaboration On Chd Risk Factor Intervention
| [[Antiretroviral Trial Looking At Sex And Treatment]]
|-
|-
| ASPECT
| [[ATAC]]
| Anticoagulants In Secondary Prevention Of Events In Coronary Thrombosis
| [[Arimidex (Anastrozole), Tamoxifen And Combination Therapy]]
|-
|-
| ASPECT
| [[ATBAT]]
| Asian Paclitaxel-Eluting Stent Clinical Trial
| [[Anticoagulant Therapy With Bivalirudin To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)]]
|-
|-
| ASPECT
| [[ATBC]]
| Anticoagulants In The Secondary Prevention Of Events In Coronary Thrombosis;
| [[Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study]]
|-
|-
| ASPECT-2
| [[ATHENA]]
| Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
| [[Effect Of Dronedarone On Cardiovascular Outcomes In High-Risk Patients With Atrial Fibrillation Or Atrial Flutter]]
|-
|-
| ASPEN
| [[ATHEROMA]]
| Atorvastatin Study For The Prevention Of Endpoints For Patients With Niddm
| [[Atorvastatin Therapy: Effects Of Reduction Of Macrophage Activity]]
|-
|-
| ASPIRE
| [[ATICH]]
| Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
| [[Antifibrinolytic Therapy In Acute Intracerebral Hemorrhage]]
|-
|-
| ASSENT
| [[ATLANTIC]]
| Assessment Of The Safety And Efficacy Of A New Thrombolytic
| [[Angina Treatments - - Lasers And Normal Therapies In Comparison]]
|-
|-
| ASSENT 3
| [[ATLANTIS]]
| The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi
| [[Alteplase Thrombolysis For Acute Noninterventional Therapy In Ischemic Stroke]]
|-
|-
| ASSENT 3 PLUS
| [[ATLAS]]
| Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen
| [[Assessment Of Treatment With Lisinopril And Survival]]
|-
|-
| ASSENT-1
| [[ATLAS]]
| Assessment Of The Safety Of A New Thrombolytic: Tnk-Tpa
| [[Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts Assessment Of Treatment With Lisinopril And Survival]]
|-
|-
| ASSENT-2
| [[ATLAS - SVG]]
| Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa
| [[Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts]]
|-
|-
| ASSENT-4 PCI
| [[ATLAST]]
| Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
| [[Antiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy In Patients At Increased Risk Of Stent Thrombosis]]
|-
|-
| ASSERT
| [[ATLAS-TIMI 46]]
| Aortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial
| [[Anti-Xa Therapy To Lower Cardiovascular Events In Addition To Aspirin With Or Without Thienopyridine In Subjects With Acute Coronary Syndromes–Thrombolysis In Myocardial Infarction 46]]
|-
|-
| ASSET
| [[AtoZ]]
| Anglo-Scandinavian Study Of Early Thrombolysis
| [[Aggrastat To Zocor Study]]
|-
|-
| ASSIST
| [[ATRAMI]]
| Assessment Of Implementation Strategies
| [[Baroreflex Sensitivity And Heart-Rate Variability In Prediction Of Total Cardiac Mortality After Myocardial Infarction. Atrami (Autonomic Tone And Reflexes After Myocardial Infarction) Investigators.]]
|-
|-
| ASSIST
| [[ATRIA]]
| A Stop Smoking In Schools Trial
| [[The Anticoagulation And Risk Factors In Atrial Fibrillation Study]]
|-
|-
| ASSURE
| [[ATRIA]]
| Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations
| [[Anticoagulation And Risk Factors In Atrial Fibrillation ]]
|-
|-
| ASTAMI
| [[Atrial Arrhythmia Conversion Trial]]
| Astami
| [[Vernakalant Hydrochloride For Rapid Conversion Of Atrial Fibrillation]]
|-
|-
| ASTEROID
| [[ATS]]
| A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
| [[Amblyopia Treatment Study]]
|-
|-
| ASTIS
| [[ATTACH]]
| Autologous Stem Cell Transplantation International Scleroderma Trial
| [[Anti-Tnf Therapy Against Congestive Heart Failure Trial]]
|-
|-
| ASTRAL
| [[ATTEST]]
| Angioplasty And Stenting For Renal Artery Lesions
| [[Atrial Therapy Efficacy And Safety Trial]]
|-
|-
| ASTRID
| [[ATTRACT]]
| Atrial Sensing Trial To Prevent Inappropriate Detections
| [[Anti-Tnf Trial In Rheumatoid Arthritis With Ca2 Treatment ]]
|-
|-
| ASTRONAUT
| [[AURORA]]
| Acid Suppression Trial: Ranitidine (Zantac®] Versus Omeprazole
| [[A Study To Evaluate The Use Of Rosuvastatin In Subjects On Regular Hemodialysis: An Assessment Of Survival And Cardiovascular Events]]
|-
|-
| AT LAST
| [[AVASIS]]
| Antiretroviral Trial Looking At Sex And Treatment
| [[Aspirin Versus Anticoagulants In Symptomatic Intracranial Stenosis]]
|-
|-
| ATAC
| [[AVERT]]
| Arimidex (Anastrozole), Tamoxifen And Combination Therapy
| [[Atorvastatin Versus Revascularization Treatments]]
|-
|-
| ATBAT
| [[AVERT]]
| Anticoagulant Therapy With Bivalirudin (Angiomax™] To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)
| [[Artificial Valve Endocarditis Reduction Trial]]
|-
|-
| ATBC
| [[AVID]]
| Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study
| [[Antiarrhythmics Versus Implantable Defibrillators]]
|-
|-
| ATHENA
| [[AVID]]
| Effect Of Dronedarone On Cardiovascular Outcomes In High-Risk Patients With Atrial Fibrillation Or Atrial Flutter
| [[Angiography Versus Intravascular Ultrasound-Directed Stent Placement]]
|-
|-
| ATHEROMA
| [[AVID Electrical Storm Substudy]]
| Atorvastatin Therapy: Effects Of Reduction Of Macrophage Activity
| [[Electrical Storm Presages Nonsudden Death. The Antiarrhythmics Vs. Implantable Defibrillators (Avid) Trial]]
|-
|-
| ATICH
| [[AVOID]]
| Antifibrinolytic Therapy In Acute Intracerebral Hemorrhage
| [[Aliskiren In The Evaluation Of Proteinuria In Diabetes]]
|-
|-
| ATLANTIC
| [[AWESOME]]
| Angina Treatments - - Lasers And Normal Therapies In Comparison
| [[Angina With Extremely Serious Operative Mortality Evaluation]]
|-
|-
| ATLANTIS
| [[AZACS]]
| Alteplase Thrombolysis For Acute Noninterventional Therapy In Ischemic Stroke
| [[Azithromycin In Acute Coronary Syndrome]]
|-
|-
| ATLAS
| [[BAATAF]]
| Assessment Of Treatment With Lisinopril And Survival
| [[Boston Area Anticoagulation Trial For Atrial Fibrillation]]
|-
|-
| ATLAS
| [[BACH]]
| Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts Assessment Of Treatment With Lisinopril And Survival
| [[Bach]]
|-
|-
| ATLAS - SVG
| [[BARI]]
| Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts
| [[Bypass Angioplasty Revascularization Investigation]]
|-
|-
| ATLAST
| [[BARI 2D]]
| Antiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy In Patients At Increased Risk Of Stent Thrombosis
| [[Bypass Angioplasty Revascularization Investigation In Type 2 Diabetics]]
|-
|-
| ATLAS-TIMI 46
| [[BARS]]
| Anti-Xa Therapy To Lower Cardiovascular Events In Addition To Aspirin With Or Without Thienopyridine In Subjects With Acute Coronary Syndromes–Thrombolysis In Myocardial Infarction 46
| [[Beaumont Alcohol Restenosis Study]]
|-
|-
| AtoZ
| [[BASC]]
| Aggrastat® To Zocor® Study
| [[Blood Pressure In Acute Stroke Collaboration]]
|-
|-
| ATRAMI
| [[BASEL]]
| Baroreflex Sensitivity And Heart-Rate Variability In Prediction Of Total Cardiac Mortality After Myocardial Infarction. Atrami (Autonomic Tone And Reflexes After Myocardial Infarction) Investigators.
| [[Brain Natriuretic Peptide For Acute Shortness Of Breath Evaluation: A Randomized Comparison]]
|-
|-
| ATRIA
| [[BASIS]]
| The Anticoagulation And Risk Factors In Atrial Fibrillation Study
| [[Basel Antiarrhythmic Study Of Infarct Survival]]
|-
|-
| Atrial Arrhythmia Conversion Trial
| [[BASKET]]
| Vernakalant Hydrochloride For Rapid Conversion Of Atrial Fibrillation
| [[Basel Stent Cost-Effectiveness Trial]]
|-
|-
| ATS
| [[BASKET LATE]]
| Amblyopia Treatment Study
| [[Late Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel]]
|-
|-
| ATTACH
| [[BAT]]
| Anti-Tnf Therapy Against Congestive Heart Failure Trial
| [[Bivalirudin Angioplasty Study]]
|-
|-
| ATTEST
| [[BATMAN]]
| Atrial Therapy Efficacy And Safety Trial
| [[Biodivysio 'Bat'Imastat Sv Stent Versus Balloon Angioplasty For The Reduction Of Restenosis In Small Coronary Arteries ]]
|-
|-
| ATTRACT
| [[BBC ONE]]
| Anti-Tnf Trial In Rheumatoid Arthritis With Ca2 Treatment;
| [[British Bifurcation Coronary Study: Old, New, And Evolving Strategies]]
|-
|-
| AURORA
| [[BBS—Cognitive Study]]
| A Study To Evaluate The Use Of Rosuvastatin In Subjects On Regular Hemodialysis: An Assessment Of Survival And Cardiovascular Events
| [[Best Bypass Surgery—Cognitive Study]]
|-
|-
| AVASIS
| [[BCAPS]]
| Aspirin Versus Anticoagulants In Symptomatic Intracranial Stenosis
| [[Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study]]
|-
|-
| AVERT
| [[BCPT]]
| Atorvastatin Versus Revascularization Treatments
| [[Breast Cancer Prevention Trial]]
|-
|-
| AVERT
| [[BEACH]]
| Artificial Valve Endocarditis Reduction Trial
| [[Boston Scientific Epi: A Carotid Stenting Trial For High-Risk Surgical Patients]]
|-
|-
| AVID
| [[BEAT]]
| Antiarrhythmics Versus Implantable Defibrillators
| [[Bucindolol Evaluation In Acute Myocardial Infarction Trial ]]
|-
|-
| AVID
| [[BEAUTIFUL]]
| Angiography Versus Intravascular Ultrasound-Directed Stent Placement
| [[Morbidity-Mortality Evaluation Of The If Inhibitor Ivabradine In Patients With Coronary Disease And Left-Ventricular Dysfunction]]
|-
|-
| AVID Electrical Storm Substudy
| [[BECAIT]]
| Electrical Storm Presages Nonsudden Death. The Antiarrhythmics Vs. Implantable Defibrillators (Avid) Trial
| [[Bezafibrate Coronary Atherosclerosis Intervention Trial]]
|-
|-
| AVOID
| [[BECAIT]]
| Aliskiren In The Evaluation Of Proteinuria In Diabetes
| [[Bezafibrate Coronary Atherosclerosis Intervention Trial]]
|-
|-
| AWESOME
| [[BELLES]]
| Angina With Extremely Serious Operative Mortality Evaluation
| [[Beyond Endorsed Lipid Lowering With Ebt Scanning]]
|-
|-
| AZACS
| [[BENEDICT]]
| Azithromycin In Acute Coronary Syndrome
| [[Bergamo Nephrologic Diabetes Complications Trial]]
|-
|-
| BAATAF
| [[BENEFiT]]
| Boston Area Anticoagulation Trial For Atrial Fibrillation
| [[Bosentan Effects In Inoperable Forms Of Chronic Thromboembolic Pulmonary Hypertension]]
|-
|-
| BACH
| [[BENEFIT]]
| Bach
| [[Betaferon (Betaseron In U.S.) In Newly Emerging Ms For Initial Treatment Information]]
|-
|-
| BARI
| [[BENESTENT I]]
| Bypass Angioplasty Revascularization Investigation
| [[Belgian-Netherlands Stent Study (I)]]
|-
|-
| BARI 2D
| [[BENESTENT II]]
| Bypass Angioplasty Revascularization Investigation In Type 2 Diabetics
| [[Belgian-Netherlands Stent Study II (Pilot)]]
|-
|-
| BARS
| [[BERT]]
| Beaumont Alcohol Restenosis Study
| [[Beta Energy Restenosis Trial - 1]]
|-
|-
| BASC
| [[BESMART]]
| Blood Pressure In Acute Stroke Collaboration
| [[Bestent In Small Arteries Trial]]
|-
|-
| BASEL
| [[BESSAMI]]
| Brain Natriuretic Peptide For Acute Shortness Of Breath Evaluation: A Randomized Comparison
| [[Berlin Stent Study In Acute Myocardial Infarction]]
|-
|-
| BASIS
| [[BEST]]
| Basel Antiarrhythmic Study Of Infarct Survival
| [[Beta Blocker Evaluation Of Survival Trial]]
|-
|-
| BASKET
| [[BEST]]
| Basel Stent Cost-Effectiveness Trial
| [[Balloon Equivalent To Stent Trial]]
|-
|-
| BASKET LATE
| [[BEST-ICD]]
| Late Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel
| [[Beta-Blocker Evaluation Of Survival Trial Plus Icd]]
|-
|-
| BAT
| [[BETA WRIST]]
| Bivalirudin Angioplasty Study
| [[Washington Radiation For In-Stent Restenosis Trial]]
|-
|-
| BATMAN
| [[BETACATH]]
| Biodivysio® 'Bat'Imastat Sv Stent Versus Balloon Angioplasty For The Reduction Of Restenosis In Small Coronary Arteries;
| [[Clinical And Angiographic Outcomes After Use Of Sr-90 Beta Radiation For The Treatment Of De Novo And Restenotic Coronary Lesions]]
|-
|-
| BBC ONE
| [[BETTER]]
| British Bifurcation Coronary Study: Old, New, And Evolving Strategies
| [[Beta Radiation Trial To Eliminate Restenosis]]
|-
|-
| BBS—Cognitive Study
| [[BHACAS]]
| Best Bypass Surgery—Cognitive Study
| [[Early And Midterm Outcome After Off-Pump And On-Pump Surgery In Beating Heart Against Cardioplegic Arrest Studies (Bhacas 1 And 2): A Pooled Analysis Of Two Randomised Controlled Trials.]]
|-
|-
| BCAPS
| [[BHAT]]
| Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study
| [[Beta Blocker Heart Attack Trial]]
|-
|-
| BCPT
| [[BiCard]]
| Breast Cancer Prevention Trial
| [[Biphasic Vs. Monophasic Shock Waveform For Conversion Of Atrial Fibrillation. The Results Of An International Randomized, Double-Blind Multicenter Trial]]
|-
|-
| BEACH
| [[BICC]]
| Boston Scientific Epi: A Carotid Stenting Trial For High-Risk Surgical Patients
| [[Beta-Interferon In Chronic Viral Cardiomyopathy]]
|-
|-
| BEAT
| [[BIP]]
| Bucindolol Evaluation In Acute Myocardial Infarction Trial;
| [[Bezafibrate Infarction Prevention Study]]
|-
|-
| BEAUTIFUL
| [[BIRD]]
| Morbidity-Mortality Evaluation Of The If Inhibitor Ivabradine In Patients With Coronary Disease And Left-Ventricular Dysfunction
| [[ Bolus Versus Infusion In Rescupase (Saruplase) Development]]
|-
|-
| BECAIT
| [[BLIND-DATE]]
| Bezafibrate Coronary Atherosclerosis Intervention Trial
| [[Blinded Withdrawal Of Deprenyl In The Datatop Extension Trial]]
|-
|-
| BELLES
| [[BLOSS]]
| Beyond Endorsed Lipid Lowering With Ebt Scanning
| [[Beta Blocker Length Of Stay Study]]
|-
|-
| BENEDICT
| [[BNP]]
| Bergamo Nephrologic Diabetes Complications Trial
| [[Breathing Not Properly]]
|-
|-
| BENEFiT
| [[BOAT]]
| Bosentan Effects In Inoperable Forms Of Chronic Thromboembolic Pulmonary Hypertension
| [[Balloon Angioplasty Versus Optimal Atherectomy Trial]]
|-
|-
| BENEFIT
| [[Bogalusa]]
| Betaferon® (Betaseron® In U.S.] In Newly Emerging Ms For Initial Treatment; Information
| [[Bogalusa Heart Study]]
|-
|-
| BENESTENT
| [[BOOST]]
| Belgium Netherlands Stent
| [[Bone Marrow Transfer To Enhance St-Elevation Infarct Regeneration]]
|-
|-
| BENESTENT I
| [[BPAV]]
| Belgian-Netherlands Stent Study (I)
| [[Balloon Prophylaxis Of Aneurysmal Vasospasm]]
|-
|-
| BENESTENT II
| [[BRAINS]]
| Belgian-Netherlands Stent Study Ii (Pilot)
| [[Bayer Randomized Acute Ischemia Neuroprotectant Study]]
|-
|-
| BERT
| [[BRAVE]]
| Beta Energy Restenosis Trial - 1
| [[Bavarian Reperfusion Alternatives Evaluation]]
|-
|-
| BESMART
| [[BRAVE-2]]
| Bestent In Small Arteries Trial
| [[Beyond 12 Hours Reperfusion Alternative Evaluation Trial]]
|-
|-
| BESSAMI
| [[BRAVE-3]]
| Berlin Stent Study In Acute Myocardial Infarction
| [[Value Of Abciximab In Patients With Ami Undergoing Pci After High Loading Dose Of Clopidogrel Pretreatment]]
|-
|-
| BEST
| [[BRAVO]]
| Beta Blocker Evaluation Of Survival Trial
| [[Blockade Of The Glycoprotein IIb/IIia Receptor To Avoid Vascular Occlusion]]
|-
|-
| BEST
| [[BRAVO]]
| Balloon Equivalent To Stent Trial
| [[Beta Radiation For Treatment Of Arteriovenous Graft Outflow Sponsor:]]
|-
|-
| BEST-ICD
| [[BREATHE-1]]
| Beta-Blocker Evaluation Of Survival Trial Plus Icd
| [[Bosentan (Tracleer): Randomized Trial Of Endothelin Receptor Antagonist Therapy For Pulmonary Hypertension]]
|-
|-
| BETA WRIST
| [[BRIDGE]]
| Washington Radiation For In-Stent Restenosis Trial
| [[Beta-Radiation Investigation With Direct Stenting And Galileo In Europe]]
|-
|-
| BETACATH
| [[BRIE]]
| Clinical And Angiographic Outcomes After Use Of Sr-90 Beta Radiation For The Treatment Of De Novo And Restenotic Coronary Lesions
| [[Beta Radiation In Europe]]
|-
|-
| BETTER
| [[BRIEF-PCI]]
| Beta Radiation Trial To Eliminate Restenosis
| [[Brief Infusion Of Eptifibatide Following Percutaneous Coronary Intervention]]
|-
|-
| BHACAS
| [[BRILLIANT]]
| Early And Midterm Outcome After Off-Pump And On-Pump Surgery In Beating Heart Against Cardioplegic Arrest Studies (Bhacas 1 And 2): A Pooled Analysis Of Two Randomised Controlled Trials.
| [[Batimastat (Bb-94) Antirestenosis Trial Utilizing The Biodivysio Local Drug Delivery Pc Stent ]]
|-
|-
| BHACAS
| [[BRITE]]
| Beating Heart Against Cardioplegic Arrest Studies
| [[Beta Radiation To Reduce In-Stent Restenosis ]]
|-
|-
| BHAT
| [[BRITE II]]
| Beta Blocker Heart Attack Trial
| [[Beta Radiation To Reduce In-Stent Restenosis II]]
|-
|-
| BiCard
| [[BRITE-SVG]]
| Biphasic Vs. Monophasic Shock Waveform For Conversion Of Atrial Fibrillation. The Results Of An International Randomized, Double-Blind Multicenter Trial
| [[Beta Radiation To Reduce In-Stent Restenosis In Saphenous Vein Grafts]]
|-
|-
| BICC
| [[CABERNET]]
| Beta-Interferon In Chronic Viral Cardiomyopathy
| [[A Prospective Registry Of Carotid Stenting With The Nexstent And Distal Protection With The Filterwire Ex In High Risk Patients]]
|-
|-
| BIP
| [[CABERNET]]
| Bezafibrate Infarction Prevention Study
| [[Carotid Artery Revascularization Using The Boston Scientific Epi Filterwire Ex And The Endotex Nexstent]]
|-
|-
| BIRD
| [[CABG PATCH]]
| Bolus Versus Infusion In Rescupase (Saruplase) Development
| [[The Coronary Artery Bypass Graft Patch Trial]]
|-
|-
| BLIND-DATE
| [[CABG Patch Cardioplegia Substudy]]
| Blinded Withdrawal Of Deprenyl In The Datatop Extension Trial
| [[Does Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria]]
|-
|-
| BLOSS
| [[CABRI]]
| Beta Blocker Length Of Stay Study
| [[Coronary Angioplasty Versus Bypass Revascularization Investigation]]
|-
|-
| BNP
| [[CACAF]]
| Breathing Not Properly
| [[Catheter Ablation For The Cure Of Atrial Fibrillation Study]]
|-
|-
| BOAT
| [[CACHET]]
| Balloon Angioplasty Versus Optimal Atherectomy Trial
| [[Comparison Of Abciximab Complications With Hirulog (Angiomax As Of 1999) Ischemic Events Trial]]
|-
|-
| Bogalusa
| [[CACTUS]]
| Bogalusa Heart Study
| [[Coronary Bifurcations: Application Of The Crushing Technique Using Sirolimus-Eluting Stents]]
|-
|-
| BOOST
| [[CADILLAC]]
| Bone Marrow Transfer To Enhance St-Elevation Infarct Regeneration
| [[Controlled Abciximab (Reopro) And Device Investigation To Lower Late Angioplasty Complications]]
|-
|-
| BPAV
| [[CAESAR]]
| Balloon Prophylaxis Of Aneurysmal Vasospasm
| [[Canada, Australia, Europe, South Africa Aids Study ]]
|-
|-
| BRAINS
| [[CAFA]]
| Bayer Randomized Acute Ischemia Neuroprotectant Study
| [[Canadian Atrial Fibrillation Anticoagulation Study]]
|-
|-
| BRAVE
| [[CAFE]]
| Bavarian Reperfusion Alternatives Evaluation
| [[Conduit Artery Function Evaluation]]
|-
|-
| BRAVE-2
| [[CALM]]
| Beyond 12 Hours Reperfusion Alternative Evaluation Trial
| [[Candesartan And Lisinopril Microalbuminuria Study]]
|-
|-
| BRAVE-3
| [[CALM-PD]]
| Value Of Abciximab In Patients With Ami Undergoing Pci After High Loading Dose Of Clopidogrel Pretreatment
| [[Comparison Of The Agonist Pramipexole Vs. Levodopa On Motor Complications In Parkinson Disease]]
|-
|-
| BRAVO
| [[CALYPSO]]
| Blockade Of The Glycoprotein Iib/Iiia Receptor To Avoid Vascular Occlusion
| [[Cylexin As An Adjunct To Lytic Therapy To Prevent Superoxide Reflow Injury]]
|-
|-
| BRAVO
| [[CAMELOT]]
| Beta Radiation For Treatment Of Arteriovenous Graft Outflow; Sponsor:
| [[Comparison Of Amlodipine Versus Enalapril (Lipitor) To Limit Occurrences Of Thrombosis]]
|-
|-
| BREATHE-1
| [[CAMEO]]
| Bosentan (Tracleer™]: Randomized Trial Of Endothelin Receptor Antagonist Therapy For Pulmonary Hypertension
| [[Cerebral Aneurysm Multicenter European]]
|-
|-
| BRIDGE
| [[CAMIAT]]
| Beta-Radiation Investigation With Direct Stenting And Galileo In Europe
| [[Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (Pilot)]]
|-
|-
| BRIE
| [[CANDLE]]
| Beta Radiation In Europe
| [[Candesartan Versus Losartan Efficacy Comparison ]]
|-
|-
| BRIEF-PCI
| [[Cangrelor during PCI]]
| Brief Infusion Of Eptifibatide Following Percutaneous Coronary Intervention
| [[Cangrelor During Percutaneous Coronary Intervention]]
|-
|-
| BRILLIANT
| [[CANPAP]]
| Batimastat (Bb-94) Antirestenosis Trial Utilizing The Biodivysio® Local Drug Delivery Pc Stent;
| [[Continuous Positive Airway Pressure For Heart Failure Patients With Central Sleep Apnea]]
|-
|-
| BRITE
| [[CAPARES]]
| Beta Radiation To Reduce In-Stent Restenosis
| [[Coronary Angioplasty Amlodipine Restenosis Study]]
|-
|-
| BRITE II
| [[CAPE II]]
| Beta Radiation To Reduce In-Stent Restenosis Ii
| [[Medical Treatment Of Myocardial Ischemia In Coronary Artery Disease: Effect Of Drug Regime And Irregular Dosing In The Cape II Trial]]
|-
|-
| BRITE-SVG
| [[CAPITAL AMI]]
| Beta Radiation To Reduce In-Stent Restenosis In Saphenous Vein Grafts
| [[Combined Angioplasty And Pharmacological Intervention Versus Thrombolytics Alone In Acute Myocardial Infarction]]
|-
|-
| CABERNET
| [[CAPPP]]
| A Prospective Registry Of Carotid Stenting With The Nexstent And Distal Protection With The Filterwire Ex In High Risk Patients
| [[Captopril Prevention Project]]
|-
|-
| CABERNET
| [[CAPRICORN]]
| Carotid Artery Revascularization Using The Boston Scientific Epi Filterwire Ex And The Endotex Nexstent
| [[Carvedilol Post Infarct Survival Control in Left Ventricular Dysfunction Study]]
|-
|-
| CABG PATCH
| [[CAPRIE]]
| The Coronary Artery Bypass Graft Patch Trial
| [[Clopidogrel Versus Aspirin In Patients At Risk Of Ischemic Events ]]
|-
|-
| CABG Patch Cardioplegia Substudy
| [[CAPS]]
| Does Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria
| [[The Cardiac Arrhythmic Pilot Study]]
|-
|-
| CABRI
| [[CAPT]]
| Coronary Angioplasty Versus Bypass Revascularization Investigation
| [[Complications Of Amd (Age-Related Macular Degeneration) Prevention Trial]]
|-
|-
| CACAF
| [[CAPTEN]]
| Catheter Ablation For The Cure Of Atrial Fibrillation Study
| [[Captopril After Thrombolysis Trial ]]
|-
|-
| CACHET
| [[CAPTIM]]
| Comparison Of Abciximab Complications With Hirulog® (Angiomax™ As Of 1999] Ischemic Events Trial
| [[Comparison Of Angioplasty And Prehospital Thrombolysis In Acute Myocardial Infarction]]
|-
|-
| CACTUS
| [[CAPTIN]]
| Coronary Bifurcations: Application Of The Crushing Technique Using Sirolimus-Eluting Stents
| [[Captopril Plus Tissue Plasminogen Activator Following Acute Myocardial Infarction]]
|-
|-
| CADILLAC
| [[CAPTIVATE]]
| Controlled Abciximab And Device Investigation To Lower Late Angioplasty Complications
| [[Carotid Atherosclerosis Progression Trial Investigating Vascular Acat Inhibition Treatment Effects]]
|-
|-
| CAESAR
| [[CAPTIVE]]
| Canada, Australia, Europe, South Africa Aids Study;
| [[A Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire]]
|-
|-
| CAFA
| [[CAPTURE]]
| Canadian Atrial Fibrillation Anticoagulation Study
| [[Chimeric 7E3 Antiplatelet Therapy In Unstable Angina Refractory To Standard Treatment]]
|-
|-
| CAFE
| [[CAPTURE Registry]]
| Conduit Artery Function Evaluation
| [[Carotid Acculink/Accunet Post-Approval Trial To Uncover Unanticipated Or Rare Events Registry]]
|-
|-
| CALM
| [[CARAT]]
| Candesartan And Lisinopril Microalbuminuria (Calm) Study
| [[Coronary Angioplasty And Rotational Atherectomy Trial]]
|-
|-
| CALM-PD
| [[CARDIA]]
| Comparison Of The Agonist Pramipexole Vs. Levodopa On Motor Complications In Parkinson Disease
| [[Coronary Artery Risk Development In Young Adults]]
|-
|-
| CALYPSO
| [[CARDia]]
| Cylexin As An Adjunct To Lytic Therapy To Prevent Superoxide Reflow Injury
| [[Coronary Artery Revascularization In Diabetes Trial]]
|-
|-
| CAMELOT
| [[CARDINAL]]
| Comparison Of Amlodipine Vs Enalapril To Limit Occurrences Of Thrombosis
| [[Complement And Reduction Of Infarct Size After Angioplasty Or Lytics]]
|-
|-
| CAMEO
| [[CARDS]]
| Cerebral Aneurysm Multicenter European
| [[Collaborative Atorvastatin (Lipitor) And Diabetes Study]]
|-
|-
| CAMIAT
| [[CARE]]
| Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (Pilot)
| [[Cardiac Angiography In Renally Impaired Patients]]
|-
|-
| CANDLE
| [[CARE]]
| Candesartan Versus Losartan Efficacy Comparison Study Group
| [[Cholesterol And Recurrent Events]]
|-
|-
| Cangrelor during PCI
| [[CARE]]
| Cangrelor During Percutaneous Coronary Intervention
| [[Calcium Antagonist In Reperfusion Cholesterol And Recurrent Events Carvedilol Atherectomy Restenosis ]]
|-
|-
| CANPAP
| [[CARE-HD]]
| Continuous Positive Airway Pressure For Heart Failure Patients With Central Sleep Apnea
| [[Coenzyme Q10 And Remacemide: Evaluation In Huntington Disease]]
|-
|-
| CAPARES
| [[CARE-HF]]
| Coronary Angioplasty Amlodipine Restenosis Study
| [[Cardiac Resynchronization - Heart Failure European Complement To U.S./Canada Miracle Study]]
|-
|-
| CAPE II
| [[CARESS]]
| Medical Treatment Of Myocardial Ischemia In Coronary Artery Disease: Effect Of Drug Regime And Irregular Dosing In The Cape Ii Trial
| [[Clopidogrel And Aspirin For Reduction Of Emboli In Symptomatic Carotid Stenosis]]
|-
|-
| CAPITAL AMI
| [[CARESS-in-AMI: 30-Day and 1-Year Results]]
| Combined Angioplasty And Pharmacological Intervention Versus Thrombolytics Alone In Acute Myocardial Infarction
| [[Combined Abciximab Reteplase Stent Study In Acute Myocardial Infarction: 30-Day and 1-Year Results]]
|-
|-
| CAPPP
| [[CARET]]
| Captopril Prevention Project
| [[The Beta Carotene And Retinol Efficacy Trial]]
|-
|-
| CAPRICORN
| [[CARIBE]]
| Carvedilol Post-Infarct Survival Controlled Evaluation
| [[Carvedilol Insuficiencia Cardiaca (Heart Failure) Beta-Receptor]]
|-
|-
| CAPRIE
| [[CARISA]]
| Clopidogrel Versus Aspirin In Patients At Risk Of Ischaemic Events
| [[Combination Assessment Of Ranolazine In Stable Angina ]]
|-
|-
| CAPS
| [[CARMEN]]
| The Cardiac Arrhythmic Pilot Study
| [[The Carvedilol And Ace-Inhibitor Remodeling Mild Heart Failure Evaluation Trial]]
|-
|-
| CAPT
| [[CARMEN]]
| Complications Of Amd (Age-Related Macular Degeneration] Prevention Trial
| [[Carvedilol Ace Inhibitors Remodelling Mild Heart Failure Evaluation]]
|-
|-
| CAPTEN
| [[CARP]]
| Captopril After Thrombolysis Trial;
| [[Coronary Artery Revascularization Prophylaxis]]
|-
|-
| CAPTIM
| [[CARS]]
| Comparison Of Angioplasty And Prehospital Thrombolysis In Acute Myocardial Infarction
| [[Coumadin Aspirin Reinfarction Study]]
|-
|-
| CAPTIN
| [[CART]]
| Captopril Plus Tissue Plasminogen Activator Following Acute Myocardial Infarction
| [[Canadian Antioxidant Restenosis Trial]]
|-
|-
| CAPTIVATE
| [[CARVEDILOL]]
| Carotid Atherosclerosis Progression Trial Investigating Vascular Acat Inhibition Treatment Effects
| [[The Effects Of Carvedilol On Morbidity And Mortality In Patients With Chronic Heart Failure]]
|-
|-
| CAPTIVE
| [[CASCADE]]
| A Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire
| [[Cardiac Arrest In Seattle: Conventional Versus Amiodarone Drug Evaluation Study]]
|-
|-
| CAPTURE
| [[CASES]]
| Chimeric 7E3 Antiplatelet Therapy In Unstable Angina Refractory To Standard Treatment
| [[Canadian Activase For Stroke Effectiveness Study]]
|-
|-
| CAPTURE Registry
| [[CASH]]
| Carotid Acculink/Accunet Post-Approval Trial To Uncover Unanticipated Or Rare Events Registry
| [[Cardiac Arrest Study-Hamburg]]
|-
|-
| CARAT
| [[CASIS]]
| Coronary Angioplasty And Rotational Atherectomy Trial
| [[Canadian Amlodipine/Atenolol In Silent Ischemia Study]]
|-
|-
| CARDIA
| [[CASS]]
| Coronary Artery Risk Development In Young Adults
| [[Coronary Artery Surgery Study]]
|-
|-
| CARDia
| [[CAST]]
| Coronary Artery Revascularization In Diabetes Trial
| [[Cardiac Arrhythmia Suppression Trial]]
|-
|-
| CARDINAL
| [[CASTEMI]]
| Complement And Reduction Of Infarct Size After Angioplasty Or Lytics
| [[Calderet In St Elevation Myocardial Infarction]]
|-
|-
| CARDS
| [[CAST-II]]
| Collaborative Atorvastatin Diabetes Study
| [[The Cardiac Arrhythmia Suppression Trial II]]
|-
|-
| CARE
| [[CASTLE]]
| Cardiac Angiography In Renally Impaired Patients
| [[Candesartan Amlodipine Study Of Tolerability And Efficacy]]
|-
|-
| CARE
| [[CAT]]
| Cholesterol And Recurrent Events
| [[Cardiomyopathy Trial]]
|-
|-
| CARE
| [[CAT]]
| Calcium Antagonist In Reperfusion; Cholesterol And Recurrent Events; Carvedilol Atherectomy Restenosis;
| [[Chinese Ace Inhibitor In Acute Myocardial Infarction Trial  Cardiomyopathy Trial]]
|-
|-
| CARE-HD
| [[CATAPULT]]
| Coenzyme Q10 And Remacemide: Evaluation In Huntington Disease
| [[Cisplatin And Tirapazamine In Subjects With Advanced Previously Untreated Non–Small Cell Lung Tumors]]
|-
|-
| CARE-HF
| [[Cathedia Study]]
| Cardiac Resynchronization Heart Failure Study
| [[Femoral Vs. Jugular Venous Catheterization And Risk Of Nosocomial Events In Adults Requiring Acute Renal Replacement Therapy]]
|-
|-
| CARESS
| [[CATIE]]
| Clopidogrel And Aspirin For Reduction Of Emboli In Symptomatic Carotid Stenosis
| [[Clinical Antipsychotic Trials Of Intervention Effectiveness]]
|-
|-
| CARESS-in-AMI: 30-Day and 1-Year Results
| [[CATS]]
| Combined Abciximab Reteplase Stent Study In Acute Myocardial Infarction
| [[Canadian American Ticlopidine Study]]
|-
|-
| CARET
| [[CATS]]
| The Beta Carotene And Retinol Efficacy Trial
| [[Captopril And Thrombolysis Study]]
|-
|-
| CARIBE
| [[CAVATAS]]
| Carvedilol Insuficiencia Cardiaca (Heart Failure) Beta-Receptor
| [[Endovascular Versus Surgical Treatment In Patients With Carotid Stenosis In The Carotid And Vertebral Artery Transluminal Angioplasty Study (Cavatas)]]
|-
|-
| CARISA
| [[CAVEAT I]]
| Combination Assessment Of Ranolazine In Stable Angina
| [[Coronary Angioplasty Versus Excisional Atherectomy Trial I]]
|-
|-
| CARMEN
| [[CAVEAT II]]
| The Carvedilol And Ace-Inhibitor Remodeling Mild Heart Failure Evaluation Trial
| [[Coronary Angioplasty Versus Excisional Atherectomy Trial II]]
|-
|-
| CARP
| [[CBT-CD]]
| Coronary Artery Revascularization Prophylaxis
| [[Cognitive Behavior Therapy For The Chronic Depressions]]
|-
|-
| CARS
| [[CCAT]]
| Coumadin Aspirin Reinfarction Study
| [[Canadian Coronary Atherectomy Trial]]
|-
|-
| CART
| [[CCP]]
| Canadian Antioxidant Restenosis Trial
| [[The Cooperative Cardiovascular Project]]
|-
|-
| CARVEDILOL
| [[CCS-1]]
| The Effects Of Carvedilol On Morbidity And Mortality In Patients With Chronic Heart Failure
| [[Chinese Cardiac Study]]
|-
|-
| CASCADE
| [[CDP]]
| Cardiac Arrest In Seattle: Conventional Versus Amiodarone Drug Evaluation Study
| [[Coronary Drug Project]]
|-
|-
| CASES
| [[CEDARS]]
| Canadian Activase For Stroke Effectiveness Study
| [[Comprehensive Evaluation Of Defibrillators And Resuscitative Shock]]
|-
|-
| CASH
| [[CELL]]
| Cardiac Arrest Study Hamburg
| [[Cost Effectiveness Of Lipid Lowering Study]]
|-
|-
| CASIS
| [[CEOS]]
| Canadian Amlodipine/Atenolol In Silent Ischemia Study
| [[Congenital Esotropia Observational Study]]
|-
|-
| CASS
| [[CHAMP]]
| Coronary Artery Surgery Study
| [[Combination Hemotherapy And Mortality Prevention (Champ) Study]]
|-
|-
| CAST
| [[CHAMP]]
| The Cardiac Arrhythmia Suppression Trial
| [[Children's Hiv And Aids Model Program]]
|-
|-
| CASTEMI
| [[CHAMPIONS]]
| Calderet In St Elevation Myocardial Infarction
| [[Controlled High-Risk Subjects Avonex Ms Prevention In Ongoing Neurologic Surveillance]]
|-
|-
| CAST-II
| [[CHAMPS]]
| The Cardiac Arrhythmia Suppression Trial Ii
| [[Controlled High-Risk Subjects Avonex Ms Prevention Study]]
|-
|-
| CASTLE
| [[CHAOS]]
| Candesartan Amlodipine Study Of Tolerability And Efficacy
| [[Cambridge Heart Antioxidant Study]]
|-
|-
| CAT
| [[CHARISMA]]
| Cardiomyopathy Trial
| [[Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance]]
|-
|-
| CAT
| [[CHARM]]
| Chinese Ace Inhibitor In Acute Myocardial Infarction Trial ; Cardiomyopathy Trial
| [[Candesartan Cilexitil (Atacand) In Heart Failure Assessment Of Reduction Mortality And Morbidity]]
|-
|-
| CATAPULT
| [[CHARM Added Trial]]
| Cisplatin And Tirapazamine In Subjects With Advanced Previously Untreated Non–Small Cell Lung Tumors
| [[Candesartan In Heart Failure—Added Trial]]
|-
|-
| Cathedia Study
| [[CHARM Alternative Trial]]
| Femoral Vs. Jugular Venous Catheterization And Risk Of Nosocomial Events In Adults Requiring Acute Renal Replacement Therapy
| [[Candesartan In Heart Failure—Alternative Trial]]
|-
|-
| CATIE
| [[CHARM Overall Programme Results]]
| Clinical Antipsychotic Trials Of Intervention Effectiveness
| [[Candesartan In Heart Failure—Assessment Of Reduction In Mortality And Morbidity]]
|-
|-
| CATS
| [[CHARM Preserved Trial]]
| Canadian American Ticlopidine Study
| [[Candesartan In Heart Failure—Preserved Trial]]
|-
|-
| CATS
| [[CHEESE]]
| Captopril And Thrombolysis Study
| [[Comparative Trial Of Hiv-Infected Patients Evaluating Efficacy And Safety Of Saquinavir-Enhanced Oral Formulation And Indinavir Given As Part Of A Triple Drug Therapy ]]
|-
|-
| CAVATAS
| [[CHF-STAT]]
| Endovascular Versus Surgical Treatment In Patients With Carotid Stenosis In The Carotid And Vertebral Artery Transluminal Angioplasty Study (Cavatas)
| [[Congestive Heart Failure Survival Trial Of Antiarrhythmic Therapy]]
|-
|-
| CAVATAS
| [[CHICAGO]]
| Carotid And Vertebral Artery Transluminal Angioplasty Study
| [[Carotid Intima-Media Thickness In Atherosclerosis Using Pioglitazone]]
|-
|-
| CAVEAT I
| [[CHRISTMAS]]
| Coronary Angioplasty Versus Excisional Atherectomy Trial I
| [[Carvedilol Hibernating Reversible Ischaemia Trial]]
|-
|-
| CAVEAT II
| [[CHS]]
| Coronary Angioplasty Versus Excisional Atherectomy Trial Ii
| [[Cardiovascular Health Study]]
-----
---- [[CHS]]
---- [[Charleston Heart Study]]
-----
---- [[CHS]]
---- [[Community Health Study]]
-----
---- [[CHS]]
---- [[Congenital Heart Surgeons Society Study]]
-----
---- [[CHS]]
---- [[Coronary Heart Study]]
|-
|-
| CBT-CD
| [[CIAO]]
| Cognitive Behavior Therapy For The Chronic Depressions;
| [[Coronary Interventions Antiplatelet-Based Only]]
|-
|-
| CCAT
| [[CIBIS]]
| Canadian Coronary Atherectomy Trial
| [[Cardiac Insufficiency Bisoprolol Study]]
|-
|-
| CCP
| [[CIBIS II]]
| The Cooperative Cardiovascular Project
| [[The Cardiac Insufficiency Bisoprolol Study II]]
|-
|-
| CCS-1
| [[CIBIS III]]
| Chinese Cardiac Study
| [[The Cardiac Insufficiency Bisoprolol Study III]]
|-
|-
| CDP
| [[CIDS]]
| Coronary Drug Project
| [[Canadian Implantable Defibrillator Study]]
|-
|-
| CEDARS
| [[CIGTS]]
| Comprehensive Evaluation Of Defibrillators And Resuscitative Shock
| [[Collaborative Initial Glaucoma Treatment Study]]
|-
|-
| CELL
| [[CLARIDI]]
| Cost Effectiveness Of Lipid Lowering Study
| [[Cholesterol Lowering And Arrhythmias Recurrences After Internal Defibrillator Implantation]]
|-
|-
| CEOS
| [[CLARITY-TIMI 28]]
| Congenital Esotropia Observational Study
| [[Clopidogrel As Adjunctive Reperfusion Therapy]]
|-
|-
| CHAMP
| [[CLAS I AND II]]
| Combination Hemotherapy And Mortality Prevention (Champ) Study
| [[Cholesterol Lowering Atherosclerosis Study (I And II)]]
|-
|-
| CHAMP
| [[CLASS]]
| Children'S Hiv And Aids Model Program
| [[Celecoxib (Celebrex) Long-Term Arthritis Safety Study]]
|-
|-
| CHAMPIONS
| [[CLASSICS]]
| Controlled High-Risk Subjects Avonex™ Ms Prevention In Ongoing Neurologic Surveillance
| [[Clopidogrel (Plavix) Aspirin Stent International Cooperative Study]]
|-
|-
| CHAMPS
| [[CLASS-IHT]]
| Controlled High-Risk Subjects Avonex™ Ms Prevention Study
| [[Clomethiazole Acute Stroke Study In Ischemic, Hemorrhagic, And Tpa Treated Stroke]]
|-
|-
| CHAOS
| [[CLEAR PLATELETS]]
| Cambridge Heart Antioxidant Study
| [[Clopidogrel Loading With Eptifibatide To Arrest The Reactivity Of Platelets Study]]
|-
|-
| CHARISMA
| [[CLEAR PLATELETS-2]]
| Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
| [[Clopidogrel With Eptifibatide To Arrest The Reactivity Of Platelets-2]]
|-
|-
| CHARM
| [[CLEERE]]
| Candesartan Cilexitil (Atacand™] In Heart Failure Assessment Of Reduction Mortality And Morbidity
| [[Collaborative Longitudinal Evaluation Of Ethnicity And Refractive Error]]
|-
|-
| CHARM Added Trial
| [[COACH]]
| Candesartan In Heart Failure—Added Trial
| [[Coordinating Study Evaluating Outcomes Of Advising And Counseling In Heart Failure]]
|-
|-
| CHARM Alternative Trial
| [[COAST]]
| Candesartan In Heart Failure—Alternative Trial
| [[Heparin-Coated Stents In Small Coronary Arteries]]
|-
|-
| CHARM Overall Programme Results
| [[COBALT]]
| Candesartan In Heart Failure—Assessment Of Reduction In Mortality And Morbidity
| [[Continuous Infusion Versus Double-Bolus Administration Of Alteplase]]
|-
|-
| CHARM Preserved Trial
| [[COCAD]]
| Candesartan In Heart Failure—Preserved Trial
| [[Cognitive Outcomes In Coronary Artery Disease]]
|-
|-
| CHEESE
| [[COLA]]
| Comparative Trial Of Hiv-Infected Patients Evaluating Efficacy And Safety Of Saquinavir-Enhanced Oral Formulation And Indinavir Given As Part Of A Triple Drug Therapy;
| [[Carvedilol Open Label Assessment]]
|-
|-
| CHF STAT
| [[COLUMBUS]]
| Amiodarone In Patients With Congestive Heart Failue And Asymptomatic Ventricular Arrhythmia
| [[Low Molecular Weight Heparin In The Treatment Of Patients With Venous Thromboembolism]]
|-
|-
| CHF-STAT
| [[COMBINE]]
| Congestive Heart Failure Survival Trial Of Antiarrhythmic Therapy
| [[Combining Medications And Behavorial Interventions ]]
|-
|-
| CHICAGO
| [[COMET]]
| Carotid Intima-Media Thickness In Atherosclerosis Using Pioglitazone
| [[Carvedilol Or Metoprolol European Trial]]
|-
|-
| CHRISTMAS
| [[COMMA]]
| Carvedilol Hibernating Reversible Ischaemia Trial
| [[Compliment Inhibition In Myocardial Infarction Treated With Percutaneous Transluminal Coronary Angioplasty (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv) ]]
|-
|-
| CHS
| [[COMMIT/CCS-2 – Clopidogrel]]
| Cardiovascular Health Study
| [[Randomized, Placebo-Controlled Trial Of Adding Clopidogrel To Aspirin In 46,000 Acute Myocardial Infarction Patients]]
|-
|-
| CIAO
| [[COMMIT/CCS-2 – Metoprolol]]
| Coronary Interventions Antiplatelet-Based Only
| [[Randomized, Placebo-Controlled Trial Of Early Metoprolol In 46,000 Acute Myocardial Infarction Patients]]
|-
|-
| CIBIS
| [[COMPANION]]
| The Cardiac Insufficiency Bisoprolol Study
| [[Comparison Of Medical Therapy, Pacing And Defibrillation In Chronic Heart Failure]]
|-
|-
| CIBIS II
| [[Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenosis]]
| The Cardiac Insufficiency Bisoprolol Study Ii
| [[Randomized Clinical Trial Investigators. Randomized Comparison Of Gr-II Stent And Palmaz-Schatz Stent For Elective Treatment Of Coronary Stenosis]]
|-
|-
| CIBIS III
| [[Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus]]
| Canadian Implantable Defibrillator Study
| [[A Comparison Of Ibuprofen And Indomethacin For Closure Of Patent Ductus Arteriosus]]
|-
|-
| CIDS
| [[COMPASS]]
| Canadian Implantable Defibrillator Study
| [[Comparison Trial Of Saruplase And Streptokinase]]
|-
|-
| CIGTS
| [[COMPASS-HF]]
| Collaborative Initial Glaucoma Treatment Study
| [[Chronicle Offers Management To Patients With Advanced Signs And Symptoms Of Heart Failure]]
|-
|-
| CLARIDI
| [[COMPLY]]
| Cholesterol Lowering And Arrhythmias Recurrences After Internal Defibrillator Implantation
| [[Compliment Inhibition In Myocardial Infarction Treated With Thrombolytics (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv) Sponsors]]
|-
|-
| CLARITY-TIMI 28
| [[COMS]]
| Clopidogrel As Adjunctive Reperfusion Therapy
| [[Collaborative Ocular Melanoma Study]]
|-
|-
| CLAS I AND II
| [[CONSENSUS]]
| Cholesterol Lowering Atherosclerosis Study (I And Ii)
| [[The Effects Of Enalapril On Mortality In Severe Congestive Heart Failure]]
|-
|-
| CLASS
| [[CONSENSUS II]]
| Celecoxib (Celebrex®] Long-Term Arthritis Safety Study
| [[The Effects Of The Early Administration Of Enalapril On Mortality In Patients With Acute Myocardial Infarction: Results Of The Cooperative New Scandin-2]]
|-
|-
| CLASSICS
| [[CONVERTIBLE]]
| The Clopidogrel Aspirin Stent International Cooperative Study (Classics)
| [[Conventional Stenting Versus Direct Stenting In (Un)Stable Angina Pectoris]]
|-
|-
| CLASS-IHT
| [[CONVINCE]]
| Clomethiazole Acute Stroke Study In Ischemic, Hemorrhagic, And Tpa Treated Stroke
| [[Controlled Onset Verapamil Investigation Of Cardiovascular Endpoints Trial]]
|-
|-
| CLEAR PLATELETS
| [[COOL]]
| Clopidogrel Loading With Eptifibatide To Arrest The Reactivity Of Platelets Study
| [[Cardiovascular Thrombolytic To Open Occluded Lines]]
|-
|-
| CLEAR PLATELETS-2
| [[COOL AID]]
| Clopidogrel With Eptifibatide To Arrest The Reactivity Of Platelets
| [[Cooling For Acute Ischemic Brain Damage]]
|-
|-
| CLEERE
| [[COOL MI]]
| Collaborative Longitudinal Evaluation Of Ethnicity And Refractive Error
| [[Cooling As An Adjunctive Therapy To Percutaneous Intervention In Patients With Acute Myocardial Infarction]]
|-
|-
| COACH
| [[COOLRCN]]
| Coordinating Study Evaluating Outcomes Of Advising And Counseling In Heart Failure
| [[Cooling To Prevent Radiocontrast Nephropathy]]
|-
|-
| COAST
| [[COPERNICUS]]
| Heparin-Coated Stents In Small Coronary Arteries
| [[Effect Of Carvedilol On Survival In Severe Chronic Heart Failure]]
|-
|-
| COBALT
| [[COPPA]]
| Continuous Infusion Versus Double-Bolus Administration Of Alteplase
| [[Clinical Outcomes From The Prevention Of Postoperative Arrhythmia]]
|-
|-
| COCAD
| [[CORE]]
| Cognitive Outcomes In Coronary Artery Disease
| [[International Variation In Invasive Procedures And Outcomes In Acute Myocardial Infarction]]
|-
|-
| COLA
| [[CORE]]
| Carvedilol Open Label Assessment
| [[Continuing Outcomes Relevant To Evista]]
|-
|-
| COLUMBUS
| [[CORONA]]
| Low Molecular Weight Heparin In The Treatment Of Patients With Venous Thromboembolism
| [[Controlled Rosuvastatin Multinational Trial In Heart Failure]]
|-
|-
| COMBINE
| [[CORSICA]]
| Combining Medications And Behavorial Interventions;
| [[Chronic Occlusion Revascularization With Stent Implantation Versus Coronary Angioplasty]]
|-
|-
| COMET
| [[COSS]]
| Carvedilol Or Metoprolol European Trial
| [[Carotid Occlusion Surgery Study]]
|-
|-
| COMMA
| [[COURAGE]]
| Compliment Inhibition In Myocardial Infarction Treated With Percutaneous Transluminal Coronary Angioplasty (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv];
| [[Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation ]]
|-
|-
| COMMIT/CCS-2 – Clopidogrel
| [[COURT]]
| Randomized, Placebo-Controlled Trial Of Adding Clopidogrel To Aspirin In 46,000 Acute Myocardial Infarction Patients
| [[Contrast Utilization In High Risk Patients Undergoing Ptca]]
|-
|-
| COMMIT/CCS-2 – Metoprolol
| [[C-PORT]]
| Randomized, Placebo-Controlled Trial Of Early Metoprolol In 46,000 Acute Myocardial Infarction Patients
| [[Atlantic Cardiovascular Patient Outcomes Research Team Trial]]
|-
|-
| COMPANION
| [[CPVA for Chronic Atrial Fibrillation]]
| Comparison Of Medical Therapy, Pacing And Defibrillation In Heart Failure
| [[Circumferential Pulmonary Vein Ablation For Chronic Atrial Fibrillation]]
|-
|-
| Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenosis
| [[CQI in CABG]]
| Randomized Clinical Trial Investigators. Randomized Comparison Of Gr-Ii Stent And Palmaz-Schatz Stent For Elective Treatment Of Coronary Stenosis
| [[Continuous Quality Improvement In Coranary Artery Bypass Graft]]
|-
|-
| Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus
| [[CRASH]]
| A Comparison Of Ibuprofen And Indomethacin For Closure Of Patent Ductus Arteriosus
| [[Corticosteroid Randomization After Significant Head Injury]]
|-
|-
| COMPASS
| [[CREATE]]
| Comparison Trial Of Saruplase And Streptokinase
| [[Canadian Cardiac Randomized Evaluation Of Antidepressant And Psychotherapy Efficacy]]
|-
|-
| COMPASS-HF
| [[CREATE ELCA - Reviparin]]
| Chronicle Offers Management To Patients With Advanced Signs And Symptoms Of Heart Failure
| [[Low Molecular Weight Heparin (Reviparin) In Preventing Mortality, Reinfarction, And Strokes In Over 15,500 Patients With St Elevation Acute Myocardial Infarction]]
|-
|-
| COMPLY
| [[CREATE-ECLA - GIK]]
| Compliment Inhibition In Myocardial Infarction Treated With Thrombolytics (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv]; Sponsors
| [[Impact Of Glucose-Insulin-Potassium On Mortality And Morbidity In Over 20,000 Patients With Acute Myocardial Infarction: The Create-Ecla International Trial]]
|-
|-
| COMS
| [[CREDO]]
| Collaborative Ocular Melanoma Study
| [[Clopidogrel For Reduction Of Events During Observation]]
|-
|-
| CONSENSUS
| [[CREST]]
| The Effects Of Enalapril On Mortality In Severe Congestive Heart Failure
| [[Cilostazol For Restenosis]]
|-
|-
| CONSENSUS II
| [[CREST]]
| The Effects Of The Early Administration Of Enalapril On Mortality In Patients With Acute Myocardial Infarction: Results Of The Cooperative New Scandin
| [[Carotid Revascularization Endarterectomy Vs Stenting Trial]]
|-
|-
| CONVERTIBLE
| [[CRIS]]
| Conventional Stenting Versus Direct Stenting In (Un)Stable Angina Pectoris
| [[A Controlled Trial Of Verapamil In Patients After Acute Myocardial Infarction: Results Of The Calcium, Antagonist Reinfarction Italian Study]]
|-
|-
| CONVINCE
| [[CRUISE]]
| Controlled Onset Verapamil Investigation Of Cardiovascular Endpoints Trial
| [[Can Routine Ultrasound Influence Stent Expansion]]
|-
|-
| CONVINCE
| [[C-SIRIUS]]
| Controlled Onset Verapamil Investigation Of Cardiovascular Endpoints
| [[Canadian Sirolimus-Eluting Stent In Coronary Lesions]]
|-
|-
| COOL
| [[CSSS]]
| Cardiovascular Thrombolytic To Open Occluded Lines
| [[China Salt Substitute Study]]
|-
|-
| COOL AID
| [[CTAF]]
| Cooling For Acute Ischemic Brain Damage
| [[Canadian Trial Of Atrial Fibrillation]]
|-
|-
| COOL MI
| [[CTOPP]]
| Cooling As An Adjunctive Therapy To Percutaneous Intervention In Patients With Acute Myocardial Infarction
| [[Canadian Trial Of Physiologic Pacing]]
|-
|-
| COOL-MI
| [[CUBA]]
| Cooling As An Adjunctive Therapy To Percutaneous Intervention In Patients With Acute Myocardial Infarction
| [[Cutting Balloon Versus Conventional Angioplasty Study]]
|-
|-
| COOLRCN
| [[CURE]]
| Cooling To Prevent Radiocontrast Nephropathy
| [[The Clopidogrel In Unstable Angina To Prevent Recurrent Events Trial Investigators: Effects Of Clopidogrel In Addition To Aspirin In Patients With Acute Coronary Syndromes Without St-Segment Elevation]]
|-
|-
| COPERNICUS
| [[CURE]]
| Effect Of Carvedilol On Survival In Severe Chronic Heart Failure
| [[Clopidogrel In Unstable Angina To Prevent Recurrent Ischemic Events]]
|-
|-
| COPPA
| [[DAIS]]
| Clinical Outcomes From The Prevention Of Postoperative Arrhythmia
| [[Diabetes Atherosclerosis Intervention Study]]
|-
|-
| CORE
| [[DAISY]]
| International Variation In Invasive Procedures And Outcomes In Acute Myocardial Infarction
| [[Diabetes Autoimmunity Study In The Young]]
|-
|-
| CORE
| [[DANAMI]]
| Continuing Outcomes Relevant To Evista™
| [[Danish Myocardial Infarction Trial]]
|-
|-
| CORONA
| [[DANAMI-2]]
| Controlled Rosuvastatin Multinational Trial In Heart Failure
| [[Danish Trial In Acute Myocardial Infarction-2]]
|-
|-
| CORSICA
| [[DANTE]]
| Chronic Occlusion Revascularization With Stent Implantation Versus Coronary Angioplasty
| [[Diabetes Abciximab Stent Evaluation]]
|-
|-
| COSS
| [[DAPPAF]]
| Carotid Occlusion Surgery Study
| [[Dual Site Atrial Pacing To Prevent Atrial Fibrillation]]
|-
|-
| COURAGE
| [[DART]]
| Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation;
| [[Dilation Versus Ablation Revascularization Trial]]
|-
|-
| COURAGE
| [[DASH]]
| Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation
| [[Dietary Approaches To Stop Hypertension]]
|-
|-
| COURT
| [[DATATOP]]
| Contrast Utilization In High Risk Patients Undergoing Ptca
| [[Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism]]
|-
|-
| C-PORT
| [[DAVID]]
| Atlantic Cardiovascular Patient Outcomes Research Team Trial
| [[Dual-Chamber And Vvi Implantable Defibrillator]]
|-
|-
| CPVA for Chronic Atrial Fibrillation
| [[DAVID – (Picotamide vs. Aspirin)]]
| Circumferential Pulmonary Vein Ablation For Chronic Atrial Fibrillation
| [[Drug Evaluation In Atherosclerotic Vascular Disease In Diabetics]]
|-
|-
| CQI in CABG
| [[DAVID II]]
| Continuous Quality Improvement In Coranary Artery Bypass Graft
| [[Dual Chamber And Vvi Implantable Defibrillator II]]
|-
|-
| CRASH
| [[DAVIT II]]
| Corticosteroid Randomization After Significant Head Injury
| [[Danish Study Group On Verapamil In Mi]]
|-
|-
| CREATE
| [[DCCT]]
| Canadian Cardiac Randomized Evaluation Of Antidepressant And Psychotherapy Efficacy
| [[Diabetes Control And Complications Trial]]
|-
|-
| CREATE ELCA - Reviparin
| [[DEAR-MI]]
| Low Molecular Weight Heparin (Reviparin) In Preventing Mortality, Reinfarction, And Strokes In Over 15,500 Patients With St Elevation Acute Myocardial Infarction
| [[Dethrombosis To Enhance Acute Reperfusion In Myocardial Infarction]]
|-
|-
| CREATE-ECLA - GIK
| [[DEBATE]]
| Impact Of Glucose-Insulin-Potassium On Mortality And Morbidity In Over 20,000 Patients With Acute Myocardial Infarction: The Create-Ecla International Trial
| [[Doppler Endpoints Balloon Angioplasty Trial Europe]]
|-
|-
| CREDO
| [[DEBATE II]]
| Clopidogrel For Reduction Of Events During Observation
| [[Doppler Endpoints Balloon Angioplasty Trial Europe-2]]
|-
|-
| CREST
| [[DEBUT]]
| Cilostazol For Restenosis
| [[Defibrillator Versus Beta-Blockers For Unexplained Death In Thailand]]
|-
|-
| CREST
| [[DECLARE-DIABETES]]
| Carotid Revascularization Endarterectomy Vs Stenting Trial
| [[Drug-Eluting Stenting Followed By Cilostazol Treatment Reduces Late Restenosis In Patients With Diabetes Mellitus]]
|-
|-
| CRIS
| [[DECOPI]]
| A Controlled Trial Of Verapamil In Patients After Acute Myocardial Infarction: Results Of The Calcium, Antagonist Reinfarction Italian Study
| [[Randomized Trial Of Occluded Artery Angioplasty After Acute Myocardial Infarction]]
|-
|-
| CRUISE
| [[DECOPI]]
| Final Results Of The Can Routine Ultrasound Influence Stent Expansion (Cruise) Study
| [[La Desobstruction Coronaire En Post-Infarctus ]]
|-
|-
| C-SIRIUS
| [[DECREASE III]]
| Canadian Sirolimus-Eluting Stent In Coronary Lesions
| [[Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo III]]
|-
|-
| CSSS
| [[DECREASE-V]]
| China Salt Substitute Study
| [[Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-V]]
|-
|-
| CTAF
| [[DEDICATION: Distal Protection Study]]
| Canadian Trial Of Atrial Fibrillation
| [[Drug Elution And Distal Protection In St-Elevation Myocardial Infarction]]
|-
|-
| CTOPP
| [[DEDICATION: Stent Study]]
| Canadian Trial Of Physiologic Pacing
| [[Drug Elution And Distal Protection In Acute Myocardial Infarction]]
|-
|-
| CUBA
| [[DEFER]]
| Cutting Balloon Versus Conventional Angioplasty Study
| [[Deferral Versus Performance Of Ptca In Patients Without Documented Ischemia]]
|-
|-
| CURE
| [[DEFINITE]]
| The Clopidogrel In Unstable Angina To Prevent Recurrent Events Trial Investigators: Effects Of Clopidogrel In Addition To Aspirin In Patients With Acute Coronary Syndromes Without St-Segment Elevation
| [[Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation]]
|-
|-
| DAIS
| [[DEFUSE]]
| Diabetes Atherosclerosis Intervention Study
| [[Diffusion-Weighted Imaging Evaluation For Understanding Stroke Evaluation ]]
|-
|-
| DAISY
| [[DELTA MI]]
| Diabetes Autoimmunity Study In The Young
| [[Direct Inhibition Of Δ-Protein Kinase C Enzyme To Limit Total Infarct Size In Acute Mi]]
|-
|-
| DANAMI
| [[DES-DIABETES]]
| Danish Myocardial Infarction Trial
| [[A Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus]]
|-
|-
| DANAMI-2
| [[DESTINI-CFR]]
| Danish Trial In Acute Myocardial Infarction-2
| [[Doppler Endpoints Stenting International Investigation - Coronary Flow Reserve ]]
|-
|-
| DANTE
| [[DETAIL]]
| Diabetes Abciximab Stent Evaluation
| [[Diabetics Exposed To Telmisartan And Enalapril]]
|-
|-
| DAPPAF
| [[DIABETES]]
| Dual Site Atrial Pacing To Prevent Atrial Fibrillation
| [[A Prospective, Randomized, Controlled Trial Of The Polymer-Based, Sirolimus-Eluting Stent Versus A Bare Metal Stent In Patients With Diabetes Mellitus]]
|-
|-
| DART
| [[DIACOR]]
| Dilation Versus Ablation Revascularization Trial
| [[Diabetes And Combined Lipid Therapy Regimen]]
|-
|-
| DASH
| [[DIAD]]
| Dietary Approaches To Stop Hypertension
| [[Detection Of Ischemia In Asymptomatic Diabetics]]
|-
|-
| DATATOP
| [[DIADS]]
| Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism
| [[Depression In Alzheimer Disease Study]]
|-
|-
| DAVID
| [[DIAGNOSIS]]
| Dual Chamber And Vvi Implantable Defibrillator (David) Trial
| [[Diffusion-Weighted Imaging Assessment Of The Genuine Need For Other Studies In Ischemic Stroke]]
|-
|-
| DAVID – (Picotamide vs. Aspirin)
| [[DIAL]]
| Drug Evaluation In Atherosclerotic Vascular Disease In Diabetics
| [[Randomized Trial Of Telephone Intervention In Chronic Heart Failure]]
|-
|-
| DAVID II
| [[DIAMOND]]
| Dual Chamber And Vvi Implantable Defibrillator Ii
| [[Danish Investigations Of Arrhythmia And Mortality On Dofetilide]]
|-
|-
| DAVIT II
| [[DIAMOND]]
| Danish Study Group On Verapamil In Mi
| [[Distensibility Improvement With Alt-711 Remodeling In Diastolic Heart Failure Sponsor]]
|-
|-
| DCCT
| [[DIAMOND CHF]]
| Diabetes Control And Complications Trial
| [[Danish Investigators Of Arrhythmia And Mortality On Dofetilde Congestive Heart Failure ]]
|-
|-
| DEAR-MI
| [[DIDI]]
| Dethrombosis To Enhance Acute Reperfusion In Myocardial Infarction
| [[Diltiazem In Dilated Cardiomyopathy]]
|-
|-
| DEBATE
| [[DIG]]
| Doppler Endpoints Balloon Angioplasty Trial Europe
| [[Digoxin Investigation Group]]
|-
|-
| DEBATE II
| [[DIG Enalapril]]
| Doppler Endpoints Balloon Angioplasty Trial Europe
| [[Enalapril Versus Digoxin In Patients With Congestive Heart Failure: A Multicenter Study (Canadian Enalapril Versus Digoxin Study Group)]]
|-
|-
| DEBUT
| [[DIGAMI]]
| Defibrillator Versus Beta-Blockers For Unexplained Death In Thailand
| [[Diabetes Mellitus Insulin-Glucose Infusion In Acute Myocardial Infarction]]
|-
|-
| DECLARE-DIABETES
| [[DIMT]]
| Drug-Eluting Stenting Followed By Cilostazol Treatment Reduces Late Restenosis In Patients With Diabetes Mellitus
| [[Double-Blind Placebo-Controlled Study Of Ibopamine And Digoxin In Patients With Mild To Moderate Heart Failure: Results Of The Dutch Ibopamine Multic]]
|-
|-
| DECOPI
| [[DINAMIT]]
| Randomized Trial Of Occluded Artery Angioplasty After Acute Myocardial Infarction
| [[Defibrillation In Acute Myocardial Infarction Trial]]
|-
|-
| DECREASE III
| [[DIPOM]]
| Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Iii
| [[Diabetic Postoperative Mortality And Morbidity Trial]]
|-
|-
| DECREASE-V
| [[DIRECT]]
| Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-V
| [[Direct Stenting Using The Sirolimus-Eluting Stent]]
|-
|-
| DEDICATION: Distal Protection Study
| [[DIRECT]]
| Drug Elution And Distal Protection In St-Elevation Myocardial Infarction
| [[Direct Myocardial Revascularization In Regeneration Of Endocardial Channels Trial]]
|-
|-
| DEDICATION: Stent Study
| [[DIRECT]]
| Drug Elution And Distal Protection In Acute Myocardial Infarction
| [[Diabetic Retinopathy Candesartan Trial Candesartan Cilexetil (Atacand)]]
|-
|-
| DEFER
| [[DIRECTOR]]
| Deferral Versus Performance Of Ptca In Patients Without Documented Ischemia
| [[Direct Stenting Study With Orbus R Stent]]
|-
|-
| DEFINITE
| [[DISC]]
| Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation
| [[Disability In Strategies For Care]]
|-
|-
| DEFUSE
| [[DISCO]]
| Diffusion-Weighted Imaging Evaluation For Understanding Stroke Evaluation;
| [[Direct Coronary Stenting Versus Stenting With Balloon Predilation: Immediate And Follow-Up Results]]
|-
|-
| DELTA MI
| [[DISTINCT]]
| Direct Inhibition Of Δ-Protein Kinase C Enzyme To Limit Total Infarct Size In Acute Mi
| [[Biodivysio Stent In Controlled Trial]]
|-
|-
| DES-DIABETES
| [[DMIST]]
| A Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus
| [[Digital Mammographic Imaging Screening Trial]]
|-
|-
| DESTINI-CFR
| [[DPP]]
| Doppler Endpoints Stenting International Investigation - Coronary Flow Reserve;
| [[Diabetes Prevention Program Trial]]
|-
|-
| DETAIL
| [[DPT-1]]
| Diabetics Exposed To Telmisartan And Enalapril
| [[Diabetes Prevention Trial - Type 1 ]]
|-
|-
| DIABETES
| [[DREAM]]
| Diabetes And Sirolimus-Eluting Stent Trial
| [[Diabetes Reduction Approaches With Ramipril And Rosiglitazone Medications]]
|-
|-
| DIABETES
| [[DREAM - Ramipril]]
| A Prospective, Randomized, Controlled Trial Of The Polymer-Based, Sirolimus-Eluting Stent Versus A Bare Metal Stent In Patients With Diabetes Mellitus
| [[Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication]]
|-
|-
| DIACOR
| [[DREAM - Rosiglitazone]]
| Diabetes And Combined Lipid Therapy Regimen
| [[Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication]]
|-
|-
| DIAD
| [[DUCCS-1]]
| Detection Of Ischemia In Asymptomatic Diabetics
| [[Duke University Clinical Cardiology Study - 1]]
|-
|-
| DIADS
| [[DUCCS-2]]
| Depression In Alzheimer Disease Study
| [[Duke University Clinical Cardiology Study - 2]]
|-
|-
| DIAGNOSIS
| [[DYSBOT]]
| Diffusion-Weighted Imaging Assessment Of The Genuine Need For Other Studies In Ischemic Stroke
| [[Dysport And Botox Study ]]
|-
|-
| DIAL
| [[EAFT]]
| Randomized Trial Of Telephone Intervention In Chronic Heart Failure
| [[European Atrial Fibrillation Trial]]
|-
|-
| DIAMOND
| [[EAGAR]]
| Danish Investigations Of Arrhythmia And Mortality On Dofetilide
| [[Estrogen And Graft Atherosclerosis Research Trial]]
|-
|-
| DIAMOND
| [[EARLY]]
| Distensibility Improvement With Alt-711 Remodeling In Diastolic Heart Failure; Sponsor
| [[Eptifibatide For Acute Coronary Syndromes—Rapid Versus Late Administration For Therapeutic Yield]]
|-
|-
| DIAMOND CHF
| [[EARLY]]
| Danish Investigators Of Arrhythmia And Mortality On Dofetilde Congestive Heart Failure;
| [[Endothelin Antagonist Trial In Mildly Symptomatic Pulmonary Arterial Hypertension Patient]]
|-
|-
| DIDI
| [[EARLY ACS]]
| Diltiazem In Dilated Cardiomyopathy
| [[Early Glycoprotein IIb/IIia Inhibition In Non–St-Segment Elevation Acute Coronary Syndromes]]
|-
|-
| DIG
| [[EARS]]
| Digoxin Investigation Group
| [[European Atherosclerosis Research Study]]
|-
|-
| DIG Enalapril
| [[EARTH]]
| Enalapril Versus Digoxin In Patients With Congestive Heart Failure: A Multicenter Study (Canadian Enalapril Versus Digoxin Study Group)
| [[Endothelin Receptor Antagonist Trial In Heart Failure]]
|-
|-
| DIGAMI
| [[EASE]]
| Diabetic Insulin-Glucose Infusion In Acute Mi
| [[Ezetimibe Add-On To Statin Therapy For Effectiveness Trial]]
|-
|-
| DIMT
| [[EAST]]
| Double-Blind Placebo-Controlled Study Of Ibopamine And Digoxin In Patients With Mild To Moderate Heart Failure: Results Of The Dutch Ibopamine Multic
| [[Emory Angioplasty Vs Surgery Trial]]
|-
|-
| DINAMIT
| [[EASTER]]
| Defibrillator In Acute Myocardial Infarction Trial
| [[Estrogen And Stents To Eliminate Restenosis]]
|-
|-
| DIPOM
| [[EASY]]
| Diabetic Postoperative Mortality And Morbidity Trial
| [[Early Discharge After Transradial Stenting Of Coronary Arteries]]
|-
|-
| DIRECT
| [[EASYAS]]
| Direct Stenting Using The Sirolimus-Eluting Stent
| [[Eastbourne Syncope Assessment Study]]
|-
|-
| DIRECT
| [[ECASS III]]
| Direct Myocardial Revascularization In Regeneration Of Endocardial Channels Trial
| [[European Cooperative Acute Stroke Study III]]
|-
|-
| DIRECT
| [[ECCE]]
| Diabetic Retinopathy Candesartan Trial; Candesartan Cilexetil (Atacand®)
| [[Effects Of Captopril On Cardiopulmonary Exercise Parameters (Ecce)]]
|-
|-
| DIRECTOR
| [[ECCO 2000]]
| Direct Stenting Study With Orbus R Stent™
| [[Effects Of Citicoline (Ceraxon) On Clinical Outcome - 2000 Mg ]]
|-
|-
| DISC
| [[ECHO in PPH]]
| Disability In Strategies For Care
| [[Echocardiographic Predictors Of Adverse Outcomes In Primary Pulmonary Hypertension.]]
|-
|-
| DISCO
| [[ECLA GIK]]
| Direct Coronary Stenting Versus Stenting With Balloon Predilation: Immediate And Follow-Up Results
| [[Estudios Cardiologicos Latinoamerica Glucose-Insulin-Potassium Pilot Trial]]
|-
|-
| DISTINCT
| [[ECLIPSE]]
| Biodivysio™ Stent In Controlled Trial
| [[Ensure's Vascular Closure Device Speeds Hemostasis Trial]]
|-
|-
| DMIST
| [[ECRIS]]
| Digital Mammographic Imaging Screening Trial
| [[Endocoronary-Rhenium-Irradiation-Study]]
|-
|-
| DPP
| [[ECSG-1]]
| Diabetes Prevention Program Trial
| [[European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator]]
|-
|-
| DPT-1
| [[ECSG-6]]
| Diabetes Prevention Trial - Type 1;
| [[European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator II]]
|-
|-
| DREAM
| [[ECSS]]
| Diabetes Reduction Approaches With Ramipril And Rosiglitazone Medications
| [[European Coronary Surgery Study Group]]
|-
|-
| DREAM - Ramipril
| [[ECST]]
| Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication
| [[European Carotid Surgery Trial]]
|-
|-
| DREAM - Rosiglitazone
| [[EDGECAP]]
| Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication
| [[Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Community-Acquired Pneumonia]]
|-
|-
| DUCCS-1
| [[EDGESST]]
| Duke University Clinical Cardiology Study - 1
| [[Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Skin And Soft Tissue Infections]]
|-
|-
| DUCCS-2
| [[EDGE]]
| Duke University Clinical Cardiology Study - 2
| [[Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities]]
|-
|-
| DYSBOT
| [[EDGEUTI]]
| Dysport And Botox Study;
| [[Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Urinary Tract Infection]]
|-
|-
| EAFT
| [[ED-IMPACT]]
| European Atrial Fibrillation Trial
| [[Emergency Department Impedance Cardiography-Aided Assessment Changes Therapy Sponsor: Cardiodynamics International]]
|-
|-
| EAGAR
| [[EFICAT]]
| Estrogen And Graft Atherosclerosis Research Trial
| [[Ejection Fraction In Cardiac Transplant Patients]]
|-
|-
| EARLY
| [[EGASIS]]
| Eptifibatide For Acute Coronary Syndromes—Rapid Versus Late Administration For Therapeutic Yield
| [[Early Gaba-Ergic Activation Sin Troke]]
|-
|-
| EARLY
| [[ELATE]]
| Endothelin Antagonist Trial In Mildly Symptomatic Pulmonary Arterial Hypertension Patient
| [[Extended Low-Intensity Anticoagulation For Thrombo-Embolism Investigators]]
|-
|-
| EARLY ACS
| [[ELECT]]
| Early Glycoprotein Iib/Iiia Inhibition In Non–St-Segment Elevation Acute Coronary Syndromes
| [[Evaluating Enoxaparin (Lovenox) Clotting Times]]
|-
|-
| EARS
| [[ELITE]]
| European Atherosclerosis Research Study
| [[Evaluation Of Losartan In The Elderly]]
|-
|-
| EARTH
| [[ELITE-II]]
| Endothelin Receptor Antagonist Trial In Heart Failure
| [[Losartan Heart Failure Survival Study]]
|-
|-
| EASE
| [[ELLDOPA]]
| Ezetimibe Add-On To Statin Therapy For Effectiveness Trial
| [[Earlier Versus Later Levodopa In Parkinson Disease]]
|-
|-
| EAST
| [[ELUTES]]
| Emory Angioplasty Vs Surgery Trial
| [[European Evaluation Of Paclitaxel Eluting Stent]]
|-
|-
| EASTER
| [[ELVD-CHF]]
| Estrogen And Stents To Eliminate Restenosis
| [[Exercise In Left Ventricular Dysfunction And Chronic Heart Failure Trial]]
|-
|-
| EASY
| [[EMERALD]]
| Early Discharge After Transradial Stenting Of Coronary Arteries
| [[Enhanced Myocardial Efficacy And Removal By Aspiration Of Liberated Debris]]
|-
|-
| EASYAS
| [[EMERALD]]
| Eastbourne Syncope Assessment Study
| [[European And Australian Multicenter Evaluative Research On Atrial Fibrillation—Dofetilide]]
|-
|-
| ECASS III
| [[EMERAS]]
| European Cooperative Acute Stroke Study Iii
| [[Estudio Multicentrico Estreptoquinasa Republicas De America Del Sur]]
|-
|-
| ECCE
| [[EMIAT]]
| Effects Of Captopril On Cardiopulmonary Exercise Parameters (Ecce)
| [[European Myocardial Infarction Amiodarone Trial]]
|-
|-
| ECCO 2000
| [[EMIP]]
| Effects Of Citicoline (Ceraxon™) On Clinical Outcome - 2000 Mg;
| [[Prehospital Thrombolytic Therapy In Patients With Suspected Acute Myocardial Infarction]]
|-
|-
| ECHO in PPH
| [[EMIP-FR]]
| Echocardiographic Predictors Of Adverse Outcomes In Primary Pulmonary Hypertension.
| [[European Myocardial Infarction Project—Free Radicals]]
|-
|-
| ECLA GIK
| [[EMIT]]
| Estudios Cardiologicos Latinoamerica Glucose-Insulin-Potassium Pilot Trial
| [[European Mivazerol Trial]]
|-
|-
| ECLIPSE
| [[EMPIRIC]]
| Ensure'S Vascular Closure Device Speeds Hemostasis Trial
| [[Comparison Of Empiric To Physician-Tailored Programming Of Implantable Cardioverter Defibrillators Trial]]
|-
|-
| ECRIS
| [[ENABLE]]
| Endocoronary-Rhenium-Irradiation-Study
| [[Effects Of The Endothelin Receptor Antagonist Bosentan On The Morbidity And Mortality In Patients With Chronic Heart Failure]]
|-
|-
| ECSG-1
| [[ENCOR]]
| European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator
| [[Enrasentan Cooperative Randomized Evaluation]]
|-
|-
| ECSG-6
| [[ENCORE I]]
| European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator Ii
| [[Evaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function]]
|-
|-
| ECSS
| [[ENCORE II]]
| European Coronary Surgery Study Group
| [[Long-Term Effect Of Nifedipine On Vasomotion And Vessel Morphology In Patients With Coronary Artery Disease: An Intravascular Ultrasound-Assisted Evaluation]]
|-
|-
| ECST
| [[ENDEAVOR II]]
| European Carotid Surgery Trial
| [[Randomized Comparison Of The Endeavor Abt-578 Drug Eluting Stent With A Bare Metal Stent For Coronary Revascularization]]
|-
|-
| EDGECAP
| [[ENDEAVOR III]]
| Evaluation Of Daptomycin (Cidecin™] In Gram-Positive Entities In The Treatment Of Community-Acquired Pneumonia
| [[Randomized Comparison Of Zotarolimus-Eluting And Sirolimus-Eluting Stents In Patients With Coronary Artery Disease-3]]
|-
|-
| EDGESST
| [[ENDEAVOR IV]]
| Evaluation Of Daptomycin (Cidecin™] In Gram-Positive Entities In The Treatment Of Complicated Skin And Soft Tissue Infections
| [[Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease-4]]
|-
|-
| EDGE™
| [[ENDEAVOR-1]]
| Evaluation Of Daptomycin (Cidecin™] In Gram-Positive Entities
| [[Multicenter Evaluation Of Abt-578 Elution From A Phosphorylcholine-Coated Stent]]
|-
|-
| EDGEUTI
| [[ENHANCE]]
| Evaluation Of Daptomycin (Cidecin™] In Gram-Positive Entities In The Treatment Of Complicated Urinary Tract Infection
| [[Simvastatin With Or Without Ezetimibe In Familial Hypercholesterolemia]]
|-
|-
| ED-IMPACT
| [[ENRICHD]]
| Emergency Department Impedance Cardiography-Aided Assessment Changes Therapy; Sponsor: Cardiodynamics International
| [[Enhancing Recovery In Coronary Heart Disease]]
|-
|-
| EFICAT
| [[ENTIRE]]
| Ejection Fraction In Cardiac Transplant Patients
| [[Enoxaparin And Tnk-Tpa With Or Without Gp IIb/IIia Inhibitor As Reperfusion Strategy In St Elevation Mi (TIMI-23) ]]
|-
|-
| EGASIS
| [[EPAMSA]]
| Early Gaba-Ergic Activation Sin Troke
| [[Estudio Piloto Argentino De Muerte Subita Y Amioda Rone (Argentine Pilot Study Of Sudden Death And Amiodarone)]]
|-
|-
| ELATE
| [[EPAT]]
| Extended Low-Intensity Anticoagulation For Thrombo-Embolism Investigators
| [[Estrogen In The Prevention Of Atherosclerosis Trial]]
|-
|-
| ELECT
| [[EPHESUS]]
| Evaluating Enoxaparin (Lovenox®] Clotting Times
| [[Eplerenone Post-Ami Heart Failure Efficacy And Survival Study]]
|-
|-
| ELITE
| [[EPIC]]
| Evaluation Of Losartan In The Elderly
| [[Evaluation Of C7E3 For The Prevention Of Ischemic Complications]]
|-
|-
| ELITE-II
| [[EPILOG]]
| Losartan Heart Failure Survival Study
| [[Evaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp IIb/IIia Receptor (Abciximab) Blockade]]
|-
|-
| ELLDOPA
| [[EPISTENT]]
| Earlier Versus Later Levodopa In Parkinson Disease
| [[Evaluation Of Platelet IIb/IIia Inhibitor For Stenting Trial]]
|-
|-
| ELUTES
| [[EPOS]]
| European Evaluation Of Paclitaxel Eluting Stent
| [[Elective Pci In Outpatient Study]]
|-
|-
| ELVD-CHF
| [[ERA]]
| Exercise In Left Ventricular Dysfunction And Chronic Heart Failure Trial
| [[Enoxaparin Restenosis (Era) Trial.]]
|-
|-
| EMERALD
| [[ERA]]
| Enhanced Myocardial Efficacy And Removal By Aspiration Of Liberated Debris
| [[Early Rheumatoid Arthritis (Ra) Enoxaparin Restenosis After Angioplasty StudyEstrogen Replacement And Atherosclerosis Study]]
|-
|-
| EMERALD
| [[ERA (HRT)]]
| European And Australian Multicenter Evaluative Research On Atrial Fibrillation—Dofetilide
| [[Effect Of Estrogen Replacement On The Progression Of Coronary Artery Atherosclerosis]]
|-
|-
| EMERAS
| [[ERACI]]
| Estudio Multicentrico Estreptoquinasa Republicas De America Del Sur
| [[Estudio Randomizado Argentino De Angioplastia Vs. Cirugía (Argentine Randomized Trial Of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery In Multivessel Disease)]]
|-
|-
| EMIAT
| [[ERACI II]]
| European Myocardial Infarction Amiodarone Trial
| [[Argentine Randomized Study: Coronary Angioplasty With Stenting Vs. Coronary Artery Bypass Surgery In Patients With Multiple-Vessel Disease (Eraci II): 30-Day And One Year Follow-Up Results]]
|-
|-
| EMIP
| [[ERASE]]
| Prehospital Thrombolytic Therapy In Patients With Suspected Acute Myocardial Infarction
| [[Emergency Room Assessment Of Sestamibi For Evaluation Of Chest Pain]]
|-
|-
| EMIP-FR
| [[ERASE]]
| European Myocardial Infarction Project—Free Radicals
| [[Effects Of Rhdl On Atherosclerosis–Safety And Efficacy]]
|-
|-
| EMIT
| [[ERASER]]
| European Mivazerol Trial
| [[Evaluation Of Reopro And Stenting To Eliminate Restenosis]]
|-
|-
| EMPIRIC
| [[ERBAC]]
| Comparison Of Empiric To Physician-Tailored Programming Of Implantable Cardioverter Defibrillators Trial
| [[Excimer Laser, Rotational Atherectomy, Balloon Angioplasty Complications Study]]
|-
|-
| ENABLE
| [[ERGO]]
| Effects Of The Endothelin Receptor Antagonist Bosentan On The Morbidity And Mortality In Patients With Chronic Heart Failure
| [[Etomoxir For The Recovery Of Glucose Oxidation]]
|-
|-
| ENABLE
| [[ERICA]]
| Endothelin Antagonist Bosentan For Lowering Cardiac Events In Heart Failure
| [[Efficacy Of Ranolazine In Chronic Angina]]
|-
|-
| ENCOR
| [[ERNA]]
| Enrasentan Cooperative Randomized Evaluation
| [[Early Return To Normal Activities At Two Weeks After Acute Myocardial Infarction: Preliminary Results Of A Randomized Study]]
|-
|-
| ENCORE
| [[ER-TIMI]]
| Evaluation Of Nifedipine And Cerivastatin On The Recovery Of Endothelial Function; Web Site
| [[Early Retavase - Thrombolysis In Myocardial Infarction]]
|-
|-
| ENCORE I
| [[ESCAMI]]
| Evaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function
| [[Evaluation Of The Safety And Cardioprotective Effects Of Eniporide In Acute Myocardial Infarction]]
|-
|-
| ENCORE II
| [[ESCAPE]]
| Long-Term Effect Of Nifedipine On Vasomotion And Vessel Morphology In Patients With Coronary Artery Disease: An Intravascular Ultrasound-Assisted Evaluation
| [[Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness]]
|-
|-
| ENDEAVOR II
| [[ESCAPE]]
| Randomized Comparison Of The Endeavor Abt-578 Drug Eluting Stent With A Bare Metal Stent For Coronary Revascularization
| [[Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness]]
|-
|-
| ENDEAVOR III
| [[E-SIRIUS]]
| Randomized Comparison Of Zotarolimus-Eluting And Sirolimus-Eluting Stents In Patients With Coronary Artery Disease
| [[European Sirolimus-Eluting Stent In Coronary Lesions]]
|-
|-
| ENDEAVOR IV
| [[ESPRIT]]
| Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease
| [[Enhanced Suppression Of The Platelet IIb/IIia Receptor With Integrilin TherapyEuropean Study Of The Prevention Of Reocclusion After Initial ThrombolysisEvaluation Of Subcutaneous Proleukin In A Randomized International Trial]]
|-
|-
| ENDEAVOR-1
| [[ESPRIT HRT]]
| Multicenter Evaluation Of Abt-578 Elution From A Phosphorylcholine-Coated Stent
| [[Oestrogen In The Prevention Of Reinfarction Trial]]
|-
|-
| ENHANCE
| [[ESPS2]]
| Simvastatin With Or Without Ezetimibe In Familial Hypercholesterolemia
| [[European Stroke Prevention Study 2]]
|-
|-
| ENRICHD
| [[ESPS-2]]
| Enhancing Recovery In Coronary Heart Disease
| [[European Stroke Prevention Study 2]]
|-
|-
| ENTIRE
| [[ESSENCE]]
| Enoxaparin As Adjunctive Antithrombin Therapy For St-Elevation Myocardial Infarction
| [[Efficacy And Safety Of Subcutaneous Enoxaparin In Unstable Angina And Non-Q-Wave Mi]]
|-
|-
| EPAMSA
| [[ESSENCE]]
| Estudio Piloto Argentino De Muerte Subita Y Amioda Rone (Argentine Pilot Study Of Sudden Death And Amiodarone)
| [[Efficacy And Safety Of Subcutaneous Enoxaparin In Non–Q-Wave Coronary Events ]]
|-
|-
| EPAT
| [[ESSENTIAL]]
| Estrogen In The Prevention Of Atherosclerosis Trial
| [[The Studies Of Oral Enoximone Therapy In Advanced Heart Failure]]
|-
|-
| EPHESUS
| [[ESSENTIAL]]
| Eplerenone Post-Ami Heart Failure Efficacy And Survival Study
| [[The Studies Of Oral Enoximone Therapy In Advanced Heart Failure]]
|-
|-
| EPIC
| [[ESTAT]]
| Evaluation Of C7E3 For The Prevention Of Ischemic Complications
| [[European Stroke Treatment With Ancrod Trial]]
|-
|-
| EPILOG
| [[ESTEEM]]
| Evaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp Iib/Iiia Receptor (Abciximab) Blockade
| [[Efficacy And Safety Of The Oral Direct Thrombin Inhibitor Ximelagatran In Patients After Acute Myocardial Infarction]]
|-
|-
| EPISTENT
| [[ESVEM]]
| Evaluation Of Platelet Iib/Iiia Inhibitor For Stenting Trial
| [[Electrophysiologic Study Versus Electrocardiographic Monitoring Trial]]
|-
|-
| EPOS
| [[ETHECC]]
| Elective Pci In Outpatient Study
| [[Evaluation Of Thymitaq In Hepatocellular Carcinoma]]
|-
|-
| ERA
| [[ETICA]]
| Enoxaparin Restenosis (Era) Trial.
| [[Exercise Training Intervention After Coronary Angioplasty: The Etica Trial]]
|-
|-
| ERA
| [[ETROP]]
| Early Rheumatoid Arthritis (Ra) ;Enoxaparin Restenosis After Angioplasty Study;Estrogen Replacement And Atherosclerosis Study
| [[Early Treatment Of Retinopathy Of Prematurity]]
|-
|-
| ERA (HRT)
| [[EURIDIS and ADONIS]]
| Effect Of Estrogen Replacement On The Progression Of Coronary Artery Atherosclerosis
| [[Maintenance Of Sinus Rhythm With Dronedarone In Patients With Atrial Fibrillation Or Flutter]]
|-
|-
| ERACI
| [[EUROACTION]]
| Estudio Randomizado Argentino De Angioplastia Vs. Cirugía (Argentine Randomized Trial Of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery In Multivessel Disease)
| [[Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme]]
|-
|-
| ERACI II
| [[EUROCARE]]
| Argentine Randomized Study: Coronary Angioplasty With Stenting Vs. Coronary Artery Bypass Surgery In Patients With Multiple-Vessel Disease (Eraci Ii): 30-Day And One Year Follow-Up Results
| [[Carvedilol For Prevention Of Restenosis After Directional Coronary Atherectomy]]
|-
|-
| ERASE
| [[EUROPA]]
| Emergency Room Assessment Of Sestamibi For Evaluation Of Chest Pain
| [[European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease]]
|-
|-
| ERASE
| [[EURO-SPAH]]
| Effects Of Rhdl On Atherosclerosis–Safety And Efficacy
| [[European Sonotherapy Trial To Prevent Arterial Hyperplasia]]
|-
|-
| ERASER
| [[Euro-SPAH]]
| Evaluation Of Reopro And Stenting To Eliminate Restenosis
| [[European-Sonotherapy Prevention Of Arterial Hyperplasia]]
|-
|-
| ERBAC
| [[EUROSTAR]]
| Excimer Laser, Rotational Atherectomy, Balloon Angioplasty Complications Study
| [[European Cobalt Stent With Antiproliferative For Restenosis Trial]]
|-
|-
| ERGO
| [[EUTOPIA]]
| Etomoxir For The Recovery Of Glucose Oxidation
| [[European Trial On Olmesartan And Pravastatin In Inflammation And Atherosclerosis]]
|-
|-
| ERICA
| [[EVA]]
| Efficacy Of Ranolazine In Chronic Angina
| [[Common Carotid Intima-Media Thickness Predicts Occurrence Of Carotid Atherosclerotic Plaques: Longitudinal Results From The Aging Vascular Study]]
|-
|-
| ERNA
| [[EVA-AMI]]
| Early Return To Normal Activities At Two Weeks After Acute Myocardial Infarction: Preliminary Results Of A Randomized Study
| [[Eptifibatide Versus Abciximab In Primary Pci For Acute St Elevation Myocardial Infarction]]
|-
|-
| ER-TIMI
| [[EVEREST]]
| Early Retavase™ - Thrombolysis In Myocardial Infarction
| [[Efficacy Of Vasopressin Antagonism In Heart Failure: Outcome Study With Tolvaptan]]
|-
|-
| ESCAMI
| [[EVEREST I]]
| Evaluation Of The Safety And Cardioprotective Effects Of Eniporide In Acute Myocardial Infarction
| [[Endovascular Valve Edge-To-Edge Repair Study]]
|-
|-
| ESCAPE
| [[EVET]]
| Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness
| [[Enoxaparin Versus Tinzaparin In Non-St-Segment Elevation Acute Coronary Syndromes]]
|-
|-
| E-SIRIUS
| [[EVIDENCE]]
| European Sirolimus-Eluting Stent In Coronary Lesions
| [[Evidence For Interferon Dose-Effect: European-North American Comparative Efficacy Study (Rebif V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms))]]
|-
|-
| ESPRIT
| [[EVIDENT]]
| Enhanced Suppression Of The Platelet Iib/Iiia Receptor With Integrilin™ Therapy;European Study Of The Prevention Of Reocclusion After Initial Thrombolysis;Evaluation Of Subcutaneous Proleukin In A Randomized International Trial
| [[Endo-Vascular Investigation Determining The Safety Of A New Tacrolimus Eluting Stent Graft]]
|-
|-
| ESPRIT HRT
| [[EVIDENT]]
| Oestrogen In The Prevention Of Reinfarction Trial
| [[Endovascular Investigation Determining The Safety Of A New Tacrolimus-Eluting Stent Graft]]
|-
|-
| ESPS2
| [[EXCITE]]
| European Stroke Prevention Study 2
| [[Evaluation Of Oral Xemilofiban In Controlling Thrombotic Events]]
|-
|-
| ESPS-2
| [[EXCITE]]
| European Stroke Prevention Study 2
| [[Evaluation Of Oral Xemilofiban In Controlling Thrombotic Events ]]
|-
|-
| ESSENCE
| [[EXCITe]]
| Efficacy And Safety Of Subcutaneous Enoxaparin In Unstable Angina And Non-Q-Wave Mi
| [[Extremity Constraint-Induced Therapy]]
|-
|-
| ESSENCE
| [[EXCLAIM]]
| Efficacy And Safety Of Subcutaneous Enoxaparin In Non–Q-Wave Coronary Events;
| [[Extended Clinical Prophylaxis In Acutely Ill Medical Patients (Lovenox (Enoxaparin) Postmarketing (Phase Iv) Trial) ]]
|-
|-
| ESSENTIAL
| [[EXPEDITION]]
| The Studies Of Oral Enoximone Therapy In Advanced Heart Failure
| [[Na+/H+ Exchange Inhibition To Prevent Coronary Events In Acute Cardiac Conditions]]
|-
|-
| ESTAT
| [[EXPIRA]]
| European Stroke Treatment With Ancrod Trial
| [[ Thrombectomy With Export Catheter In Infarct-Related Artery During Primary Percutaneous Coronary Intervention]]
|-
|-
| ESTEEM
| [[ExTRACT]]
| Efficacy And Safety Of The Oral Direct Thrombin Inhibitor Ximelagatran In Patients After Acute Myocardial Infarction
| [[Enoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction Treatment]]
|-
|-
| ESVEM
| [[F.I.R.E.]]
| Electrophysiologic Study Versus Electrocardiographic Monitoring Trial
| [[Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial]]
|-
|-
| ETHECC
| [[FAAT]]
| Evaluation Of Thymitaq™ In Hepatocellular Carcinoma;
| [[Fatty Acid Antiarrhythmia Trial]]
|-
|-
| ETICA
| [[FACET]]
| Exercise Training Intervention After Coronary Angioplasty: The Etica Trial
| [[Flosequinan - Ace Inhibition Trial]]
|-
|-
| ETROP
| [[FACET]]
| Early Treatment Of Retinopathy Of Prematurity
| [[Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial]]
|-
|-
| EURIDIS and ADONIS
| [[FACIT]]
| Maintenance Of Sinus Rhythm With Dronedarone In Patients With Atrial Fibrillation Or Flutter
| [[Folate After Coronary Intervention Trial]]
|-
|-
| EUROACTION
| [[FACT]]
| Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme
| [[Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty]]
|-
|-
| EUROCARE
| [[FAME]]
| Carvedilol For Prevention Of Restenosis After Directional Coronary Atherectomy
| [[Fractional Flow Reserve Versus Angiography For Multivessel Evaluation]]
|-
|-
| EUROPA
| [[FAME]]
| European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease
| [[Fluvastatin (Lescol) Assessment Of Morbi-Mortality In The Elderly]]
|-
|-
| EURO-SPAH
| [[FAMIS]]
| European Sonotherapy Trial To Prevent Arterial Hyperplasia
| [[Fosinopril In Acute Myocardial Infarction Study]]
|-
|-
| EUROSTAR
| [[FANTASTIC]]
| European Cobalt Stent With Antiproliferative For Restenosis Trial
| [[Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting]]
|-
|-
| EUTOPIA
| [[FAST]]
| European Trial On Olmesartan And Pravastatin In Inflammation And Atherosclerosis
| [[Femoral Artery Stenting Trial]]
|-
|-
| EVA
| [[FASTER]]
| Common Carotid Intima-Media Thickness Predicts Occurrence Of Carotid Atherosclerotic Plaques: Longitudinal Results From The Aging Vascular Study
| [[Fibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk]]
|-
|-
| EVA-AMI
| [[FAST-MAG]]
| Eptifibatide Versus Abciximab In Primary Pci For Acute St Elevation Myocardial Infarction
| [[Field Administration Of Stroke Therapy - Magnesium]]
|-
|-
| EVEREST
| [[FATS]]
| Efficacy Of Vasopressin Antagonism In Heart Failure: Outcome Study With Tolvaptan
| [[Familial Atherosclerosis Treatment Study]]
|-
|-
| EVEREST I
| [[FEMINA]]
| Endovascular Valve Edge-To-Edge Repair Study
| [[Addition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade]]
|-
|-
| EVET
| [[FERRIC-HF]]
| Enoxaparin Versus Tinzaparin In Non-St-Segment Elevation Acute Coronary Syndromes
| [[Effect Of Intravenous Ferrous Sucrose On Exercise Capacity In Chronic Heart Failure]]
|-
|-
| EVIDENCE
| [[FEST]]
| Evidence For Interferon Dose-Effect: European-North American Comparative Efficacy Study (Rebif® V. Avonex™ In Relapsing-Remitting Multiple Sclerosis (Rrms)]
| [[Fosinopril Efficacy/Safety Trial]]
|-
|-
| EVIDENT
| [[FIELD]]
| Endo-Vascular Investigation Determining The Safety Of A New Tacrolimus Eluting Stent Graft
| [[Fenofibrate Intervention And Event Lowering In Diabetes]]
|-
|-
| EXCITE
| [[FIELD]]
| Evaluation Of Oral Xemilofiban In Controlling Thrombotic Events
| [[Fenofibrate (Tricor) Intervention And Event Lowering In Diabetes]]
|-
|-
| EXCITe
| [[FINESSE]]
| Extremity Constraint-Induced Therapy
| [[Facilitated Intervention With Enhanced Reperfusion Speed To Stop Events]]
|-
|-
| EXCLAIM
| [[FIRE]]
| Extended Clinical Prophylaxis In Acutely Ill Medical Patients (Lovenox™ (Enoxaparin) Postmarketing (Phase Iv) Trial];
| [[Filterwire Ex Randomized Evaluation]]
|-
|-
| EXPEDITION
| [[FIRST]]
| Na+/H+ Exchange Inhibition To Prevent Coronary Events In Acute Cardiac Conditions
| [[Flolan International Randomized Survival Trial (Phase IIi (Develop Economic Data))]]
|-
|-
| EXPIRA
| [[FIRST]]
| Thrombectomy With Export Catheter In Infarct-Related Artery During Primary Percutaneous Coronary Intervention
| [[Flolan (Dobutamine) International Randomized Survival Trial First Trimester Integrated Risk Screening For Trisomy]]
|-
|-
| ExTRACT
| [[FLARE]]
| Enoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction Treatment
| [[Fluvastatin Angioplasty Restenosis]]
|-
|-
| F.I.R.E.
| [[FLARE]]
| Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
| [[Fluvastatin (Lescol) Angiographic Restenosis]]
|-
|-
| FAAT
| [[FLORIDA]]
| Fatty Acid Antiarrhythmia Trial
| [[Fluvastatin On Risk Diminishing After Acute Myocardial Infarction]]
|-
|-
| FACET
| [[FLUCAD]]
| Flosequinan - Ace Inhibition Trial
| [[Influenza Vaccination In Secondary Prevention From Coronary Ischemic Events In Coronary Artery Disease]]
|-
|-
| FACET
| [[FOOD]]
| Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial
| [[Feed Or Ordinary Diet]]
|-
|-
| FACIT
| [[FOSIT]]
| Folate After Coronary Intervention Trial
| [[Fosamax International Trial]]
|-
|-
| FACT
| [[FRAXIS]]
| Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
| [[Fraxiparin Versus Unfractionated Heparin In The Treatment Of Unstable Angina]]
|-
|-
| FAME
| [[FRAXIS / FRAX.I.S.]]
| Fractional Flow Reserve Versus Angiography For Multivessel Evaluation
| [[Fraxiparine In Ischemic Syndromes]]
|-
|-
| FAME
| [[FRESCO]]
| Fluvastatin (Lescol®] Assessment Of Morbi-Mortality In The Elderly
| [[Investigators In The Florence Randomized Elective Stenting In Acute Coronary Occlusions]]
|-
|-
| FAMIS
| [[FRIC]]
| Fosinopril In Acute Myocardial Infarction Study
| [[Fragmin In Unstable Coronary Artery Disease]]
|-
|-
| FANTASTIC
| [[FRIC]]
| Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
| [[Fragmin In Unstable Coronary Artery Disease]]
|-
|-
| FAST
| [[FRISC]]
| Femoral Artery Stenting Trial
| [[Fast Revascularization During Instability In Coronary Artery Disease]]
|-
|-
| FASTER
| [[FRISC II]]
| Fibrinolytic And Aggrastat® St Elevation Resolution; First Abarelix Depot Study For Treating Endometriosis Rapidly;First And Second Trimester Evaluation Of Risk;
| [[Fragmin And Fast Revascularization During Instability In Coronary Artery Disease]]
|-
|-
| FAST-MAG
| [[FROST]]
| Field Administration Of Stroke Therapy - Magnesium
| [[French Optimal Stenting Trial]]
|-
|-
| FATS
| [[FROSTY]]
| Familial Atherosclerosis Treatment Study
| [[Freezor Trial Of Supraventricular Tachycardia]]
|-
|-
| FEMINA
| [[FTT]]
| Addition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
| [[Fibrinolytic Therapy Trialists' Collaborative Group]]
|-
|-
| FERRIC-HF
| [[FUSION]]
| Effect Of Intravenous Ferrous Sucrose On Exercise Capacity In Chronic Heart Failure
| [[Fractional Flow Reserve And Ultrasound Indices For Objective Narrowing Assessment]]
|-
|-
| FEST
| [[FUSION I]]
| Fosinopril Efficacy/Safety Trial
| [[Follow-Up Serial Infusions Of Nesiritide Trial]]
|-
|-
| FIELD
| [[FUTURE I]]
| Fenofibrate Intervention And Event Lowering In Diabetes
| [[First Use To Underscore Restenosis Reduction With Everolimus]]
|-
|-
| FINESSE
| [[FUTURE II]]
| Facilitated Intervention With Enhanced Reperfusion Speed To Stop Events
| [[Multicenter Evaluation Of The Biosbsorbable Polymer-Based Everolimus-Eluting Stent]]
|-
|-
| FIRE
| [[GABI]]
| Filterwire Ex Randomized Evaluation
| [[German Angioplasty Vs. Bypass Surgery Investigation]]
|-
|-
| FIRST
| [[GABI-2]]
| Flolan International Randomized Survival Trial (Phase Iii (Develop Economic Data])
| [[German Angioplasty Bypass Investigation - 2]]
|-
|-
| FLARE
| [[GAMI]]
| Fluvastatin Angioplasty Restenosis
| [[ Glucose Abnormalities In Patients With Myocardial Infarction: Prevalence, Diagnosis, And Prognostic Implications]]
|-
|-
| FLORIDA
| [[GAMMA II]]
| Fluvastatin On Risk Diminishing After Acute Myocardial Infarction
| [[Gamma II Localized Radiation Therapy To Inhibit Restenosis]]
|-
|-
| FLUCAD
| [[GAMMA V]]
| Influenza Vaccination In Secondary Prevention From Coronary Ischemic Events In Coronary Artery Disease
| [[Gamma V Localized Radiation Therapy To Inhibit Restenosis]]
|-
|-
| FOOD
| [[Gamma-One]]
| Feed Or Ordinary Diet
| [[Localized Intracoronary Gamma-Radiation Therapy To Inhibit The Recurrence Of Restenosis After Stenting]]
|-
|-
| FOSIT
| [[GART study]]
| Fosamax® International Trial
| [[Genotypic Antiretroviral Resistance Testing]]
|-
|-
| FRAXIS
| [[GEMICA]]
| Fraxiparin Versus Unfractionated Heparin In The Treatment Of Unstable Angina
| [[Morbidity And Mortality Following Early Administration Of Amiodarone In Myocardial Infarction]]
|-
|-
| FRAXIS / FRAX.I.S.
| [[GEMINI]]
| Fraxiparine® In Ischemic Syndromes
| [[Glycemic Effects In Diabetes Mellitus: Carvedilol - Metoprolol Comparison In Hypertensives Trial]]
|-
|-
| FRESCO
| [[GEMS]]
| Investigators In The Florence Randomized Elective Stenting In Acute Coronary Occlusions
| [['Ginkgo Biloba 'Evaluation Memory Study]]
|-
|-
| FRIC
| [[GENESIS]]
| Fragmin In Unstable Coronary Artery Disease
| [[A Randomized, Multicenter Study Of The Pimecrolimus-Eluting And Pimecrolimus/Paclitaxel-Eluting Coronary Stent System In Patients With De Novo Lesions Of The Native Coronary Arteries]]
|-
|-
| FRISC
| [[GENEVA]]
| Fast Revascularization During Instability In Coronary Artery Disease
| [[ Intracoronary Beta Irradiation To Reduce Restenosis After Balloon Angioplasty]]
|-
|-
| FRISC II
| [[GENIUS-STEMI]]
| Fragmin And Fast Revascularization During Instability In Coronary Artery Disease
| [[A Randomized Comparison Of Genous Stent Versus Chromium-Cobalt Stent For Treatment Of St-Elevation Myocardial Infarction]]
|-
|-
| FROST
| [[GenSalt]]
| French Optimal Stenting Trial
| [[Genetic Epidemiology Network Of Salt Sensitivity]]
|-
|-
| FROSTY
| [[GESICA]]
| Freezor™ Trial Of Supraventricular Tachycardia
| [[Randomized Trial Of Low-Dose Amiodarone In Severe Congestive Heart Failure]]
|-
|-
| FTT
| [[GIPS]]
| Fibrinolytic Therapy Trialists' Collaborative Group
| [[Randomized Trial Of Glucose-Insulin-Potassium Infusion On 30 Day Mortality In Patients With Acute Myocardial Infarction Treated With Primary Angioplasty]]
|-
|-
| FUSION
| [[GIPS II]]
| Fractional Flow Reserve And Ultrasound Indices For Objective Narrowing Assessment
| [[ Glucose - Insulin - Potassium Study In Patients With St Elevation Myocardial Infarction Without Signs Of Heart Failure]]
|-
|-
| FUSION I
| [[GISEN]]
| Follow-Up Serial Infusions Of Nesiritide Trial
| [[Gruppo Italiano Di Studi Epidemiologici In Nefrologia]]
|-
|-
| FUTURE I
| [[GISSI-1]]
| First Use To Underscore Restenosis Reduction With Everolimus
| [[Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-1]]
|-
|-
| FUTURE II
| [[GISSI-2]]
| Multicenter Evaluation Of The Biosbsorbable Polymer-Based Everolimus-Eluting Stent
| [[Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-2]]
|-
|-
| GABI
| [[GISSI-3]]
| German Angioplasty Vs. Bypass Surgery Investigation
| [[Effects Of Lisinopril And Transdermal Glycerol Trinitrate Singly And Together On 6-Week Mortality And Ventricular Function After Ami]]
|-
|-
| GABI-2
| [[GISSI-HF: n-3 PUFA]]
| German Angioplasty Bypass Investigation - 2
| [[Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: N-3 Pufa]]
|-
|-
| GAMI
| [[GISSI-HF: Rosuvastatin]]
| Glucose Abnormalities In Patients With Myocardial Infarction: Prevalence, Diagnosis, And Prognostic Implications
| [[Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: Rosuvastatin]]
|-
|-
| GAMMA II
| [[GOSPEL]]
| Gamma Ii Localized Radiation Therapy To Inhibit Restenosis
| [[Global Secondary Prevention Strategies To Limit Event Recurrence After Myocardial Infarction]]
|-
|-
| GAMMA V
| [[G-PAD]]
| Gamma V Localized Radiation Therapy To Inhibit Restenosis
| [[Granulocyte-Macrophage Colony Stimulating Factor In Patients With Intermittent Claudication]]
|-
|-
| Gamma-One
| [[GRACIA I]]
| Localized Intracoronary Gamma-Radiation Therapy To Inhibit The Recurrence Of Restenosis After Stenting
| [[Randomized Trial Comparing Stenting Within 24 Hours Of Thrombolysis Versus Ischemia-Guided Approach To Thrombolysed Acute Myocardial Infarction With St Elevation]]
|-
|-
| GART study
| [[GRACIA II]]
| Genotypic Antiretroviral Resistance Testing
| [[Primary Optimal Percutaneous Coronary Intervention Versus Facilitated Intervention In Stemi Patients]]
|-
|-
| GEMICA
| [[GRAPE]]
| Morbidity And Mortality Following Early Administration Of Amiodarone In Myocardial Infarction
| [[Grampian Region Early Anistreplase Trial]]
|-
|-
| GEMINI
| [[GUARDIAN]]
| Glycemic Effects In Diabetes Mellitus: Carvedilol - Metoprolol Comparison In Hypertensives Trial
| [[Inhibition Of The Sodium-Hydrogen Exchanger With Cariporide To Prevent Myocardial Infarction In High-Risk Ischemic Situations: Main Results Of The Guard During Ischemia Against Necrosis (Guardian) Trial]]
|-
|-
| GEMS
| [[GUSTO]]
| 'Ginkgo Biloba 'Evaluation Memory Study
| [[Global Utilization Of Streptokinase And Tpa For Occluded Arteries ]]
|-
|-
| GENESIS
| [[GUSTO IIB]]
| A Randomized, Multicenter Study Of The Pimecrolimus-Eluting And Pimecrolimus/Paclitaxel-Eluting Coronary Stent System In Patients With De Novo Lesions Of The Native Coronary Arteries
| [[Global Utilization Of Streptokinase And Tpa For Occluded Arteries IIb]]
|-
|-
| GENEVA
| [[GUSTO V]]
| Intracoronary Beta Irradiation To Reduce Restenosis After Balloon Angioplasty
| [[The Gusto V Randomised Trial]]
|-
|-
| GENIUS-STEMI
| [[GUSTO-3]]
| A Randomized Comparison Of Genous Stent Versus Chromium-Cobalt Stent For Treatment Of St-Elevation Myocardial Infarction
| [[Global Utilization Of Streptokinase And Tpa For Occluded Arteries-III]]
|-
|-
| GenSalt
| [[GUSTO-SPEED]]
| Genetic Epidemiology Network Of Salt Sensitivity
| [[Global Utilization Of Streptokinase And Tpa For Occluded Arteries–Strategies For Patency Enhancement In The Emergency Department]]
|-
|-
| GESICA
| [[HAAMU-STENT]]
| Randomized Trial Of Low-Dose Amiodarone In Severe Congestive Heart Failure
| [[Helsinki Area Acute Myocardial Infarction Treatment Re-Evaluation - Should The Patients Get A Drug-Eluting Or Normal Stent]]
|-
|-
| GIPS
| [[HACA]]
| Randomized Trial Of Glucose-Insulin-Potassium Infusion On 30 Day Mortality In Patients With Acute Myocardial Infarction Treated With Primary Angioplasty
| [[Mild Therapeuric Hypothermia To Improve The Neurologic Outcome After Cardiac Arrest]]
|-
|-
| GIPS II
| [[HAEST]]
| Glucose - Insulin - Potassium Study In Patients With St Elevation Myocardial Infarction Without Signs Of Heart Failure
| [[Heparin In Acute Embolic Stroke Trial]]
|-
|-
| GISEN
| [[HALT-C]]
| Gruppo Italiano Di Studi Epidemiologici In Nefrologia
| [[Hepatitis C Antiviral Long-Term Treatment To Prevent Cirrhosis ]]
|-
|-
| GISSI-1
| [[HALT-MI]]
| Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-1
| [[Hu23F2G Anti-Adhesion To Limit Cytotoxic Injury Following Ami]]
|-
|-
| GISSI-2
| [[HANDLS]]
| Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-2
| [[Health Aging In Nationally Diverse Longitudinal Samples]]
|-
|-
| GISSI-3
| [[HANE]]
| Effects Of Lisinopril And Transdermal Glycerol Trinitrate Singly And Together On 6-Week Mortality And Ventricular Function After Ami
| [[Randomized, Double-Blind Multicenter Comparison Of Hydrochlorothiazide, Atenolol, Nitrendipine, And Enalapril In Antihypertensive Treatment]]
|-
|-
| GISSI-HF: n-3 PUFA
| [[HARDBALL]]
| Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: N-3 Pufa
| [[Heart Allograft Rejection: Detection With Breath Alkanes In Low Level]]
|-
|-
| GISSI-HF: Rosuvastatin
| [[HARDBALL]]
| Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: Rosuvastatin
| [[Heart Allograft Rejection: Detection With Breath Alkanes In Low Levels]]
|-
|-
| GOSPEL
| [[HARP]]
| Global Secondary Prevention Strategies To Limit Event Recurrence After Myocardial Infarction
| [[Harvard Atherosclerosis Reversibility Project]]
|-
|-
| G-PAD
| [[HART]]
| Granulocyte-Macrophage Colony Stimulating Factor In Patients With Intermittent Claudication
| [[Heparin-Aspirin Reperfusion Trial]]
|-
|-
| GRACIA I
| [[HART II]]
| Randomized Trial Comparing Stenting Within 24 Hours Of Thrombolysis Versus Ischemia-Guided Approach To Thrombolysed Acute Myocardial Infarction With St Elevation
| [[Randomized Comparison Of Enoxaparin, A Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive To Recombinant Tissue Plasminogen Activator Thrombolysis And Aspirin: Second Trial Of Heparin And Aspirin Reperfusion Therapy]]
|-
|-
| GRACIA II
| [[HAT]]
| Primary Optimal Percutaneous Coronary Intervention Versus Facilitated Intervention In Stemi Patients
| [[Home Automatic External Defibrillator Trial]]
|-
|-
| GRAPE
| [[HAT 1]]
| Grampian Region Early Anistreplase Trial
| [[Heparin-Associated Thrombocytopenia 1]]
|-
|-
| GUARDIAN
| [[HAT 2]]
| Inhibition Of The Sodium-Hydrogen Exchanger With Cariporide To Prevent Myocardial Infarction In High-Risk Ischemic Situations: Main Results Of The Guard During Ischemia Against Necrosis (Guardian) Trial
| [[Heparin-Associated Thrombocytopenia 2]]
|-
|-
| GUSTO
| [[HATS]]
| Global Utilization Of Streptokinase And Tpa For Occluded Arteries;
| [[Hdl-Atherosclerosis Treatment Study]]
|-
|-
| GUSTO IIB
| [[HDFP]]
| Global Utilization Of Streptokinase And Tpa For Occluded Arteries Iib
| [[Hypertension Detection And Follow-Up Program]]
|-
|-
| GUSTO V
| [[HDOM]]
| The Gusto V Randomised Trial
| [[Heart Disease On The Mend]]
|-
|-
| GUSTO-3
| [[HeADDFIRST]]
| Global Utilization Of Streptokinase And Tpa For Occluded Arteries-Iii
| [[Hemicraniectomy And Durotomy For Deterioration From Infarction Relating Swelling Trial]]
|-
|-
| GUSTO-SPEED
| [[HEART]]
| Global Utilization Of Streptokinase And Tpa For Occluded Arteries–Strategies For Patency Enhancement In The Emergency Department
| [[Healing And Early Afterload Reducing Therapy Trial]]
|-
|-
| HAAMU-STENT
| [[HEART]]
| Helsinki Area Acute Myocardial Infarction Treatment Re-Evaluation - Should The Patients Get A Drug-Eluting Or Normal Stent
| [[Healing And Early Afterload Reducing Therapy]]
|-
|-
| HACA
| [[HEAT 2]]
| Mild Therapeuric Hypothermia To Improve The Neurologic Outcome After Cardiac Arrest
| [[Hypertension Endothelin Antagonist Treatment]]
|-
|-
| HAEST
| [[Heidelberg]]
| Heparin In Acute Embolic Stroke Trial
| [[Heidelberg Trial]]
|-
|-
| HALT-C
| [[HELAS]]
| Hepatitis C Antiviral Long-Term Treatment To Prevent Cirrhosis;
| [[Antithrombotic Therapy In Heart Failure: A Randomized Comparison Of Warfarin Vs. Aspirin]]
|-
|-
| HALT-MI
| [[HELAS]]
| Hu23F2G Anti-Adhesion To Limit Cytotoxic Injury Following Ami
| [[Antithrombotic Therapy In Heart Failure: A Randomized Comparison Of Warfarin Vs. Aspirin]]
|-
|-
| HANDLS
| [[Helsinki Heart Study]]
| Health Aging In Nationally Diverse Longitudinal Samples
| [[Helsinski Heart Study]]
|-
|-
| HANE
| [[Helsinki Heart Study]]
| Randomized, Double-Blind Multicenter Comparison Of Hydrochlorothiazide, Atenolol, Nitrendipine, And Enalapril In Antihypertensive Treatment
| [[Helsinski Heart Study]]
|-
|-
| HARDBALL
| [[HEME]]
| Heart Allograft Rejection: Detection With Breath Alkanes In Low Level
| [[Hemorrhage Early Mri Evaluation]]
|-
|-
| HARP
| [[HERO]]
| Harvard Atherosclerosis Reversibility Project
| [[Hirulog Early Reperfusion/Occlusion Trial]]
|-
|-
| HART
| [[HERO]]
| Heparin-Aspirin Reperfusion Trial
| [[Hirulog Early Reperfusion/Occlusion Trial]]
|-
|-
| HART II
| [[HERO-2]]
| Randomized Comparison Of Enoxaparin, A Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive To Recombinant Tissue Plasminogen Activator Thrombolysis And Aspirin: Second Trial Of Heparin And Aspirin Reperfusion Therapy
| [[Hirulog And Early Reperfusion Or Occlusion Trial]]
|-
|-
| HAT
| [[HERS]]
| Home Automatic External Defibrillator Trial
| [[Heart And Estrogen/Progestin Replacement Study]]
|-
|-
| HAT 1
| [[HERS]]
| Heparin-Associated Thrombocytopenia 1
| [[Heart And Estrogen/Progestin Replacement Study Hiv Epidemiology Research Study]]
|-
|-
| HAT 2
| [[HESTIA]]
| Heparin-Associated Thrombocytopenia 2
| [[Home Evaluation Of Stroke Induced Aid]]
|-
|-
| HATS
| [[HF-ACTION]]
| Hdl-Atherosclerosis Treatment Study
| [[Heart Failure–A Randomized Controlled Trial Investigating Outcomes Of Exercise Training]]
|-
|-
| HDFP
| [[HF-ACTION Substudy]]
| Hypertension Detection And Follow-Up Program
| [[Effect Of Exercise Training On Health-Related Quality Of Life In Patients With Chronic Heart Failure]]
|-
|-
| HDOM
| [[HHH]]
| Heart Disease On The Mend
| [[Home Or Hospital Heart Failure]]
|-
|-
| HeADDFIRST
| [[HIJ-CREATE]]
| Hemicraniectomy And Durotomy For Deterioration From Infarction Relating Swelling Trial
| [[Heart Institute Of Japan Candesartan Randomized Trial For Evaluation In Coronary Artery Disease]]
|-
|-
| HEART
| [[HIPS]]
| Healing And Early Afterload Reducing Therapy Trial
| [[Heparin Infusion Prior To Stenting ]]
|-
|-
| HEAT 2
| [[HIT]]
| Hypertension Endothelin Antagonist Treatment
| [[Hdl-Cholesterol Intervention Trial Hirudin For The Improvement Of Thrombolysis]]
|-
|-
| Heidelberg
| [[HIT-I]]
| Heidelberg Trial
| [[Hirudin For The Improvement Of Thrombolysis]]
|-
|-
| HELAS
| [[HIT-III]]
| Antithrombotic Therapy In Heart Failure: A Randomized Comparison Of Warfarin Vs. Aspirin
| [[Hirudin For Improvement Of Thrombolysis]]
|-
|-
| Helsinki Heart Study
| [[HOME]]
| Helsinski Heart Study
| [[Hyperinsulinemia: The Outcome Of Its Metabolic Effects]]
|-
|-
| HEME
| [[HOPE]]
| Hemorrhage Early Mri Evaluation
| [[Heart Outcomes Prevention Evaluation ]]
|-
|-
| HERO
| [[HOPE]]
| Hirulog Early Reperfusion/Occlusion Trial
| [[The Heart Outcomes Prevention Evaluation Study]]
|-
|-
| HERO-2
| [[HOPE-2]]
| Hirulog And Early Reperfusion Or Occlusion Trial
| [[Heart Outcomes Prevention Evaluation]]
|-
|-
| HERS
| [[HOPE-TOO]]
| Heart And Estrogen/Progestin Replacement Study
| [[Heart Outcomes Prevention Evaluation - The Ongoing Outcomes ]]
|-
|-
| HESTIA
| [[HORIZON]]
| Home Evaluation Of Stroke Induced Aid
| [[Health Outcomes And Reduced Incidence With Zoledronic Once Yearly]]
|-
|-
| HF-ACTION
| [[HORIZONS-AMI]]
| Heart Failure–A Randomized Controlled Trial Investigating Outcomes Of Exercise Training
| [[Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction]]
|-
|-
| HF-ACTION Substudy
| [[HORIZONS-AMI Stent]]
| Effect Of Exercise Training On Health-Related Quality Of Life In Patients With Chronic Heart Failure
| [[Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction]]
|-
|-
| HHH
| [[HOS]]
| Home Or Hospital Heart Failure
| [[Hypertension-Obesity-Sibutramine]]
|-
|-
| HIJ-CREATE
| [[HOT]]
| Heart Institute Of Japan Candesartan Randomized Trial For Evaluation In Coronary Artery Disease
| [[Hypertension Optimal Treatment Study]]
|-
|-
| HIPS
| [[HOT]]
| Heparin Infusion Prior To Stenting;
| [[Hypertension Optimum Treatment]]
|-
|-
| HIT
| [[HPS]]
| Hdl-Cholesterol Intervention Trial; Hirudin For The Improvement Of Thrombolysis
| [[Medical Research Council/British Heart Foundation Heart Protection Study]]
|-
|-
| HIT-I
| [[HPS]]
| Hirudin For The Improvement Of Thrombolysis
| [[Heart Protection Study]]
|-
|-
| HIT-III
| [[HRS]]
| Hirudin For Improvement Of Thrombolysis
| [[Health And Retirement Study]]
|-
|-
| HOME
| [[Hy-C]]
| Hyperinsulinemia: The Outcome Of Its Metabolic Effects
| [[The Hydralazine Captopril Trial]]
|-
|-
| HOPE
| [[HYVET]]
| Heart Outcomes Prevention Evaluation;
| [[Hypertension In The Very Elderly Trial]]
|-
|-
| HOPE
| [[HYVET]]
| The Heart Outcomes Prevention Evaluation Study
| [[Hypertension In The Very Elderly Trial]]
|-
|-
| HOPE-2
| [[IBIS-2]]
| Heart Outcomes Prevention Evaluation
| [[Integrated Biomarker And Imaging Study-2]]
|-
|-
| HOPE-TOO
| [[ICE-IT]]
| Heart Outcomes Prevention Evaluation - The Ongoing Outcomes
| [[Intravascular Cooling Adjunctive To Primary Coronary Intervention]]
|-
|-
| HORIZON
| [[ICON]]
| Health Outcomes And Reduced Incidence With Zoledronic Once Yearly
| [[Ionic Versus Nonionic Contrast To Obviate Worsening Nephropathy After Angioplasty In Chronic Renal Failure Patients]]
|-
|-
| HORIZONS-AMI
| [[ICSS]]
| Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
| [[International Carotid Stenting Study (Cavatas-2)]]
|-
|-
| HOS
| [[ICTUS]]
| Hypertension-Obesity-Sibutramine
| [[Invasive Versus Conservative Treatment In Unstable Coronary Syndromes]]
|-
|-
| HOT
| [[IDEAL]]
| Hypertension Optimal Treatment Study
| [[Incremental Decrease In Clinical Endpoints Through Aggressive Lipid Lowering]]
|-
|-
| HPS
| [[IDEAL]]
| Medical Research Council/British Heart Foundation Heart Protection Study
| [[Incremental Decrease In Endpoints Through Aggressive Lipid Lowering  Iressa Dose Evaluation In Advanced Lung Cancer]]
|-
|-
| HRS
| [[IDNT]]
| Health And Retirement Study
| [[Irbesartan Diabetic Nephropathy Trial]]
|-
|-
| Hy-C
| [[IDNT]]
| The Hydralazine Captopril Trial
| [[Irbesartan In Diabetic Nephropathy Trial]]
|-
|-
| HYVET
| [[IHAST]]
| Hypertension In The Very Elderly Trial
| [[Intraoperative Hypothermia For Aneurysm Surgery Trial]]
|-
|-
| IBIS-2
| [[ILLUMINATE]]
| Integrated Biomarker And Imaging Study-2
| [[ Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events]]
|-
|-
| ICE-IT
| [[ILLUSTRATE]]
| Intravascular Cooling Adjunctive To Primary Coronary Intervention
| [[Investigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation]]
|-
|-
| ICON
| [[IMAGES]]
| Ionic Versus Nonionic Contrast To Obviate Worsening Nephropathy After Angioplasty In Chronic Renal Failure Patients
| [[Intravenous Magnesium Efficacy In Stroke]]
|-
|-
| ICSS
| [[IMAGINE]]
| International Carotid Stenting Study (Cavatas-2)
| [[Ischemia Management With Accupril Post-Bypass Graft Via Inhibition Of The Converting Enzyme]]
|-
|-
| ICTUS
| [[IMAGINE]]
| Invasive Versus Conservative Treatment In Unstable Coronary Syndromes
| [[Ischemic Management With Accupril Post Bypass Graft Via Inhibition Of Converting Enzyme]]
|-
|-
| IDEAL
| [[IMPACT]]
| Incremental Decrease In Clinical Endpoints Through Aggressive Lipid Lowering
| [[Integrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial]]
|-
|-
| IDNT
| [[IMPACT II]]
| Irbesartan Diabetic Nephropathy Trial
| [[Integrilin To Minimise Platelet Aggregation And Coronary Thrombus - II]]
|-
|-
| IHAST
| [[IMPACT-HF]]
| Intraoperative Hypothermia For Aneurysm Surgery Trial
| [[Initiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure]]
|-
|-
| ILLUMINATE
| [[IMPRESS]]
| Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events
| [[ Immunosuppressive Therapy For The Prevention Of Restenosis After Coronary Artery Stent Implantation]]
|-
|-
| ILLUSTRATE
| [[IMPRESS]]
| Investigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation
| [[Inhibition Of Metalloprotease By Bms-186716 In A Randomized Exercise And Symptoms Study ]]
|-
|-
| IMAGES
| [[IMPROVE-CHF]]
| Intravenous Magnesium Efficacy In Stroke
| [[Improved Management Of Patients With Congestive Heart Failure]]
|-
|-
| IMAGINE
| [[IMS]]
| Ischemia Management With Accupril Post-Bypass Graft Via Inhibition Of The Converting Enzyme
| [[Interventional Management Of Stroke Study]]
|-
|-
| IMPACT
| [[IN-CHF]]
| Integrilin™ To Manage Platelet Aggregation To Prevent Coronary Thrombosis; International Mexiletine Or Placebo Antiarrhythmic Coronary Trial;;International Multiple Sclerosis Secondary Progressive Avonex™ Controlled Trial
| [[Italian Network - Congestive Heart Failure]]
|-
|-
| IMPACT II
| [[INCOMIN]]
| Integrilin To Minimise Platelet Aggregation And Coronary Thrombus - Ii
| [[Independent Comparison Of Interferon (Betaseron V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms)]]
|-
|-
| IMPACT-HF
| [[InDDEx]]
| Initiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
| [[Investigation Into Delay To Diagnosis Of Alzheimer Disease With Exelon]]
|-
|-
| IMPRESS
| [[INHIBIT]]
| Immunosuppressive Therapy For The Prevention Of Restenosis After Coronary Artery Stent Implantation
| [[Intimal Hyperplasia Inhibition With Beta In-Stent Trial]]
|-
|-
| IMPRESS
| [[INHIBIT]]
| Inhibition Of Metalloprotease By Bms-186716 In A Randomized Exercise And Symptoms Study;
| [[Intimal Hyperplasia Inhibition With Beta In-Stent Trial]]
|-
|-
| IMPROVE-CHF
| [[INJECT]]
| Improved Management Of Patients With Congestive Heart Failure
| [[International Joint Efficacy Comparison Of Thrombolytics]]
|-
|-
| IMS
| [[INSIGHT]]
| Interventional Management Of Stroke Study
| [[International Nifedipine Gits Study: Intervention As A Goal In Hypertension Treatment]]
|-
|-
| IN-CHF
| [[INSIGHT]]
| Italian Network - Congestive Heart Failure
| [[International Nifedipine Once-Daily Study – Intervention As A Goal In Hypertension Treatment]]
|-
|-
| INCOMIN
| [[INSPIRE]]
| Independent Comparison Of Interferon (Betaseron® V. Avonex™ In Relapsing-Remitting Multiple Sclerosis (Rrms)]
| [[Adenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial]]
|-
|-
| InDDEx
| [[INSYNC]]
| Investigation Into Delay To Diagnosis Of Alzheimer Disease With Exelon™
| [[Multisite Pacing As A Supplemental Treatment Of Congestive Heart Failure: The Medtronic Inc. Insync Study]]
|-
|-
| INHIBIT
| [[INTACT]]
| Intimal Hyperplasia Inhibition With Beta In-Stent Trial
| [[Iressa Non–Small Cell Lung Cancer Trial Assessing Combination Treatment]]
|-
|-
| INJECT
| [[INTAMI]]
| International Joint Efficacy Comparison Of Thrombolytics
| [[Integrilin In Acute Myocardial Infarction]]
|-
|-
| INSIGHT
| [[INTEGRITI]]
| International Nifedipine Gits Study: Intervention As A Goal In Hypertension Treatment
| [[Integrilin And Tenecteplase In Acute Myocardial Infarction]]
|-
|-
| INSPIRE
| [[INTEGRITI]]
| Adenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial
| [[Integrilin And Tenecteplase  In Acute Myocardial Infarction ]]
|-
|-
| INSYNC
| [[INTERACT]]
| Multisite Pacing As A Supplemental Treatment Of Congestive Heart Failure: The Medtronic Inc. Insync Study
| [[Integrilin And Enoxaparin Randomized Assessment Of Acute Coronary Syndrome Treatment]]
|-
|-
| INTACT
| [[INTERCEPT]]
| Iressa® Non–Small Cell Lung Cancer Trial Assessing Combination Treatment
| [[Incomplete Infarction Trial Of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem)]]
|-
|-
| INTAMI
| [[INTERHEART]]
| Integrilin In Acute Myocardial Infarction
| [[A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects]]
|-
|-
| INTEGRITI
| [[InTIME]]
| Integrilin And Tenecteplase In Acute Myocardial Infarction
| [[Intravenous Npa For Treatment Of Infarcting Myocardium Early ]]
|-
|-
| INTERACT
| [[InTime-2]]
| Integrilin And Enoxaparin Randomized Assessment Of Acute Coronary Syndrome Treatment
| [[Intravenous Npa For Treatment Of Infarcting Myocardium Early]]
|-
|-
| INTERCEPT
| [[INTrEPID]]
| Incomplete Infarction Trial Of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem]
| [[Investigation Of Non–Transplant-Eligible Patients Who Are Inotrope Dependent See ]]
|-
|-
| INTERHEART
| [[INTRINSIC RV]]
| A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
| [[ Inhibition Of Unnecessary Rv Pacing With Av Search Hysteresis In Icds]]
|-
|-
| InTIME
| [[INTRO-AMI]]
| Intravenous Npa For Treatment Of Infarcting Myocardium Early;
| [[Integrilin And Reduced Dose Of Thrombolytic In Acute Myocardial Infarction]]
|-
|-
| InTime-2
| [[INVEST]]
| Intravenous Npa For Treatment Of Infarcting Myocardium Early
| [[International Verapamil-Trandolapril Study]]
|-
|-
| INTrEPID
| [[IONA]]
| Investigation Of Non–Transplant-Eligible Patients Who Are Inotrope Dependent; See
| [[Effect Of Nicorandil On Coronary Events In Patients With Stable]]
|-
|-
| INTRINSIC RV
| [[IONA]]
| Inhibition Of Unnecessary Rv Pacing With Av Search Hysteresis In Icds
| [[Impact Of Nicorandil In Angina]]
|-
|-
| INTRO-AMI
| [[IONDT]]
| Integrilin® And Reduced Dose Of Thrombolytic In Acute Myocardial Infarction
| [[Ischemic Optic Neuropathy Decompression Trial]]
|-
|-
| INVEST
| [[I-PRESERVE]]
| International Verapamil-Trandolapril Study
| [[Rbesartan In Heart Failure With Preserved Ejection Fraction Study]]
|-
|-
| IONA
| [[IRAS]]
| Effect Of Nicorandil On Coronary Events In Patients With Stable
| [[Insulin Resistance Atherosclerosis Study]]
|-
|-
| IONDT
| [[IRIS]]
| Ischemic Optic Neuropathy Decompression Trial
| [[Isostent For Restenosis Intervention Study]]
|-
|-
| I-PRESERVE
| [[IRIS]]
| Rbesartan In Heart Failure With Preserved Ejection Fraction Study
| [[Isostent For Restenosis Intervention Study]]
|-
|-
| IRAS
| [[IRMA 2]]
| Insulin Resistance Atherosclerosis Study
| [[Irbesartan In Type 2 Diabetes With Microalbuminuria 2]]
|-
|-
| IRIS
| [[IRMA 2]]
| Isostent For Restenosis Intervention Study
| [[Irbesartan (Avapro) Microalbuminuria Type 2]]
|-
|-
| IRIS
| [[ISAAC]]
| Isostent For Restenosis Intervention Study
| [[International Study Of Asthma And Allergies In Childhood]]
|-
|-
| IRMA 2
| [[ISAM]]
| Irbesartan In Type 2 Diabetes With Microalbuminuria 2
| [[Intravenous Streptokinase In Acute Myocardial Infarction]]
|-
|-
| ISAAC
| [[ISAR]]
| International Study Of Asthma And Allergies In Childhood
| [[Intracoronary Stenting And Antithrombotic Regimen Trial]]
|-
|-
| ISAM
| [[ISAR]]
| Intravenous Streptokinase In Acute Myocardial Infarction
| [[Individualizable Drug-Eluting Stent System To Abrogate Restenosis Project]]
|-
|-
| ISAR
| [[ISAR]]
| Intracoronary Stenting And Antithrombotic Regimen Trial
| [[Intracoronary Stenting And Antithrombotic Regimen]]
|-
|-
| ISAR
| [[ISAR DIABETES]]
| Individualizable Drug-Eluting Stent System To Abrogate Restenosis Project
| [[Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease]]
|-
|-
| ISAR
| [[ISAR REACT]]
| Intracoronary Stenting And Antithrombotic Regimen
| [[Intracoronary Stenting And Antithrombotic Regimen Rapid Early Action For Coronary Treatment]]
|-
|-
| ISAR DIABETES
| [[ISAR-CHOICE]]
| Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease
| [[Intracoronary Stenting And Antithrombotic Regimen: Choose Between 3 High Oral Doses For Immediate Clopidogrel Effect]]
|-
|-
| ISAR REACT
| [[ISAR-COOL]]
| Intracoronary Stenting And Antithrombotic Regimen Rapid Early Action For Coronary Treatment
| [[Intracoronary Stenting With Antithrombotic Regimen Cooling-Off]]
|-
|-
| ISAR-CHOICE
| [[ISAR-DESIRE]]
| Intracoronary Stenting And Antithrombotic Regimen: Choose Between 3 High Oral Doses For Immediate Clopidogrel Effect
| [[Drug-Eluting Stents For In-Stent Restenosis]]
|-
|-
| ISAR-COOL
| [[ISAR-LEFT MAIN]]
| Intracoronary Stenting With Antithrombotic Regimen Cooling-Off
| [[Intracoronary Stenting And Angiographic Results: Drug-Eluting Stents For Unprotected Coronary Left Main Lesions]]
|-
|-
| ISAR-DESIRE
| [[ISAR-PEACE]]
| Drug-Eluting Stents For In-Stent Restenosis
| [[ Intracoronary Stenting And Angiographic Restenosis: Promote Endothelial Cells With Estradiol]]
|-
|-
| ISAR-LEFT MAIN
| [[ISAR-REACT 2]]
| Intracoronary Stenting And Angiographic Results: Drug-Eluting Stents For Unprotected Coronary Left Main Lesions
| [[Intracoronary Stenting And Antithrombotic Regimen: Rapid Early Action For Coronary Treatment]]
|-
|-
| ISAR-PEACE
| [[ISAR-REACT 3]]
| Intracoronary Stenting And Angiographic Restenosis: Promote Endothelial Cells With Estradiol
| [[Bivalirudin Versus Unfractionated Heparin During Percutaneous Coronary Intervention]]
|-
|-
| ISAR-REACT 2
| [[ISAR-SHOCK]]
| Intracoronary Stenting And Antithrombotic Regimen: Rapid Early Action For Coronary Treatment
| [[Impella Lp2.5 Vs. Iabp In Cardiogenic Shock]]
|-
|-
| ISAR-REACT 3
| [[ISAR-STEREO]]
| Bivalirudin Versus Unfractionated Heparin During Percutaneous Coronary Intervention
| [[Intracoronary Stenting And Angiographic Results: Strut Thickness Effect On Restenosis Outcomes (Isar-Stereo) Trial]]
|-
|-
| ISAR-SHOCK
| [[ISAR-STEREO]]
| Impella Lp2.5 Vs. Iabp In Cardiogenic Shock
| [[Intracoronary Stenting And Angiographic Results - Strut Thickness Effect On Restenosis Outcome]]
|-
|-
| ISAR-STEREO
| [[ISAR-STEREO - 2]]
| Intracoronary Stenting And Angiographic Results: Strut Thickness Effect On Restenosis Outcomes (Isar-Stereo) Trial
| [[Intracoronary Stenting And Angiographic Results - Strut Thicness Effect On Restenosis Outcome Trial - 2]]
|-
|-
| ISAR-STEREO - 2
| [[ISAR-SWEET]]
| Intracoronary Stenting And Angiographic Results - Strut Thicness Effect On Restenosis Outcome Trial - 2
| [[Is Abciximab A Superior Way To Eliminate Elevated Thrombotic Risk In Diabetics]]
|-
|-
| ISAR-SWEET
| [[ISAR-TEST]]
| Is Abciximab A Superior Way To Eliminate Elevated Thrombotic Risk In Diabetics
| [[Randomized Trial Of The Yukon Nonpolymer-Based Rapamycin-Coated Stent And The Polymer-Based Paclitaxel-Eluting Stent In Patients With Coronary Artery Disease]]
|-
|-
| ISAR-TEST
| [[ISAR-TEST-2]]
| Randomized Trial Of The Yukon Nonpolymer-Based Rapamycin-Coated Stent And The Polymer-Based Paclitaxel-Eluting Stent In Patients With Coronary Artery Disease
| [[Intracoronary Stenting And Angiographic Results–Test Efficacy Of 3 Limus-Eluting Stents]]
|-
|-
| ISAR-TEST-2
| [[ISAR-TEST-3]]
| Intracoronary Stenting And Angiographic Results–Test Efficacy Of 3 Limus-Eluting Stents
| [[Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies]]
|-
|-
| ISAR-TEST-3
| [[ISAT]]
| Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies
| [[International Subarachnoid Aneurysm Trial]]
|-
|-
| ISAT
| [[ISIS-1]]
| International Subarachnoid Aneurysm Trial
| [[First International Study Of Infarct Survival]]
|-
|-
| ISIS-1
| [[ISIS-2]]
| First International Study Of Infarct Survival
| [[International Study Of Infarct Survival-2]]
|-
|-
| ISIS-2
| [[ISIS-3]]
| International Study Of Infarct Survival-2
| [[ International Study Of Infarct Survival-3]]
|-
|-
| ISIS-3
| [[ISIS-4]]
| International Study Of Infarct Survival-3
| [[Fourth International Study Of Infarct Survival]]
|-
|-
| ISIS-4
| [[IST]]
| Fourth International Study Of Infarct Survival
| [[The International Stroke Trial]]
|-
|-
| IST
| [[ISTICH]]
| The International Stroke Trial
| [[International Surgical Trial In Intracerebral Hemorrhage]]
|-
|-
| ISTICH
| [[ITALICS]]
| International Surgical Trial In Intracerebral Hemorrhage
| [[Investigation By The Thoraxcenter On Antisense Dna Using Local Delivery And Ivus After Coronary Stenting]]
|-
|-
| ITALICS
| [[ITT]]
| Investigation By The Thoraxcenter On Antisense Dna Using Local Delivery And Ivus After Coronary Stenting
| [[Intraventricular Thrombolysis Trial]]
|-
|-
| ITT
| [[IVAT]]
| Intraventricular Thrombolysis Trial
| [[Intermediate Sized Vessel Atherectomy Trial]]
|-
|-
| IVAT
| [[JAMIS]]
| Intermediate Sized Vessel Atherectomy Trial
| [[Effects Of Aspirin And Trapidil On Cardiovascular Events After Acute Myocardial Infarction]]
|-
|-
| JAMIS
| [[JELIS]]
| Effects Of Aspirin And Trapidil On Cardiovascular Events After Acute Myocardial Infarction
| [[Japan Epa Lipid Intervention Study]]
|-
|-
| JELIS
| [[JPAD]]
| Japan Epa Lipid Intervention Study
| [[Japanese Primary Prevention Of Atherosclerosis With Aspirin For Diabetes]]
|-
|-
| JPAD
| [[JSAP]]
| Japanese Primary Prevention Of Atherosclerosis With Aspirin For Diabetes
| [[Japanese Stable Angina Pectoris Study]]
|-
|-
| JSAP
| [[JUMBO-TIMI 26]]
| Japanese Stable Angina Pectoris Study
| [[Joint Utilisation Of Medications To Block Platelets Optimally]]
|-
|-
| JUMBO-TIMI 26
| [[JUPITER]]
| Joint Utilisation Of Medications To Block Platelets Optimally
| [[Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin]]
|-
|-
| JUPITER
| [[J-WIND]]
| Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
| [[Japan Working Groups Of Acute Myocardial Infarction For The Reduction Of Necrotic Damage By Atrial Natriuretic Peptide Or Nicorandil]]
|-
|-
| J-WIND
| [[KAT II]]
| Japan Working Groups Of Acute Myocardial Infarction For The Reduction Of Necrotic Damage By Atrial Natriuretic Peptide Or Nicorandil
| [[Kuopio Angiogenesis Trial]]
|-
|-
| KAT II
| [[LACI]]
| Kuopio Angiogenesis Trial
| [[Laser Angioplasty For Critical Ischemia ]]
|-
|-
| LACI
| [[LADIP]]
| Laser Angioplasty For Critical Ischemia;
| [[Loire-Ardèche-Drôme-Isère-Puy-De-Dôme]]
|-
|-
| LADIP
| [[LAMP]]
| Loire-Ardèche-Drôme-Isère-Puy-De-Dôme
| [[Locally Advanced Multimodality Protoco]]
|-
|-
| LAMP
| [[LARS]]
| Locally Advanced Multimodality Protoco
| [[Laser Angioplasty In Restenosed Stents]]
|-
|-
| LARS
| [[LATE]]
| Laser Angioplasty In Restenosed Stents
| [[Late Assessment Of Thrombolytic Efficacy Study]]
|-
|-
| LATE
| [[LAVA]]
| Late Assessment Of Thrombolytic Efficacy Study
| [[Prospective, Randomized, Multicenter Comparison Of Laser-Facilitated Balloon Angioplasty Versus Stand-Alone Balloon Angioplasty In Patients With Obstructive Coronary Artery Disease]]
|-
|-
| LAVA
| [[L-CAD]]
| Prospective, Randomized, Multicenter Comparison Of Laser-Facilitated Balloon Angioplasty Versus Stand-Alone Balloon Angioplasty In Patients With Obstructive Coronary Artery Disease
| [[Lipid-Coronary Artery Disease (Pravastatin)]]
|-
|-
| L-CAD
| [[LCAS]]
| Lipid-Coronary Artery Disease (Pravastatin];
| [[The Lipoprotein And Coronary Atherosclerosis Study (Lcas): Lipid And Metabolic Factors Related To Atheroma And Clinical Events]]
|-
|-
| LCAS
| [[LEADER]]
| The Lipoprotein And Coronary Atherosclerosis Study (Lcas): Lipid And Metabolic Factors Related To Atheroma And Clinical Events
| [[ Lower Extremity Arterial Disease Event Reduction Trial]]
|-
|-
| LEADER
| [[LEADERS]]
| Lower Extremity Arterial Disease Event Reduction Trial
| [[Limus Eluted From A Durable Vs Erodable Stent Coating]]
|-
|-
| LEADERS
| [[LHT]]
| Limus Eluted From A Durable Vs Erodable Stent Coating
| [[Lifestyle Heart Trial]]
|-
|-
| LHT
| [[LIDO]]
| Lifestyle Heart Trial
| [[Levosimendan Infusion Versus Dobutamine]]
|-
|-
| LIDO
| [[LIFE]]
| Levosimendan Infusion Versus Dobutamine
| [[Losartan Intervention For Endpoint Reduction In Hypertension (Life) Study]]
|-
|-
| LIFE
| [[LIMB]]
| Losartan Intervention For Endpoint Reduction In Hypertension (Life) Study
| [[Limbs International Medical Buflomedil Trial]]
|-
|-
| LIMB
| [[LIMIT AMI]]
| Limbs International Medical Buflomedil Trial
| [[Limitation Of Myocardial Infarction Following Thrombolysis In Acute]]
|-
|-
| LIMIT AMI
| [[LIMIT-2]]
| Limitation Of Myocardial Infarction Following Thrombolysis In Acute
| [[Second Leicester Magnesium Intervention Trial]]
|-
|-
| LIMIT-2
| [[LIPID]]
| Second Leicester Magnesium Intervention Trial
| [[Long-Term Intervention With Pravastatin In Ischemic Disease Trial]]
|-
|-
| LIPID
| [[LIPS]]
| Long-Term Intervention With Pravastatin In Ischemic Disease Trial
| [[Lescol Intervention Prevention Study]]
|-
|-
| LIPS
| [[LISA]]
| Lescol Intervention Prevention Study
| [[Lescol In Severe Atherosclerosis Trial]]
|-
|-
| LISA
| [[LOCAT]]
| Lescol In Severe Atherosclerosis Trial
| [[Prevention Of The Angiographic Progression Of Coronary And Vein-Graft Atherosclerosis By Gemfibrozil After Coronary Bypass Surgery In Men With Low Levels Of Hdl Cholesterol]]
|-
|-
| LOCAT
| [[LONG DES II]]
| Prevention Of The Angiographic Progression Of Coronary And Vein-Graft Atherosclerosis By Gemfibrozil After Coronary Bypass Surgery In Men With Low Levels Of Hdl Cholesterol
| [[Randomized Comparison Of The Efficacy Of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent In The Treatment Of Long Native Coronary Lesions]]
|-
|-
| LONG DES II
| [[LONG-DES]]
| Randomized Comparison Of The Efficacy Of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent In The Treatment Of Long Native Coronary Lesions
| [[Multicenter Prospective Nonrandomized Registry Study For Drug-Eluting Stents In Very Long Coronary Lesions (Cypher Vs Taxus)]]
|-
|-
| LONG-DES
| [[LRC-CPPT]]
| Multicenter Prospective Nonrandomized Registry Study For Drug-Eluting Stents In Very Long Coronary Lesions (Cypher Vs Taxus)
| [[Lipid Research Clinics Coronary Primary Prevention Trial]]
|-
|-
| LRC-CPPT
| [[MACH-1]]
| Lipid Research Clinics Coronary Primary Prevention Trial
| [[Mortality Assessment In Congestive Heart Failure Trial]]
|-
|-
| MACH-1
| [[MADIT]]
| Mortality Assessment In Congestive Heart Failure Trial
| [[Multicenter Automatic Defibrillator Implantation Trial]]
|-
|-
| MADIT
| [[MADIT-II]]
| Multicenter Automatic Defibrillator Implantation Trial
| [[Multicenter Automatic Defibrillator Implantation Trial II]]
|-
|-
| MADIT-II
| [[MAGIC]]
| Multicenter Automatic Defibrillator Implantation Trial Ii
| [[Magnesium In Coronaries]]
|-
|-
| MAGIC
| [[MAGIC]]
| Magnesium In Coronaries
| [[Myoblast Autologous Grafting In Ischemic Cardiomyopathy]]
|-
|-
| MAGIC
| [[MAGIC – Presented at AHA 2006]]
| Myoblast Autologous Grafting In Ischemic Cardiomyopathy
| [[Myoblast Autologous Grafting In Ischemic Cardiomyopathy]]
|-
|-
| MAGIC – Presented at AHA 2006
| [[Male Health]]
| Myoblast Autologous Grafting In Ischemic Cardiomyopathy
| [[ Male Health Professionals Study]]
|-
|-
| Male Health
| [[MAPPET-3]]
| Male Health Professionals Study
| [[ Management Strategies And Prognosis Of Pulmonary Embolism-3 Trial]]
|-
|-
| MAPPET-3
| [[MARS]]
| Management Strategies And Prognosis Of Pulmonary Embolism-3 Trial
| [[The Monitored Atherosclerosis Regression Study]]
|-
|-
| MARS
| [[MASCOT]]
| The Monitored Atherosclerosis Regression Study
| [[Management Of Atrial Fibrillation Suppression In Af-Hf Comorbidity Therapy]]
|-
|-
| MASCOT
| [[MASS]]
| Management Of Atrial Fibrillation Suppression In Af-Hf Comorbidity Therapy
| [[The Medicine, Angioplasty Or Surgery Study]]
|-
|-
| MASS
| [[MASS]]
| The Medicine, Angioplasty Or Surgery Study
| [[The Multicenter Aneurysm Screening Study (Mass) Into The Effect Of Abdominal Aortic Aneurysm Screening On Mortality In Men: A Randomized Controlled Trial]]
|-
|-
| MASS
| [[MASS-II]]
| The Multicenter Aneurysm Screening Study (Mass) Into The Effect Of Abdominal Aortic Aneurysm Screening On Mortality In Men: A Randomized Controlled Trial
| [[Second Medicine, Angioplasty, Or Surgery Study]]
|-
|-
| MASS-II
| [[MAST-E]]
| Second Medicine, Angioplasty, Or Surgery Study
| [[Thrombolytic Therapy With Streptokinase In Acute Ischemic Stroke]]
|-
|-
| MAST-E
| [[MASTER]]
| Thrombolytic Therapy With Streptokinase In Acute Ischemic Stroke
| [[Microvolt T Wave Alternans Testing For Risk Stratification Of Post-Myocardial Infarction Patients]]
|-
|-
| MASTER
| [[MATCH]]
| Microvolt T Wave Alternans Testing For Risk Stratification Of Post-Myocardial Infarction Patients
| [[Management Of Atherothrombosis With Clopidogrel In High-Risk Patients]]
|-
|-
| MATCH
| [[MATE]]
| Management Of Atherothrombosis With Clopidogrel In High-Risk Patients
| [[Medicine Versus Angiography In Thrombolytic Exclusion Trial]]
|-
|-
| MATE
| [[MATH]]
| Medicine Versus Angiography In Thrombolytic Exclusion Trial
| [[Endocrine And Renal Effects Of Nifedipine Gastrointestinal Theraputic System In Patients With Essential Hypertension: Results Of A Multicenter Trial]]
|-
|-
| MATH
| [[Matisse]]
| Endocrine And Renal Effects Of Nifedipine Gastrointestinal Theraputic System In Patients With Essential Hypertension: Results Of A Multicenter Trial
| [[Subcutaneous Fondaparinux Versus Intravenous Unfractionated Heparin In The Initial Treatment Of Pulmonary Embolism]]
|-
|-
| Matisse
| [[MATTIS]]
| Subcutaneous Fondaparinux Versus Intravenous Unfractionated Heparin In The Initial Treatment Of Pulmonary Embolism
| [[Randomized Evaluation Of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation In High-Risk Patients: The Multicenter Aspirin And Ticlopidine Trial After Intracoronary Stenting]]
|-
|-
| MATTIS
| [[MAVErIC II]]
| Randomized Evaluation Of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation In High-Risk Patients: The Multicenter Aspirin And Ticlopidine Trial After Intracoronary Stenting
| [[30-Day Results From A Prospective Registry Of Carotid Stenting With The Exponent Stent And Distal Protection With The Guardwire In High Risk Patients]]
|-
|-
| MAVErIC II
| [[MaVS]]
| 30-Day Results From A Prospective Registry Of Carotid Stenting With The Exponent Stent And Distal Protection With The Guardwire In High Risk Patients
| [[Metoprolol After Vascular Surgery]]
|-
|-
| MaVS
| [[MDC]]
| Metoprolol After Vascular Surgery
| [[Metoprolol In Dilated Cardiomyopathy Trial]]
|-
|-
| MDC
| [[MDPIT]]
| Metoprolol In Dilated Cardiomyopathy Trial
| [[The Multicenter Diltiazem Post Infarction Trial]]
|-
|-
| MDPIT
| [[MDRD]]
| The Multicenter Diltiazem Post Infarction Trial
| [[Modification Of Diet In Renal Disease Study]]
|-
|-
| MDRD
| [[MEDAL Program]]
| Modification Of Diet In Renal Disease Study
| [[Multinational Etoricoxib And Diclofenac Arthritis Long-Term Study Program]]
|-
|-
| MEDAL Program
| [[MEDENOX]]
| Multinational Etoricoxib And Diclofenac Arthritis Long-Term Study Program
| [[Prophylaxis In Medical Patients With Enoxaparin]]
|-
|-
| MEDENOX
| [[MEGA]]
| Prophylaxis In Medical Patients With Enoxaparin
| [[Management Of Elevated Cholesterol In The Primary Prevention Group Of Adult Japanese]]
|-
|-
| MEGA
| [[MEND-CABG II]]
| Management Of Elevated Cholesterol In The Primary Prevention Group Of Adult Japanese
| [[Mc-1 To Eliminate Necrosis And Damage In Coronary Artery Bypass Graft Surgery II — Presented At Scai-Acc I2 Summit/Acc 2008]]
|-
|-
| MEND-CABG II
| [[MERIT-HF]]
| Mc-1 To Eliminate Necrosis And Damage In Coronary Artery Bypass Graft Surgery Ii — Presented At Scai-Acc I2 Summit/Acc 2008
| [[Metoprolol Cr/Xl Randomized Intervention Trial In Congestive Heart Failure]]
|-
|-
| MERIT-HF
| [[MERLIN]]
| Metoprolol Cr/Xl Randomized Intervention Trial In Congestive Heart Failure
| [[Middlesbrough Early Revascularization To Limit Infarction]]
|-
|-
| MERLIN
| [[MERLIN-TIMI 36]]
| Middlesbrough Early Revascularization To Limit Infarction
| [[Metabolic Efficiency With Ranolazine For Less Ischemia In Nste-Acs]]
|-
|-
| MERLIN-TIMI 36
| [[METAFER]]
| Metabolic Efficiency With Ranolazine For Less Ischemia In Nste-Acs
| [[Use Of Metoprolol To Maintain Sinus Rhythm After Conversion From Persistent Atrial Fibrillation]]
|-
|-
| METAFER
| [[METEOR]]
| Use Of Metoprolol To Maintain Sinus Rhythm After Conversion From Persistent Atrial Fibrillation
| [[Measuring Effects On Intima-Media Thickness: An Evaluation Of Rosuvastatin]]
|-
|-
| METEOR
| [[MEXIS]]
| Measuring Effects On Intima-Media Thickness: An Evaluation Of Rosuvastatin
| [[The Effects Of B-Receptor Antagonists In Patients With Clinical Evidence Of Heart Failure After Myocardial Infarction: Double Blind Comparison Of Meto]]
|-
|-
| MEXIS
| [[M-HART]]
| The Effects Of B-Receptor Antagonists In Patients With Clinical Evidence Of Heart Failure After Myocardial Infarction: Double Blind Comparison Of Meto
| [[Montreal Heart Attack Readjustment Trial]]
|-
|-
| M-HART
| [[MHFT]]
| Montreal Heart Attack Readjustment Trial
| [[Munich Mild Heart Failure Trial]]
|-
|-
| MHFT
| [[MIAMI]]
| Munich Mild Heart Failure Trial
| [[Metoprolol In Acute Myocardial Infarction]]
|-
|-
| MIAMI
| [[MICRO-HOPE]]
| Metoprolol In Acute Myocardial Infarction
| [[Microalbuminuria, Cardiovascular, And Renal Outcomes - Heart Outcomes Prevention Evaluation]]
|-
|-
| MICRO-HOPE
| [[MILIS]]
| Microalbuminuria, Cardiovascular, And Renal Outcomes - Heart Outcomes Prevention Evaluation
| [[Multiple Center Investigation Of The Limit Of Infarction]]
|-
|-
| MILIS
| [[MINT]]
| Multiple Center Investigation Of The Limit Of Infarction
| [[A Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study]]
|-
|-
| MINT
| [[MIRACL]]
| A Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
| [[Effects Of Atorvastatin On Early Recurrent Ischemic Events In Acute Coronary Syndromes. The Miracl Study: A Randomized Controlled Trial]]
|-
|-
| MIRACL
| [[MIRACLE ICD]]
| Effects Of Atorvastatin On Early Recurrent Ischemic Events In Acute Coronary Syndromes. The Miracl Study: A Randomized Controlled Trial
| [[Multicenter Insync Implantable Cardioversion Defibrillation Randomized Clinical Evaluation]]
|-
|-
| MIRACLE ICD
| [[MIST]]
| Multicenter Insync Implantable Cardioversion Defibrillation Randomized Clinical Evaluation
| [[Migraine Intervention With Starflex Technology]]
|-
|-
| MIST
| [[MITI I]]
| Migraine Intervention With Starflex Technology
| [[Myocardial Infarction Triage And Intervention Project--Phase I]]
|-
|-
| MITI I
| [[MITI II]]
| Myocardial Infarction Triage And Intervention Project--Phase I
| [[Myocardial Infarction Triage And Intervention Project--Phase I]]
|-
|-
| MITI II
| [[MITRA]]
| Myocardial Infarction Triage And Intervention Project--Phase I
| [[Maximal Individual Therapy In Acute Myocardial Infarction]]
|-
|-
| MITRA
| [[MOMENTUM]]
| Maximal Individual Therapy In Acute Myocardial Infarction
| [[Multicenter Trial Of The Orqis Medical Cancion System For The Enhanced Treatment Of Heart Failure Unresponsive To Medical Therapy]]
|-
|-
| MOMENTUM
| [[MONICA]]
| Multicenter Trial Of The Orqis Medical Cancion System For The Enhanced Treatment Of Heart Failure Unresponsive To Medical Therapy
| [[Monitoring Trends And Determinants In Cardiovascular Disease]]
|-
|-
| MONICA
| [[MOST]]
| Monitoring Trends And Determinants In Cardiovascular Disease
| [[Mode Selection Trial (Most) In Sinus Node Dysfunction]]
|-
|-
| MOST
| [[MOXCON]]
| Mode Selection Trial (Most) In Sinus Node Dysfunction
| [[Excess Mortality In Chf Patients Treated With Sr Moxonidine Leads To Study Termination: Results Of The Sr Moxonidine For Congestive Heart Failure Trial]]
|-
|-
| MOXCON
| [[M-PATHY]]
| Excess Mortality In Chf Patients Treated With Sr Moxonidine Leads To Study Termination: Results Of The Sr Moxonidine For Congestive Heart Failure Trial
| [[Multicenter Pacing Therapy]]
|-
|-
| M-PATHY
| [[MPIP]]
| Multicenter Pacing Therapy
| [[Multicenter Post-Infarction Program]]
|-
|-
| MPIP
| [[MR PCI]]
| Multicenter Post-Infarction Program
| [[Multicenter Registry Of High-Risk Percutaneous Coronary Intervention And Adequate Platelet Inhibition]]
|-
|-
| MR PCI
| [[MRFIT]]
| Multicenter Registry Of High-Risk Percutaneous Coronary Intervention And Adequate Platelet Inhibition
| [[Multiple Risk Factor Intervention Trial]]
|-
|-
| MRFIT
| [[MUSIC]]
| Multiple Risk Factor Intervention Trial
| [[Multicenter Ultrasound Guided Stent Implantation In The Coronaries]]
|-
|-
| MUSIC
| [[MUST-EECP]]
| Multicenter Ultrasound Guided Stent Implantation In The Coronaries
| [[Multicenter Enhanced External Counterpulsation]]
|-
|-
| MUST-EECP
| [[MUSTIC]]
| Multicenter Enhanced External Counterpulsation
| [[Multisite Stimulation In Cardiomyopathies Study]]
|-
|-
| MUSTIC
| [[MUSTT]]
| Multisite Stimulation In Cardiomyopathies Study
| [[Multicenter Unsustained Tachycardia Trial]]
|-
|-
| MUSTT
| [[MVP]]
| Multicenter Unsustained Tachycardia Trial
| [[Multivitamins And Probucol Study]]
|-
|-
| MVP
| [[NAMIS]]
| Multivitamins And Probucol Study
| [[Nifedipine Angina Myocardial Infarction Study]]
|-
|-
| NAMIS
| [[NAPA]]
| Nifedipine Angina Myocardial Infarction Study
| [[Nesiritide Administered Peri-Anesthesia In Patients Undergoing Cardiac Surgery]]
|-
|-
| NAPA
| [[NAPLES II]]
| Nesiritide Administered Peri-Anesthesia In Patients Undergoing Cardiac Surgery
| [[Novel Approaches For Preventing Or Limiting Events II]]
|-
|-
| NAPLES II
| [[NASCET]]
| Novel Approaches For Preventing Or Limiting Events Ii
| [[North American Symptomatic Carotid Endarterectomy Trial]]
|-
|-
| NASCET
| [[NEPHRIC]]
| North American Symptomatic Carotid Endarterectomy Trial
| [[Nephrotoxicity In High-Risk Patients Study Of Isoosmolar And Low-Osmolar Non-Ionic Contrast Media Study]]
|-
|-
| NEPHRIC
| [[NETWORK]]
| Nephrotoxicity In High-Risk Patients Study Of Isoosmolar And Low-Osmolar Non-Ionic Contrast Media Study
| [[Clinical Outcome With Enalapril In Symptomatic Chronic Heart Failure: A Dose Comparison]]
|-
|-
| NETWORK
| [[NHANES III]]
| Clinical Outcome With Enalapril In Symptomatic Chronic Heart Failure: A Dose Comparison
| [[Third National Health And Nutrition Examination Survey]]
|-
|-
| NHANES III
| [[NHLBI]]
| Third National Health And Nutrition Examination Survey
| [[The National Heart, Lung And Blood Institute Type II Coronary Intervention Study]]
|-
|-
| NHLBI
| [[NHLBI Dynamic]]
| The National Heart, Lung And Blood Institute Type Ii Coronary Intervention Study
| [[Nhlbi Dynamic Registry Of Percutaneous Interventions: A Comparison To The 1985-86 Registry]]
|-
|-
| NHLBI Dynamic
| [[NICE]]
| Nhlbi Dynamic Registry Of Percutaneous Interventions: A Comparison To The 1985-86 Registry
| [[Nitrates In Congestive Heart Failure (Nice) Study]]
|-
|-
| NICE
| [[NICE-SUGAR]]
| Nitrates In Congestive Heart Failure (Nice) Study
| [[Normoglycemia In Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation]]
|-
|-
| NICE-SUGAR
| [[NICOLE]]
| Normoglycemia In Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation
| [[Nisoldipine For Coronary Artery Disease In Leuven]]
|-
|-
| NICOLE
| [[NICS-EH]]
| Nisoldipine For Coronary Artery Disease In Leuven
| [[National Intervention Cooperative Study In Elderly Hypertensives]]
|-
|-
| NICS-EH
| [[NO-PAIN]]
| National Intervention Cooperative Study In Elderly Hypertensives
| [[Nitric Oxide In Peripheral Arterial Insufficiency]]
|-
|-
| NO-PAIN
| [[NORDIL]]
| Nitric Oxide In Peripheral Arterial Insufficiency
| [[Nordic Diltiazem Study]]
|-
|-
| NORDIL
| [[NORVIT]]
| Nordic Diltiazem Study
| [[Norwegian Vitamin Trial]]
|-
|-
| NORVIT
| [[Norwegian Nifedipine]]
| Norwegian Vitamin Trial
| [[Norwegian Nifedipine Multi-Center Trial]]
|-
|-
| Norwegian Nifedipine
| [[NRMI-2]]
| Norwegian Nifedipine Multi-Center Trial
| [[National Registry Of Myocardial Infarction (Second Phase)]]
|-
|-
| NRMI-2
| [[NUT-2]]
| National Registry Of Myocardial Infarction (Second Phase)
| [[Efficacy Assessment Of Meloxicam, A Preferential Cyclooxygenase-2 Inhibitor, In Acute Coronary Syndromes Without St-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs In Unstable Angina Treatment-2 (Nut-2) Pilot Study]]
|-
|-
| NUT-2
| [[OARS]]
| Efficacy Assessment Of Meloxicam, A Preferential Cyclooxygenase-2 Inhibitor, In Acute Coronary Syndromes Without St-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs In Unstable Angina Treatment-2 (Nut-2) Pilot Study
| [[Optimal Atherectomy Restenosis Study]]
|-
|-
| OARS
| [[OASIS-1]]
| Optimal Atherectomy Restenosis Study
| [[Organization To Assess Strategies For Ischemic Syndromes]]
|-
|-
| OASIS-1
| [[OASIS-2]]
| Organization To Assess Strategies For Ischemic Syndromes
| [[Effects Of Long-Term, Moderate-Intensity Oral Anticoagulation In Addition To Aspirin In Unstable Angina]]
|-
|-
| OASIS-2
| [[OASIS-6]]
| Effects Of Long-Term, Moderate-Intensity Oral Anticoagulation In Addition To Aspirin In Unstable Angina
| [[Organization For The Assessment Of Strategies For Ischemic Syndromes 6]]
|-
|-
| OASIS-6
| [[OASIS-6 – GIK]]
| Organization For The Assessment Of Strategies For Ischemic Syndromes 6
| [[Oasis-6 – Glucose-Insulin-Potassium]]
|-
|-
| OASIS-6 – GIK
| [[OAT]]
| Oasis-6 – Glucose-Insulin-Potassium
| [[Occluded Artery Trial]]
|-
|-
| OAT
| [[OCBAS]]
| Occluded Artery Trial
| [[Optimal Coronary Balloon Angioplasty With Provisional Stenting Vs. Stent Trial]]
|-
|-
| OCBAS
| [[OCLA]]
| Optimal Coronary Balloon Angioplasty With Provisional Stenting Vs. Stent Trial
| [[Omeprazole Clopidogrel Aspirin]]
|-
|-
| OCLA
| [[ODESSA]]
| Omeprazole Clopidogrel Aspirin
| [[Optical Coherence Tomography For Des Safety]]
|-
|-
| ODESSA
| [[ODIXa-DVT]]
| Optical Coherence Tomography For Des Safety
| [[Oral Direct Factor Xa Inhibitor Bay 59-7939 In Patients With Acute Symptomatic Deep-Vein Thrombosis]]
|-
|-
| ODIXa-DVT
| [[ODIXa-HIP]]
| Oral Direct Factor Xa Inhibitor Bay 59-7939 In Patients With Acute Symptomatic Deep-Vein Thrombosis
| [[Oral, Direct Factor Xa Inhibitor, Bay 59-7939, Given Once Daily In Patients Undergoing Total Hip Replacement]]
|-
|-
| ODIXa-HIP
| [[OMEGA]]
| Oral, Direct Factor Xa Inhibitor, Bay 59-7939, Given Once Daily In Patients Undergoing Total Hip Replacement
| [[Randomized Trial Of Omega-3 Fatty Acids On Top Of Modern Therapy After Acute Myocardial Infarction]]
|-
|-
| OMEGA
| [[ONTARGET]]
| Randomized Trial Of Omega-3 Fatty Acids On Top Of Modern Therapy After Acute Myocardial Infarction
| [[Ongoing Telmisartan Alone And In Combination With Ramipril Global Endpoint Trial]]
|-
|-
| ONTARGET
| [[ON-TIME]]
| Ongoing Telmisartan Alone And In Combination With Ramipril Global Endpoint Trial
| [[Ongoing Tirofiban In Myocardial Infarction Evaluation Trial]]
|-
|-
| ON-TIME
| [[On-TIME 2]]
| Ongoing Tirofiban In Myocardial Infarction Evaluation Trial
| [[Ongoing Tirofiban In Myocardial Infarction Evaluation 2 Trial]]
|-
|-
| On-TIME 2
| [[OPALS]]
| Ongoing Tirofiban In Myocardial Infarction Evaluation 2 Trial
| [[Ontario Prehospital Advanced Life Support]]
|-
|-
| OPALS
| [[OPT-CHF]]
| Ontario Prehospital Advanced Life Support
| [[Oxypurinol Compared With Placebo For Class III-Iv Nyha Congestive Heart Failure]]
|-
|-
| OPT-CHF
| [[OPTIC]]
| Oxypurinol Compared With Placebo For Class Iii-Iv Nyha Congestive Heart Failure
| [[Optimal Pharmacological Therapy In Cardioverter Defibrillator Patients Trial]]
|-
|-
| OPTIC
| [[OPTIMAAL]]
| Optimal Pharmacological Therapy In Cardioverter Defibrillator Patients Trial
| [[Effects Of Losartan And Captopril On Mortality And Morbidity In High-Risk Patients After Acute Myocardial Infarction]]
|-
|-
| OPTIMAAL
| [[OPTIME-CHF]]
| Effects Of Losartan And Captopril On Mortality And Morbidity In High-Risk Patients After Acute Myocardial Infarction
| [[Outcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations Of Chronic Heart Failure]]
|-
|-
| OPTIME-CHF
| [[OPTIMIZE]]
| Outcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations Of Chronic Heart Failure
| [[Effect Of Image Optimization With Contrast On The Diagnostic Accuracy Of Dobutamine Echocardiography In Coronary Artery Disease]]
|-
|-
| OPTIMIZE
| [[OPUS]]
| Effect Of Image Optimization With Contrast On The Diagnostic Accuracy Of Dobutamine Echocardiography In Coronary Artery Disease
| [[Optimal Angioplasty Versus Primary Stenting]]
|-
|-
| OPUS
| [[ORAR II]]
| Optimal Angioplasty Versus Primary Stenting
| [[Oral Treatment Of Restenosis]]
|-
|-
| ORAR II
| [[ORBIT]]
| Oral Treatment Of Restenosis
| [[Oral Glycoprotein IIb/IIia Receptor Blockade To Inhibit Thrombosis]]
|-
|-
| ORBIT
| [[OSIRIS]]
| Oral Glycoprotein Iib/Iiia Receptor Blockade To Inhibit Thrombosis
| [[Oral Sirolimus To Inhibit Recurrent In-Stent Stenosis]]
|-
|-
| OSIRIS
| [[OVERTURE]]
| Oral Sirolimus To Inhibit Recurrent In-Stent Stenosis
| [[Omapatrilat Versus Enalapril Randomized Trial Of Utility In Reducing Events]]
|-
|-
| OVERTURE
| [[PABA CHF]]
| Omapatrilat Versus Enalapril Randomized Trial Of Utility In Reducing Events
| [[Pulmonary Vein Antrum Isolation Vs. Av Node Ablation With Biventricular Pacing For Treatment Of Atrial Fibrillation In Patients With Congestive Heart Failure]]
|-
|-
| PABA CHF
| [[PACCOCATH ISR]]
| Pulmonary Vein Antrum Isolation Vs. Av Node Ablation With Biventricular Pacing For Treatment Of Atrial Fibrillation In Patients With Congestive Heart Failure
| [[Treatment Of In-Stent Restenosis By Paclitaxel Coated Ptca Balloons]]
|-
|-
| PACCOCATH ISR
| [[PACE]]
| Treatment Of In-Stent Restenosis By Paclitaxel Coated Ptca Balloons
| [[Prevention By Low Dose Aspirin Of Cardiovascular Disease In The Elderly]]
|-
|-
| PACE
| [[PACIFIC]]
| Prevention By Low Dose Aspirin Of Cardiovascular Disease In The Elderly
| [[Percutaneous Transmyocardial Laser Revascularization For Severe Angina: The Pacific Randomized Trial]]
|-
|-
| PACIFIC
| [[PACT]]
| Percutaneous Transmyocardial Laser Revascularization For Severe Angina: The Pacific Randomized Trial
| [[Plasminogen Activator-Angioplasty Compatibility Trial]]
|-
|-
| PACT
| [[PACT (Pravastatin)]]
| Plasminogen Activator-Angioplasty Compatibility Trial
| [[Pravastatin In Acute Coronary Treatment]]
|-
|-
| PACT (Pravastatin)
| [[PAD]]
| Pravastatin In Acute Coronary Treatment
| [[Public Access Defibrillation Trial]]
|-
|-
| PAD
| [[PAMI]]
| Public Access Defibrillation Trial
| [[The Primary Angioplasty In Myocardial Infarction Study]]
|-
|-
| PAMI
| [[PAMI-stent]]
| The Primary Angioplasty In Myocardial Infarction Study
| [[The Primary Angioplasty In Myocardial Infarction Study]]
|-
|-
| PAMI-stent
| [[PAPABEAR]]
| The Primary Angioplasty In Myocardial Infarction Study
| [[Prophylactic Amiodarone For The Prevention Of Arrhythmias That Begin Early After Revascularization, Valvular Repair Or Replacement]]
|-
|-
| PAPABEAR
| [[PARAGON]]
| Prophylactic Amiodarone For The Prevention Of Arrhythmias That Begin Early After Revascularization, Valvular Repair Or Replacement
| [[Delaying And Preventing Ischemic Events In Patient With Acute Coronary Syndromes Using The Platelet Gp IIb/IIia Inhibitor Lamifiban]]
|-
|-
| PARAGON
| [[PARAGON B]]
| Delaying And Preventing Ischemic Events In Patient With Acute Coronary Syndromes Using The Platelet Gp Iib/Iiia Inhibitor Lamifiban
| [[Platelet IIb/IIia Antagonist For The Reduction Of Acute Coronary Syndrome Events In A Global Organization Network]]
|-
|-
| PARAGON B
| [[PARIS]]
| Platelet Iib/Iiia Antagonist For The Reduction Of Acute Coronary Syndrome Events In A Global Organization Network
| [[Effect Of Ace Inhibitors On Angiographic Restenosis After Coronary Stenting (Paris): A Randomised, Double-Blind, Placebo-Controlled Trial]]
|-
|-
| PARIS
| [[PASE]]
| Effect Of Ace Inhibitors On Angiographic Restenosis After Coronary Stenting (Paris): A Randomised, Double-Blind, Placebo-Controlled Trial
| [[Pacemaker Selection In The Elderly]]
|-
|-
| PASE
| [[PASE(QOL)]]
| Pacemaker Selection In The Elderly
| [[Quality Of Life And Clinical Outcomes In Elderly Patients Treated With Ventricular Pacing As Compared With Dual-Chamber Pacing]]
|-
|-
| PASE(QOL)
| [[PASSION]]
| Quality Of Life And Clinical Outcomes In Elderly Patients Treated With Ventricular Pacing As Compared With Dual-Chamber Pacing
| [[Paclitaxel Eluting Stent Versus Conventional Stent In St-Segment Elevation Myocardial Infarction]]
|-
|-
| PASSION
| [[PATAF]]
| Paclitaxel Eluting Stent Versus Conventional Stent In St-Segment Elevation Myocardial Infarction
| [[Primary Prevention Of Arterial Thromboembolism In Non-Rheumatic Atrial Fibrillation In Primary Care: Randomised Controlled Trial Comparing Two Intensities Of Coumarin With Aspirin]]
|-
|-
| PATAF
| [[PATCH]]
| Primary Prevention Of Arterial Thromboembolism In Non-Rheumatic Atrial Fibrillation In Primary Care: Randomised Controlled Trial Comparing Two Intensities Of Coumarin With Aspirin
| [[Program To Assess Alternative Treatment Strategies To Achieve Cardiac Health]]
|-
|-
| PATCH
| [[PATH-CHF]]
| Program To Assess Alternative Treatment Strategies To Achieve Cardiac Health
| [[The Pacing Therapies For Congestive Heart Failure (Path-Chf) Study]]
|-
|-
| PATH-CHF
| [[PAVE]]
| The Pacing Therapies For Congestive Heart Failure (Path-Chf) Study
| [[Biventricular Pacing After Ablate Compared With Right Ventricular Therapy]]
|-
|-
| PAVE
| [[PCI CLARITY]]
| Biventricular Pacing After Ablate Compared With Right Ventricular Therapy
| [[Clopidogrel As Adjunctive Reperfusion Therapy: Percutaneous Coronary Intervention Subgroup Study]]
|-
|-
| PCI CLARITY
| [[PCI-CURE]]
| Clopidogrel As Adjunctive Reperfusion Therapy: Percutaneous Coronary Intervention Subgroup Study
| [[Effects Of Pretreatment With Clopidogrel And Aspirin Followed By Long-Term Therapy In Patients Undergoing Percutaneous Coronary Intervention: The Pci-Cure Study]]
|-
|-
| PCI-CURE
| [[PCI-ExTRACT-TIMI 25]]
| Effects Of Pretreatment With Clopidogrel And Aspirin Followed By Long-Term Therapy In Patients Undergoing Percutaneous Coronary Intervention: The Pci-Cure Study
| [[Percutaneous Coronary Intervention Among Patients Treated With Enoxaparin Versus Unfractionated Heparin Following Fibrinolytic Administration For St-Elevation Mi]]
|-
|-
| PCI-ExTRACT-TIMI 25
| [[PC-Trial]]
| Percutaneous Coronary Intervention Among Patients Treated With Enoxaparin Versus Unfractionated Heparin Following Fibrinolytic Administration For St-Elevation Mi
| [[Physical Counterpressure Manoeuvre Trial]]
|-
|-
| PC-Trial
| [[PEACE]]
| Physical Counterpressure Manoeuvre Trial
| [[Platelet Activity Extinction In Non–Q-Wave Myocardial Infarction With Aspirin, Clopidogrel, And Eptifibatide]]
|-
|-
| PEACE
| [[PEACE]]
| Platelet Activity Extinction In Non–Q-Wave Myocardial Infarction With Aspirin, Clopidogrel, And Eptifibatide
| [[Prevention Of Events With Angiotensin-Converting Enzyme Inhibition Trial]]
|-
|-
| PEACE
| [[PEECH]]
| Prevention Of Events With Angiotensin-Converting Enzyme Inhibition Trial
| [[Prospective Evaluation Of Enhanced External Counterpulsation In Congestive Heart Failure]]
|-
|-
| PEECH
| [[PENTUA]]
| Prospective Evaluation Of Enhanced External Counterpulsation In Congestive Heart Failure
| [[Pentasaccharide In Unstable Angina]]
|-
|-
| PENTUA
| [[PEP]]
| Pentasaccharide In Unstable Angina
| [[Pulmonary Embolism Prevention Trial]]
|-
|-
| PEP
| [[PEPAF]]
| Pulmonary Embolism Prevention Trial
| [[Experimental Program For Physical Activity Promotion]]
|-
|-
| PEPAF
| [[PEP-CHF]]
| Experimental Program For Physical Activity Promotion
| [[Perindopril For Elderly People With Chronic Heart Failure]]
|-
|-
| PEP-CHF
| [[PEPI]]
| Perindopril For Elderly People With Chronic Heart Failure
| [[Postmenopausal Estrogen/Progestin Interventions]]
|-
|-
| PEPI
| [[PERISCOPE]]
| Postmenopausal Estrogen/Progestin Interventions
| [[Pioglitazone Effect On Regression Of Intravascular Sonographic Coronary Obstruction Prospective Evaluation]]
|-
|-
| PERISCOPE
| [[PERM]]
| Pioglitazone Effect On Regression Of Intravascular Sonographic Coronary Obstruction Prospective Evaluation
| [[Prospective Evaluation Of Reperfusion Markers]]
|-
|-
| PERM
| [[PERSUADE]]
| Prospective Evaluation Of Reperfusion Markers
| [[Perindopril Substudy In Coronary Artery Disease And Diabetes: The Diabetic Substudy Of Europa]]
|-
|-
| PERSUADE
| [[Perth]]
| Perindopril Substudy In Coronary Artery Disease And Diabetes: The Diabetic Substudy Of Europa
| [[Perth Community Stroke Study]]
|-
|-
| Perth
| [[PERTINENT]]
| Perth Community Stroke Study
| [[Perindopril, Thrombosis, Inflammation, Endothelial Dysfunction, And Neurohormonal Activation Trial, A Subanalysis Of Europa]]
|-
|-
| PERTINENT
| [[PHS II]]
| Perindopril, Thrombosis, Inflammation, Endothelial Dysfunction, And Neurohormonal Activation Trial, A Subanalysis Of Europa
| [[Physicians' Health Study II]]
|-
|-
| PHS II
| [[PIAF]]
| Physicians' Health Study Ii
| [[Rhythm Or Rate Control In Atrial Fibrillation-Pharmacological Intervention In Atrial Fibrillation (Piaf): A Randomised Trial]]
|-
|-
| PIAF
| [[PICTURE]]
| Rhythm Or Rate Control In Atrial Fibrillation-Pharmacological Intervention In Atrial Fibrillation (Piaf): A Randomised Trial
| [[Post-Intracoronary Treatment Ultrasound Result Evaluation]]
|-
|-
| PICTURE
| [[PIHRATE]]
| Post-Intracoronary Treatment Ultrasound Result Evaluation
| [[Polish-Italian-Hungarian Randomized Thrombectomy Trial]]
|-
|-
| PIHRATE
| [[PIONEER]]
| Polish-Italian-Hungarian Randomized Thrombectomy Trial
| [[Proactive, Prospective Pioglitazone Clinical Trial In Macrovascular Events]]
|-
|-
| PIONEER
| [[PIOPED]]
| Proactive, Prospective Pioglitazone Clinical Trial In Macrovascular Events
| [[Prospective Investigation Of Pulmonary Embolism Diagnosis Study]]
|-
|-
| PIOPED
| [[PLAC-II]]
| Prospective Investigation Of Pulmonary Embolism Diagnosis Study
| [[Pravastatin, Lipids, And Atherosclerosis In The Carotid Arteries II]]
|-
|-
| PLAC-II
| [[PLASMA]]
| Pravastatin, Lipids, And Atherosclerosis In The Carotid Arteries Ii
| [[Phospholipase Levels And Serological Markers Of Atherosclerosis]]
|-
|-
| PLASMA
| [[POISE]]
| Phospholipase Levels And Serological Markers Of Atherosclerosis
| [[Perioperative Ischemic Evaluation]]
|-
|-
| POISE
| [[POSCH]]
| Perioperative Ischemic Evaluation
| [[Program On The Surgical Control Of The Hyperlipidemias]]
|-
|-
| POSCH
| [[POST]]
| Program On The Surgical Control Of The Hyperlipidemias
| [[Prevention Of Syncope Trial]]
|-
|-
| POST
| [[Post CABG]]
| Prevention Of Syncope Trial
| [[Post Coronary Artery Bypass Graft Trial]]
|-
|-
| Post CABG
| [[POZNAN]]
| Post Coronary Artery Bypass Graft Trial
| [[Percutaneous Transvenous Transplantation Of Autologous Myoblasts In The Treatment Of Postinfarction Heart Failure]]
|-
|-
| POZNAN
| [[PPAR Study]]
| Percutaneous Transvenous Transplantation Of Autologous Myoblasts In The Treatment Of Postinfarction Heart Failure
| [[Peroxisome Proliferator–Activated Receptor Study]]
|-
|-
| PPAR Study
| [[PPP]]
| Peroxisome Proliferator–Activated Receptor Study
| [[Primary Prevention Project]]
|-
|-
| PPP
| [[PQRST]]
| Primary Prevention Project
| [[Probucol Quantitative Regression Swedish Trial]]
|-
|-
| PQRST
| [[PRACTICAL]]
| Probucol Quantitative Regression Swedish Trial
| [[Comparison Of Enalapril Versus Captopril On Left Ventricular Function And Survival Three Months After Acute Myocardial Infarction]]
|-
|-
| PRACTICAL
| [[PRAGUE]]
| Comparison Of Enalapril Versus Captopril On Left Ventricular Function And Survival Three Months After Acute Myocardial Infarction
| [[Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis]]
|-
|-
| PRAGUE
| [[PRAGUE-8]]
| Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis
| [[Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis-8]]
|-
|-
| PRAGUE-8
| [[PRAISE]]
| Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis-8
| [[Prospective Randomized Amlopidine Survival Evaluation]]
|-
|-
| PRAISE
| [[PRAISE-1]]
| Prospective Randomized Amlopidine Survival Evaluation
| [[Prospective Randomized Amlodipine Survival Evaluation-1]]
|-
|-
| PRAISE-1
| [[PRAISE-2]]
| Prospective Randomized Amlodipine Survival Evaluation-1
| [[Prospective Randomized Amlodipine Survival Evaluation-2]]
|-
|-
| PRAISE-2
| [[PREAMI]]
| Prospective Randomized Amlodipine Survival Evaluation-2
| [[Perindopril Remodeling In Elderly With Acute Myocardial Infarction]]
|-
|-
| PREAMI
| [[PRECISE]]
| Perindopril Remodeling In Elderly With Acute Myocardial Infarction
| [[Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure]]
|-
|-
| PRECISE
| [[PREDICT]]
| Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
| [[Effect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty]]
|-
|-
| PREDICT
| [[PREMIAR]]
| Effect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty
| [[Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction]]
|-
|-
| PREMIAR
| [[PREMIER]]
| Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
| [[Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction]]
|-
|-
| PREMIER
| [[PREPAIR]]
| Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
| [[Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens]]
|-
|-
| PREPAIR
| [[PREPARE — Presented at TCT 2008]]
| Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
| [[Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation]]
|-
|-
| PREPARE — Presented at TCT 2008
| [[PREPIC]]
| Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
| [[A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis]]
|-
|-
| PREPIC
| [[Pre-RELAX-AHF]]
| A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
| [[Preliminary Study Of Relaxin In Acute Heart Failure]]
|-
|-
| Pre-RELAX-AHF
| [[PRESENT]]
| Preliminary Study Of Relaxin In Acute Heart Failure
| [[Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents]]
|-
|-
| PRESENT
| [[PRESERVE]]
| Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
| [[Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement]]
|-
|-
| PRESERVE
| [[PRESTO]]
| Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
| [[Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.]]
|-
|-
| PRESTO
| [[PREVEND IT]]
| Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
| [[Prevention Of Renal And Vascular End-Stage Disease Intervention Trial]]
|-
|-
| PREVEND IT
| [[PREVENT]]
| Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
| [[Prospective Randomized Evaluation Of The Vascular Effects Of Norvasc Trial]]
|-
|-
| PREVENT
| [[PREVENT (Dalteparin)]]
| Prospective Randomized Evaluation Of The Vascular Effects Of Norvasc Trial
| [[Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial]]
|-
|-
| PREVENT (Dalteparin)
| [[PREVENT (Warfarin)]]
| Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
| [[Prevention Of Recurrent Venous Thromboembolism]]
|-
|-
| PREVENT (Warfarin)
| [[PREVENT II]]
| Prevention Of Recurrent Venous Thromboembolism
| [[The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg]]
|-
|-
| PREVENT II
| [[PREVENT IV]]
| The Program In Ex Vivo Vein Graft Engineering Via Transfection Ii Study: E2F Decoy In Cabg
| [[Project Of Ex-Vivo Vein Graft Engineering Via Transfection]]
|-
|-
| PREVENT IV
| [[PREVENT(Radiation)]]
| Project Of Ex-Vivo Vein Graft Engineering Via Transfection
| [[Proliferation Reduction With Vascular Energy Trial]]
|-
|-
| PREVENT(Radiation)
| [[PRIDE]]
| Proliferation Reduction With Vascular Energy Trial
| [[A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire]]
|-
|-
| PRIDE
| [[PRIMA — Presented at ACC.09/i2]]
| A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
| [[Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?]]
|-
|-
| PRIMA — Presented at ACC.09/i2
| [[PRIME-2]]
| Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
| [[Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure]]
|-
|-
| PRIME-2
| [[PRIMI]]
| Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
| [[Pro-Urokinase For Myocardial Infarction]]
|-
|-
| PRIMI
| [[PRIMO-CABG]]
| Pro-Urokinase For Myocardial Infarction
| [[Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study]]
|-
|-
| PRIMO-CABG
| [[PRIMO-CABG II]]
| Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
| [[Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II]]
|-
|-
| PRIMO-CABG II
| [[PRINCE]]
| Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Ii
| [[Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study]]
|-
|-
| PRINCE
| [[PRINCESS]]
| Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
| [[Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction]]
|-
|-
| PRINCESS
| [[PRINCIPLE-TIMI 44]]
| Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
| [[The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial]]
|-
|-
| PRINCIPLE-TIMI 44
| [[PRISM]]
| The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
| [[Platelet-Receptor Inhibition For Ischemic Syndrome Management]]
|-
|-
| PRISM
| [[PRISM-PLUS]]
| Platelet-Receptor Inhibition For Ischemic Syndrome Management
| [[Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms]]
|-
|-
| PRISM-PLUS
| [[PRISM-Troponin]]
| Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
| [[Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study]]
|-
|-
| PRISM-Troponin
| [[PRISON II]]
| Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
| [[Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions]]
|-
|-
| PRISON II
| [[PROactive]]
| Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
| [[Prospective Pioglitazone Clinical Trial In Macrovascular Events]]
|-
|-
| PROactive
| [[PROCAM]]
| Prospective Pioglitazone Clinical Trial In Macrovascular Events
| [[Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study]]
|-
|-
| PROCAM
| [[PRoFESS]]
| Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
| [[Prevention Regimen For Effectively Avoiding Second Strokes]]
|-
|-
| PRoFESS
| [[PROFILE]]
| Prevention Regimen For Effectively Avoiding Second Strokes
| [[Prospective Randomized Flosequinan Longevity Evaluation]]
|-
|-
| PROFILE
| [[PROGRESS]]
| Prospective Randomized Flosequinan Longevity Evaluation
| [[Perindopril Protection Against Recurrent Stroke Study]]
|-
|-
| PROGRESS
| [[PROGRESS-1]]
| Perindopril Protection Against Recurrent Stroke Study
| [[Coronary Stenting With Absorbable Metal Stents]]
|-
|-
| PROGRESS-1
| [[PROMISE]]
| Coronary Stenting With Absorbable Metal Stents
| [[Protection Devices In Pci-Treatment Of Myocardial Infarction For Salvage Of Endangered Myocardium Study]]
|-
|-
| PROMISE
| [[PROMISE]]
| Protection Devices In Pci-Treatment Of Myocardial Infarction For Salvage Of Endangered Myocardium Study
| [[The Effects Of Oral Milrinone On Mortality In Severe Chronic Heart Failure]]
|-
|-
| PROMISE
| [[PROSPER]]
| The Effects Of Oral Milrinone On Mortality In Severe Chronic Heart Failure
| [[Prospective Study Of Pravastatin In The Elderly At Risk]]
|-
|-
| PROSPER
| [[PROTECT - TIMI 30]]
| Prospective Study Of Pravastatin In The Elderly At Risk
| [[Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents]]
|-
|-
| PROTECT - TIMI 30
| [[PROTECT AF]]
| Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
| [[Randomized Prospective Trial Of Percutaneous Left Atrial Appendage Closure Versus Warfarin For Stroke Prevention In Atrial Fibrillation]]
|-
|-
| PROTECT AF
| [[PROTECT-CAD]]
| Randomized Prospective Trial Of Percutaneous Left Atrial Appendage Closure Versus Warfarin For Stroke Prevention In Atrial Fibrillation
| [[Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases]]
|-
|-
| PROTECT-CAD
| [[PROVE IT/TIMI 22]]
| Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
| [[Pravastatin Or Atorvastatin Evaluation And Infection Therapy: Thrombolysis In Myocardial Infarction 22]]
|-
|-
| PROVE IT/TIMI 22
| [[PROVE IT-TIMI 22 (Gatifloxacin)]]
| Pravastatin Or Atorvastatin Evaluation And Infection Therapy: Thrombolysis In Myocardial Infarction 22
| [[Pravastatin Or Atorvastatin Evaluation And Infection Therapy]]
|-
|-
| PROVE IT-TIMI 22 (Gatifloxacin)
| [[PROVED]]
| Pravastatin Or Atorvastatin Evaluation And Infection Therapy
| [[Randomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved]]
|-
|-
| PROVED
| [[PROVIDENCE 1]]
| Randomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved
| [[Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients]]
|-
|-
| PROVIDENCE 1
| [[PROXIMAL]]
| Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients
| [[Proximal Protection During Saphenous Vein Graft Intervention]]
|-
|-
| PROXIMAL
| [[PURSUIT]]
| Proximal Protection During Saphenous Vein Graft Intervention
| [[Platelet Glycoprotein IIb/IIia In Unstable Angina:Receptor Suppression Using Integrilin Therapy]]
|-
|-
| PURSUIT
| [[QUASAR]]
| Platelet Glycoprotein Iib/Iiia In Unstable Angina:Receptor Suppression Using Integrilin Therapy
| [[Quinapril Anti-Ischemia And Symptoms Of Angina Reduction]]
|-
|-
| QUASAR
| [[QUIET]]
| Quinapril Anti-Ischemia And Symptoms Of Angina Reduction
| [[Quinapril Ischemic Event Trial]]
|-
|-
| QUIET
| [[R3]]
| Quinapril Ischemic Event Trial
| [[Reopro Readministration Registry]]
|-
|-
| R3
| [[RAAMI]]
| Reopro Readministration Registry
| [[Randomized Angiographic Trial Of Recombinant Tissue-Type Plasminogen Activator (Alteplase) In Myocardial Infarction]]
|-
|-
| RAAMI
| [[RABBIT II]]
| Randomized Angiographic Trial Of Recombinant Tissue-Type Plasminogen Activator (Alteplase) In Myocardial Infarction
| [[Randomized Angioplasty Beta Blocker Intracoronary Trial II]]
|-
|-
| RABBIT II
| [[RACE]]
| Randomized Angioplasty Beta Blocker Intracoronary Trial Ii
| [[Rate Control Versus Electrical Cardioversion For Persistent Atrial Fibrillation]]
|-
|-
| RACE
| [[RACS]]
| Rate Control Versus Electrical Cardioversion For Persistent Atrial Fibrillation
| [[Randomized Argentine Clopidogrel Stent Trial]]
|-
|-
| RACS
| [[RACTS]]
| Randomized Argentine Clopidogrel Stent Trial
| [[A Prospective, Randomized Multicenter Trial Of Cilostozal Vs Ticlopidine In Patients Undergoing Stent Implantation]]
|-
|-
| RACTS
| [[RADIANCE]]
| A Prospective, Randomized Multicenter Trial Of Cilostozal Vs Ticlopidine In Patients Undergoing Stent Implantation
| [[Withdrawal Of Digoxin From Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibitors]]
|-
|-
| RADIANCE
| [[RADIANCE 1]]
| Withdrawal Of Digoxin From Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibitors
| [[Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor]]
|-
|-
| RADIANCE 1
| [[RADIANCE 2]]
| Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor
| [[Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor - 2]]
|-
|-
| RADIANCE 2
| [[RALES]]
| Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor - 2
| [[Randomized Aldactone Evaluation Study]]
|-
|-
| RALES
| [[RaMI]]
| Randomized Aldactone Evaluation Study
| [[Prehospital Thrombolysis In Rural Emergency Room And Subsequent Transport To A Coronary Care Unit: Ravenna Myocardial Infarction (Rami) Trial]]
|-
|-
| RaMI
| [[RAPID-1]]
| Prehospital Thrombolysis In Rural Emergency Room And Subsequent Transport To A Coronary Care Unit: Ravenna Myocardial Infarction (Rami) Trial
| [[Recombinant Plasminogen Activator Angiographic Phase II International Dose-Finding Study]]
|-
|-
| RAPID-1
| [[RAPID-2]]
| Recombinant Plasminogen Activator Angiographic Phase Ii International Dose-Finding Study
| [[Reteplase Vs Alteplase Patency Investigation During Myocardial Infarction]]
|-
|-
| RAPID-2
| [[RAPPORT]]
| Reteplase Vs Alteplase Patency Investigation During Myocardial Infarction
| [[Reopro And Primary Ptca Organization And Randomized Trial]]
|-
|-
| RAPPORT
| [[RAPS]]
| Reopro And Primary Ptca Organization And Randomized Trial
| [[Radial Artery Patency Study]]
|-
|-
| RAPS
| [[RAPT]]
| Radial Artery Patency Study
| [[Ridogrel Versus Aspirin Patency Trial]]
|-
|-
| RAPT
| [[RAVE]]
| Ridogrel Versus Aspirin Patency Trial
| [[Regional Angiogenesis With Vascular Endothelial Growth Factor In Peripheral Arterial Disease]]
|-
|-
| RAVE
| [[RAVEL]]
| Regional Angiogenesis With Vascular Endothelial Growth Factor In Peripheral Arterial Disease
| [[A Randomized Comparison Of A Sirolimus-Eluting Stent With A Standard Stent For Coronary Revascularization]]
|-
|-
| RAVEL
| [[REACH]]
| A Randomized Comparison Of A Sirolimus-Eluting Stent With A Standard Stent For Coronary Revascularization
| [[Reinforcing Education About Cholesterol]]
|-
|-
| REACH
| [[REACH Registry]]
| Reinforcing Education About Cholesterol
| [[Reduction Of Atherothrombosis For Continued Health Registry]]
|-
|-
| REACH Registry
| [[REACT]]
| Reduction Of Atherothrombosis For Continued Health Registry
| [[Rescue Angioplasty Versus Conservative Therapy Or Repeat Thrombolysis Trial]]
|-
|-
| REACT
| [[REACT]]
| Rescue Angioplasty Versus Conservative Therapy Or Repeat Thrombolysis Trial
| [[Rapid Early Action For Coronary Treatment]]
|-
|-
| REACT
| [[REALITY]]
| Rapid Early Action For Coronary Treatment
| [[Prospective Randomized Multi-Center Head-To-Head Comparison Of The Sirolimus-Eluting Stent (Cypher) And The Paclitaxel-Eluting Stent (Taxus]]
|-
|-
| REALITY
| [[RECORD]]
| Prospective Randomized Multi-Center Head-To-Head Comparison Of The Sirolimus-Eluting Stent (Cypher) And The Paclitaxel-Eluting Stent (Taxus
| [[Rosiglitazone Evaluated For Cardiovascular Outcomes — An Interim Analysis]]
|-
|-
| RECORD
| [[RECORD1]]
| Rosiglitazone Evaluated For Cardiovascular Outcomes — An Interim Analysis
| [[Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 1]]
|-
|-
| RECORD1
| [[RECORD2]]
| Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 1
| [[Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 2]]
|-
|-
| RECORD2
| [[RECORD3]]
| Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 2
| [[Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 3]]
|-
|-
| RECORD3
| [[RECOVER]]
| Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 3
| [[Renal Toxicity Evaluation And Comparison Between Visipaque And Hexabrix In Patients With Renal Insufficiency Undergoing Coronary Angiography]]
|-
|-
| RECOVER
| [[RECOVERS]]
| Renal Toxicity Evaluation And Comparison Between Visipaque And Hexabrix In Patients With Renal Insufficiency Undergoing Coronary Angiography
| [[Randomized Evaluation Of Polytetrafluoroethylene-Covered Stent In Saphenous Vein Grafts]]
|-
|-
| RECOVERS
| [[REDHOT]]
| Randomized Evaluation Of Polytetrafluoroethylene-Covered Stent In Saphenous Vein Grafts
| [[Rapid Emergency Department Heart Failure Outpatient Trial]]
|-
|-
| REDHOT
| [[RED-LIP]]
| Rapid Emergency Department Heart Failure Outpatient Trial
| [[Trial Of Pravastatin In Primary Isolated Hypercholesterolemia]]
|-
|-
| RED-LIP
| [[REDUCE]]
| Trial Of Pravastatin In Primary Isolated Hypercholesterolemia
| [[Low Molecular Weight Heparin (Reviparin) In Percutaneous Transluminal Coronary Angioplasty]]
|-
|-
| REDUCE
| [[REDUCE III]]
| Low Molecular Weight Heparin (Reviparin) In Percutaneous Transluminal Coronary Angioplasty
| [[A Prospective, Randomized Multicenter Trial Of Cutting Balloon Before Stenting In Patients Undergoing Pci]]
|-
|-
| REDUCE III
| [[REFLECT]]
| A Prospective, Randomized Multicenter Trial Of Cutting Balloon Before Stenting In Patients Undergoing Pci
| [[Double-Blind, Placebo-Controlled Study Of The Efficacy Of Flosequinan In Patients With Chronic Heart Failure]]
|-
|-
| REFLECT
| [[REGENT]]
| Double-Blind, Placebo-Controlled Study Of The Efficacy Of Flosequinan In Patients With Chronic Heart Failure
| [[Myocardial Regeneration By Intracoronary Infusion Of Selected Population Of Stem Cells In Acute Myocardial Infarction]]
|-
|-
| REGENT
| [[REGICOR]]
| Myocardial Regeneration By Intracoronary Infusion Of Selected Population Of Stem Cells In Acute Myocardial Infarction
| [[Improvement In Survival After Myocardial Infarction Between 1978-85 And 1986-88 In The Regicor Study]]
|-
|-
| REGICOR
| [[REGRESS]]
| Improvement In Survival After Myocardial Infarction Between 1978-85 And 1986-88 In The Regicor Study
| [[Effects Of Lipid Lowering By Pravastatin On Progression And Regression Of Coronary Artery Disease In Symptomatic Men With Normal To Moderately Elevated Serum Cholesterol Levels. The Regression Growth Evaluation Statin Study (Regress)]]
|-
|-
| REGRESS
| [[RELAx-AMI]]
| Effects Of Lipid Lowering By Pravastatin On Progression And Regression Of Coronary Artery Disease In Symptomatic Men With Normal To Moderately Elevated Serum Cholesterol Levels. The Regression Growth Evaluation Statin Study (Regress)
| [[Randomized Early Versus Late Abciximab In Acute Myocardial Infarction Treated With Primary Coronary Intervention]]
|-
|-
| RELAx-AMI
| [[RELOAD]]
| Randomized Early Versus Late Abciximab In Acute Myocardial Infarction Treated With Primary Coronary Intervention
| [[Reload With Clopidogrel Before Coronary Angioplasty In Subjects Treated Long Term With Dual Antiplatelet Therapy]]
|-
|-
| RELOAD
| [[REMATCH]]
| Reload With Clopidogrel Before Coronary Angioplasty In Subjects Treated Long Term With Dual Antiplatelet Therapy
| [[Randomized Evaluation Of Mechanical Assistance For The Treatment Of Congestive Heart Failure]]
|-
|-
| REMATCH
| [[REMEDIA]]
| Randomized Evaluation Of Mechanical Assistance For The Treatment Of Congestive Heart Failure
| [[Randomized Evaluation Of The Effect Of Mechanical Reduction Of Distal Embolization By Thrombus-Aspiration In Primary And Rescue Angioplasty]]
|-
|-
| REMEDIA
| [[REMEDIAL]]
| Randomized Evaluation Of The Effect Of Mechanical Reduction Of Distal Embolization By Thrombus-Aspiration In Primary And Rescue Angioplasty
| [[Renal Insufficiency Following Contrast Media Administration Trial]]
|-
|-
| REMEDIAL
| [[RENAAL]]
| Renal Insufficiency Following Contrast Media Administration Trial
| [[Effects Of Losartan On Renal And Cardiovascular Outcomes In Patients With Type 2 Diabetes And Nephropathy]]
|-
|-
| RENAAL
| [[RENEWAL - RECOVER]]
| Effects Of Losartan On Renal And Cardiovascular Outcomes In Patients With Type 2 Diabetes And Nephropathy
| [[Research Into Etanercept Cytokine Antagonism In Ventricular Dysfunction]]
|-
|-
| RENEWAL - RECOVER
| [[RENEWAL - RENAISSANCE]]
| Research Into Etanercept Cytokine Antagonism In Ventricular Dysfunction
| [[Randomized Etanercept North American Strategy To Study Antagonism Of Cytokines]]
|-
|-
| RENEWAL - RENAISSANCE
| [[REPAIR-AMI]]
| Randomized Etanercept North American Strategy To Study Antagonism Of Cytokines
| [[Reinfusion Of Enriched Progenitor Cells And Infarct Remodeling In Acute Myocardial Infarction]]
|-
|-
| REPAIR-AMI
| [[REPLACE 2]]
| Reinfusion Of Enriched Progenitor Cells And Infarct Remodeling In Acute Myocardial Infarction
| [[Randomized Evaluation Of Pci Linking Angiomax To Reduced Clinical Events]]
|-
|-
| REPLACE 2
| [[RESCUE]]
| Randomized Evaluation Of Pci Linking Angiomax To Reduced Clinical Events
| [[Randomized Evaluation Of Salvage Angioplasty With Combined Utilization Of Endpoints]]
|-
|-
| RESCUE
| [[RESEARCH]]
| Randomized Evaluation Of Salvage Angioplasty With Combined Utilization Of Endpoints
| [[Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital Registry]]
|-
|-
| RESEARCH
| [[RESIST]]
| Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital Registry
| [[Impact Of Intravascular Ultrasound Guidance In Stent Deployment On 6-Month Restenosis Rate: A Multicenter, Randomized Study Comparing Two Strategies--With And Without Intravascular Ultrasound Guidance]]
|-
|-
| RESIST
| [[RESOLVD]]
| Impact Of Intravascular Ultrasound Guidance In Stent Deployment On 6-Month Restenosis Rate: A Multicenter, Randomized Study Comparing Two Strategies--With And Without Intravascular Ultrasound Guidance
| [[Randomized Evaluation Of Strategies For Left Ventricular Dysfunction Pilot]]
|-
|-
| RESOLVD
| [[REST]]
| Randomized Evaluation Of Strategies For Left Ventricular Dysfunction Pilot
| [[Restenosis Stent Trial]]
|-
|-
| REST
| [[Restenosis Stent]]
| Restenosis Stent Trial
| [[Coronary-Artery Stenting Compared With Balloon Angioplasty For Restenosis After Initial Balloon Angioplasty]]
|-
|-
| Restenosis Stent
| [[RESTORE]]
| Coronary-Artery Stenting Compared With Balloon Angioplasty For Restenosis After Initial Balloon Angioplasty
| [[Randomized Efficacy Study Of Tirofiban For Outcome And Restenosis]]
|-
|-
| RESTORE
| [[RethinQ]]
| Randomized Efficacy Study Of Tirofiban For Outcome And Restenosis
| [[Resynchronization Therapy In Patients With Narrow Qrs]]
|-
|-
| RethinQ
| [[REVERSAL]]
| Resynchronization Therapy In Patients With Narrow Qrs
| [[Reversing Atherosclerosis With Aggressive Lipid Lowering]]
|-
|-
| REVERSAL
| [[REVERSE]]
| Reversing Atherosclerosis With Aggressive Lipid Lowering
| [[Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction]]
|-
|-
| REVERSE
| [[REVERT]]
| Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction
| [[Reversal Of Ventricular Remodeling With Toprol-Xl]]
|-
|-
| REVERT
| [[REVIVAL-3]]
| Reversal Of Ventricular Remodeling With Toprol-Xl
| [[The Regeneration Of Vital Myocardium In St-Segment Elevation Myocardial Infarction By Erythropoietin]]
|-
|-
| REVIVAL-3
| [[RHYTHM II ICD]]
| The Regeneration Of Vital Myocardium In St-Segment Elevation Myocardial Infarction By Erythropoietin
| [[Resynchronization For The Hemodynamic Treatment For Heart Failure Management II Implantable Cardioverter Defibrillator]]
|-
|-
| RHYTHM II ICD
| [[RIO-Europe]]
| Resynchronization For The Hemodynamic Treatment For Heart Failure Management Ii Implantable Cardioverter Defibrillator
| [[A Randomized Double-Blind Study Of Weight Reducing Effect And Safety Of Rimonabant In Obese Patients With Or Without Comorbidities]]
|-
|-
| RIO-Europe
| [[RIO-Lipids]]
| A Randomized Double-Blind Study Of Weight Reducing Effect And Safety Of Rimonabant In Obese Patients With Or Without Comorbidities
| [[Rimonabant In Obesity]]
|-
|-
| RIO-Lipids
| [[RIO-NA]]
| Rimonabant In Obesity
| [[Rimonabant On Weight Reduction And Weight Maintenance: Rio-North America]]
|-
|-
| RIO-NA
| [[RIS]]
| Rimonabant On Weight Reduction And Weight Maintenance: Rio-North America
| [[Efficacy Of Multiple Risk Factor Intervention In Treated Hypertensive Men]]
|-
|-
| RIS
| [[RISC]]
| Efficacy Of Multiple Risk Factor Intervention In Treated Hypertensive Men
| [[Research On Instability In Coronary Artery Disease]]
|-
|-
| RISC
| [[RITA]]
| Research On Instability In Coronary Artery Disease
| [[Randomized Intervention Treatment Of Angina Trial]]
|-
|-
| RITA
| [[RITA II]]
| Randomized Intervention Treatment Of Angina Trial
| [[The Second Randomized Intervention Treatment Of Angina]]
|-
|-
| RITA II
| [[RITA-3]]
| The Second Randomized Intervention Treatment Of Angina
| [[Randomized Trial Of A Conservative Treatment Strategy Versus An Interventional Treatment Strategy In Patients With Unstable Angina]]
|-
|-
| RITA-3
| [[RITZ 2]]
| Randomized Trial Of A Conservative Treatment Strategy Versus An Interventional Treatment Strategy In Patients With Unstable Angina
| [[Randomized Intravenous Tezosentan For The Treatment Of Acute Heart Failure]]
|-
|-
| RITZ 2
| [[RITZ-4]]
| Randomized Intravenous Tezosentan For The Treatment Of Acute Heart Failure
| [[Randomized Intravenous Tezosentan Study]]
|-
|-
| RITZ-4
| [[RIVIERA Registry]]
| Randomized Intravenous Tezosentan Study
| [[Registry On Intra-Venous Anticoagulation In The Elective And Primary Real World Of Angioplasty]]
|-
|-
| RIVIERA Registry
| [[ROADMAP]]
| Registry On Intra-Venous Anticoagulation In The Elective And Primary Real World Of Angioplasty
| [[Randomized Olmesartan And Diabetes Microalbuminuria Prevention Trial]]
|-
|-
| ROADMAP
| [[ROBUST]]
| Randomized Olmesartan And Diabetes Microalbuminuria Prevention Trial
| [[Recanalization Of Chronically Occluded Aorto-Coronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion Of Urokinase Trial]]
|-
|-
| ROBUST
| [[ROMAS]]
| Recanalization Of Chronically Occluded Aorto-Coronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion Of Urokinase Trial
| [[Romanian Multicenter Study - Accelerated Streptokinase In Acute Myocardial Infarction]]
|-
|-
| ROMAS
| [[ROSTER]]
| Romanian Multicenter Study - Accelerated Streptokinase In Acute Myocardial Infarction
| [[Randomized Trial Of Rotational Atherectomy Versus Balloon Angioplasty For Diffuse In-Stent Restenosis]]
|-
|-
| ROSTER
| [[ROXIS]]
| Randomized Trial Of Rotational Atherectomy Versus Balloon Angioplasty For Diffuse In-Stent Restenosis
| [[Roxithromycin In Non-Q Wave Coronary Syndromes]]
|-
|-
| ROXIS
| [[RSVP]]
| Roxithromycin In Non-Q Wave Coronary Syndromes
| [[Radial Artery Versus Saphenous Vein Patency]]
|-
|-
| RSVP
| [[RUSSLAN]]
| Radial Artery Versus Saphenous Vein Patency
| [[Safety And Efficacy Of A Novel Calcium Sensitizer, Levosimendan, In Patients With Left Ventricular Failure Due To An Acute Myocardial Infarction]]
|-
|-
| RUSSLAN
| [[RUTH]]
| Safety And Efficacy Of A Novel Calcium Sensitizer, Levosimendan, In Patients With Left Ventricular Failure Due To An Acute Myocardial Infarction
| [[Raloxifene Use For The Heart]]
|-
|-
| RUTH
| [[SADHART]]
| Raloxifene Use For The Heart
| [[Sertraline Treatment Of Major Depression In Patients With Acute Mi Or Unstable Angina]]
|-
|-
| SADHART
| [[SAFE]]
| Sertraline Treatment Of Major Depression In Patients With Acute Mi Or Unstable Angina
| [[Safety After Fifty Evaluation]]
|-
|-
| SAFE
| [[SAFER]]
| Safety After Fifty Evaluation
| [[The Saphenous Vein Graft Angioplasty Free Of Emboli Randomized Trial]]
|-
|-
| SAFER
| [[SAFE-T]]
| The Saphenous Vein Graft Angioplasty Free Of Emboli Randomized Trial
| [[Sotalol Amiodarone Atrial Fibrillation Efficacy Trial]]
|-
|-
| SAFE-T
| [[SAGE]]
| Sotalol Amiodarone Atrial Fibrillation Efficacy Trial
| [[Study Assessing Goals In The Elderly]]
|-
|-
| SAGE
| [[SALT]]
| Study Assessing Goals In The Elderly
| [[Swedish Aspirin Low-Dose Trial]]
|-
|-
| SALT
| [[SALT 1 and 2]]
| Swedish Aspirin Low-Dose Trial
| [[Study Of Ascending Levels Of Tolvaptan In Hyponatremia]]
|-
|-
| SALT 1 and 2
| [[SALTIRE]]
| Study Of Ascending Levels Of Tolvaptan In Hyponatremia
| [[Scottish Aortic Stenosis And Lipid Lowering Trial]]
|-
|-
| SALTIRE
| [[SANDS]]
| Scottish Aortic Stenosis And Lipid Lowering Trial
| [[Stop Atherosclerosis In Native Diabetics Study]]
|-
|-
| SANDS
| [[SAPAT]]
| Stop Atherosclerosis In Native Diabetics Study
| [[Double-Blind Trial Of Aspirin In Primary Prevention Of Myocardial Infarction In Patients With Stable Chronic Angina Pectoris]]
|-
|-
| SAPAT
| [[SAPPHIRE]]
| Double-Blind Trial Of Aspirin In Primary Prevention Of Myocardial Infarction In Patients With Stable Chronic Angina Pectoris
| [[Stenting And Angioplasty With Protection In Patients At High Risk For Endarterectomy]]
|-
|-
| SAPPHIRE
| [[SARECCO]]
| Stenting And Angioplasty With Protection In Patients At High Risk For Endarterectomy
| [[Stent Or Angioplasty After Recanalization Of Chronic Coronary Occlusions Trial]]
|-
|-
| SARECCO
| [[SAVE]]
| Stent Or Angioplasty After Recanalization Of Chronic Coronary Occlusions Trial
| [[Survival And Ventricular Enlargement Trial]]
|-
|-
| SAVE
| [[SAVE PACe]]
| Survival And Ventricular Enlargement Trial
| [[Search Av Extension And Managed Ventricular Pacing For Promoting Atrioventricular Conduction]]
|-
|-
| SAVE PACe
| [[SAVED]]
| Search Av Extension And Managed Ventricular Pacing For Promoting Atrioventricular Conduction
| [[Saphenous Vein De Novo]]
|-
|-
| SAVED
| [[SCANDSTENT]]
| Saphenous Vein De Novo
| [[Stenting Of Coronary Arteries In Non Stress/Benestent Disease Trial]]
|-
|-
| SCANDSTENT
| [[SCAT]]
| Stenting Of Coronary Arteries In Non Stress/Benestent Disease Trial
| [[Long-Term Effects Of Cholesterol Lowering And Angiotension-Converting Enzyme Inhibition On Coronary Atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (Scat).]]
|-
|-
| SCAT
| [[SCD-HeFT]]
| Long-Term Effects Of Cholesterol Lowering And Angiotension-Converting Enzyme Inhibition On Coronary Atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (Scat).
| [[Sudden Cardiac Death In Heart Failure Trial]]
|-
|-
| SCD-HeFT
| [[SCOR]]
| Sudden Cardiac Death In Heart Failure Trial
| [[University Of California, San Francisco, Arteriosclerosis Specialized Center Of Research (Scor) Intervention Trial]]
|-
|-
| SCOR
| [[SCORE]]
| University Of California, San Francisco, Arteriosclerosis Specialized Center Of Research (Scor) Intervention Trial
| [[Study To Compare Restenosis Rate Between Quest And Quadds-Qp2]]
|-
|-
| SCORE
| [[SCRIP]]
| Study To Compare Restenosis Rate Between Quest And Quadds-Qp2
| [[Study Of Cardiovascular Risk Intervention By Pharmacists]]
|-
|-
| SCRIP
| [[SCRIPPS]]
| Study Of Cardiovascular Risk Intervention By Pharmacists
| [[Scripps Coronary Radiation To Inhibit Proliferation Post Stenting]]
|-
|-
| SCRIPPS
| [[SCRIPPS II]]
| Scripps Coronary Radiation To Inhibit Proliferation Post Stenting
| [[Scripps Coronary Radiation To Inhibit Proliferation Post Stenting II]]
|-
|-
| SCRIPPS II
| [[SCRIPPS III]]
| Scripps Coronary Radiation To Inhibit Proliferation Post Stenting Ii
| [[Scripps Coronary Radiation To Inhibit Proliferation Post Stenting III]]
|-
|-
| SCRIPPS III
| [[SCRIPPS IV]]
| Scripps Coronary Radiation To Inhibit Proliferation Post Stenting Iii
| [[Scripps Coronary Radiation To Inhibit Proliferation Post Stenting Iv]]
|-
|-
| SCRIPPS IV
| [[SEARCH]]
| Scripps Coronary Radiation To Inhibit Proliferation Post Stenting Iv
| [[Study Of The Effectiveness Of Additional Reductions In Cholesterol And Homocysteine]]
|-
|-
| SEARCH
| [[SEAS]]
| Study Of The Effectiveness Of Additional Reductions In Cholesterol And Homocysteine
| [[Simvastatin And Ezetimibe In Aortic Stenosis]]
|-
|-
| SEAS
| [[SECURE]]
| Simvastatin And Ezetimibe In Aortic Stenosis
| [[Study To Evaluate Carotid Ultrasound Changes In Patients Treated With Ramipril And Vitamin E]]
|-
|-
| SECURE
| [[SEEDS]]
| Study To Evaluate Carotid Ultrasound Changes In Patients Treated With Ramipril And Vitamin E
| [[Syncope Evaluation In The Emergency Department Study]]
|-
|-
| SEEDS
| [[SEISMIC]]
| Syncope Evaluation In The Emergency Department Study
| [[Safety And Effects Of Implanted (Autologous) Skeletal Myoblasts (Myocell) Using An Injection Catheter]]
|-
|-
| SEISMIC
| [[SENIOR PAMI]]
| Safety And Effects Of Implanted (Autologous) Skeletal Myoblasts (Myocell™) Using An Injection Catheter
| [[Senior Primary Angioplasty In Myocardial Infarction Study]]
|-
|-
| SENIOR PAMI
| [[SENIORS]]
| Senior Primary Angioplasty In Myocardial Infarction Study
| [[Study Of Effects Of Nebivolol Intervention On Outcomes And Rehospitalisation In Seniors With Heart Failure]]
|-
|-
| SENIORS
| [[SESAIR]]
| Study Of Effects Of Nebivolol Intervention On Outcomes And Rehospitalisation In Seniors With Heart Failure
| [[Randomised Comparison Of Subcutaneous Heparin, Intravenous Heparin, And Aspirin In Unstable Angina]]
|-
|-
| SESAIR
| [[SESAMI]]
| Randomised Comparison Of Subcutaneous Heparin, Intravenous Heparin, And Aspirin In Unstable Angina
| [[Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction]]
|-
|-
| SESAMI
| [[SES-SMART]]
| Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction
| [[Sirolimus-Eluting Stent And A Standard Stent In The Prevention Of Restenosis In Small Coronary Arteries]]
|-
|-
| SES-SMART
| [[SHARP]]
| Sirolimus-Eluting Stent And A Standard Stent In The Prevention Of Restenosis In Small Coronary Arteries
| [[The Subcutaneous Heparin And Angioplasty Restenosis Prevention (Sharp) Trial. Results Of A Multicentre Randomized Trial Investigating The Effects Of High Dose Unfractionated Heparin On Angiographic Restenosis And Clinical Outcome]]
|-
|-
| SHARP
| [[SHEP]]
| The Subcutaneous Heparin And Angioplasty Restenosis Prevention (Sharp) Trial. Results Of A Multicentre Randomized Trial Investigating The Effects Of High Dose Unfractionated Heparin On Angiographic Restenosis And Clinical Outcome
| [[Systolic Hypertension In Elderly Program]]
|-
|-
| SHEP
| [[SHIELD]]
| Systolic Hypertension In Elderly Program
| [[Shock Inhibition Evaluation With Azimilide]]
|-
|-
| SHIELD
| [[SHOCK]]
| Shock Inhibition Evaluation With Azimilide
| [[Should We Emergently Revascularize Occluded Coronaries For Cardiogenic Shock?]]
|-
|-
| SHOCK
| [[SIAM]]
| Should We Emergently Revascularize Occluded Coronaries For Cardiogenic Shock?
| [[Comparison Of Invasive And Conservative Strategies After Treatment With Streptokinase In Acute Myocardial Infarction]]
|-
|-
| SIAM
| [[SIAM III]]
| Comparison Of Invasive And Conservative Strategies After Treatment With Streptokinase In Acute Myocardial Infarction
| [[Southwest German Interventional Study In Acute Myocardial Infarction]]
|-
|-
| SIAM III
| [[SICCO]]
| Southwest German Interventional Study In Acute Myocardial Infarction
| [[Stenting In Chronic Coronary Occlusion]]
|-
|-
| SICCO
| [[SIMPADICO]]
| Stenting In Chronic Coronary Occlusion
| [[Study Of Immune Modulation Therapy In Patients With Symptomatic Peripheral Arterial Disease]]
|-
|-
| SIMPADICO
| [[SIPS]]
| Study Of Immune Modulation Therapy In Patients With Symptomatic Peripheral Arterial Disease
| [[Ultrasound-Guided Stratification For Provisional Stenting With Focal Balloon Combination Catheter. Results From The Randomized Strategy For Intracoronary Ultrasound-Guided Ptca And Stenting (Sips) Trial]]
|-
|-
| SIPS
| [[SIRIUS]]
| Ultrasound-Guided Stratification For Provisional Stenting With Focal Balloon Combination Catheter. Results From The Randomized Strategy For Intracoronary Ultrasound-Guided Ptca And Stenting (Sips) Trial
| [[Sirolimus-Eluting Stent In Coronary Lesions]]
|-
|-
| SIRIUS
| [[SIRIUS-2]]
| Sirolimus-Eluting Stent In Coronary Lesions
| [[Safety And Efficacy Of An Intravenous Placebo-Controlled Randomized Infusion Of Ularitide]]
|-
|-
| SIRIUS-2
| [[SIRTAX]]
| Safety And Efficacy Of An Intravenous Placebo-Controlled Randomized Infusion Of Ularitide
| [[Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization]]
|-
|-
| SIRTAX
| [[SISR]]
| Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization
| [[Sirolimus-Eluting Stent Vs. Brachytherapy In Patients With Bare Metal In-Stent Restenosis]]
|-
|-
| SISR
| [[SLIP]]
| Sirolimus-Eluting Stent Vs. Brachytherapy In Patients With Bare Metal In-Stent Restenosis
| [[Lipid Profile During Antihypertensive Treatment]]
|-
|-
| SLIP
| [[SMART]]
| Lipid Profile During Antihypertensive Treatment
| [[Surgical Management Of Arterial Revascularization Therapies]]
|-
|-
| SMART
| [[SMART]]
| Surgical Management Of Arterial Revascularization Therapies
| [[Sirolimus-Eluting Stents For The Treatment Of Obstructive Superficial Femoral Artery Disease]]
|-
|-
| SMART
| [[SMARTT]]
| Sirolimus-Eluting Stents For The Treatment Of Obstructive Superficial Femoral Artery Disease
| [[A Randomized Trial Of The Effects Of Early Cardiac Serum Marker Availability On Reperfusion Therapy In Patients With Acute Myocardial Infarction. The Serial Markers, Acute Myocardial Infarction And Rapid Treatment Trial (Smartt)]]
|-
|-
| SMARTT
| [[SMASH-VT]]
| A Randomized Trial Of The Effects Of Early Cardiac Serum Marker Availability On Reperfusion Therapy In Patients With Acute Myocardial Infarction. The Serial Markers, Acute Myocardial Infarction And Rapid Treatment Trial (Smartt)
| [[Substrate Mapping And Ablation In Sinus Rhythm To Halt Ventricular Tachycardia]]
|-
|-
| SMASH-VT
| [[SMILE]]
| Substrate Mapping And Ablation In Sinus Rhythm To Halt Ventricular Tachycardia
| [[The Effects Of The Angiotensin-Converting-Enzyme Inhibitor Zofenopril On Mortality And Morbidity After Anterior Myocardial Infarction]]
|-
|-
| SMILE
| [[SMT]]
| The Effects Of The Angiotensin-Converting-Enzyme Inhibitor Zofenopril On Mortality And Morbidity After Anterior Myocardial Infarction
| [[Stockholm Metoprolol Trial]]
|-
|-
| SMT
| [[SOFA]]
| Stockholm Metoprolol Trial
| [[Study On Omega-3 Fatty Acids And Ventricular Arrhythmia]]
|-
|-
| SOFA
| [[SOLVD-Treatment]]
| Study On Omega-3 Fatty Acids And Ventricular Arrhythmia
| [[The Effects Of Enalapril On Survival In Patients With Reduced Left Ventricular Ejection Fractions And Congestive Heart Failure (Treatment Trial)]]
|-
|-
| SOLVD-Treatment
| [[SORT OUT II]]
| The Effects Of Enalapril On Survival In Patients With Reduced Left Ventricular Ejection Fractions And Congestive Heart Failure (Treatment Trial)
| [[Comparison Of Paclitaxel- And Sirolimus-Eluting Stents In Everyday Clinical Practice]]
|-
|-
| SORT OUT II
| [[SoS]]
| Comparison Of Paclitaxel- And Sirolimus-Eluting Stents In Everyday Clinical Practice
| [[Coronary Artery Bypass Surgery Vs. Percutaneous Coronary Intervention With Stent Implantation In Patients With Multivessel Coronary Disease (The Stent Or Surgery Trial)]]
|-
|-
| SoS
| [[SPACE]]
| Coronary Artery Bypass Surgery Vs. Percutaneous Coronary Intervention With Stent Implantation In Patients With Multivessel Coronary Disease (The Stent Or Surgery Trial)
| [[Secondary Prevention With Antioxidants Of Cardiovascular Disease In End-Stage Renal Disease (Space): Randomized Placebo-Controlled Trial]]
|-
|-
| SPACE
| [[SPAF]]
| Secondary Prevention With Antioxidants Of Cardiovascular Disease In End-Stage Renal Disease (Space): Randomized Placebo-Controlled Trial
| [[Stroke Prevention In Atrial Fibrillation Study]]
|-
|-
| SPAF
| [[SPAN CHF]]
| Stroke Prevention In Atrial Fibrillation Study
| [[Specialized Primary And Networked Care In Heart Failure]]
|-
|-
| SPAN CHF
| [[SPARCL]]
| Specialized Primary And Networked Care In Heart Failure
| [[Stroke Prevention By Aggressive Reduction In Cholesterol Levels]]
|-
|-
| SPARCL
| [[SPIC]]
| Stroke Prevention By Aggressive Reduction In Cholesterol Levels
| [[Long-Term Survival Effect Of Metoprolol In Dilated Cardiomyopathy]]
|-
|-
| SPIC
| [[SPICE]]
| Long-Term Survival Effect Of Metoprolol In Dilated Cardiomyopathy
| [[Study Of Patients Intolerant Of Converting Enzyme Inhibitors]]
|-
|-
| SPICE
| [[SPICE – Presented at ACC 2007]]
| Study Of Patients Intolerant Of Converting Enzyme Inhibitors
| [[Survival And Prognosis: Investigation Of Crataegus Extract Ws 1442 In Chf]]
|-
|-
| SPICE – Presented at ACC 2007
| [[SPINAF]]
| Survival And Prognosis: Investigation Of Crataegus Extract Ws 1442 In Chf
| [[Stroke Prevention In Nonrheumatic Atrial Fibrillation]]
|-
|-
| SPINAF
| [[SPIRIT]]
| Stroke Prevention In Nonrheumatic Atrial Fibrillation
| [[A Randomized Trial Of Anticoagulants Versus Aspirin After Cerebral Ischemia Of Presumed Arterial Origin]]
|-
|-
| SPIRIT
| [[SPORTIF II]]
| A Randomized Trial Of Anticoagulants Versus Aspirin After Cerebral Ischemia Of Presumed Arterial Origin
| [[Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation]]
|-
|-
| SPORTIF II
| [[SPORTIF III]]
| Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
| [[Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation]]
|-
|-
| SPORTIF III
| [[SPORTIF V]]
| Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
| [[Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation]]
|-
|-
| SPORTIF V
| [[SPRINT]]
| Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
| [[Secondary Prevention Reinfarction Israeli Nifedipine Trial]]
|-
|-
| SPRINT
| [[SSSD]]
| Secondary Prevention Reinfarction Israeli Nifedipine Trial
| [[Spanish Study On Sudden Death]]
|-
|-
| SSSD
| [[STAF]]
| Spanish Study On Sudden Death
| [[Strategies Of Treatment Of Atrial Fibrillation]]
|-
|-
| STAF
| [[STAI]]
| Strategies Of Treatment Of Atrial Fibrillation
| [[Antiplatelet Treatment With Ticlopidine In Unstable Angina (Studio Della Ticlopidine Nell'Angina Instabile)]]
|-
|-
| STAI
| [[STAMI]]
| Antiplatelet Treatment With Ticlopidine In Unstable Angina (Studio Della Ticlopidine Nell'Angina Instabile)
| [[Ticlopidine Versus Aspirin After Myocardial Infarction (Stami) Trial]]
|-
|-
| STAMI
| [[STAMINA]]
| Ticlopidine Versus Aspirin After Myocardial Infarction (Stami) Trial
| [[Effect Of Treatment For Chlamydia Pneumoniae And Helicobacter Pylori On Markers Of Inflammation And Cardiac Events In Patients With Acute Coronary Syndromes]]
|-
|-
| STAMINA
| [[STAMINA]]
| Effect Of Treatment For Chlamydia Pneumoniae And Helicobacter Pylori On Markers Of Inflammation And Cardiac Events In Patients With Acute Coronary Syndromes. South Thames Trial Of Antibiotics In Myocardial Infarction And Unstable Angina Pectoris (Stamina).
| [[South Thames Trial Of Antibiotics In Myocardial Infarction And Unstable Angina Pectoris]]
|-
|-
| STAR
| [[STAR]]
| A Randomized Trial Of Recombinant Staphylokinase Versus Altepase For Coronary Artery Patency In Acute Myocardial Infarction
| [[A Randomized Trial Of Recombinant Staphylokinase Versus Altepase For Coronary Artery Patency In Acute Myocardial Infarction]]
|-
|-
| STARC
| [[STARC]]
| Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study
| [[Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study]]
|-
|-
| STARS-Antithrombotic
| [[STARS-Antithrombotic]]
| Stent Antithrombotic Regimen Study
| [[Stent Antithrombotic Regimen Study]]
|-
|-
| STARS-Atherosclerosis
| [[STARS-Atherosclerosis]]
| St. Thomas Atherosclerosis Regression Study
| [[St. Thomas Atherosclerosis Regression Study]]
|-
|-
| START
| [[START]]
| Sr90 Treatment Of Angiographic Restenosis
| [[Sr90 Treatment Of Angiographic Restenosis]]
|-
|-
| STAT
| [[STAT]]
| Stenting Vs. Thrombolysis In Acute Myocardial Infarction Trial (Stat)
| [[Stenting Vs. Thrombolysis In Acute Myocardial Infarction Trial (Stat)]]
|-
|-
| STEEPLE
| [[STEEPLE]]
| Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation
| [[Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation]]
|-
|-
| STEMMI
| [[STEMMI]]
| Stem Cells In Myocardial Infarction
| [[Stem Cells In Myocardial Infarction]]
|-
|-
| STENT PAMI
| [[STENT PAMI]]
| Stent Primary Angioplasty In Mi
| [[Stent Primary Angioplasty In Mi]]
|-
|-
| STENTIM-2
| [[STENTIM-2]]
| Immediate Coronary Angioplasty With Elective Wiktor Stent Implantation Compared With Conventional Balloon Angioplasty In Acute Myocardial Infarction
| [[Immediate Coronary Angioplasty With Elective Wiktor Stent Implantation Compared With Conventional Balloon Angioplasty In Acute Myocardial Infarction]]
|-
|-
| STEP
| [[STEP]]
| Study Of The Therapeutic Effects Of Intercessory Prayer
| [[Study Of The Therapeutic Effects Of Intercessory Prayer]]
|-
|-
| STICH
| [[STICH]]
| Surgical Treatments For Ischemic Heart Failure Hypothesis 2
| [[Surgical Treatments For Ischemic Heart Failure Hypothesis 2]]
|-
|-
| STIMS
| [[STIMS]]
| Prevention Of Myocardial Infarction And Stroke In Patients With Intermittent Claudication
| [[Prevention Of Myocardial Infarction And Stroke In Patients With Intermittent Claudication]]
|-
|-
| STING
| [[STING]]
| Stents In Grafts
| [[Stents In Grafts]]
|-
|-
| STONE
| [[STONE]]
| Shanghai Trial Of Nifedipine In The Elderly
| [[Shanghai Trial Of Nifedipine In The Elderly]]
|-
|-
| STOP-AMI 1
| [[STOP-AMI 1]]
| Stent Versus Thrombolysis For Occluded Coronary Arteries In Patients With Acute Myocardial Infarction 1
| [[Stent Versus Thrombolysis For Occluded Coronary Arteries In Patients With Acute Myocardial Infarction 1]]
|-
|-
| STOP-HTN
| [[STOP-HTN]]
| Swedish Trial In Old Patients With Hypertension
| [[Swedish Trial In Old Patients With Hypertension]]
|-
|-
| STOP-NIDDM
| [[STOP-NIDDM]]
| Study To Prevent Noninsulin Dependent Diabetes Mellitus Trial
| [[Study To Prevent Noninsulin Dependent Diabetes Mellitus Trial]]
|-
|-
| STRATAS
| [[STRATAS]]
| Study To Determine Rotablator And Transluminal Angioplasty Strategy
| [[Study To Determine Rotablator And Transluminal Angioplasty Strategy]]
|-
|-
| STRATEGY
| [[STRATEGY]]
| Single High-Dose Bolus Tirofiban And Sirolimus-Eluting Stent Vs. Abciximab And Bare-Metal Stent In Myocardial Infarction
| [[Single High-Dose Bolus Tirofiban And Sirolimus-Eluting Stent Vs. Abciximab And Bare-Metal Stent In Myocardial Infarction]]
|-
|-
| STRATUS-US
| [[STRATUS-US]]
| Smoking Cessation In Smokers Motivated To Quit
| [[Smoking Cessation In Smokers Motivated To Quit]]
|-
|-
| STRESS I
| [[STRESS I]]
| Stent Restenosis Study I
| [[Stent Restenosis Study I]]
|-
|-
| SURVIVE
| [[SURVIVE]]
| Survival Of Patients With Acute Heart Failure In Need Of Intravenous Inotropic Support
| [[Survival Of Patients With Acute Heart Failure In Need Of Intravenous Inotropic Support]]
|-
|-
| SUTAMI
| [[SUTAMI]]
| Double-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group
| [[Double-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group]]
|-
|-
| SWEDES
| [[SWEDES]]
| Swedish Early Decision Trial
| [[Swedish Early Decision Trial]]
|-
|-
| SWIFT
| [[SWIFT]]
| Should We Intervene Following Thrombolysis?
| [[Should We Intervene Following Thrombolysis?]]
|-
|-
| SWISH
| [[SWISH]]
| Swedish Isradipine Study In Hypertension
| [[Swedish Isradipine Study In Hypertension]]
|-
|-
| SWISSI II
| [[SWISSI II]]
| Swiss Interventional Study On Silent Ischemia Type Ii
| [[Swiss Interventional Study On Silent Ischemia Type II]]
|-
|-
| SWITCH
| [[SWITCH]]
| Switching From Lovenox To Angiomax In Patients With Acute Coronary Syndromes Without St Elevation Undergoing Pci
| [[Switching From Lovenox To Angiomax In Patients With Acute Coronary Syndromes Without St Elevation Undergoing Pci]]
|-
|-
| SWORD
| [[SWORD]]
| Survival With Oral D-Sotalol Trial
| [[Survival With Oral D-Sotalol Trial]]
|-
|-
| SYMBIOT III
| [[SYMBIOT III]]
| A Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
| [[A Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results]]
|-
|-
| SYMPHONY I
| [[SYMPHONY I]]
| Sibrafiban Versus Aspirin To Yield Maximum Protection From Ischemic Heart Events Post-Acute Coronary Syndromes
| [[Sibrafiban Versus Aspirin To Yield Maximum Protection From Ischemic Heart Events Post-Acute Coronary Syndromes]]
|-
|-
| SYMPHONY II
| [[SYMPHONY II]]
| Randomized Trial Of Aspirin, Sibrafiban, Or Both For Secondary Prevention After Acute Coronary Syndromes
| [[Randomized Trial Of Aspirin, Sibrafiban, Or Both For Secondary Prevention After Acute Coronary Syndromes]]
|-
|-
| SYNERGY
| [[SYNERGY]]
| Superior Yield Of The New Strategy Of Enoxaparin, Revascularization, And Glycoprotein Iib/Iiia Inhibitors
| [[Superior Yield Of The New Strategy Of Enoxaparin, Revascularization, And Glycoprotein IIb/IIia Inhibitors]]
|-
|-
| SYNERGY-PCI
| [[SYNERGY-PCI]]
| A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
| [[A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention]]
|-
|-
| SYNTAX
| [[SYNTAX]]
| Synergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery
| [[Synergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery]]
|-
|-
| Syst-China
| [[Syst-China]]
| Systolic Hypertension In China Trial
| [[Systolic Hypertension In China Trial]]
|-
|-
| Syst-Eur
| [[Syst-Eur]]
| For The Syst-Eur Investigators. The Prevention Of Dementia With Antihypertensive Treatment. New Evidence From The Systolic Hypertension In Europe (Syst-Eur) Study
| [[For The Syst-Eur Investigators. The Prevention Of Dementia With Antihypertensive Treatment. New Evidence From The Systolic Hypertension In Europe (Syst-Eur) Study]]
|-
|-
| TACT
| [[TACT]]
| Therapeutic Angiogenesis For Patients With Limb Ischaemia By Autologous Transplantation Of Bone-Marrow Cells:A Pilot Study And A Randomized Controlled Trial.
| [[Therapeutic Angiogenesis For Patients With Limb Ischaemia By Autologous Transplantation Of Bone-Marrow Cells:A Pilot Study And A Randomized Controlled Trial.]]
|-
|-
| TACTICS-TIMI 18
| [[TACTICS-TIMI 18]]
| Treat Angina With Aggrastat And Determine Cost Of Therapy With An Invasive Or Conservative Strategy
| [[Treat Angina With Aggrastat And Determine Cost Of Therapy With An Invasive Or Conservative Strategy]]
|-
|-
| TAIM
| [[TAIM]]
| Trial Of Antihypertensive Interventions And Management
| [[Trial Of Antihypertensive Interventions And Management]]
|-
|-
| TAIST
| [[TAIST]]
| Tinzaparin In Acute Ischaemic Stroke Trial
| [[Tinzaparin In Acute Ischaemic Stroke Trial]]
|-
|-
| TALISMAN
| [[TALISMAN]]
| Therapeutic Angiogenesis With Intramuscular Nv1Fgf In Patients With Critical Limb Ischemia
| [[Therapeutic Angiogenesis With Intramuscular Nv1Fgf In Patients With Critical Limb Ischemia]]
|-
|-
| TAMI-5
| [[TAMI-5]]
| Thrombolysis And Angioplasty In Myocardial Infarction - Phase V
| [[Thrombolysis And Angioplasty In Myocardial Infarction - Phase V]]
|-
|-
| TAPAS
| [[TAPAS]]
| Thrombus Aspiration During Percutaneous Coronary Intervention In Acute Myocardial Infarction
| [[Thrombus Aspiration During Percutaneous Coronary Intervention In Acute Myocardial Infarction]]
|-
|-
| TAPS
| [[TAPS]]
| The Rt-Pa-Apsac Patency Study
| [[The Rt-Pa-Apsac Patency Study]]
|-
|-
| TARGET
| [[TARGET]]
| Comparison Of Two Platelet Glycoprotein Iib/Iiia Inhibitors, Tirofiban And Abciximab, For The Prevention Of Ischemic Events With Percutaneous Coronary Revascularization
| [[Comparison Of Two Platelet Glycoprotein IIb/IIia Inhibitors, Tirofiban And Abciximab, For The Prevention Of Ischemic Events With Percutaneous Coronary Revascularization]]
|-
|-
| TAUSA
| [[TAUSA]]
| Thrombolysis And Angioplasty In Unstable Angina
| [[Thrombolysis And Angioplasty In Unstable Angina]]
|-
|-
| TAXi
| [[TAXi]]
| Paclitaxel And Sirolimus Stents In The Real World Of Interventional Cardiology
| [[Paclitaxel And Sirolimus Stents In The Real World Of Interventional Cardiology]]
|-
|-
| TAXUS III
| [[TAXUS III]]
| In-Stent Restenosis Treated With Stent-Based Delivery Of Paclitaxel Incorporated In A Slow-Release Polymer Formulation
| [[In-Stent Restenosis Treated With Stent-Based Delivery Of Paclitaxel Incorporated In A Slow-Release Polymer Formulation]]
|-
|-
| TAXUS V ISR
| [[TAXUS V ISR]]
| Paclitaxel-Eluting Stents Vs. Brachytherapy For In-Stent Restenosis
| [[Paclitaxel-Eluting Stents Vs. Brachytherapy For In-Stent Restenosis]]
|-
|-
| TEAHAT
| [[TEAHAT]]
| Very Early Thrombolytic Therapy In Suspected Acute Myocardial Infarction
| [[Very Early Thrombolytic Therapy In Suspected Acute Myocardial Infarction]]
|-
|-
| TEAM-2
| [[TEAM-2]]
| Multicenter Patency Trial Of Intravenous Antistreplase Compared With Streptokinase In Acute Myocardial Infarction
| [[ Multicenter Patency Trial Of Intravenous Antistreplase Compared With Streptokinase In Acute Myocardial Infarction]]
|-
|-
| TEAM-3
| [[TEAM-3]]
| Third Thrombolysis Trial Of Anistreplase (Eminase®) In Acute Myocardial Infarction
| [[Third Thrombolysis Trial Of Anistreplase (Eminase) In Acute Myocardial Infarction]]
|-
|-
| TEN-HMS
| [[TEN-HMS]]
| Telemonitoring For Heart Failure: Patient Characteristics And First Results
| [[Telemonitoring For Heart Failure: Patient Characteristics And First Results]]
|-
|-
| TETAMI
| [[TETAMI]]
| Treatment Of Enoxaparin And Tirofiban In Acute Myocardial Infarction
| [[Treatment Of Enoxaparin And Tirofiban In Acute Myocardial Infarction]]
|-
|-
| THESEE
| [[THESEE]]
| A Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism
| [[A Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism]]
|-
|-
| THINRS
| [[THINRS]]
| The Home Inr Study
| [[The Home Inr Study]]
|-
|-
| THOP
| [[THOP]]
| Treatment Of Hypertension Based On Home Or Office Blood Pressure
| [[Treatment Of Hypertension Based On Home Or Office Blood Pressure]]
|-
|-
| THRIVE
| [[THRIVE]]
| Thrombin Inhibitor In Venous Thromboembolism
| [[Thrombin Inhibitor In Venous Thromboembolism]]
|-
|-
| Thrombectomy in STEMI
| [[Thrombectomy in STEMI]]
| Thrombectomy In St Elevation Myocardial Infarction
| [[Thrombectomy In St Elevation Myocardial Infarction]]
|-
|-
| THUNDER
| [[THUNDER]]
| Taxan With Short Time For Contact For Reduction Of Restenosis In Distal Arteries
| [[Taxan With Short Time For Contact For Reduction Of Restenosis In Distal Arteries]]
|-
|-
| TIBBS
| [[TIBBS]]
| Total Ischemic Burden Bisoprolol Study
| [[Total Ischemic Burden Bisoprolol Study]]
|-
|-
| TIBET
| [[TIBET]]
| Total Ischemic Burden European Trial
| [[Total Ischemic Burden European Trial]]
|-
|-
| TIGER-PA
| [[TIGER-PA]]
| Tirofiban Given In The Emergency Room Before Primary Angioplasty
| [[Tirofiban Given In The Emergency Room Before Primary Angioplasty]]
|-
|-
| TIM
| [[TIM]]
| Triflusal In Myocardial Infarction
| [[Triflusal In Myocardial Infarction]]
|-
|-
| TIMACS
| [[TIMACS]]
| Timing Of Intervention In Patients With Acute Coronary Syndromes
| [[Timing Of Intervention In Patients With Acute Coronary Syndromes]]
|-
|-
| TIMBER
| [[TIMBER]]
| Transthoracic Incremental Monophasic Versus Biphasic Defibrillation By Emergency Responders
| [[Transthoracic Incremental Monophasic Versus Biphasic Defibrillation By Emergency Responders]]
|-
|-
| TIME
| [[TIME]]
| Trial Of Invasive Versus Medical Therapy In The Elderly
| [[Trial Of Invasive Versus Medical Therapy In The Elderly]]
|-
|-
| TIME-CHF
| [[TIME-CHF]]
| Trial Of Intensified Vs Standard Medical Therapy In Elderly Patients With Congestive Heart Failure
| [[Trial Of Intensified Vs Standard Medical Therapy In Elderly Patients With Congestive Heart Failure]]
|-
|-
| TIMI 1
| [[TIMI 1]]
| Thrombolysis In Myocardial Infarction Trial, Phase I
| [[Thrombolysis In Myocardial Infarction Trial, Phase I]]
|-
|-
| TIMI 10B
| [[TIMI 10B]]
| Tnk-Tissue Plasminogen Activator Compared With Front-Loaded Tissue Plasminogen Activator In Acute Myocardial Infarction
| [[Tnk-Tissue Plasminogen Activator Compared With Front-Loaded Tissue Plasminogen Activator In Acute Myocardial Infarction]]
|-
|-
| TIMI 11B
| [[TIMI 11B]]
| Thrombolysis In Myocardial Ischemia Trial, Phase 11B
| [[Thrombolysis In Myocardial Ischemia Trial, Phase 11B]]
|-
|-
| TIMI 16-OPUS
| [[TIMI 16-OPUS]]
| Orbofiban In Patients With Unstable Coronary Syndromes, Thrombolysis In Myocardial Infarction
| [[Orbofiban In Patients With Unstable Coronary Syndromes, Thrombolysis In Myocardial Infarction]]
|-
|-
| TIMIC
| [[TIMIC]]
| Efficacy Of Immunosuppressive Therapy In Patients With Virus-Negative Inflammatory Cardiomyopathy
| [[Efficacy Of Immunosuppressive Therapy In Patients With Virus-Negative Inflammatory Cardiomyopathy]]
|-
|-
| TITAN - TIMI 34
| [[TITAN - TIMI 34]]
| Time To Integrilin Therapy In Acute Myocardial Infarction
| [[Time To Integrilin Therapy In Acute Myocardial Infarction]]
|-
|-
| TITAX AMI
| [[TITAX AMI]]
| Titanium Nitride Oxide Coated Stents And Paclitaxel Eluting Stents For Acute Myocardial Infarction
| [[Titanium Nitride Oxide Coated Stents And Paclitaxel Eluting Stents For Acute Myocardial Infarction]]
|-
|-
| TMLR
| [[TMLR]]
| Transmyocardial Laser Revascularization In Patients With Refractory Angina: A Randomised
| [[Transmyocardial Laser Revascularization In Patients With Refractory Angina: A Randomised]]
|-
|-
| TMR
| [[TMR]]
| Revascularization With Co2 Laser In Patients With Refractory Angina Pectoris: Clinical Results From The Norwegian Randomized Trial
| [[Revascularization With Co2 Laser In Patients With Refractory Angina Pectoris: Clinical Results From The Norwegian Randomized Trial]]
|-
|-
| TNT
| [[TNT]]
| Treating To New Targets Study
| [[Treating To New Targets Study]]
|-
|-
| TOAT
| [[TOAT]]
| The Occluded Artery Trial
| [[The Occluded Artery Trial]]
|-
|-
| TOHP II
| [[TOHP II]]
| Effects Of Weight Loss And Sodium Reduction Intervention On Blood Pressure And Hypertension Incidence In Overweight People With High-Normal Blood Pressure: The Trials Of Hypertension Prevention, Phase Ii
| [[Effects Of Weight Loss And Sodium Reduction Intervention On Blood Pressure And Hypertension Incidence In Overweight People With High-Normal Blood Pressure: The Trials Of Hypertension Prevention, Phase II]]
|-
|-
| TOMHS
| [[TOMHS]]
| Treatment Of Mild Hypertension Study
| [[Treatment Of Mild Hypertension Study]]
|-
|-
| TOMIIS
| [[TOMIIS]]
| Total Occlusion Post-Myocardial Infarction Intervention Study
| [[Total Occlusion Post-Myocardial Infarction Intervention Study]]
|-
|-
| TONE
| [[TONE]]
| Sodium Reduction And Weight Loss In The Treatment Of Hypertension In Older Persons: A Randomized Controlled Trial Of Nonpharmacologic Interventions In The Elderly
| [[Sodium Reduction And Weight Loss In The Treatment Of Hypertension In Older Persons: A Randomized Controlled Trial Of Nonpharmacologic Interventions In The Elderly]]
|-
|-
| TOPAS
| [[TOPAS]]
| A Comparison Of Recombinant Urokinase With Vascular Surgery As Initial Treatment For Acute Arterial Occlusion Of The Legs
| [[A Comparison Of Recombinant Urokinase With Vascular Surgery As Initial Treatment For Acute Arterial Occlusion Of The Legs]]
|-
|-
| TOSCA
| [[TOSCA]]
| Total Occlusion Study Of Canada
| [[Total Occlusion Study Of Canada]]
|-
|-
| TOTAL
| [[TOTAL]]
| Total Occlusion Trial With Angioplasty By Using Laser Guidewire
| [[Total Occlusion Trial With Angioplasty By Using Laser Guidewire]]
|-
|-
| TPT
| [[TPT]]
| Thrombosis Prevention Trial
| [[Thrombosis Prevention Trial]]
|-
|-
| TRACE
| [[TRACE]]
| The Trandolapril Cardiac Evaluation Trace Study
| [[The Trandolapril Cardiac Evaluation Trace Study]]
|-
|-
| TRAFFIC
| [[TRAFFIC]]
| Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 For Intermittent Claudication (The Traffic Study)
| [[Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 For Intermittent Claudication (The Traffic Study)]]
|-
|-
| TRANSCEND
| [[TRANSCEND]]
| Telmisartan Randomised Assessment Study In Ace Intolerant Subjects With Cardiovascular Disease
| [[Telmisartan Randomised Assessment Study In Ace Intolerant Subjects With Cardiovascular Disease]]
|-
|-
| TRANSFER-AMI
| [[TRANSFER-AMI]]
| Trial Of Routine Angioplasty And Stenting After Fibrinolysis To Enhance Reperfusion In Acute Myocardial Infarction
| [[Trial Of Routine Angioplasty And Stenting After Fibrinolysis To Enhance Reperfusion In Acute Myocardial Infarction]]
|-
|-
| TRAPIST
| [[TRAPIST]]
| Trapidil In Stent
| [[Trapidil In Stent]]
|-
|-
| TREND
| [[TREND]]
| Trial On Reversing Endothelial Dysfunction
| [[Trial On Reversing Endothelial Dysfunction]]
|-
|-
| TRENDS
| [[TRENDS]]
| Tetra Randomized European Direct Stenting Study
| [[Tetra Randomized European Direct Stenting Study]]
|-
|-
| TRENT
| [[TRENT]]
| Trial Of Early Nifedipine Treatment In Acute Myocardial Infarction
| [[Trial Of Early Nifedipine Treatment In Acute Myocardial Infarction]]
|-
|-
| TRIC
| [[TRIC]]
| Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator During Instability In Coronary Artery Disease: Effect On Myocardial Ischemia And Need For Coronary Revascularization
| [[Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator During Instability In Coronary Artery Disease: Effect On Myocardial Ischemia And Need For Coronary Revascularization]]
|-
|-
| TRIP-HF
| [[TRIP-HF]]
| Triple Resynchronization In Paced Heart Failure Patients
| [[Triple Resynchronization In Paced Heart Failure Patients]]
|-
|-
| TRITON-TIMI 38
| [[TRITON-TIMI 38]]
| Trial To Assess Improvement In Therapeutic Outcomes By Optimizing Platelet Inhibition With Prasugrel
| [[Trial To Assess Improvement In Therapeutic Outcomes By Optimizing Platelet Inhibition With Prasugrel]]
|-
|-
| TRIUMPH
| [[TRIUMPH]]
| Tilarginine Acetate Injection In A Randomized International Study In Unstable Mi Patients With Cardiogenic Shock
| [[Tilarginine Acetate Injection In A Randomized International Study In Unstable Mi Patients With Cardiogenic Shock]]
|-
|-
| TROICA
| [[TROICA]]
| Thrombolysis In Cardiac Arrest
| [[Thrombolysis In Cardiac Arrest]]
|-
|-
| TROPHY
| [[TROPHY]]
| Trial Of Preventing Hypertension
| [[Trial Of Preventing Hypertension]]
|-
|-
| TWA in CHF
| [[TWA in CHF]]
| T Wave Alternans In Congestive Heart Failure
| [[T Wave Alternans In Congestive Heart Failure]]
|-
|-
| TYPHOON
| [[TYPHOON]]
| Trial To Assess The Use Of The Cypher Stent In Acute Myocardial Infarction Treated With Angioplasty
| [[Trial To Assess The Use Of The Cypher Stent In Acute Myocardial Infarction Treated With Angioplasty]]
|-
|-
| UKPACE
| [[UKPACE]]
| United Kingdom Pacing And Cardiovascular Events
| [[United Kingdom Pacing And Cardiovascular Events]]
|-
|-
| UKPDS
| [[UKPDS]]
| United Kingdom Prospective Diabetes Study
| [[United Kingdom Prospective Diabetes Study]]
|-
|-
| UK-TIA
| [[UK-TIA]]
| The United Kingdom Transient Ischemic Attack Aspirin Trial: Final Results
| [[The United Kingdom Transient Ischemic Attack Aspirin Trial: Final Results]]
|-
|-
| UNASEM
| [[UNASEM]]
| Thrombolysis In Patients With Unstable Angina Improves The Angiographic But Not The Clinical Outcome
| [[Thrombolysis In Patients With Unstable Angina Improves The Angiographic But Not The Clinical Outcome]]
|-
|-
| UNLOAD
| [[UNLOAD]]
| Ultrafiltration Versus Intravenous Diuretics For Patients Hospitalized For Acute Decompensated Heart Failure
| [[Ultrafiltration Versus Intravenous Diuretics For Patients Hospitalized For Acute Decompensated Heart Failure]]
|-
|-
| USIM
| [[USIM]]
| Urochinasi Per Via Sistemica Nell'Infarto Miocardico
| [[Urochinasi Per Via Sistemica Nell'Infarto Miocardico]]
|-
|-
| VA-CABG
| [[VA-CABG]]
| Veterans Affairs (Va) Coronary Artery Bypass Surgery Cooperative Study Group
| [[Veterans Affairs (Va) Coronary Artery Bypass Surgery Cooperative Study Group]]
|-
|-
| VADT
| [[VADT]]
| Veterans Affairs Diabetes Trial
| [[Veterans Affairs Diabetes Trial]]
|-
|-
| VA-HIT
| [[VA-HIT]]
| Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial
| [[Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial]]
|-
|-
| Val-HeFT
| [[Val-HeFT]]
| Valsartan Heart Failuretrial
| [[Valsartan Heart Failuretrial]]
|-
|-
| VALIANT
| [[VALIANT]]
| Valsartan In Acute Myocardial Infarction Trial Investigators
| [[Valsartan In Acute Myocardial Infarction Trial Investigators]]
|-
|-
| VALIDD
| [[VALIDD]]
| Valsartan In Diastolic Dysfunction
| [[Valsartan In Diastolic Dysfunction]]
|-
|-
| VALUE
| [[VALUE]]
| Valsartan Antihypertensive Long-Term Use Evaluation
| [[Valsartan Antihypertensive Long-Term Use Evaluation]]
|-
|-
| VANQWISH
| [[VANQWISH]]
| Veterans Affairs (Va) Non-Q-Wave Infarction Strategies In-Hospital
| [[Veterans Affairs (Va) Non-Q-Wave Infarction Strategies In-Hospital]]
|-
|-
| VASIS
| [[VASIS]]
| Vasovagal Syncope International Study
| [[Vasovagal Syncope International Study]]
|-
|-
| VASP-02
| [[VASP-02]]
| Vasodilator-Stimulated Phosphoprotein-02
| [[Vasodilator-Stimulated Phosphoprotein-02]]
|-
|-
| VEAPS
| [[VEAPS]]
| Vitamin E Atherosclerosis Prevention Study
| [[Vitamin E Atherosclerosis Prevention Study]]
|-
|-
| VeGAS I
| [[VEGAS I]]
| The Vein Graft Angiojet Study I Pilot Trial
| [[The Vein Graft Angiojet Study I Pilot Trial]]
|-
|-
| VEGAS-2
| [[VEGAS-2]]
| Vein Graft Angiojet Study 2
| [[Vein Graft Angiojet Study 2]]
|-
|-
| VENUS
| [[VENUS]]
| Very Early Nimodipine Use In Stroke
| [[Very Early Nimodipine Use In Stroke]]
|-
|-
| VERBS
| [[VERBS]]
| Ventricular Endocardial Right Bifocal Stimulation In The Treatment Of Severe Dilated Cardiomyopathy Heart Failure With Wide Qrs
| [[Ventricular Endocardial Right Bifocal Stimulation In The Treatment Of Severe Dilated Cardiomyopathy Heart Failure With Wide Qrs]]
|-
|-
| VERDICT
| [[VERDICT]]
| Verapamil Versus Digoxin And Acute Versus Routine Serial Cardioversion Trial
| [[Verapamil Versus Digoxin And Acute Versus Routine Serial Cardioversion Trial]]
|-
|-
| VERITAS
| [[VERITAS]]
| Value Of Endothelin Receptor Inhibition With Tezosentan In Acute Heart Failure Studies
| [[Value Of Endothelin Receptor Inhibition With Tezosentan In Acute Heart Failure Studies]]
|-
|-
| VEST
| [[VEST]]
| Vesnarinone Survival Trial
| [[Vesnarinone Survival Trial]]
|-
|-
| VHAS
| [[VHAS]]
| Clinical Results Of The Verapamil In Hypertension And Atherosclerosis Study
| [[Clinical Results Of The Verapamil In Hypertension And Atherosclerosis Study]]
|-
|-
| VHEFT-I
| [[VHEFT-I]]
| The Effects Of Vasodilator Therapy On Mortality In Chronic Congestive Heart Failure
| [[The Effects Of Vasodilator Therapy On Mortality In Chronic Congestive Heart Failure]]
|-
|-
| VHEFT-II
| [[VHEFT-II]]
| Efficacy And Outcome With Felodipine In Heart Failure
| [[Efficacy And Outcome With Felodipine In Heart Failure]]
|-
|-
| VIAMI
| [[VIAMI]]
| Viability-Guided Angioplasty After Acute Myocardial Infarction
| [[Viability-Guided Angioplasty After Acute Myocardial Infarction]]
|-
|-
| VICTOR
| [[VICTOR]]
| Vioxx In Colorectal Cancer Therapy: Definition Of Optimal Regimen
| [[Vioxx In Colorectal Cancer Therapy: Definition Of Optimal Regimen]]
|-
|-
| VINTAGE-MI
| [[VINTAGE-MI]]
| Vascular Interaction With Age In Myocardial Infarction
| [[Vascular Interaction With Age In Myocardial Infarction]]
|-
|-
| VITAL
| [[VITAL]]
| Vasoflux International Trial For Acute Myocardial Infarction Lysis
| [[Vasoflux International Trial For Acute Myocardial Infarction Lysis]]
|-
|-
| VIVA
| [[VIVA]]
| Vascular Endothelial Growth Factor In Ischemia For Vascular Angiogenesis
| [[ Vascular Endothelial Growth Factor In Ischemia For Vascular Angiogenesis]]
|-
|-
| VMAC
| [[VMAC]]
| Vasodilation In The Management Of Acute Congestive Heart Failure
| [[Vasodilation In The Management Of Acute Congestive Heart Failure]]
|-
|-
| VPS
| [[VPS]]
| The North American Vasovagal Pacemaker Study
| [[The North American Vasovagal Pacemaker Study]]
|-
|-
| VPS II
| [[VPS II]]
| Vasovagal Pacemaker Study Ii
| [[Vasovagal Pacemaker Study II]]
|-
|-
| WAFACS
| [[WAFACS]]
| Women'S Antioxidant And Folic Acid Cardiovascular Study
| [[Women's Antioxidant And Folic Acid Cardiovascular Study]]
|-
|-
| WARIS-II
| [[WARIS-II]]
| Warfarin, Aspirin, Or Both After Myocardial Infarction
| [[Warfarin, Aspirin, Or Both After Myocardial Infarction]]
|-
|-
| WARSS
| [[WARSS]]
| Warfarin–Aspirin Recurrent Stroke Stud
| [[Warfarin–Aspirin Recurrent Stroke Stud]]
|-
|-
| WATCH
| [[WATCH]]
| Warfarin And Antiplatelet Trial In Chronic Heart Failure
| [[Warfarin And Antiplatelet Trial In Chronic Heart Failure]]
|-
|-
| WAVE
| [[WAVE]]
| Warfarin Antiplatelet Vascular Evaluation
| [[Warfarin Antiplatelet Vascular Evaluation]]
|-
|-
| WAVE
| [[WAVE]]
| Women'S Angiographic Vitamin And Estrogen Trial
| [[Women's Angiographic Vitamin And Estrogen Trial]]
|-
|-
| WELL-HART
| [[WELL-HART]]
| Women’S Estrogen–Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial
| [[Women’s Estrogen–Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial]]
|-
|-
| WENBIT
| [[WENBIT]]
| Western Norway B-Vitamin Intervention Trial
| [[Western Norway B-Vitamin Intervention Trial]]
|-
|-
| WEST
| [[WEST]]
| Which Early St-Elevation Myocardial Infarction Therapy
| [[Which Early St-Elevation Myocardial Infarction Therapy]]
|-
|-
| WHI
| [[WHI]]
| Women'S Health Initiative
| [[Women's Health Initiative]]
|-
|-
| WINS
| [[WINS]]
| Women'S Initiative For Nonsmoking
| [[Women's Initiative For Nonsmoking]]
|-
|-
| WISE
| [[WISE]]
| Women'S Ischemia Syndrome Evaluation
| [[Women's Ischemia Syndrome Evaluation]]
|-
|-
| WITTI Women
| [[WITTI Women]]
| Secondary Prevention Beyond Walls Intervention Trial In Women
| [[Secondary Prevention Beyond Walls Intervention Trial In Women]]
|-
|-
| WIZARD
| [[WIZARD]]
| Weekly Intervention With Zithromax For Atherosclerosis And Its Related Disorders
| [[Weekly Intervention With Zithromax For Atherosclerosis And Its Related Disorders]]
|-
|-
| WRIST
| [[WRIST]]
| Washington Radiation For In-Stent Restenosis Trial
| [[Washington Radiation For In-Stent Restenosis Trial]]
|-
|-
| ZEST-AMI
| [[ZEST-AMI]]
| Zotarolimus-Eluting Stent Vs. Sirolimus-Eluting Stent Vs. Paclitaxel-Eluting Stent For Acute Myocardial Infarction Patients
| [[Zotarolimus-Eluting Stent Vs. Sirolimus-Eluting Stent Vs. Paclitaxel-Eluting Stent For Acute Myocardial Infarction Patients]]
|}
|}


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 20:38, 8 August 2012

WikiDoc Resources for Acronyms of Clinical Trial Names

Articles

Most recent articles on Acronyms of Clinical Trial Names

Most cited articles on Acronyms of Clinical Trial Names

Review articles on Acronyms of Clinical Trial Names

Articles on Acronyms of Clinical Trial Names in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Acronyms of Clinical Trial Names

Images of Acronyms of Clinical Trial Names

Photos of Acronyms of Clinical Trial Names

Podcasts & MP3s on Acronyms of Clinical Trial Names

Videos on Acronyms of Clinical Trial Names

Evidence Based Medicine

Cochrane Collaboration on Acronyms of Clinical Trial Names

Bandolier on Acronyms of Clinical Trial Names

TRIP on Acronyms of Clinical Trial Names

Clinical Trials

Ongoing Trials on Acronyms of Clinical Trial Names at Clinical Trials.gov

Trial results on Acronyms of Clinical Trial Names

Clinical Trials on Acronyms of Clinical Trial Names at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Acronyms of Clinical Trial Names

NICE Guidance on Acronyms of Clinical Trial Names

NHS PRODIGY Guidance

FDA on Acronyms of Clinical Trial Names

CDC on Acronyms of Clinical Trial Names

Books

Books on Acronyms of Clinical Trial Names

News

Acronyms of Clinical Trial Names in the news

Be alerted to news on Acronyms of Clinical Trial Names

News trends on Acronyms of Clinical Trial Names

Commentary

Blogs on Acronyms of Clinical Trial Names

Definitions

Definitions of Acronyms of Clinical Trial Names

Patient Resources / Community

Patient resources on Acronyms of Clinical Trial Names

Discussion groups on Acronyms of Clinical Trial Names

Patient Handouts on Acronyms of Clinical Trial Names

Directions to Hospitals Treating Acronyms of Clinical Trial Names

Risk calculators and risk factors for Acronyms of Clinical Trial Names

Healthcare Provider Resources

Symptoms of Acronyms of Clinical Trial Names

Causes & Risk Factors for Acronyms of Clinical Trial Names

Diagnostic studies for Acronyms of Clinical Trial Names

Treatment of Acronyms of Clinical Trial Names

Continuing Medical Education (CME)

CME Programs on Acronyms of Clinical Trial Names

International

Acronyms of Clinical Trial Names en Espanol

Acronyms of Clinical Trial Names en Francais

Business

Acronyms of Clinical Trial Names in the Marketplace

Patents on Acronyms of Clinical Trial Names

Experimental / Informatics

List of terms related to Acronyms of Clinical Trial Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


For other acronyms involved in clinical trials, click here

For detailed instructions on how to contribute to WikiDoc's Clinical Trials Wiki, click here


Acronym Trial Name
3CPO Effect Of Continuous Positive Airway Pressure And Noninvasive Positive Pressure Ventilation In Acute Cardiogenic Pulmonary Oedema
3T/2R Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
4D Deutsche Diabetes Dialysis Study
4E Efficacy And Safety Of Eplerenone, Enalapril, And Eplerenone/Enalapril Combination Therapy In Patients With Left Ventricular Hypertrophy
4S Scandinavian Simvastatin Survival Study
6C trial Cooperative Colorectal Cancer Combination Chemotherapy Clinical
A to Z, Phase A Aggrastat To Zocor
A to Z, Phase Z Evaluation Of Early Versus Delayed Initiation Of Simvastatin In Patients Who Receive Guideline Based Treatment For Acute Coronary Syndrome
A4 Study Catheter Ablation Versus Antiarrhythmic Drugs For Atrial Fibrillation
AAASPS African American Antiplatelet Stroke Prevention Study
AACHEN Angiotensin II Receptor Blocker Candesartan Cilexetil On Intimal Hyperplasia After Coronary Stent Implantation
AASK African American Study Of Kidney Disease And Hypertension
ABACAS Adjunctive Balloon Angioplasty Following Coronary Atherectomy Study
ABC study Association Of Black Cardiologists Study Of Hypertension
ABCD Alternans Before Cardioverter Defibrillator
AbESTT Abciximab Emergent Stroke Treatment Trial
ABOARD Immediate Versus Next Day Catheterization In Non-St Elevation Acute Coronary Syndrome
ABSORB: 6-month and 2-year results A Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions
ACADEMIC Azithromycin In Coronary Artery Disease: Elimination Of Myocardial Infection With Chlamydia
ACAS Asymptomatic Carotid Atherosclerosis Study
ACC AMI GAP American College Of Cardiology Acute Myocardial Infarction Guidelines Applied To Practice Study
ACCENT A Crohn's Disease Clinical Trial Evaluating Infliximab In A New Long-Term Treatment Regimen
ACCEPT The Accupril Canadian Clinical Evaluation And Patient Teaching Study
ACCESS Acute Candesartan Cilexetil Evaluation In Stroke Survivors
ACCLAIM Advanced Chronic Heart Failure Clinical Assessment Of Immune Modulation Therapy
ACCOMPLISH Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
ACCORD Action To Control Cardiovascular Risk In Diabetes
ACCT Sex And Age Related Antihypertensive Effects Of Amlodipine
ACCURACY Assessment By Coronary Computed Tomographic Angiography Of Individuals Undergoing Invasive Coronary Angiography
ACE Abciximab-Carbostent Evaluation
ACE Anticoagulation For Cardioversion Using Enoxaparin
ACE (Carotid Endarterectomy) Asa And Carotid Endarterectomy Trial
ACES Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease
ACES Clinical Experience Study
ACIP Asymptomatic Cardiac Ischemia Pilot Study
ACME Angioplasty Compared To Medicine
ACME-2 Angioplasty Compared To Medicine - Two-Vessel Disease
A-COMET-I Azimilide—Cardioversion Maintenance Trial–I
A-COMET-II Azimilide—Cardioversion Maintenance Trial–II
ACORN Assessment Of A Cardiac Support Device (Csd) In Patients With Heart Failure
ACRE Appropriateness Of Coronary Revascularization
ACST Asymptomatic Carotid Surgery Trial
ACT Effects Of Physical Activity Counseling In Primary Care: The Activity Counseling Trial
ACT Angioplasty Compliance Trial
ACTION Coronary Disease Trial Investigating Outcome With Nifedipine Gits
ACTION Actinomycin Eluting Stent Improves Outcomes By Reducing Neointimal Hyperplasia
ACTIV in CHF Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure
ACTIVATE Acat Inhibition On The Progression Of Coronary Atherosclerosis
ACTIVE A The Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
ACTIVE W Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
ACUITY Acute Catheterization And Urgent Intervention Triage Strategy Trial
ACUITY PCI: 30-day and 1-Year Results Acute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results
ACUITY Timing Trial Acute Catheterization And Urgent Intervention Triage Strategy Timing Trial
ACUTE Assessment Of Cardioversion Using Transesophageal Echocardiography
ACUTE Analysis Of Coronary Ultrasound Thrombolysis Endpoints In Acute Myocardial Infarction
ACUTE II Assessment Of Cardioversion Using Transesophageal Echocardiography
ADAM Aneurysm Detection And Management Veterans Affairs Cooperative Study
ADAM Amsterdam Duration Of Antiretroviral Medication Study
ADAPT Alzheimer's Disease Anti-Inflammatory Prevention Trial
ADCS Alzheimer's Disease Cooperative Study
ADEMEX Adequacy Of Peritoneal Dialysis In Mexico
ADEPT Advanced Elements Of Pacing Trial
ADIOS Antiarrhythmic Drug Improve Outcome Study
ADMIRAL Platelet Glycoprotein IIb/IIia Inhibition With Coronary Stenting For Acute Myocardial Infarction
ADMIRAL Abciximab Before Direct Angioplasty And Stenting In Myocardial Infarction Regarding Acute And Long-Term Followup
ADMIT Arterial Disease Multiple Intervention Trial
ADONIS Aspirin Dose Optimized In Noncardioembolic Ischemic Stroke
ADOPT Atrial Dynamic Overdrive Pacing Trial
ADOPT A Diabetes Outcome Progression Trial
ADOPT-A Atrial Dynamic Overdrive Pacing Trial-A
ADVANCE A Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions
ADVANCE Additive Value Of Tirofiban Administered With The High-Dose Bolus In The Prevention Of Ischemic Complications During High-Risk Coronary Angioplasty
ADVANCE Action In Diabetes And Vascular Disease: Preterax And Diamicron Modified Release Controlled Evaluation
ADVANCE A Dosing Evaluation Of A Vasopressin Antagonist In Chf Patients Undergoing Exercise
ADVENT Assessment Of Diabetes Control And Evaluation Of The Efficacy Of Niaspan Trial
AEGIS Alternative Graft Investigational Study
A-F Vascular Protection In High-Risk Non–St-Elevation Acute Coronary Syndromes: The Angioplasty Balloon-Associated Coronary Debris And The Ez Filterwire
AFASAK Atrial Fibrillation, Aspirin, Antikoagulation
AFASAK-2 Second Copenhagen Atrial Fibrillation, Aspirin, And Anticoagulation Study
AFCAPS Air Force Coronary Atherosclerosis Prevention Study
AFCAPS/TEXCAPS Air Force Texas Coronary Atherosclerosis Prevention Study
AF-CHF Atrial Fibrillation And Congestive Heart Failure
AFFIRM Atrial Fibrillation Follow-Up Investigation Of Rhythm Management
AFIB Atrial Fibrillation Investigation With Bidisomide
AFREGS Armed Forces Regression Study
AGENT Angiogenic Gene Therapy
AGENT-2 Angiogenic Gene Therapy Trial 2
AGENT-3 A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options
AGIS Advanced Glaucoma Intervention Study
A-HeFT African-American Heart Failure Trial
AiMI A Prospective, Randomized, Controlled Trial Of Thrombectomy With The Angiojet In Acute Myocardial Infarction
AIMS Apsac Intervention Mortality Study
AIR Aerosolized Iloprost Randomized Placebo-Controlled Study
Air PAMI The Air Primary Angioplasty In Myocardial Infarction Study
AIRCRAFT The Australian Intervention Randomized Control Of Rate In Atrial Fibrillation Trial
AIRE Acute Infarction Ramipril Efficacy Study
AIST-ASH Acute Ischemic Stroke Trial: Oral Aspirin Vs Intravenous Heparin On Stroke Progression
ALBION Assessment Of The Best Loading Dose Of Clopidogrel To Blunt Platelet Activation, Inflammation, And On-Going Necrosis
ALERT Assessment Of Lescol In Renal Transplantation
ALERT Adjunctive Lamictal In Epilepsy And Response To Treatment
ALIVE Azimilide Post-Infarct Survival Evaluation
ALIVE Adenosine Lidocaine Infarct Zone Viability Enhancement
ALIVE (amio vs. lidocaine Amiodarone As Compared With Lidocaine For Shock-Resistant Ventricular Fibrillation
ALKK Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte
ALLAY Aliskiren In Left Ventricular Hypertrophy
ALLHAT Antihypertensive And Lipid-Lowering Treatment To Prevent Heart Attack Trial
ALLIANCE Aggressive Lipid-Lowering Initiation Abates New Cardiac Events
ALOFT Aliskiren Observations Of Heart Failure Treatment
ALPHA T-Wave Alternans In Patients With Heart Failure
ALPHABET Effects Of Beraprost Sodium, An Oral Prostacyclin Analogue, In Patients With Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
ALTS Ascus/Lsil Triage Study
AMADEUS Comparison Of Idraparinux With Vitamin K Antagonists For Prevention Of Thromboembolism In Patients With Atrial Fibrillation
AMAZE A Multicenter Trial Using-Zestril Versus To Evaluate The Effects On Lowering Blood Pressure
AMEthyst Assessment Of The Medtronic Ave Interceptor Saphenous Vein Graft Filter System
AMIGO Atherectomy And Multilink Stenting Improves Gain In Outcome Trial
AMIGO Ac2993: Diabetes Management For Improving Glucose Outcome
AMIHOT Acute Myocardial Infarction With Hyperoxemic Therapy
AMIHOT II Acute Myocardial Infarction With Hyperoxemic Therapy II
AMIOVIRT Amiodarone Versus Implantable Defibrillator In Patients With Nonischemic Cardiomyopathy And Asymptomatic Nonsustained Ventricular Tachycardia Study
AMISTAD I Acute Myocardial Infarction Study Of Adenosine Trial
AMISTAD II Acute Myocardial Infarction Study Of Adenosine II
AMRO Amsterdam-Rotterdam Trial
ANBP2 Australian National Blood Pressure Study Group
ANDROMEDA Increased Mortality After Dronedarone Therapy For Severe Heart Failure
ANTHEM–TIMI-32 Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32
ANTIBIO Antibiotic Therapy After An Acute Myocardial Infarction
ANZ-Carvedilol Australia-New Zealand Heart Failure Research Collaborative Group Carvedilol Trial
APAF Ablation For Paroxysmal Atrial Fibrillation (Apaf) Trial
APASS Antiphospholipid Antibody Stroke Study
APC Adenoma Prevention With Celecoxib
APEX AMI Assessment Of Pexelizumab In Acute Myocardial Infarction
APLAUSE Anti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
APOCARD Imaging In Cardiac Transplant Patients
APPRAISE-1 Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial
APPROACH Assessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
APRES Angiotensin-Converting Enzyme Inhibition Post Revascularization Study
APRICOT Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
APRICOT-2 Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
ARBITER 2 Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2
ARCH Amiodarone Reduction In Coronary Heart Trial
ARCHeR For Revascularization Of Carotids In High-Risk Patients
AREDS Age-Related Eye Disease Study
ARG-911 Argatroban-911
ARG-915 Argatroban-915
ARGAMI-2 Argatroban For Acute Myocardial Infarction
ARIC Atherosclerosis Risk In Communities
ARIES 1 and 2 Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
ARISE Aggressive Reduction Of Inflammation Stops Events
ARMS Apsac Reocclusion Multicenter Study
ARMYDA Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
ARMYDA-2 Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
ARMYDA-3 Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
ARMYDA-4 Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
ARMYDA-5 Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
ARMYDA-ACS Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
ARMYDA-RECAPTURE Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
ARMYDA-RELOAD Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
ARPEGGIO Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
ARREST Amiodarone For Resuscitation After Out-Of-Hospital Cardiac Arrest Due To Ventricular Fibrillation
ARREST Angiorad Radiation For Restenosis
ARTIST Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
ARTISTIC Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary
ARTS Arterial Revascularization Therapies Study
ARTS I - Five year follow-up Five Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
ARTS-II Arterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
ASAP Effect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia
ASAP Azimilide Supraventricular Arrhythmia Program
ASCENT Acs Stent Clinical Equivalence In De Novo Lesions Trial
ASCOT Anglo-Scandinavian Cardiac Outcome Trial
ASCOT - Blood Pressure Arm Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
ASCOT - Lipid Arm Anglo-Scandinavian Cardiac Outcomes Trial
ASFAST Atherosclerosis And Folic Acid Supplementation Trial
ASIS Angina And Silent Ischemia Study
ASPAC Asian-Pacific Collaboration On Chd Risk Factor Intervention
ASPECT Anticoagulants In Secondary Prevention Of Events In Coronary Thrombosis
ASPECT Asian Paclitaxel-Eluting Stent Clinical Trial
ASPECT-2 Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
ASPEN Atorvastatin Study For The Prevention Of Endpoints For Patients With Niddm
ASPIRE Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
ASSENT 3 The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi
ASSENT 3 PLUS Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3
ASSENT-1 Assessment Of The Safety and Efficacy Of A New Thrombolytic: Tnk-Tpa
ASSENT-2 Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
ASSENT-4 PCI Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
ASSERT Aortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial
ASSET Anglo-Scandinavian Study Of Early Thrombolysis
ASSIST Assessment Of Implementation Strategies
ASSIST A Stop Smoking In Schools Trial
ASSURE Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations
ASTAMI Astami
ASTEROID A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
ASTIS Autologous Stem Cell Transplantation International Scleroderma Trial
ASTRAL Angioplasty And Stenting For Renal Artery Lesions
ASTRID Atrial Sensing Trial To Prevent Inappropriate Detections
ASTRONAUT Acid Suppression Trial: Ranitidine Zantac Versus Omeprazole
AT LAST Antiretroviral Trial Looking At Sex And Treatment
ATAC Arimidex (Anastrozole), Tamoxifen And Combination Therapy
ATBAT Anticoagulant Therapy With Bivalirudin To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)
ATBC Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study
ATHENA Effect Of Dronedarone On Cardiovascular Outcomes In High-Risk Patients With Atrial Fibrillation Or Atrial Flutter
ATHEROMA Atorvastatin Therapy: Effects Of Reduction Of Macrophage Activity
ATICH Antifibrinolytic Therapy In Acute Intracerebral Hemorrhage
ATLANTIC Angina Treatments - - Lasers And Normal Therapies In Comparison
ATLANTIS Alteplase Thrombolysis For Acute Noninterventional Therapy In Ischemic Stroke
ATLAS Assessment Of Treatment With Lisinopril And Survival
ATLAS Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts Assessment Of Treatment With Lisinopril And Survival
ATLAS - SVG Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts
ATLAST Antiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy In Patients At Increased Risk Of Stent Thrombosis
ATLAS-TIMI 46 Anti-Xa Therapy To Lower Cardiovascular Events In Addition To Aspirin With Or Without Thienopyridine In Subjects With Acute Coronary Syndromes–Thrombolysis In Myocardial Infarction 46
AtoZ Aggrastat To Zocor Study
ATRAMI Baroreflex Sensitivity And Heart-Rate Variability In Prediction Of Total Cardiac Mortality After Myocardial Infarction. Atrami (Autonomic Tone And Reflexes After Myocardial Infarction) Investigators.
ATRIA The Anticoagulation And Risk Factors In Atrial Fibrillation Study
ATRIA Anticoagulation And Risk Factors In Atrial Fibrillation
Atrial Arrhythmia Conversion Trial Vernakalant Hydrochloride For Rapid Conversion Of Atrial Fibrillation
ATS Amblyopia Treatment Study
ATTACH Anti-Tnf Therapy Against Congestive Heart Failure Trial
ATTEST Atrial Therapy Efficacy And Safety Trial
ATTRACT Anti-Tnf Trial In Rheumatoid Arthritis With Ca2 Treatment
AURORA A Study To Evaluate The Use Of Rosuvastatin In Subjects On Regular Hemodialysis: An Assessment Of Survival And Cardiovascular Events
AVASIS Aspirin Versus Anticoagulants In Symptomatic Intracranial Stenosis
AVERT Atorvastatin Versus Revascularization Treatments
AVERT Artificial Valve Endocarditis Reduction Trial
AVID Antiarrhythmics Versus Implantable Defibrillators
AVID Angiography Versus Intravascular Ultrasound-Directed Stent Placement
AVID Electrical Storm Substudy Electrical Storm Presages Nonsudden Death. The Antiarrhythmics Vs. Implantable Defibrillators (Avid) Trial
AVOID Aliskiren In The Evaluation Of Proteinuria In Diabetes
AWESOME Angina With Extremely Serious Operative Mortality Evaluation
AZACS Azithromycin In Acute Coronary Syndrome
BAATAF Boston Area Anticoagulation Trial For Atrial Fibrillation
BACH Bach
BARI Bypass Angioplasty Revascularization Investigation
BARI 2D Bypass Angioplasty Revascularization Investigation In Type 2 Diabetics
BARS Beaumont Alcohol Restenosis Study
BASC Blood Pressure In Acute Stroke Collaboration
BASEL Brain Natriuretic Peptide For Acute Shortness Of Breath Evaluation: A Randomized Comparison
BASIS Basel Antiarrhythmic Study Of Infarct Survival
BASKET Basel Stent Cost-Effectiveness Trial
BASKET LATE Late Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel
BAT Bivalirudin Angioplasty Study
BATMAN Biodivysio 'Bat'Imastat Sv Stent Versus Balloon Angioplasty For The Reduction Of Restenosis In Small Coronary Arteries
BBC ONE British Bifurcation Coronary Study: Old, New, And Evolving Strategies
BBS—Cognitive Study Best Bypass Surgery—Cognitive Study
BCAPS Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study
BCPT Breast Cancer Prevention Trial
BEACH Boston Scientific Epi: A Carotid Stenting Trial For High-Risk Surgical Patients
BEAT Bucindolol Evaluation In Acute Myocardial Infarction Trial
BEAUTIFUL Morbidity-Mortality Evaluation Of The If Inhibitor Ivabradine In Patients With Coronary Disease And Left-Ventricular Dysfunction
BECAIT Bezafibrate Coronary Atherosclerosis Intervention Trial
BECAIT Bezafibrate Coronary Atherosclerosis Intervention Trial
BELLES Beyond Endorsed Lipid Lowering With Ebt Scanning
BENEDICT Bergamo Nephrologic Diabetes Complications Trial
BENEFiT Bosentan Effects In Inoperable Forms Of Chronic Thromboembolic Pulmonary Hypertension
BENEFIT Betaferon (Betaseron In U.S.) In Newly Emerging Ms For Initial Treatment Information
BENESTENT I Belgian-Netherlands Stent Study (I)
BENESTENT II Belgian-Netherlands Stent Study II (Pilot)
BERT Beta Energy Restenosis Trial - 1
BESMART Bestent In Small Arteries Trial
BESSAMI Berlin Stent Study In Acute Myocardial Infarction
BEST Beta Blocker Evaluation Of Survival Trial
BEST Balloon Equivalent To Stent Trial
BEST-ICD Beta-Blocker Evaluation Of Survival Trial Plus Icd
BETA WRIST Washington Radiation For In-Stent Restenosis Trial
BETACATH Clinical And Angiographic Outcomes After Use Of Sr-90 Beta Radiation For The Treatment Of De Novo And Restenotic Coronary Lesions
BETTER Beta Radiation Trial To Eliminate Restenosis
BHACAS Early And Midterm Outcome After Off-Pump And On-Pump Surgery In Beating Heart Against Cardioplegic Arrest Studies (Bhacas 1 And 2): A Pooled Analysis Of Two Randomised Controlled Trials.
BHAT Beta Blocker Heart Attack Trial
BiCard Biphasic Vs. Monophasic Shock Waveform For Conversion Of Atrial Fibrillation. The Results Of An International Randomized, Double-Blind Multicenter Trial
BICC Beta-Interferon In Chronic Viral Cardiomyopathy
BIP Bezafibrate Infarction Prevention Study
BIRD Bolus Versus Infusion In Rescupase (Saruplase) Development
BLIND-DATE Blinded Withdrawal Of Deprenyl In The Datatop Extension Trial
BLOSS Beta Blocker Length Of Stay Study
BNP Breathing Not Properly
BOAT Balloon Angioplasty Versus Optimal Atherectomy Trial
Bogalusa Bogalusa Heart Study
BOOST Bone Marrow Transfer To Enhance St-Elevation Infarct Regeneration
BPAV Balloon Prophylaxis Of Aneurysmal Vasospasm
BRAINS Bayer Randomized Acute Ischemia Neuroprotectant Study
BRAVE Bavarian Reperfusion Alternatives Evaluation
BRAVE-2 Beyond 12 Hours Reperfusion Alternative Evaluation Trial
BRAVE-3 Value Of Abciximab In Patients With Ami Undergoing Pci After High Loading Dose Of Clopidogrel Pretreatment
BRAVO Blockade Of The Glycoprotein IIb/IIia Receptor To Avoid Vascular Occlusion
BRAVO Beta Radiation For Treatment Of Arteriovenous Graft Outflow Sponsor:
BREATHE-1 Bosentan (Tracleer): Randomized Trial Of Endothelin Receptor Antagonist Therapy For Pulmonary Hypertension
BRIDGE Beta-Radiation Investigation With Direct Stenting And Galileo In Europe
BRIE Beta Radiation In Europe
BRIEF-PCI Brief Infusion Of Eptifibatide Following Percutaneous Coronary Intervention
BRILLIANT Batimastat (Bb-94) Antirestenosis Trial Utilizing The Biodivysio Local Drug Delivery Pc Stent
BRITE Beta Radiation To Reduce In-Stent Restenosis
BRITE II Beta Radiation To Reduce In-Stent Restenosis II
BRITE-SVG Beta Radiation To Reduce In-Stent Restenosis In Saphenous Vein Grafts
CABERNET A Prospective Registry Of Carotid Stenting With The Nexstent And Distal Protection With The Filterwire Ex In High Risk Patients
CABERNET Carotid Artery Revascularization Using The Boston Scientific Epi Filterwire Ex And The Endotex Nexstent
CABG PATCH The Coronary Artery Bypass Graft Patch Trial
CABG Patch Cardioplegia Substudy Does Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria
CABRI Coronary Angioplasty Versus Bypass Revascularization Investigation
CACAF Catheter Ablation For The Cure Of Atrial Fibrillation Study
CACHET Comparison Of Abciximab Complications With Hirulog (Angiomax As Of 1999) Ischemic Events Trial
CACTUS Coronary Bifurcations: Application Of The Crushing Technique Using Sirolimus-Eluting Stents
CADILLAC Controlled Abciximab (Reopro) And Device Investigation To Lower Late Angioplasty Complications
CAESAR Canada, Australia, Europe, South Africa Aids Study
CAFA Canadian Atrial Fibrillation Anticoagulation Study
CAFE Conduit Artery Function Evaluation
CALM Candesartan And Lisinopril Microalbuminuria Study
CALM-PD Comparison Of The Agonist Pramipexole Vs. Levodopa On Motor Complications In Parkinson Disease
CALYPSO Cylexin As An Adjunct To Lytic Therapy To Prevent Superoxide Reflow Injury
CAMELOT Comparison Of Amlodipine Versus Enalapril (Lipitor) To Limit Occurrences Of Thrombosis
CAMEO Cerebral Aneurysm Multicenter European
CAMIAT Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (Pilot)
CANDLE Candesartan Versus Losartan Efficacy Comparison
Cangrelor during PCI Cangrelor During Percutaneous Coronary Intervention
CANPAP Continuous Positive Airway Pressure For Heart Failure Patients With Central Sleep Apnea
CAPARES Coronary Angioplasty Amlodipine Restenosis Study
CAPE II Medical Treatment Of Myocardial Ischemia In Coronary Artery Disease: Effect Of Drug Regime And Irregular Dosing In The Cape II Trial
CAPITAL AMI Combined Angioplasty And Pharmacological Intervention Versus Thrombolytics Alone In Acute Myocardial Infarction
CAPPP Captopril Prevention Project
CAPRICORN Carvedilol Post Infarct Survival Control in Left Ventricular Dysfunction Study
CAPRIE Clopidogrel Versus Aspirin In Patients At Risk Of Ischemic Events
CAPS The Cardiac Arrhythmic Pilot Study
CAPT Complications Of Amd (Age-Related Macular Degeneration) Prevention Trial
CAPTEN Captopril After Thrombolysis Trial
CAPTIM Comparison Of Angioplasty And Prehospital Thrombolysis In Acute Myocardial Infarction
CAPTIN Captopril Plus Tissue Plasminogen Activator Following Acute Myocardial Infarction
CAPTIVATE Carotid Atherosclerosis Progression Trial Investigating Vascular Acat Inhibition Treatment Effects
CAPTIVE A Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire
CAPTURE Chimeric 7E3 Antiplatelet Therapy In Unstable Angina Refractory To Standard Treatment
CAPTURE Registry Carotid Acculink/Accunet Post-Approval Trial To Uncover Unanticipated Or Rare Events Registry
CARAT Coronary Angioplasty And Rotational Atherectomy Trial
CARDIA Coronary Artery Risk Development In Young Adults
CARDia Coronary Artery Revascularization In Diabetes Trial
CARDINAL Complement And Reduction Of Infarct Size After Angioplasty Or Lytics
CARDS Collaborative Atorvastatin (Lipitor) And Diabetes Study
CARE Cardiac Angiography In Renally Impaired Patients
CARE Cholesterol And Recurrent Events
CARE Calcium Antagonist In Reperfusion Cholesterol And Recurrent Events Carvedilol Atherectomy Restenosis
CARE-HD Coenzyme Q10 And Remacemide: Evaluation In Huntington Disease
CARE-HF Cardiac Resynchronization - Heart Failure European Complement To U.S./Canada Miracle Study
CARESS Clopidogrel And Aspirin For Reduction Of Emboli In Symptomatic Carotid Stenosis
CARESS-in-AMI: 30-Day and 1-Year Results Combined Abciximab Reteplase Stent Study In Acute Myocardial Infarction: 30-Day and 1-Year Results
CARET The Beta Carotene And Retinol Efficacy Trial
CARIBE Carvedilol Insuficiencia Cardiaca (Heart Failure) Beta-Receptor
CARISA Combination Assessment Of Ranolazine In Stable Angina
CARMEN The Carvedilol And Ace-Inhibitor Remodeling Mild Heart Failure Evaluation Trial
CARMEN Carvedilol Ace Inhibitors Remodelling Mild Heart Failure Evaluation
CARP Coronary Artery Revascularization Prophylaxis
CARS Coumadin Aspirin Reinfarction Study
CART Canadian Antioxidant Restenosis Trial
CARVEDILOL The Effects Of Carvedilol On Morbidity And Mortality In Patients With Chronic Heart Failure
CASCADE Cardiac Arrest In Seattle: Conventional Versus Amiodarone Drug Evaluation Study
CASES Canadian Activase For Stroke Effectiveness Study
CASH Cardiac Arrest Study-Hamburg
CASIS Canadian Amlodipine/Atenolol In Silent Ischemia Study
CASS Coronary Artery Surgery Study
CAST Cardiac Arrhythmia Suppression Trial
CASTEMI Calderet In St Elevation Myocardial Infarction
CAST-II The Cardiac Arrhythmia Suppression Trial II
CASTLE Candesartan Amlodipine Study Of Tolerability And Efficacy
CAT Cardiomyopathy Trial
CAT Chinese Ace Inhibitor In Acute Myocardial Infarction Trial Cardiomyopathy Trial
CATAPULT Cisplatin And Tirapazamine In Subjects With Advanced Previously Untreated Non–Small Cell Lung Tumors
Cathedia Study Femoral Vs. Jugular Venous Catheterization And Risk Of Nosocomial Events In Adults Requiring Acute Renal Replacement Therapy
CATIE Clinical Antipsychotic Trials Of Intervention Effectiveness
CATS Canadian American Ticlopidine Study
CATS Captopril And Thrombolysis Study
CAVATAS Endovascular Versus Surgical Treatment In Patients With Carotid Stenosis In The Carotid And Vertebral Artery Transluminal Angioplasty Study (Cavatas)
CAVEAT I Coronary Angioplasty Versus Excisional Atherectomy Trial I
CAVEAT II Coronary Angioplasty Versus Excisional Atherectomy Trial II
CBT-CD Cognitive Behavior Therapy For The Chronic Depressions
CCAT Canadian Coronary Atherectomy Trial
CCP The Cooperative Cardiovascular Project
CCS-1 Chinese Cardiac Study
CDP Coronary Drug Project
CEDARS Comprehensive Evaluation Of Defibrillators And Resuscitative Shock
CELL Cost Effectiveness Of Lipid Lowering Study
CEOS Congenital Esotropia Observational Study
CHAMP Combination Hemotherapy And Mortality Prevention (Champ) Study
CHAMP Children's Hiv And Aids Model Program
CHAMPIONS Controlled High-Risk Subjects Avonex Ms Prevention In Ongoing Neurologic Surveillance
CHAMPS Controlled High-Risk Subjects Avonex Ms Prevention Study
CHAOS Cambridge Heart Antioxidant Study
CHARISMA Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
CHARM Candesartan Cilexitil (Atacand) In Heart Failure Assessment Of Reduction Mortality And Morbidity
CHARM Added Trial Candesartan In Heart Failure—Added Trial
CHARM Alternative Trial Candesartan In Heart Failure—Alternative Trial
CHARM Overall Programme Results Candesartan In Heart Failure—Assessment Of Reduction In Mortality And Morbidity
CHARM Preserved Trial Candesartan In Heart Failure—Preserved Trial
CHEESE Comparative Trial Of Hiv-Infected Patients Evaluating Efficacy And Safety Of Saquinavir-Enhanced Oral Formulation And Indinavir Given As Part Of A Triple Drug Therapy
CHF-STAT Congestive Heart Failure Survival Trial Of Antiarrhythmic Therapy
CHICAGO Carotid Intima-Media Thickness In Atherosclerosis Using Pioglitazone
CHRISTMAS Carvedilol Hibernating Reversible Ischaemia Trial
CHS Cardiovascular Health Study
CHS
Charleston Heart Study
CHS
Community Health Study
CHS
Congenital Heart Surgeons Society Study
CHS
Coronary Heart Study
CIAO Coronary Interventions Antiplatelet-Based Only
CIBIS Cardiac Insufficiency Bisoprolol Study
CIBIS II The Cardiac Insufficiency Bisoprolol Study II
CIBIS III The Cardiac Insufficiency Bisoprolol Study III
CIDS Canadian Implantable Defibrillator Study
CIGTS Collaborative Initial Glaucoma Treatment Study
CLARIDI Cholesterol Lowering And Arrhythmias Recurrences After Internal Defibrillator Implantation
CLARITY-TIMI 28 Clopidogrel As Adjunctive Reperfusion Therapy
CLAS I AND II Cholesterol Lowering Atherosclerosis Study (I And II)
CLASS Celecoxib (Celebrex) Long-Term Arthritis Safety Study
CLASSICS Clopidogrel (Plavix) Aspirin Stent International Cooperative Study
CLASS-IHT Clomethiazole Acute Stroke Study In Ischemic, Hemorrhagic, And Tpa Treated Stroke
CLEAR PLATELETS Clopidogrel Loading With Eptifibatide To Arrest The Reactivity Of Platelets Study
CLEAR PLATELETS-2 Clopidogrel With Eptifibatide To Arrest The Reactivity Of Platelets-2
CLEERE Collaborative Longitudinal Evaluation Of Ethnicity And Refractive Error
COACH Coordinating Study Evaluating Outcomes Of Advising And Counseling In Heart Failure
COAST Heparin-Coated Stents In Small Coronary Arteries
COBALT Continuous Infusion Versus Double-Bolus Administration Of Alteplase
COCAD Cognitive Outcomes In Coronary Artery Disease
COLA Carvedilol Open Label Assessment
COLUMBUS Low Molecular Weight Heparin In The Treatment Of Patients With Venous Thromboembolism
COMBINE Combining Medications And Behavorial Interventions
COMET Carvedilol Or Metoprolol European Trial
COMMA Compliment Inhibition In Myocardial Infarction Treated With Percutaneous Transluminal Coronary Angioplasty (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv)
COMMIT/CCS-2 – Clopidogrel Randomized, Placebo-Controlled Trial Of Adding Clopidogrel To Aspirin In 46,000 Acute Myocardial Infarction Patients
COMMIT/CCS-2 – Metoprolol Randomized, Placebo-Controlled Trial Of Early Metoprolol In 46,000 Acute Myocardial Infarction Patients
COMPANION Comparison Of Medical Therapy, Pacing And Defibrillation In Chronic Heart Failure
Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenosis Randomized Clinical Trial Investigators. Randomized Comparison Of Gr-II Stent And Palmaz-Schatz Stent For Elective Treatment Of Coronary Stenosis
Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus A Comparison Of Ibuprofen And Indomethacin For Closure Of Patent Ductus Arteriosus
COMPASS Comparison Trial Of Saruplase And Streptokinase
COMPASS-HF Chronicle Offers Management To Patients With Advanced Signs And Symptoms Of Heart Failure
COMPLY Compliment Inhibition In Myocardial Infarction Treated With Thrombolytics (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv) Sponsors
COMS Collaborative Ocular Melanoma Study
CONSENSUS The Effects Of Enalapril On Mortality In Severe Congestive Heart Failure
CONSENSUS II The Effects Of The Early Administration Of Enalapril On Mortality In Patients With Acute Myocardial Infarction: Results Of The Cooperative New Scandin-2
CONVERTIBLE Conventional Stenting Versus Direct Stenting In (Un)Stable Angina Pectoris
CONVINCE Controlled Onset Verapamil Investigation Of Cardiovascular Endpoints Trial
COOL Cardiovascular Thrombolytic To Open Occluded Lines
COOL AID Cooling For Acute Ischemic Brain Damage
COOL MI Cooling As An Adjunctive Therapy To Percutaneous Intervention In Patients With Acute Myocardial Infarction
COOLRCN Cooling To Prevent Radiocontrast Nephropathy
COPERNICUS Effect Of Carvedilol On Survival In Severe Chronic Heart Failure
COPPA Clinical Outcomes From The Prevention Of Postoperative Arrhythmia
CORE International Variation In Invasive Procedures And Outcomes In Acute Myocardial Infarction
CORE Continuing Outcomes Relevant To Evista
CORONA Controlled Rosuvastatin Multinational Trial In Heart Failure
CORSICA Chronic Occlusion Revascularization With Stent Implantation Versus Coronary Angioplasty
COSS Carotid Occlusion Surgery Study
COURAGE Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation
COURT Contrast Utilization In High Risk Patients Undergoing Ptca
C-PORT Atlantic Cardiovascular Patient Outcomes Research Team Trial
CPVA for Chronic Atrial Fibrillation Circumferential Pulmonary Vein Ablation For Chronic Atrial Fibrillation
CQI in CABG Continuous Quality Improvement In Coranary Artery Bypass Graft
CRASH Corticosteroid Randomization After Significant Head Injury
CREATE Canadian Cardiac Randomized Evaluation Of Antidepressant And Psychotherapy Efficacy
CREATE ELCA - Reviparin Low Molecular Weight Heparin (Reviparin) In Preventing Mortality, Reinfarction, And Strokes In Over 15,500 Patients With St Elevation Acute Myocardial Infarction
CREATE-ECLA - GIK Impact Of Glucose-Insulin-Potassium On Mortality And Morbidity In Over 20,000 Patients With Acute Myocardial Infarction: The Create-Ecla International Trial
CREDO Clopidogrel For Reduction Of Events During Observation
CREST Cilostazol For Restenosis
CREST Carotid Revascularization Endarterectomy Vs Stenting Trial
CRIS A Controlled Trial Of Verapamil In Patients After Acute Myocardial Infarction: Results Of The Calcium, Antagonist Reinfarction Italian Study
CRUISE Can Routine Ultrasound Influence Stent Expansion
C-SIRIUS Canadian Sirolimus-Eluting Stent In Coronary Lesions
CSSS China Salt Substitute Study
CTAF Canadian Trial Of Atrial Fibrillation
CTOPP Canadian Trial Of Physiologic Pacing
CUBA Cutting Balloon Versus Conventional Angioplasty Study
CURE The Clopidogrel In Unstable Angina To Prevent Recurrent Events Trial Investigators: Effects Of Clopidogrel In Addition To Aspirin In Patients With Acute Coronary Syndromes Without St-Segment Elevation
CURE Clopidogrel In Unstable Angina To Prevent Recurrent Ischemic Events
DAIS Diabetes Atherosclerosis Intervention Study
DAISY Diabetes Autoimmunity Study In The Young
DANAMI Danish Myocardial Infarction Trial
DANAMI-2 Danish Trial In Acute Myocardial Infarction-2
DANTE Diabetes Abciximab Stent Evaluation
DAPPAF Dual Site Atrial Pacing To Prevent Atrial Fibrillation
DART Dilation Versus Ablation Revascularization Trial
DASH Dietary Approaches To Stop Hypertension
DATATOP Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism
DAVID Dual-Chamber And Vvi Implantable Defibrillator
DAVID – (Picotamide vs. Aspirin) Drug Evaluation In Atherosclerotic Vascular Disease In Diabetics
DAVID II Dual Chamber And Vvi Implantable Defibrillator II
DAVIT II Danish Study Group On Verapamil In Mi
DCCT Diabetes Control And Complications Trial
DEAR-MI Dethrombosis To Enhance Acute Reperfusion In Myocardial Infarction
DEBATE Doppler Endpoints Balloon Angioplasty Trial Europe
DEBATE II Doppler Endpoints Balloon Angioplasty Trial Europe-2
DEBUT Defibrillator Versus Beta-Blockers For Unexplained Death In Thailand
DECLARE-DIABETES Drug-Eluting Stenting Followed By Cilostazol Treatment Reduces Late Restenosis In Patients With Diabetes Mellitus
DECOPI Randomized Trial Of Occluded Artery Angioplasty After Acute Myocardial Infarction
DECOPI La Desobstruction Coronaire En Post-Infarctus
DECREASE III Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo III
DECREASE-V Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-V
DEDICATION: Distal Protection Study Drug Elution And Distal Protection In St-Elevation Myocardial Infarction
DEDICATION: Stent Study Drug Elution And Distal Protection In Acute Myocardial Infarction
DEFER Deferral Versus Performance Of Ptca In Patients Without Documented Ischemia
DEFINITE Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation
DEFUSE Diffusion-Weighted Imaging Evaluation For Understanding Stroke Evaluation
DELTA MI Direct Inhibition Of Δ-Protein Kinase C Enzyme To Limit Total Infarct Size In Acute Mi
DES-DIABETES A Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus
DESTINI-CFR Doppler Endpoints Stenting International Investigation - Coronary Flow Reserve
DETAIL Diabetics Exposed To Telmisartan And Enalapril
DIABETES A Prospective, Randomized, Controlled Trial Of The Polymer-Based, Sirolimus-Eluting Stent Versus A Bare Metal Stent In Patients With Diabetes Mellitus
DIACOR Diabetes And Combined Lipid Therapy Regimen
DIAD Detection Of Ischemia In Asymptomatic Diabetics
DIADS Depression In Alzheimer Disease Study
DIAGNOSIS Diffusion-Weighted Imaging Assessment Of The Genuine Need For Other Studies In Ischemic Stroke
DIAL Randomized Trial Of Telephone Intervention In Chronic Heart Failure
DIAMOND Danish Investigations Of Arrhythmia And Mortality On Dofetilide
DIAMOND Distensibility Improvement With Alt-711 Remodeling In Diastolic Heart Failure Sponsor
DIAMOND CHF Danish Investigators Of Arrhythmia And Mortality On Dofetilde Congestive Heart Failure
DIDI Diltiazem In Dilated Cardiomyopathy
DIG Digoxin Investigation Group
DIG Enalapril Enalapril Versus Digoxin In Patients With Congestive Heart Failure: A Multicenter Study (Canadian Enalapril Versus Digoxin Study Group)
DIGAMI Diabetes Mellitus Insulin-Glucose Infusion In Acute Myocardial Infarction
DIMT Double-Blind Placebo-Controlled Study Of Ibopamine And Digoxin In Patients With Mild To Moderate Heart Failure: Results Of The Dutch Ibopamine Multic
DINAMIT Defibrillation In Acute Myocardial Infarction Trial
DIPOM Diabetic Postoperative Mortality And Morbidity Trial
DIRECT Direct Stenting Using The Sirolimus-Eluting Stent
DIRECT Direct Myocardial Revascularization In Regeneration Of Endocardial Channels Trial
DIRECT Diabetic Retinopathy Candesartan Trial Candesartan Cilexetil (Atacand)
DIRECTOR Direct Stenting Study With Orbus R Stent
DISC Disability In Strategies For Care
DISCO Direct Coronary Stenting Versus Stenting With Balloon Predilation: Immediate And Follow-Up Results
DISTINCT Biodivysio Stent In Controlled Trial
DMIST Digital Mammographic Imaging Screening Trial
DPP Diabetes Prevention Program Trial
DPT-1 Diabetes Prevention Trial - Type 1
DREAM Diabetes Reduction Approaches With Ramipril And Rosiglitazone Medications
DREAM - Ramipril Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication
DREAM - Rosiglitazone Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication
DUCCS-1 Duke University Clinical Cardiology Study - 1
DUCCS-2 Duke University Clinical Cardiology Study - 2
DYSBOT Dysport And Botox Study
EAFT European Atrial Fibrillation Trial
EAGAR Estrogen And Graft Atherosclerosis Research Trial
EARLY Eptifibatide For Acute Coronary Syndromes—Rapid Versus Late Administration For Therapeutic Yield
EARLY Endothelin Antagonist Trial In Mildly Symptomatic Pulmonary Arterial Hypertension Patient
EARLY ACS Early Glycoprotein IIb/IIia Inhibition In Non–St-Segment Elevation Acute Coronary Syndromes
EARS European Atherosclerosis Research Study
EARTH Endothelin Receptor Antagonist Trial In Heart Failure
EASE Ezetimibe Add-On To Statin Therapy For Effectiveness Trial
EAST Emory Angioplasty Vs Surgery Trial
EASTER Estrogen And Stents To Eliminate Restenosis
EASY Early Discharge After Transradial Stenting Of Coronary Arteries
EASYAS Eastbourne Syncope Assessment Study
ECASS III European Cooperative Acute Stroke Study III
ECCE Effects Of Captopril On Cardiopulmonary Exercise Parameters (Ecce)
ECCO 2000 Effects Of Citicoline (Ceraxon) On Clinical Outcome - 2000 Mg
ECHO in PPH Echocardiographic Predictors Of Adverse Outcomes In Primary Pulmonary Hypertension.
ECLA GIK Estudios Cardiologicos Latinoamerica Glucose-Insulin-Potassium Pilot Trial
ECLIPSE Ensure's Vascular Closure Device Speeds Hemostasis Trial
ECRIS Endocoronary-Rhenium-Irradiation-Study
ECSG-1 European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator
ECSG-6 European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator II
ECSS European Coronary Surgery Study Group
ECST European Carotid Surgery Trial
EDGECAP Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Community-Acquired Pneumonia
EDGESST Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Skin And Soft Tissue Infections
EDGE Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities
EDGEUTI Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Urinary Tract Infection
ED-IMPACT Emergency Department Impedance Cardiography-Aided Assessment Changes Therapy Sponsor: Cardiodynamics International
EFICAT Ejection Fraction In Cardiac Transplant Patients
EGASIS Early Gaba-Ergic Activation Sin Troke
ELATE Extended Low-Intensity Anticoagulation For Thrombo-Embolism Investigators
ELECT Evaluating Enoxaparin (Lovenox) Clotting Times
ELITE Evaluation Of Losartan In The Elderly
ELITE-II Losartan Heart Failure Survival Study
ELLDOPA Earlier Versus Later Levodopa In Parkinson Disease
ELUTES European Evaluation Of Paclitaxel Eluting Stent
ELVD-CHF Exercise In Left Ventricular Dysfunction And Chronic Heart Failure Trial
EMERALD Enhanced Myocardial Efficacy And Removal By Aspiration Of Liberated Debris
EMERALD European And Australian Multicenter Evaluative Research On Atrial Fibrillation—Dofetilide
EMERAS Estudio Multicentrico Estreptoquinasa Republicas De America Del Sur
EMIAT European Myocardial Infarction Amiodarone Trial
EMIP Prehospital Thrombolytic Therapy In Patients With Suspected Acute Myocardial Infarction
EMIP-FR European Myocardial Infarction Project—Free Radicals
EMIT European Mivazerol Trial
EMPIRIC Comparison Of Empiric To Physician-Tailored Programming Of Implantable Cardioverter Defibrillators Trial
ENABLE Effects Of The Endothelin Receptor Antagonist Bosentan On The Morbidity And Mortality In Patients With Chronic Heart Failure
ENCOR Enrasentan Cooperative Randomized Evaluation
ENCORE I Evaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function
ENCORE II Long-Term Effect Of Nifedipine On Vasomotion And Vessel Morphology In Patients With Coronary Artery Disease: An Intravascular Ultrasound-Assisted Evaluation
ENDEAVOR II Randomized Comparison Of The Endeavor Abt-578 Drug Eluting Stent With A Bare Metal Stent For Coronary Revascularization
ENDEAVOR III Randomized Comparison Of Zotarolimus-Eluting And Sirolimus-Eluting Stents In Patients With Coronary Artery Disease-3
ENDEAVOR IV Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease-4
ENDEAVOR-1 Multicenter Evaluation Of Abt-578 Elution From A Phosphorylcholine-Coated Stent
ENHANCE Simvastatin With Or Without Ezetimibe In Familial Hypercholesterolemia
ENRICHD Enhancing Recovery In Coronary Heart Disease
ENTIRE Enoxaparin And Tnk-Tpa With Or Without Gp IIb/IIia Inhibitor As Reperfusion Strategy In St Elevation Mi (TIMI-23)
EPAMSA Estudio Piloto Argentino De Muerte Subita Y Amioda Rone (Argentine Pilot Study Of Sudden Death And Amiodarone)
EPAT Estrogen In The Prevention Of Atherosclerosis Trial
EPHESUS Eplerenone Post-Ami Heart Failure Efficacy And Survival Study
EPIC Evaluation Of C7E3 For The Prevention Of Ischemic Complications
EPILOG Evaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp IIb/IIia Receptor (Abciximab) Blockade
EPISTENT Evaluation Of Platelet IIb/IIia Inhibitor For Stenting Trial
EPOS Elective Pci In Outpatient Study
ERA Enoxaparin Restenosis (Era) Trial.
ERA Early Rheumatoid Arthritis (Ra) Enoxaparin Restenosis After Angioplasty StudyEstrogen Replacement And Atherosclerosis Study
ERA (HRT) Effect Of Estrogen Replacement On The Progression Of Coronary Artery Atherosclerosis
ERACI Estudio Randomizado Argentino De Angioplastia Vs. Cirugía (Argentine Randomized Trial Of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery In Multivessel Disease)
ERACI II Argentine Randomized Study: Coronary Angioplasty With Stenting Vs. Coronary Artery Bypass Surgery In Patients With Multiple-Vessel Disease (Eraci II): 30-Day And One Year Follow-Up Results
ERASE Emergency Room Assessment Of Sestamibi For Evaluation Of Chest Pain
ERASE Effects Of Rhdl On Atherosclerosis–Safety And Efficacy
ERASER Evaluation Of Reopro And Stenting To Eliminate Restenosis
ERBAC Excimer Laser, Rotational Atherectomy, Balloon Angioplasty Complications Study
ERGO Etomoxir For The Recovery Of Glucose Oxidation
ERICA Efficacy Of Ranolazine In Chronic Angina
ERNA Early Return To Normal Activities At Two Weeks After Acute Myocardial Infarction: Preliminary Results Of A Randomized Study
ER-TIMI Early Retavase - Thrombolysis In Myocardial Infarction
ESCAMI Evaluation Of The Safety And Cardioprotective Effects Of Eniporide In Acute Myocardial Infarction
ESCAPE Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness
ESCAPE Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness
E-SIRIUS European Sirolimus-Eluting Stent In Coronary Lesions
ESPRIT Enhanced Suppression Of The Platelet IIb/IIia Receptor With Integrilin TherapyEuropean Study Of The Prevention Of Reocclusion After Initial ThrombolysisEvaluation Of Subcutaneous Proleukin In A Randomized International Trial
ESPRIT HRT Oestrogen In The Prevention Of Reinfarction Trial
ESPS2 European Stroke Prevention Study 2
ESPS-2 European Stroke Prevention Study 2
ESSENCE Efficacy And Safety Of Subcutaneous Enoxaparin In Unstable Angina And Non-Q-Wave Mi
ESSENCE Efficacy And Safety Of Subcutaneous Enoxaparin In Non–Q-Wave Coronary Events
ESSENTIAL The Studies Of Oral Enoximone Therapy In Advanced Heart Failure
ESSENTIAL The Studies Of Oral Enoximone Therapy In Advanced Heart Failure
ESTAT European Stroke Treatment With Ancrod Trial
ESTEEM Efficacy And Safety Of The Oral Direct Thrombin Inhibitor Ximelagatran In Patients After Acute Myocardial Infarction
ESVEM Electrophysiologic Study Versus Electrocardiographic Monitoring Trial
ETHECC Evaluation Of Thymitaq In Hepatocellular Carcinoma
ETICA Exercise Training Intervention After Coronary Angioplasty: The Etica Trial
ETROP Early Treatment Of Retinopathy Of Prematurity
EURIDIS and ADONIS Maintenance Of Sinus Rhythm With Dronedarone In Patients With Atrial Fibrillation Or Flutter
EUROACTION Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme
EUROCARE Carvedilol For Prevention Of Restenosis After Directional Coronary Atherectomy
EUROPA European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease
EURO-SPAH European Sonotherapy Trial To Prevent Arterial Hyperplasia
Euro-SPAH European-Sonotherapy Prevention Of Arterial Hyperplasia
EUROSTAR European Cobalt Stent With Antiproliferative For Restenosis Trial
EUTOPIA European Trial On Olmesartan And Pravastatin In Inflammation And Atherosclerosis
EVA Common Carotid Intima-Media Thickness Predicts Occurrence Of Carotid Atherosclerotic Plaques: Longitudinal Results From The Aging Vascular Study
EVA-AMI Eptifibatide Versus Abciximab In Primary Pci For Acute St Elevation Myocardial Infarction
EVEREST Efficacy Of Vasopressin Antagonism In Heart Failure: Outcome Study With Tolvaptan
EVEREST I Endovascular Valve Edge-To-Edge Repair Study
EVET Enoxaparin Versus Tinzaparin In Non-St-Segment Elevation Acute Coronary Syndromes
EVIDENCE Evidence For Interferon Dose-Effect: European-North American Comparative Efficacy Study (Rebif V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms))
EVIDENT Endo-Vascular Investigation Determining The Safety Of A New Tacrolimus Eluting Stent Graft
EVIDENT Endovascular Investigation Determining The Safety Of A New Tacrolimus-Eluting Stent Graft
EXCITE Evaluation Of Oral Xemilofiban In Controlling Thrombotic Events
EXCITE Evaluation Of Oral Xemilofiban In Controlling Thrombotic Events
EXCITe Extremity Constraint-Induced Therapy
EXCLAIM Extended Clinical Prophylaxis In Acutely Ill Medical Patients (Lovenox (Enoxaparin) Postmarketing (Phase Iv) Trial)
EXPEDITION Na+/H+ Exchange Inhibition To Prevent Coronary Events In Acute Cardiac Conditions
EXPIRA Thrombectomy With Export Catheter In Infarct-Related Artery During Primary Percutaneous Coronary Intervention
ExTRACT Enoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction Treatment
F.I.R.E. Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
FAAT Fatty Acid Antiarrhythmia Trial
FACET Flosequinan - Ace Inhibition Trial
FACET Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial
FACIT Folate After Coronary Intervention Trial
FACT Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
FAME Fractional Flow Reserve Versus Angiography For Multivessel Evaluation
FAME Fluvastatin (Lescol) Assessment Of Morbi-Mortality In The Elderly
FAMIS Fosinopril In Acute Myocardial Infarction Study
FANTASTIC Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
FAST Femoral Artery Stenting Trial
FASTER Fibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk
FAST-MAG Field Administration Of Stroke Therapy - Magnesium
FATS Familial Atherosclerosis Treatment Study
FEMINA Addition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
FERRIC-HF Effect Of Intravenous Ferrous Sucrose On Exercise Capacity In Chronic Heart Failure
FEST Fosinopril Efficacy/Safety Trial
FIELD Fenofibrate Intervention And Event Lowering In Diabetes
FIELD Fenofibrate (Tricor) Intervention And Event Lowering In Diabetes
FINESSE Facilitated Intervention With Enhanced Reperfusion Speed To Stop Events
FIRE Filterwire Ex Randomized Evaluation
FIRST Flolan International Randomized Survival Trial (Phase IIi (Develop Economic Data))
FIRST Flolan (Dobutamine) International Randomized Survival Trial First Trimester Integrated Risk Screening For Trisomy
FLARE Fluvastatin Angioplasty Restenosis
FLARE Fluvastatin (Lescol) Angiographic Restenosis
FLORIDA Fluvastatin On Risk Diminishing After Acute Myocardial Infarction
FLUCAD Influenza Vaccination In Secondary Prevention From Coronary Ischemic Events In Coronary Artery Disease
FOOD Feed Or Ordinary Diet
FOSIT Fosamax International Trial
FRAXIS Fraxiparin Versus Unfractionated Heparin In The Treatment Of Unstable Angina
FRAXIS / FRAX.I.S. Fraxiparine In Ischemic Syndromes
FRESCO Investigators In The Florence Randomized Elective Stenting In Acute Coronary Occlusions
FRIC Fragmin In Unstable Coronary Artery Disease
FRIC Fragmin In Unstable Coronary Artery Disease
FRISC Fast Revascularization During Instability In Coronary Artery Disease
FRISC II Fragmin And Fast Revascularization During Instability In Coronary Artery Disease
FROST French Optimal Stenting Trial
FROSTY Freezor Trial Of Supraventricular Tachycardia
FTT Fibrinolytic Therapy Trialists' Collaborative Group
FUSION Fractional Flow Reserve And Ultrasound Indices For Objective Narrowing Assessment
FUSION I Follow-Up Serial Infusions Of Nesiritide Trial
FUTURE I First Use To Underscore Restenosis Reduction With Everolimus
FUTURE II Multicenter Evaluation Of The Biosbsorbable Polymer-Based Everolimus-Eluting Stent
GABI German Angioplasty Vs. Bypass Surgery Investigation
GABI-2 German Angioplasty Bypass Investigation - 2
GAMI Glucose Abnormalities In Patients With Myocardial Infarction: Prevalence, Diagnosis, And Prognostic Implications
GAMMA II Gamma II Localized Radiation Therapy To Inhibit Restenosis
GAMMA V Gamma V Localized Radiation Therapy To Inhibit Restenosis
Gamma-One Localized Intracoronary Gamma-Radiation Therapy To Inhibit The Recurrence Of Restenosis After Stenting
GART study Genotypic Antiretroviral Resistance Testing
GEMICA Morbidity And Mortality Following Early Administration Of Amiodarone In Myocardial Infarction
GEMINI Glycemic Effects In Diabetes Mellitus: Carvedilol - Metoprolol Comparison In Hypertensives Trial
GEMS 'Ginkgo Biloba 'Evaluation Memory Study
GENESIS A Randomized, Multicenter Study Of The Pimecrolimus-Eluting And Pimecrolimus/Paclitaxel-Eluting Coronary Stent System In Patients With De Novo Lesions Of The Native Coronary Arteries
GENEVA Intracoronary Beta Irradiation To Reduce Restenosis After Balloon Angioplasty
GENIUS-STEMI A Randomized Comparison Of Genous Stent Versus Chromium-Cobalt Stent For Treatment Of St-Elevation Myocardial Infarction
GenSalt Genetic Epidemiology Network Of Salt Sensitivity
GESICA Randomized Trial Of Low-Dose Amiodarone In Severe Congestive Heart Failure
GIPS Randomized Trial Of Glucose-Insulin-Potassium Infusion On 30 Day Mortality In Patients With Acute Myocardial Infarction Treated With Primary Angioplasty
GIPS II Glucose - Insulin - Potassium Study In Patients With St Elevation Myocardial Infarction Without Signs Of Heart Failure
GISEN Gruppo Italiano Di Studi Epidemiologici In Nefrologia
GISSI-1 Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-1
GISSI-2 Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-2
GISSI-3 Effects Of Lisinopril And Transdermal Glycerol Trinitrate Singly And Together On 6-Week Mortality And Ventricular Function After Ami
GISSI-HF: n-3 PUFA Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: N-3 Pufa
GISSI-HF: Rosuvastatin Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: Rosuvastatin
GOSPEL Global Secondary Prevention Strategies To Limit Event Recurrence After Myocardial Infarction
G-PAD Granulocyte-Macrophage Colony Stimulating Factor In Patients With Intermittent Claudication
GRACIA I Randomized Trial Comparing Stenting Within 24 Hours Of Thrombolysis Versus Ischemia-Guided Approach To Thrombolysed Acute Myocardial Infarction With St Elevation
GRACIA II Primary Optimal Percutaneous Coronary Intervention Versus Facilitated Intervention In Stemi Patients
GRAPE Grampian Region Early Anistreplase Trial
GUARDIAN Inhibition Of The Sodium-Hydrogen Exchanger With Cariporide To Prevent Myocardial Infarction In High-Risk Ischemic Situations: Main Results Of The Guard During Ischemia Against Necrosis (Guardian) Trial
GUSTO Global Utilization Of Streptokinase And Tpa For Occluded Arteries
GUSTO IIB Global Utilization Of Streptokinase And Tpa For Occluded Arteries IIb
GUSTO V The Gusto V Randomised Trial
GUSTO-3 Global Utilization Of Streptokinase And Tpa For Occluded Arteries-III
GUSTO-SPEED Global Utilization Of Streptokinase And Tpa For Occluded Arteries–Strategies For Patency Enhancement In The Emergency Department
HAAMU-STENT Helsinki Area Acute Myocardial Infarction Treatment Re-Evaluation - Should The Patients Get A Drug-Eluting Or Normal Stent
HACA Mild Therapeuric Hypothermia To Improve The Neurologic Outcome After Cardiac Arrest
HAEST Heparin In Acute Embolic Stroke Trial
HALT-C Hepatitis C Antiviral Long-Term Treatment To Prevent Cirrhosis
HALT-MI Hu23F2G Anti-Adhesion To Limit Cytotoxic Injury Following Ami
HANDLS Health Aging In Nationally Diverse Longitudinal Samples
HANE Randomized, Double-Blind Multicenter Comparison Of Hydrochlorothiazide, Atenolol, Nitrendipine, And Enalapril In Antihypertensive Treatment
HARDBALL Heart Allograft Rejection: Detection With Breath Alkanes In Low Level
HARDBALL Heart Allograft Rejection: Detection With Breath Alkanes In Low Levels
HARP Harvard Atherosclerosis Reversibility Project
HART Heparin-Aspirin Reperfusion Trial
HART II Randomized Comparison Of Enoxaparin, A Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive To Recombinant Tissue Plasminogen Activator Thrombolysis And Aspirin: Second Trial Of Heparin And Aspirin Reperfusion Therapy
HAT Home Automatic External Defibrillator Trial
HAT 1 Heparin-Associated Thrombocytopenia 1
HAT 2 Heparin-Associated Thrombocytopenia 2
HATS Hdl-Atherosclerosis Treatment Study
HDFP Hypertension Detection And Follow-Up Program
HDOM Heart Disease On The Mend
HeADDFIRST Hemicraniectomy And Durotomy For Deterioration From Infarction Relating Swelling Trial
HEART Healing And Early Afterload Reducing Therapy Trial
HEART Healing And Early Afterload Reducing Therapy
HEAT 2 Hypertension Endothelin Antagonist Treatment
Heidelberg Heidelberg Trial
HELAS Antithrombotic Therapy In Heart Failure: A Randomized Comparison Of Warfarin Vs. Aspirin
HELAS Antithrombotic Therapy In Heart Failure: A Randomized Comparison Of Warfarin Vs. Aspirin
Helsinki Heart Study Helsinski Heart Study
Helsinki Heart Study Helsinski Heart Study
HEME Hemorrhage Early Mri Evaluation
HERO Hirulog Early Reperfusion/Occlusion Trial
HERO Hirulog Early Reperfusion/Occlusion Trial
HERO-2 Hirulog And Early Reperfusion Or Occlusion Trial
HERS Heart And Estrogen/Progestin Replacement Study
HERS Heart And Estrogen/Progestin Replacement Study Hiv Epidemiology Research Study
HESTIA Home Evaluation Of Stroke Induced Aid
HF-ACTION Heart Failure–A Randomized Controlled Trial Investigating Outcomes Of Exercise Training
HF-ACTION Substudy Effect Of Exercise Training On Health-Related Quality Of Life In Patients With Chronic Heart Failure
HHH Home Or Hospital Heart Failure
HIJ-CREATE Heart Institute Of Japan Candesartan Randomized Trial For Evaluation In Coronary Artery Disease
HIPS Heparin Infusion Prior To Stenting
HIT Hdl-Cholesterol Intervention Trial Hirudin For The Improvement Of Thrombolysis
HIT-I Hirudin For The Improvement Of Thrombolysis
HIT-III Hirudin For Improvement Of Thrombolysis
HOME Hyperinsulinemia: The Outcome Of Its Metabolic Effects
HOPE Heart Outcomes Prevention Evaluation
HOPE The Heart Outcomes Prevention Evaluation Study
HOPE-2 Heart Outcomes Prevention Evaluation
HOPE-TOO Heart Outcomes Prevention Evaluation - The Ongoing Outcomes
HORIZON Health Outcomes And Reduced Incidence With Zoledronic Once Yearly
HORIZONS-AMI Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
HORIZONS-AMI Stent Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
HOS Hypertension-Obesity-Sibutramine
HOT Hypertension Optimal Treatment Study
HOT Hypertension Optimum Treatment
HPS Medical Research Council/British Heart Foundation Heart Protection Study
HPS Heart Protection Study
HRS Health And Retirement Study
Hy-C The Hydralazine Captopril Trial
HYVET Hypertension In The Very Elderly Trial
HYVET Hypertension In The Very Elderly Trial
IBIS-2 Integrated Biomarker And Imaging Study-2
ICE-IT Intravascular Cooling Adjunctive To Primary Coronary Intervention
ICON Ionic Versus Nonionic Contrast To Obviate Worsening Nephropathy After Angioplasty In Chronic Renal Failure Patients
ICSS International Carotid Stenting Study (Cavatas-2)
ICTUS Invasive Versus Conservative Treatment In Unstable Coronary Syndromes
IDEAL Incremental Decrease In Clinical Endpoints Through Aggressive Lipid Lowering
IDEAL Incremental Decrease In Endpoints Through Aggressive Lipid Lowering Iressa Dose Evaluation In Advanced Lung Cancer
IDNT Irbesartan Diabetic Nephropathy Trial
IDNT Irbesartan In Diabetic Nephropathy Trial
IHAST Intraoperative Hypothermia For Aneurysm Surgery Trial
ILLUMINATE Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events
ILLUSTRATE Investigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation
IMAGES Intravenous Magnesium Efficacy In Stroke
IMAGINE Ischemia Management With Accupril Post-Bypass Graft Via Inhibition Of The Converting Enzyme
IMAGINE Ischemic Management With Accupril Post Bypass Graft Via Inhibition Of Converting Enzyme
IMPACT Integrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial
IMPACT II Integrilin To Minimise Platelet Aggregation And Coronary Thrombus - II
IMPACT-HF Initiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
IMPRESS Immunosuppressive Therapy For The Prevention Of Restenosis After Coronary Artery Stent Implantation
IMPRESS Inhibition Of Metalloprotease By Bms-186716 In A Randomized Exercise And Symptoms Study
IMPROVE-CHF Improved Management Of Patients With Congestive Heart Failure
IMS Interventional Management Of Stroke Study
IN-CHF Italian Network - Congestive Heart Failure
INCOMIN Independent Comparison Of Interferon (Betaseron V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms)
InDDEx Investigation Into Delay To Diagnosis Of Alzheimer Disease With Exelon
INHIBIT Intimal Hyperplasia Inhibition With Beta In-Stent Trial
INHIBIT Intimal Hyperplasia Inhibition With Beta In-Stent Trial
INJECT International Joint Efficacy Comparison Of Thrombolytics
INSIGHT International Nifedipine Gits Study: Intervention As A Goal In Hypertension Treatment
INSIGHT International Nifedipine Once-Daily Study – Intervention As A Goal In Hypertension Treatment
INSPIRE Adenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial
INSYNC Multisite Pacing As A Supplemental Treatment Of Congestive Heart Failure: The Medtronic Inc. Insync Study
INTACT Iressa Non–Small Cell Lung Cancer Trial Assessing Combination Treatment
INTAMI Integrilin In Acute Myocardial Infarction
INTEGRITI Integrilin And Tenecteplase In Acute Myocardial Infarction
INTEGRITI Integrilin And Tenecteplase In Acute Myocardial Infarction
INTERACT Integrilin And Enoxaparin Randomized Assessment Of Acute Coronary Syndrome Treatment
INTERCEPT Incomplete Infarction Trial Of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem)
INTERHEART A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
InTIME Intravenous Npa For Treatment Of Infarcting Myocardium Early
InTime-2 Intravenous Npa For Treatment Of Infarcting Myocardium Early
INTrEPID Investigation Of Non–Transplant-Eligible Patients Who Are Inotrope Dependent See
INTRINSIC RV Inhibition Of Unnecessary Rv Pacing With Av Search Hysteresis In Icds
INTRO-AMI Integrilin And Reduced Dose Of Thrombolytic In Acute Myocardial Infarction
INVEST International Verapamil-Trandolapril Study
IONA Effect Of Nicorandil On Coronary Events In Patients With Stable
IONA Impact Of Nicorandil In Angina
IONDT Ischemic Optic Neuropathy Decompression Trial
I-PRESERVE Rbesartan In Heart Failure With Preserved Ejection Fraction Study
IRAS Insulin Resistance Atherosclerosis Study
IRIS Isostent For Restenosis Intervention Study
IRIS Isostent For Restenosis Intervention Study
IRMA 2 Irbesartan In Type 2 Diabetes With Microalbuminuria 2
IRMA 2 Irbesartan (Avapro) Microalbuminuria Type 2
ISAAC International Study Of Asthma And Allergies In Childhood
ISAM Intravenous Streptokinase In Acute Myocardial Infarction
ISAR Intracoronary Stenting And Antithrombotic Regimen Trial
ISAR Individualizable Drug-Eluting Stent System To Abrogate Restenosis Project
ISAR Intracoronary Stenting And Antithrombotic Regimen
ISAR DIABETES Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease
ISAR REACT Intracoronary Stenting And Antithrombotic Regimen Rapid Early Action For Coronary Treatment
ISAR-CHOICE Intracoronary Stenting And Antithrombotic Regimen: Choose Between 3 High Oral Doses For Immediate Clopidogrel Effect
ISAR-COOL Intracoronary Stenting With Antithrombotic Regimen Cooling-Off
ISAR-DESIRE Drug-Eluting Stents For In-Stent Restenosis
ISAR-LEFT MAIN Intracoronary Stenting And Angiographic Results: Drug-Eluting Stents For Unprotected Coronary Left Main Lesions
ISAR-PEACE Intracoronary Stenting And Angiographic Restenosis: Promote Endothelial Cells With Estradiol
ISAR-REACT 2 Intracoronary Stenting And Antithrombotic Regimen: Rapid Early Action For Coronary Treatment
ISAR-REACT 3 Bivalirudin Versus Unfractionated Heparin During Percutaneous Coronary Intervention
ISAR-SHOCK Impella Lp2.5 Vs. Iabp In Cardiogenic Shock
ISAR-STEREO Intracoronary Stenting And Angiographic Results: Strut Thickness Effect On Restenosis Outcomes (Isar-Stereo) Trial
ISAR-STEREO Intracoronary Stenting And Angiographic Results - Strut Thickness Effect On Restenosis Outcome
ISAR-STEREO - 2 Intracoronary Stenting And Angiographic Results - Strut Thicness Effect On Restenosis Outcome Trial - 2
ISAR-SWEET Is Abciximab A Superior Way To Eliminate Elevated Thrombotic Risk In Diabetics
ISAR-TEST Randomized Trial Of The Yukon Nonpolymer-Based Rapamycin-Coated Stent And The Polymer-Based Paclitaxel-Eluting Stent In Patients With Coronary Artery Disease
ISAR-TEST-2 Intracoronary Stenting And Angiographic Results–Test Efficacy Of 3 Limus-Eluting Stents
ISAR-TEST-3 Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies
ISAT International Subarachnoid Aneurysm Trial
ISIS-1 First International Study Of Infarct Survival
ISIS-2 International Study Of Infarct Survival-2
ISIS-3 International Study Of Infarct Survival-3
ISIS-4 Fourth International Study Of Infarct Survival
IST The International Stroke Trial
ISTICH International Surgical Trial In Intracerebral Hemorrhage
ITALICS Investigation By The Thoraxcenter On Antisense Dna Using Local Delivery And Ivus After Coronary Stenting
ITT Intraventricular Thrombolysis Trial
IVAT Intermediate Sized Vessel Atherectomy Trial
JAMIS Effects Of Aspirin And Trapidil On Cardiovascular Events After Acute Myocardial Infarction
JELIS Japan Epa Lipid Intervention Study
JPAD Japanese Primary Prevention Of Atherosclerosis With Aspirin For Diabetes
JSAP Japanese Stable Angina Pectoris Study
JUMBO-TIMI 26 Joint Utilisation Of Medications To Block Platelets Optimally
JUPITER Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
J-WIND Japan Working Groups Of Acute Myocardial Infarction For The Reduction Of Necrotic Damage By Atrial Natriuretic Peptide Or Nicorandil
KAT II Kuopio Angiogenesis Trial
LACI Laser Angioplasty For Critical Ischemia
LADIP Loire-Ardèche-Drôme-Isère-Puy-De-Dôme
LAMP Locally Advanced Multimodality Protoco
LARS Laser Angioplasty In Restenosed Stents
LATE Late Assessment Of Thrombolytic Efficacy Study
LAVA Prospective, Randomized, Multicenter Comparison Of Laser-Facilitated Balloon Angioplasty Versus Stand-Alone Balloon Angioplasty In Patients With Obstructive Coronary Artery Disease
L-CAD Lipid-Coronary Artery Disease (Pravastatin)
LCAS The Lipoprotein And Coronary Atherosclerosis Study (Lcas): Lipid And Metabolic Factors Related To Atheroma And Clinical Events
LEADER Lower Extremity Arterial Disease Event Reduction Trial
LEADERS Limus Eluted From A Durable Vs Erodable Stent Coating
LHT Lifestyle Heart Trial
LIDO Levosimendan Infusion Versus Dobutamine
LIFE Losartan Intervention For Endpoint Reduction In Hypertension (Life) Study
LIMB Limbs International Medical Buflomedil Trial
LIMIT AMI Limitation Of Myocardial Infarction Following Thrombolysis In Acute
LIMIT-2 Second Leicester Magnesium Intervention Trial
LIPID Long-Term Intervention With Pravastatin In Ischemic Disease Trial
LIPS Lescol Intervention Prevention Study
LISA Lescol In Severe Atherosclerosis Trial
LOCAT Prevention Of The Angiographic Progression Of Coronary And Vein-Graft Atherosclerosis By Gemfibrozil After Coronary Bypass Surgery In Men With Low Levels Of Hdl Cholesterol
LONG DES II Randomized Comparison Of The Efficacy Of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent In The Treatment Of Long Native Coronary Lesions
LONG-DES Multicenter Prospective Nonrandomized Registry Study For Drug-Eluting Stents In Very Long Coronary Lesions (Cypher Vs Taxus)
LRC-CPPT Lipid Research Clinics Coronary Primary Prevention Trial
MACH-1 Mortality Assessment In Congestive Heart Failure Trial
MADIT Multicenter Automatic Defibrillator Implantation Trial
MADIT-II Multicenter Automatic Defibrillator Implantation Trial II
MAGIC Magnesium In Coronaries
MAGIC Myoblast Autologous Grafting In Ischemic Cardiomyopathy
MAGIC – Presented at AHA 2006 Myoblast Autologous Grafting In Ischemic Cardiomyopathy
Male Health Male Health Professionals Study
MAPPET-3 Management Strategies And Prognosis Of Pulmonary Embolism-3 Trial
MARS The Monitored Atherosclerosis Regression Study
MASCOT Management Of Atrial Fibrillation Suppression In Af-Hf Comorbidity Therapy
MASS The Medicine, Angioplasty Or Surgery Study
MASS The Multicenter Aneurysm Screening Study (Mass) Into The Effect Of Abdominal Aortic Aneurysm Screening On Mortality In Men: A Randomized Controlled Trial
MASS-II Second Medicine, Angioplasty, Or Surgery Study
MAST-E Thrombolytic Therapy With Streptokinase In Acute Ischemic Stroke
MASTER Microvolt T Wave Alternans Testing For Risk Stratification Of Post-Myocardial Infarction Patients
MATCH Management Of Atherothrombosis With Clopidogrel In High-Risk Patients
MATE Medicine Versus Angiography In Thrombolytic Exclusion Trial
MATH Endocrine And Renal Effects Of Nifedipine Gastrointestinal Theraputic System In Patients With Essential Hypertension: Results Of A Multicenter Trial
Matisse Subcutaneous Fondaparinux Versus Intravenous Unfractionated Heparin In The Initial Treatment Of Pulmonary Embolism
MATTIS Randomized Evaluation Of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation In High-Risk Patients: The Multicenter Aspirin And Ticlopidine Trial After Intracoronary Stenting
MAVErIC II 30-Day Results From A Prospective Registry Of Carotid Stenting With The Exponent Stent And Distal Protection With The Guardwire In High Risk Patients
MaVS Metoprolol After Vascular Surgery
MDC Metoprolol In Dilated Cardiomyopathy Trial
MDPIT The Multicenter Diltiazem Post Infarction Trial
MDRD Modification Of Diet In Renal Disease Study
MEDAL Program Multinational Etoricoxib And Diclofenac Arthritis Long-Term Study Program
MEDENOX Prophylaxis In Medical Patients With Enoxaparin
MEGA Management Of Elevated Cholesterol In The Primary Prevention Group Of Adult Japanese
MEND-CABG II Mc-1 To Eliminate Necrosis And Damage In Coronary Artery Bypass Graft Surgery II — Presented At Scai-Acc I2 Summit/Acc 2008
MERIT-HF Metoprolol Cr/Xl Randomized Intervention Trial In Congestive Heart Failure
MERLIN Middlesbrough Early Revascularization To Limit Infarction
MERLIN-TIMI 36 Metabolic Efficiency With Ranolazine For Less Ischemia In Nste-Acs
METAFER Use Of Metoprolol To Maintain Sinus Rhythm After Conversion From Persistent Atrial Fibrillation
METEOR Measuring Effects On Intima-Media Thickness: An Evaluation Of Rosuvastatin
MEXIS The Effects Of B-Receptor Antagonists In Patients With Clinical Evidence Of Heart Failure After Myocardial Infarction: Double Blind Comparison Of Meto
M-HART Montreal Heart Attack Readjustment Trial
MHFT Munich Mild Heart Failure Trial
MIAMI Metoprolol In Acute Myocardial Infarction
MICRO-HOPE Microalbuminuria, Cardiovascular, And Renal Outcomes - Heart Outcomes Prevention Evaluation
MILIS Multiple Center Investigation Of The Limit Of Infarction
MINT A Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
MIRACL Effects Of Atorvastatin On Early Recurrent Ischemic Events In Acute Coronary Syndromes. The Miracl Study: A Randomized Controlled Trial
MIRACLE ICD Multicenter Insync Implantable Cardioversion Defibrillation Randomized Clinical Evaluation
MIST Migraine Intervention With Starflex Technology
MITI I Myocardial Infarction Triage And Intervention Project--Phase I
MITI II Myocardial Infarction Triage And Intervention Project--Phase I
MITRA Maximal Individual Therapy In Acute Myocardial Infarction
MOMENTUM Multicenter Trial Of The Orqis Medical Cancion System For The Enhanced Treatment Of Heart Failure Unresponsive To Medical Therapy
MONICA Monitoring Trends And Determinants In Cardiovascular Disease
MOST Mode Selection Trial (Most) In Sinus Node Dysfunction
MOXCON Excess Mortality In Chf Patients Treated With Sr Moxonidine Leads To Study Termination: Results Of The Sr Moxonidine For Congestive Heart Failure Trial
M-PATHY Multicenter Pacing Therapy
MPIP Multicenter Post-Infarction Program
MR PCI Multicenter Registry Of High-Risk Percutaneous Coronary Intervention And Adequate Platelet Inhibition
MRFIT Multiple Risk Factor Intervention Trial
MUSIC Multicenter Ultrasound Guided Stent Implantation In The Coronaries
MUST-EECP Multicenter Enhanced External Counterpulsation
MUSTIC Multisite Stimulation In Cardiomyopathies Study
MUSTT Multicenter Unsustained Tachycardia Trial
MVP Multivitamins And Probucol Study
NAMIS Nifedipine Angina Myocardial Infarction Study
NAPA Nesiritide Administered Peri-Anesthesia In Patients Undergoing Cardiac Surgery
NAPLES II Novel Approaches For Preventing Or Limiting Events II
NASCET North American Symptomatic Carotid Endarterectomy Trial
NEPHRIC Nephrotoxicity In High-Risk Patients Study Of Isoosmolar And Low-Osmolar Non-Ionic Contrast Media Study
NETWORK Clinical Outcome With Enalapril In Symptomatic Chronic Heart Failure: A Dose Comparison
NHANES III Third National Health And Nutrition Examination Survey
NHLBI The National Heart, Lung And Blood Institute Type II Coronary Intervention Study
NHLBI Dynamic Nhlbi Dynamic Registry Of Percutaneous Interventions: A Comparison To The 1985-86 Registry
NICE Nitrates In Congestive Heart Failure (Nice) Study
NICE-SUGAR Normoglycemia In Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation
NICOLE Nisoldipine For Coronary Artery Disease In Leuven
NICS-EH National Intervention Cooperative Study In Elderly Hypertensives
NO-PAIN Nitric Oxide In Peripheral Arterial Insufficiency
NORDIL Nordic Diltiazem Study
NORVIT Norwegian Vitamin Trial
Norwegian Nifedipine Norwegian Nifedipine Multi-Center Trial
NRMI-2 National Registry Of Myocardial Infarction (Second Phase)
NUT-2 Efficacy Assessment Of Meloxicam, A Preferential Cyclooxygenase-2 Inhibitor, In Acute Coronary Syndromes Without St-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs In Unstable Angina Treatment-2 (Nut-2) Pilot Study
OARS Optimal Atherectomy Restenosis Study
OASIS-1 Organization To Assess Strategies For Ischemic Syndromes
OASIS-2 Effects Of Long-Term, Moderate-Intensity Oral Anticoagulation In Addition To Aspirin In Unstable Angina
OASIS-6 Organization For The Assessment Of Strategies For Ischemic Syndromes 6
OASIS-6 – GIK Oasis-6 – Glucose-Insulin-Potassium
OAT Occluded Artery Trial
OCBAS Optimal Coronary Balloon Angioplasty With Provisional Stenting Vs. Stent Trial
OCLA Omeprazole Clopidogrel Aspirin
ODESSA Optical Coherence Tomography For Des Safety
ODIXa-DVT Oral Direct Factor Xa Inhibitor Bay 59-7939 In Patients With Acute Symptomatic Deep-Vein Thrombosis
ODIXa-HIP Oral, Direct Factor Xa Inhibitor, Bay 59-7939, Given Once Daily In Patients Undergoing Total Hip Replacement
OMEGA Randomized Trial Of Omega-3 Fatty Acids On Top Of Modern Therapy After Acute Myocardial Infarction
ONTARGET Ongoing Telmisartan Alone And In Combination With Ramipril Global Endpoint Trial
ON-TIME Ongoing Tirofiban In Myocardial Infarction Evaluation Trial
On-TIME 2 Ongoing Tirofiban In Myocardial Infarction Evaluation 2 Trial
OPALS Ontario Prehospital Advanced Life Support
OPT-CHF Oxypurinol Compared With Placebo For Class III-Iv Nyha Congestive Heart Failure
OPTIC Optimal Pharmacological Therapy In Cardioverter Defibrillator Patients Trial
OPTIMAAL Effects Of Losartan And Captopril On Mortality And Morbidity In High-Risk Patients After Acute Myocardial Infarction
OPTIME-CHF Outcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations Of Chronic Heart Failure
OPTIMIZE Effect Of Image Optimization With Contrast On The Diagnostic Accuracy Of Dobutamine Echocardiography In Coronary Artery Disease
OPUS Optimal Angioplasty Versus Primary Stenting
ORAR II Oral Treatment Of Restenosis
ORBIT Oral Glycoprotein IIb/IIia Receptor Blockade To Inhibit Thrombosis
OSIRIS Oral Sirolimus To Inhibit Recurrent In-Stent Stenosis
OVERTURE Omapatrilat Versus Enalapril Randomized Trial Of Utility In Reducing Events
PABA CHF Pulmonary Vein Antrum Isolation Vs. Av Node Ablation With Biventricular Pacing For Treatment Of Atrial Fibrillation In Patients With Congestive Heart Failure
PACCOCATH ISR Treatment Of In-Stent Restenosis By Paclitaxel Coated Ptca Balloons
PACE Prevention By Low Dose Aspirin Of Cardiovascular Disease In The Elderly
PACIFIC Percutaneous Transmyocardial Laser Revascularization For Severe Angina: The Pacific Randomized Trial
PACT Plasminogen Activator-Angioplasty Compatibility Trial
PACT (Pravastatin) Pravastatin In Acute Coronary Treatment
PAD Public Access Defibrillation Trial
PAMI The Primary Angioplasty In Myocardial Infarction Study
PAMI-stent The Primary Angioplasty In Myocardial Infarction Study
PAPABEAR Prophylactic Amiodarone For The Prevention Of Arrhythmias That Begin Early After Revascularization, Valvular Repair Or Replacement
PARAGON Delaying And Preventing Ischemic Events In Patient With Acute Coronary Syndromes Using The Platelet Gp IIb/IIia Inhibitor Lamifiban
PARAGON B Platelet IIb/IIia Antagonist For The Reduction Of Acute Coronary Syndrome Events In A Global Organization Network
PARIS Effect Of Ace Inhibitors On Angiographic Restenosis After Coronary Stenting (Paris): A Randomised, Double-Blind, Placebo-Controlled Trial
PASE Pacemaker Selection In The Elderly
PASE(QOL) Quality Of Life And Clinical Outcomes In Elderly Patients Treated With Ventricular Pacing As Compared With Dual-Chamber Pacing
PASSION Paclitaxel Eluting Stent Versus Conventional Stent In St-Segment Elevation Myocardial Infarction
PATAF Primary Prevention Of Arterial Thromboembolism In Non-Rheumatic Atrial Fibrillation In Primary Care: Randomised Controlled Trial Comparing Two Intensities Of Coumarin With Aspirin
PATCH Program To Assess Alternative Treatment Strategies To Achieve Cardiac Health
PATH-CHF The Pacing Therapies For Congestive Heart Failure (Path-Chf) Study
PAVE Biventricular Pacing After Ablate Compared With Right Ventricular Therapy
PCI CLARITY Clopidogrel As Adjunctive Reperfusion Therapy: Percutaneous Coronary Intervention Subgroup Study
PCI-CURE Effects Of Pretreatment With Clopidogrel And Aspirin Followed By Long-Term Therapy In Patients Undergoing Percutaneous Coronary Intervention: The Pci-Cure Study
PCI-ExTRACT-TIMI 25 Percutaneous Coronary Intervention Among Patients Treated With Enoxaparin Versus Unfractionated Heparin Following Fibrinolytic Administration For St-Elevation Mi
PC-Trial Physical Counterpressure Manoeuvre Trial
PEACE Platelet Activity Extinction In Non–Q-Wave Myocardial Infarction With Aspirin, Clopidogrel, And Eptifibatide
PEACE Prevention Of Events With Angiotensin-Converting Enzyme Inhibition Trial
PEECH Prospective Evaluation Of Enhanced External Counterpulsation In Congestive Heart Failure
PENTUA Pentasaccharide In Unstable Angina
PEP Pulmonary Embolism Prevention Trial
PEPAF Experimental Program For Physical Activity Promotion
PEP-CHF Perindopril For Elderly People With Chronic Heart Failure
PEPI Postmenopausal Estrogen/Progestin Interventions
PERISCOPE Pioglitazone Effect On Regression Of Intravascular Sonographic Coronary Obstruction Prospective Evaluation
PERM Prospective Evaluation Of Reperfusion Markers
PERSUADE Perindopril Substudy In Coronary Artery Disease And Diabetes: The Diabetic Substudy Of Europa
Perth Perth Community Stroke Study
PERTINENT Perindopril, Thrombosis, Inflammation, Endothelial Dysfunction, And Neurohormonal Activation Trial, A Subanalysis Of Europa
PHS II Physicians' Health Study II
PIAF Rhythm Or Rate Control In Atrial Fibrillation-Pharmacological Intervention In Atrial Fibrillation (Piaf): A Randomised Trial
PICTURE Post-Intracoronary Treatment Ultrasound Result Evaluation
PIHRATE Polish-Italian-Hungarian Randomized Thrombectomy Trial
PIONEER Proactive, Prospective Pioglitazone Clinical Trial In Macrovascular Events
PIOPED Prospective Investigation Of Pulmonary Embolism Diagnosis Study
PLAC-II Pravastatin, Lipids, And Atherosclerosis In The Carotid Arteries II
PLASMA Phospholipase Levels And Serological Markers Of Atherosclerosis
POISE Perioperative Ischemic Evaluation
POSCH Program On The Surgical Control Of The Hyperlipidemias
POST Prevention Of Syncope Trial
Post CABG Post Coronary Artery Bypass Graft Trial
POZNAN Percutaneous Transvenous Transplantation Of Autologous Myoblasts In The Treatment Of Postinfarction Heart Failure
PPAR Study Peroxisome Proliferator–Activated Receptor Study
PPP Primary Prevention Project
PQRST Probucol Quantitative Regression Swedish Trial
PRACTICAL Comparison Of Enalapril Versus Captopril On Left Ventricular Function And Survival Three Months After Acute Myocardial Infarction
PRAGUE Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis
PRAGUE-8 Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis-8
PRAISE Prospective Randomized Amlopidine Survival Evaluation
PRAISE-1 Prospective Randomized Amlodipine Survival Evaluation-1
PRAISE-2 Prospective Randomized Amlodipine Survival Evaluation-2
PREAMI Perindopril Remodeling In Elderly With Acute Myocardial Infarction
PRECISE Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
PREDICT Effect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty
PREMIAR Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
PREMIER Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
PREPAIR Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
PREPARE — Presented at TCT 2008 Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
PREPIC A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
Pre-RELAX-AHF Preliminary Study Of Relaxin In Acute Heart Failure
PRESENT Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
PRESERVE Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
PRESTO Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
PREVEND IT Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
PREVENT Prospective Randomized Evaluation Of The Vascular Effects Of Norvasc Trial
PREVENT (Dalteparin) Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
PREVENT (Warfarin) Prevention Of Recurrent Venous Thromboembolism
PREVENT II The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
PREVENT IV Project Of Ex-Vivo Vein Graft Engineering Via Transfection
PREVENT(Radiation) Proliferation Reduction With Vascular Energy Trial
PRIDE A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
PRIMA — Presented at ACC.09/i2 Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
PRIME-2 Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
PRIMI Pro-Urokinase For Myocardial Infarction
PRIMO-CABG Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
PRIMO-CABG II Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
PRINCE Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
PRINCESS Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
PRINCIPLE-TIMI 44 The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
PRISM Platelet-Receptor Inhibition For Ischemic Syndrome Management
PRISM-PLUS Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
PRISM-Troponin Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
PRISON II Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
PROactive Prospective Pioglitazone Clinical Trial In Macrovascular Events
PROCAM Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
PRoFESS Prevention Regimen For Effectively Avoiding Second Strokes
PROFILE Prospective Randomized Flosequinan Longevity Evaluation
PROGRESS Perindopril Protection Against Recurrent Stroke Study
PROGRESS-1 Coronary Stenting With Absorbable Metal Stents
PROMISE Protection Devices In Pci-Treatment Of Myocardial Infarction For Salvage Of Endangered Myocardium Study
PROMISE The Effects Of Oral Milrinone On Mortality In Severe Chronic Heart Failure
PROSPER Prospective Study Of Pravastatin In The Elderly At Risk
PROTECT - TIMI 30 Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
PROTECT AF Randomized Prospective Trial Of Percutaneous Left Atrial Appendage Closure Versus Warfarin For Stroke Prevention In Atrial Fibrillation
PROTECT-CAD Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
PROVE IT/TIMI 22 Pravastatin Or Atorvastatin Evaluation And Infection Therapy: Thrombolysis In Myocardial Infarction 22
PROVE IT-TIMI 22 (Gatifloxacin) Pravastatin Or Atorvastatin Evaluation And Infection Therapy
PROVED Randomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved
PROVIDENCE 1 Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients
PROXIMAL Proximal Protection During Saphenous Vein Graft Intervention
PURSUIT Platelet Glycoprotein IIb/IIia In Unstable Angina:Receptor Suppression Using Integrilin Therapy
QUASAR Quinapril Anti-Ischemia And Symptoms Of Angina Reduction
QUIET Quinapril Ischemic Event Trial
R3 Reopro Readministration Registry
RAAMI Randomized Angiographic Trial Of Recombinant Tissue-Type Plasminogen Activator (Alteplase) In Myocardial Infarction
RABBIT II Randomized Angioplasty Beta Blocker Intracoronary Trial II
RACE Rate Control Versus Electrical Cardioversion For Persistent Atrial Fibrillation
RACS Randomized Argentine Clopidogrel Stent Trial
RACTS A Prospective, Randomized Multicenter Trial Of Cilostozal Vs Ticlopidine In Patients Undergoing Stent Implantation
RADIANCE Withdrawal Of Digoxin From Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibitors
RADIANCE 1 Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor
RADIANCE 2 Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor - 2
RALES Randomized Aldactone Evaluation Study
RaMI Prehospital Thrombolysis In Rural Emergency Room And Subsequent Transport To A Coronary Care Unit: Ravenna Myocardial Infarction (Rami) Trial
RAPID-1 Recombinant Plasminogen Activator Angiographic Phase II International Dose-Finding Study
RAPID-2 Reteplase Vs Alteplase Patency Investigation During Myocardial Infarction
RAPPORT Reopro And Primary Ptca Organization And Randomized Trial
RAPS Radial Artery Patency Study
RAPT Ridogrel Versus Aspirin Patency Trial
RAVE Regional Angiogenesis With Vascular Endothelial Growth Factor In Peripheral Arterial Disease
RAVEL A Randomized Comparison Of A Sirolimus-Eluting Stent With A Standard Stent For Coronary Revascularization
REACH Reinforcing Education About Cholesterol
REACH Registry Reduction Of Atherothrombosis For Continued Health Registry
REACT Rescue Angioplasty Versus Conservative Therapy Or Repeat Thrombolysis Trial
REACT Rapid Early Action For Coronary Treatment
REALITY Prospective Randomized Multi-Center Head-To-Head Comparison Of The Sirolimus-Eluting Stent (Cypher) And The Paclitaxel-Eluting Stent (Taxus
RECORD Rosiglitazone Evaluated For Cardiovascular Outcomes — An Interim Analysis
RECORD1 Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 1
RECORD2 Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 2
RECORD3 Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 3
RECOVER Renal Toxicity Evaluation And Comparison Between Visipaque And Hexabrix In Patients With Renal Insufficiency Undergoing Coronary Angiography
RECOVERS Randomized Evaluation Of Polytetrafluoroethylene-Covered Stent In Saphenous Vein Grafts
REDHOT Rapid Emergency Department Heart Failure Outpatient Trial
RED-LIP Trial Of Pravastatin In Primary Isolated Hypercholesterolemia
REDUCE Low Molecular Weight Heparin (Reviparin) In Percutaneous Transluminal Coronary Angioplasty
REDUCE III A Prospective, Randomized Multicenter Trial Of Cutting Balloon Before Stenting In Patients Undergoing Pci
REFLECT Double-Blind, Placebo-Controlled Study Of The Efficacy Of Flosequinan In Patients With Chronic Heart Failure
REGENT Myocardial Regeneration By Intracoronary Infusion Of Selected Population Of Stem Cells In Acute Myocardial Infarction
REGICOR Improvement In Survival After Myocardial Infarction Between 1978-85 And 1986-88 In The Regicor Study
REGRESS Effects Of Lipid Lowering By Pravastatin On Progression And Regression Of Coronary Artery Disease In Symptomatic Men With Normal To Moderately Elevated Serum Cholesterol Levels. The Regression Growth Evaluation Statin Study (Regress)
RELAx-AMI Randomized Early Versus Late Abciximab In Acute Myocardial Infarction Treated With Primary Coronary Intervention
RELOAD Reload With Clopidogrel Before Coronary Angioplasty In Subjects Treated Long Term With Dual Antiplatelet Therapy
REMATCH Randomized Evaluation Of Mechanical Assistance For The Treatment Of Congestive Heart Failure
REMEDIA Randomized Evaluation Of The Effect Of Mechanical Reduction Of Distal Embolization By Thrombus-Aspiration In Primary And Rescue Angioplasty
REMEDIAL Renal Insufficiency Following Contrast Media Administration Trial
RENAAL Effects Of Losartan On Renal And Cardiovascular Outcomes In Patients With Type 2 Diabetes And Nephropathy
RENEWAL - RECOVER Research Into Etanercept Cytokine Antagonism In Ventricular Dysfunction
RENEWAL - RENAISSANCE Randomized Etanercept North American Strategy To Study Antagonism Of Cytokines
REPAIR-AMI Reinfusion Of Enriched Progenitor Cells And Infarct Remodeling In Acute Myocardial Infarction
REPLACE 2 Randomized Evaluation Of Pci Linking Angiomax To Reduced Clinical Events
RESCUE Randomized Evaluation Of Salvage Angioplasty With Combined Utilization Of Endpoints
RESEARCH Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital Registry
RESIST Impact Of Intravascular Ultrasound Guidance In Stent Deployment On 6-Month Restenosis Rate: A Multicenter, Randomized Study Comparing Two Strategies--With And Without Intravascular Ultrasound Guidance
RESOLVD Randomized Evaluation Of Strategies For Left Ventricular Dysfunction Pilot
REST Restenosis Stent Trial
Restenosis Stent Coronary-Artery Stenting Compared With Balloon Angioplasty For Restenosis After Initial Balloon Angioplasty
RESTORE Randomized Efficacy Study Of Tirofiban For Outcome And Restenosis
RethinQ Resynchronization Therapy In Patients With Narrow Qrs
REVERSAL Reversing Atherosclerosis With Aggressive Lipid Lowering
REVERSE Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction
REVERT Reversal Of Ventricular Remodeling With Toprol-Xl
REVIVAL-3 The Regeneration Of Vital Myocardium In St-Segment Elevation Myocardial Infarction By Erythropoietin
RHYTHM II ICD Resynchronization For The Hemodynamic Treatment For Heart Failure Management II Implantable Cardioverter Defibrillator
RIO-Europe A Randomized Double-Blind Study Of Weight Reducing Effect And Safety Of Rimonabant In Obese Patients With Or Without Comorbidities
RIO-Lipids Rimonabant In Obesity
RIO-NA Rimonabant On Weight Reduction And Weight Maintenance: Rio-North America
RIS Efficacy Of Multiple Risk Factor Intervention In Treated Hypertensive Men
RISC Research On Instability In Coronary Artery Disease
RITA Randomized Intervention Treatment Of Angina Trial
RITA II The Second Randomized Intervention Treatment Of Angina
RITA-3 Randomized Trial Of A Conservative Treatment Strategy Versus An Interventional Treatment Strategy In Patients With Unstable Angina
RITZ 2 Randomized Intravenous Tezosentan For The Treatment Of Acute Heart Failure
RITZ-4 Randomized Intravenous Tezosentan Study
RIVIERA Registry Registry On Intra-Venous Anticoagulation In The Elective And Primary Real World Of Angioplasty
ROADMAP Randomized Olmesartan And Diabetes Microalbuminuria Prevention Trial
ROBUST Recanalization Of Chronically Occluded Aorto-Coronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion Of Urokinase Trial
ROMAS Romanian Multicenter Study - Accelerated Streptokinase In Acute Myocardial Infarction
ROSTER Randomized Trial Of Rotational Atherectomy Versus Balloon Angioplasty For Diffuse In-Stent Restenosis
ROXIS Roxithromycin In Non-Q Wave Coronary Syndromes
RSVP Radial Artery Versus Saphenous Vein Patency
RUSSLAN Safety And Efficacy Of A Novel Calcium Sensitizer, Levosimendan, In Patients With Left Ventricular Failure Due To An Acute Myocardial Infarction
RUTH Raloxifene Use For The Heart
SADHART Sertraline Treatment Of Major Depression In Patients With Acute Mi Or Unstable Angina
SAFE Safety After Fifty Evaluation
SAFER The Saphenous Vein Graft Angioplasty Free Of Emboli Randomized Trial
SAFE-T Sotalol Amiodarone Atrial Fibrillation Efficacy Trial
SAGE Study Assessing Goals In The Elderly
SALT Swedish Aspirin Low-Dose Trial
SALT 1 and 2 Study Of Ascending Levels Of Tolvaptan In Hyponatremia
SALTIRE Scottish Aortic Stenosis And Lipid Lowering Trial
SANDS Stop Atherosclerosis In Native Diabetics Study
SAPAT Double-Blind Trial Of Aspirin In Primary Prevention Of Myocardial Infarction In Patients With Stable Chronic Angina Pectoris
SAPPHIRE Stenting And Angioplasty With Protection In Patients At High Risk For Endarterectomy
SARECCO Stent Or Angioplasty After Recanalization Of Chronic Coronary Occlusions Trial
SAVE Survival And Ventricular Enlargement Trial
SAVE PACe Search Av Extension And Managed Ventricular Pacing For Promoting Atrioventricular Conduction
SAVED Saphenous Vein De Novo
SCANDSTENT Stenting Of Coronary Arteries In Non Stress/Benestent Disease Trial
SCAT Long-Term Effects Of Cholesterol Lowering And Angiotension-Converting Enzyme Inhibition On Coronary Atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (Scat).
SCD-HeFT Sudden Cardiac Death In Heart Failure Trial
SCOR University Of California, San Francisco, Arteriosclerosis Specialized Center Of Research (Scor) Intervention Trial
SCORE Study To Compare Restenosis Rate Between Quest And Quadds-Qp2
SCRIP Study Of Cardiovascular Risk Intervention By Pharmacists
SCRIPPS Scripps Coronary Radiation To Inhibit Proliferation Post Stenting
SCRIPPS II Scripps Coronary Radiation To Inhibit Proliferation Post Stenting II
SCRIPPS III Scripps Coronary Radiation To Inhibit Proliferation Post Stenting III
SCRIPPS IV Scripps Coronary Radiation To Inhibit Proliferation Post Stenting Iv
SEARCH Study Of The Effectiveness Of Additional Reductions In Cholesterol And Homocysteine
SEAS Simvastatin And Ezetimibe In Aortic Stenosis
SECURE Study To Evaluate Carotid Ultrasound Changes In Patients Treated With Ramipril And Vitamin E
SEEDS Syncope Evaluation In The Emergency Department Study
SEISMIC Safety And Effects Of Implanted (Autologous) Skeletal Myoblasts (Myocell) Using An Injection Catheter
SENIOR PAMI Senior Primary Angioplasty In Myocardial Infarction Study
SENIORS Study Of Effects Of Nebivolol Intervention On Outcomes And Rehospitalisation In Seniors With Heart Failure
SESAIR Randomised Comparison Of Subcutaneous Heparin, Intravenous Heparin, And Aspirin In Unstable Angina
SESAMI Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction
SES-SMART Sirolimus-Eluting Stent And A Standard Stent In The Prevention Of Restenosis In Small Coronary Arteries
SHARP The Subcutaneous Heparin And Angioplasty Restenosis Prevention (Sharp) Trial. Results Of A Multicentre Randomized Trial Investigating The Effects Of High Dose Unfractionated Heparin On Angiographic Restenosis And Clinical Outcome
SHEP Systolic Hypertension In Elderly Program
SHIELD Shock Inhibition Evaluation With Azimilide
SHOCK Should We Emergently Revascularize Occluded Coronaries For Cardiogenic Shock?
SIAM Comparison Of Invasive And Conservative Strategies After Treatment With Streptokinase In Acute Myocardial Infarction
SIAM III Southwest German Interventional Study In Acute Myocardial Infarction
SICCO Stenting In Chronic Coronary Occlusion
SIMPADICO Study Of Immune Modulation Therapy In Patients With Symptomatic Peripheral Arterial Disease
SIPS Ultrasound-Guided Stratification For Provisional Stenting With Focal Balloon Combination Catheter. Results From The Randomized Strategy For Intracoronary Ultrasound-Guided Ptca And Stenting (Sips) Trial
SIRIUS Sirolimus-Eluting Stent In Coronary Lesions
SIRIUS-2 Safety And Efficacy Of An Intravenous Placebo-Controlled Randomized Infusion Of Ularitide
SIRTAX Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization
SISR Sirolimus-Eluting Stent Vs. Brachytherapy In Patients With Bare Metal In-Stent Restenosis
SLIP Lipid Profile During Antihypertensive Treatment
SMART Surgical Management Of Arterial Revascularization Therapies
SMART Sirolimus-Eluting Stents For The Treatment Of Obstructive Superficial Femoral Artery Disease
SMARTT A Randomized Trial Of The Effects Of Early Cardiac Serum Marker Availability On Reperfusion Therapy In Patients With Acute Myocardial Infarction. The Serial Markers, Acute Myocardial Infarction And Rapid Treatment Trial (Smartt)
SMASH-VT Substrate Mapping And Ablation In Sinus Rhythm To Halt Ventricular Tachycardia
SMILE The Effects Of The Angiotensin-Converting-Enzyme Inhibitor Zofenopril On Mortality And Morbidity After Anterior Myocardial Infarction
SMT Stockholm Metoprolol Trial
SOFA Study On Omega-3 Fatty Acids And Ventricular Arrhythmia
SOLVD-Treatment The Effects Of Enalapril On Survival In Patients With Reduced Left Ventricular Ejection Fractions And Congestive Heart Failure (Treatment Trial)
SORT OUT II Comparison Of Paclitaxel- And Sirolimus-Eluting Stents In Everyday Clinical Practice
SoS Coronary Artery Bypass Surgery Vs. Percutaneous Coronary Intervention With Stent Implantation In Patients With Multivessel Coronary Disease (The Stent Or Surgery Trial)
SPACE Secondary Prevention With Antioxidants Of Cardiovascular Disease In End-Stage Renal Disease (Space): Randomized Placebo-Controlled Trial
SPAF Stroke Prevention In Atrial Fibrillation Study
SPAN CHF Specialized Primary And Networked Care In Heart Failure
SPARCL Stroke Prevention By Aggressive Reduction In Cholesterol Levels
SPIC Long-Term Survival Effect Of Metoprolol In Dilated Cardiomyopathy
SPICE Study Of Patients Intolerant Of Converting Enzyme Inhibitors
SPICE – Presented at ACC 2007 Survival And Prognosis: Investigation Of Crataegus Extract Ws 1442 In Chf
SPINAF Stroke Prevention In Nonrheumatic Atrial Fibrillation
SPIRIT A Randomized Trial Of Anticoagulants Versus Aspirin After Cerebral Ischemia Of Presumed Arterial Origin
SPORTIF II Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
SPORTIF III Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
SPORTIF V Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
SPRINT Secondary Prevention Reinfarction Israeli Nifedipine Trial
SSSD Spanish Study On Sudden Death
STAF Strategies Of Treatment Of Atrial Fibrillation
STAI Antiplatelet Treatment With Ticlopidine In Unstable Angina (Studio Della Ticlopidine Nell'Angina Instabile)
STAMI Ticlopidine Versus Aspirin After Myocardial Infarction (Stami) Trial
STAMINA Effect Of Treatment For Chlamydia Pneumoniae And Helicobacter Pylori On Markers Of Inflammation And Cardiac Events In Patients With Acute Coronary Syndromes
STAMINA South Thames Trial Of Antibiotics In Myocardial Infarction And Unstable Angina Pectoris
STAR A Randomized Trial Of Recombinant Staphylokinase Versus Altepase For Coronary Artery Patency In Acute Myocardial Infarction
STARC Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study
STARS-Antithrombotic Stent Antithrombotic Regimen Study
STARS-Atherosclerosis St. Thomas Atherosclerosis Regression Study
START Sr90 Treatment Of Angiographic Restenosis
STAT Stenting Vs. Thrombolysis In Acute Myocardial Infarction Trial (Stat)
STEEPLE Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation
STEMMI Stem Cells In Myocardial Infarction
STENT PAMI Stent Primary Angioplasty In Mi
STENTIM-2 Immediate Coronary Angioplasty With Elective Wiktor Stent Implantation Compared With Conventional Balloon Angioplasty In Acute Myocardial Infarction
STEP Study Of The Therapeutic Effects Of Intercessory Prayer
STICH Surgical Treatments For Ischemic Heart Failure Hypothesis 2
STIMS Prevention Of Myocardial Infarction And Stroke In Patients With Intermittent Claudication
STING Stents In Grafts
STONE Shanghai Trial Of Nifedipine In The Elderly
STOP-AMI 1 Stent Versus Thrombolysis For Occluded Coronary Arteries In Patients With Acute Myocardial Infarction 1
STOP-HTN Swedish Trial In Old Patients With Hypertension
STOP-NIDDM Study To Prevent Noninsulin Dependent Diabetes Mellitus Trial
STRATAS Study To Determine Rotablator And Transluminal Angioplasty Strategy
STRATEGY Single High-Dose Bolus Tirofiban And Sirolimus-Eluting Stent Vs. Abciximab And Bare-Metal Stent In Myocardial Infarction
STRATUS-US Smoking Cessation In Smokers Motivated To Quit
STRESS I Stent Restenosis Study I
SURVIVE Survival Of Patients With Acute Heart Failure In Need Of Intravenous Inotropic Support
SUTAMI Double-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group
SWEDES Swedish Early Decision Trial
SWIFT Should We Intervene Following Thrombolysis?
SWISH Swedish Isradipine Study In Hypertension
SWISSI II Swiss Interventional Study On Silent Ischemia Type II
SWITCH Switching From Lovenox To Angiomax In Patients With Acute Coronary Syndromes Without St Elevation Undergoing Pci
SWORD Survival With Oral D-Sotalol Trial
SYMBIOT III A Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
SYMPHONY I Sibrafiban Versus Aspirin To Yield Maximum Protection From Ischemic Heart Events Post-Acute Coronary Syndromes
SYMPHONY II Randomized Trial Of Aspirin, Sibrafiban, Or Both For Secondary Prevention After Acute Coronary Syndromes
SYNERGY Superior Yield Of The New Strategy Of Enoxaparin, Revascularization, And Glycoprotein IIb/IIia Inhibitors
SYNERGY-PCI A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
SYNTAX Synergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery
Syst-China Systolic Hypertension In China Trial
Syst-Eur For The Syst-Eur Investigators. The Prevention Of Dementia With Antihypertensive Treatment. New Evidence From The Systolic Hypertension In Europe (Syst-Eur) Study
TACT Therapeutic Angiogenesis For Patients With Limb Ischaemia By Autologous Transplantation Of Bone-Marrow Cells:A Pilot Study And A Randomized Controlled Trial.
TACTICS-TIMI 18 Treat Angina With Aggrastat And Determine Cost Of Therapy With An Invasive Or Conservative Strategy
TAIM Trial Of Antihypertensive Interventions And Management
TAIST Tinzaparin In Acute Ischaemic Stroke Trial
TALISMAN Therapeutic Angiogenesis With Intramuscular Nv1Fgf In Patients With Critical Limb Ischemia
TAMI-5 Thrombolysis And Angioplasty In Myocardial Infarction - Phase V
TAPAS Thrombus Aspiration During Percutaneous Coronary Intervention In Acute Myocardial Infarction
TAPS The Rt-Pa-Apsac Patency Study
TARGET Comparison Of Two Platelet Glycoprotein IIb/IIia Inhibitors, Tirofiban And Abciximab, For The Prevention Of Ischemic Events With Percutaneous Coronary Revascularization
TAUSA Thrombolysis And Angioplasty In Unstable Angina
TAXi Paclitaxel And Sirolimus Stents In The Real World Of Interventional Cardiology
TAXUS III In-Stent Restenosis Treated With Stent-Based Delivery Of Paclitaxel Incorporated In A Slow-Release Polymer Formulation
TAXUS V ISR Paclitaxel-Eluting Stents Vs. Brachytherapy For In-Stent Restenosis
TEAHAT Very Early Thrombolytic Therapy In Suspected Acute Myocardial Infarction
TEAM-2 Multicenter Patency Trial Of Intravenous Antistreplase Compared With Streptokinase In Acute Myocardial Infarction
TEAM-3 Third Thrombolysis Trial Of Anistreplase (Eminase) In Acute Myocardial Infarction
TEN-HMS Telemonitoring For Heart Failure: Patient Characteristics And First Results
TETAMI Treatment Of Enoxaparin And Tirofiban In Acute Myocardial Infarction
THESEE A Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism
THINRS The Home Inr Study
THOP Treatment Of Hypertension Based On Home Or Office Blood Pressure
THRIVE Thrombin Inhibitor In Venous Thromboembolism
Thrombectomy in STEMI Thrombectomy In St Elevation Myocardial Infarction
THUNDER Taxan With Short Time For Contact For Reduction Of Restenosis In Distal Arteries
TIBBS Total Ischemic Burden Bisoprolol Study
TIBET Total Ischemic Burden European Trial
TIGER-PA Tirofiban Given In The Emergency Room Before Primary Angioplasty
TIM Triflusal In Myocardial Infarction
TIMACS Timing Of Intervention In Patients With Acute Coronary Syndromes
TIMBER Transthoracic Incremental Monophasic Versus Biphasic Defibrillation By Emergency Responders
TIME Trial Of Invasive Versus Medical Therapy In The Elderly
TIME-CHF Trial Of Intensified Vs Standard Medical Therapy In Elderly Patients With Congestive Heart Failure
TIMI 1 Thrombolysis In Myocardial Infarction Trial, Phase I
TIMI 10B Tnk-Tissue Plasminogen Activator Compared With Front-Loaded Tissue Plasminogen Activator In Acute Myocardial Infarction
TIMI 11B Thrombolysis In Myocardial Ischemia Trial, Phase 11B
TIMI 16-OPUS Orbofiban In Patients With Unstable Coronary Syndromes, Thrombolysis In Myocardial Infarction
TIMIC Efficacy Of Immunosuppressive Therapy In Patients With Virus-Negative Inflammatory Cardiomyopathy
TITAN - TIMI 34 Time To Integrilin Therapy In Acute Myocardial Infarction
TITAX AMI Titanium Nitride Oxide Coated Stents And Paclitaxel Eluting Stents For Acute Myocardial Infarction
TMLR Transmyocardial Laser Revascularization In Patients With Refractory Angina: A Randomised
TMR Revascularization With Co2 Laser In Patients With Refractory Angina Pectoris: Clinical Results From The Norwegian Randomized Trial
TNT Treating To New Targets Study
TOAT The Occluded Artery Trial
TOHP II Effects Of Weight Loss And Sodium Reduction Intervention On Blood Pressure And Hypertension Incidence In Overweight People With High-Normal Blood Pressure: The Trials Of Hypertension Prevention, Phase II
TOMHS Treatment Of Mild Hypertension Study
TOMIIS Total Occlusion Post-Myocardial Infarction Intervention Study
TONE Sodium Reduction And Weight Loss In The Treatment Of Hypertension In Older Persons: A Randomized Controlled Trial Of Nonpharmacologic Interventions In The Elderly
TOPAS A Comparison Of Recombinant Urokinase With Vascular Surgery As Initial Treatment For Acute Arterial Occlusion Of The Legs
TOSCA Total Occlusion Study Of Canada
TOTAL Total Occlusion Trial With Angioplasty By Using Laser Guidewire
TPT Thrombosis Prevention Trial
TRACE The Trandolapril Cardiac Evaluation Trace Study
TRAFFIC Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 For Intermittent Claudication (The Traffic Study)
TRANSCEND Telmisartan Randomised Assessment Study In Ace Intolerant Subjects With Cardiovascular Disease
TRANSFER-AMI Trial Of Routine Angioplasty And Stenting After Fibrinolysis To Enhance Reperfusion In Acute Myocardial Infarction
TRAPIST Trapidil In Stent
TREND Trial On Reversing Endothelial Dysfunction
TRENDS Tetra Randomized European Direct Stenting Study
TRENT Trial Of Early Nifedipine Treatment In Acute Myocardial Infarction
TRIC Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator During Instability In Coronary Artery Disease: Effect On Myocardial Ischemia And Need For Coronary Revascularization
TRIP-HF Triple Resynchronization In Paced Heart Failure Patients
TRITON-TIMI 38 Trial To Assess Improvement In Therapeutic Outcomes By Optimizing Platelet Inhibition With Prasugrel
TRIUMPH Tilarginine Acetate Injection In A Randomized International Study In Unstable Mi Patients With Cardiogenic Shock
TROICA Thrombolysis In Cardiac Arrest
TROPHY Trial Of Preventing Hypertension
TWA in CHF T Wave Alternans In Congestive Heart Failure
TYPHOON Trial To Assess The Use Of The Cypher Stent In Acute Myocardial Infarction Treated With Angioplasty
UKPACE United Kingdom Pacing And Cardiovascular Events
UKPDS United Kingdom Prospective Diabetes Study
UK-TIA The United Kingdom Transient Ischemic Attack Aspirin Trial: Final Results
UNASEM Thrombolysis In Patients With Unstable Angina Improves The Angiographic But Not The Clinical Outcome
UNLOAD Ultrafiltration Versus Intravenous Diuretics For Patients Hospitalized For Acute Decompensated Heart Failure
USIM Urochinasi Per Via Sistemica Nell'Infarto Miocardico
VA-CABG Veterans Affairs (Va) Coronary Artery Bypass Surgery Cooperative Study Group
VADT Veterans Affairs Diabetes Trial
VA-HIT Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial
Val-HeFT Valsartan Heart Failuretrial
VALIANT Valsartan In Acute Myocardial Infarction Trial Investigators
VALIDD Valsartan In Diastolic Dysfunction
VALUE Valsartan Antihypertensive Long-Term Use Evaluation
VANQWISH Veterans Affairs (Va) Non-Q-Wave Infarction Strategies In-Hospital
VASIS Vasovagal Syncope International Study
VASP-02 Vasodilator-Stimulated Phosphoprotein-02
VEAPS Vitamin E Atherosclerosis Prevention Study
VEGAS I The Vein Graft Angiojet Study I Pilot Trial
VEGAS-2 Vein Graft Angiojet Study 2
VENUS Very Early Nimodipine Use In Stroke
VERBS Ventricular Endocardial Right Bifocal Stimulation In The Treatment Of Severe Dilated Cardiomyopathy Heart Failure With Wide Qrs
VERDICT Verapamil Versus Digoxin And Acute Versus Routine Serial Cardioversion Trial
VERITAS Value Of Endothelin Receptor Inhibition With Tezosentan In Acute Heart Failure Studies
VEST Vesnarinone Survival Trial
VHAS Clinical Results Of The Verapamil In Hypertension And Atherosclerosis Study
VHEFT-I The Effects Of Vasodilator Therapy On Mortality In Chronic Congestive Heart Failure
VHEFT-II Efficacy And Outcome With Felodipine In Heart Failure
VIAMI Viability-Guided Angioplasty After Acute Myocardial Infarction
VICTOR Vioxx In Colorectal Cancer Therapy: Definition Of Optimal Regimen
VINTAGE-MI Vascular Interaction With Age In Myocardial Infarction
VITAL Vasoflux International Trial For Acute Myocardial Infarction Lysis
VIVA Vascular Endothelial Growth Factor In Ischemia For Vascular Angiogenesis
VMAC Vasodilation In The Management Of Acute Congestive Heart Failure
VPS The North American Vasovagal Pacemaker Study
VPS II Vasovagal Pacemaker Study II
WAFACS Women's Antioxidant And Folic Acid Cardiovascular Study
WARIS-II Warfarin, Aspirin, Or Both After Myocardial Infarction
WARSS Warfarin–Aspirin Recurrent Stroke Stud
WATCH Warfarin And Antiplatelet Trial In Chronic Heart Failure
WAVE Warfarin Antiplatelet Vascular Evaluation
WAVE Women's Angiographic Vitamin And Estrogen Trial
WELL-HART Women’s Estrogen–Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial
WENBIT Western Norway B-Vitamin Intervention Trial
WEST Which Early St-Elevation Myocardial Infarction Therapy
WHI Women's Health Initiative
WINS Women's Initiative For Nonsmoking
WISE Women's Ischemia Syndrome Evaluation
WITTI Women Secondary Prevention Beyond Walls Intervention Trial In Women
WIZARD Weekly Intervention With Zithromax For Atherosclerosis And Its Related Disorders
WRIST Washington Radiation For In-Stent Restenosis Trial
ZEST-AMI Zotarolimus-Eluting Stent Vs. Sirolimus-Eluting Stent Vs. Paclitaxel-Eluting Stent For Acute Myocardial Infarction Patients

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Acronyms_of_Clinical_Trial_Names&oldid=667675"